Cayman Islands* |
6770 |
N/A | ||
(State or other jurisdiction of incorporation or organization) |
(Primary Standard Industrial Classification Code Number) |
(I.R.S. Employer Identification No.) |
Josh Bayliss Chief Executive Officer |
Evan Lovell Chief Financial Officer |
Derek J. Dostal Lee Hochbaum Davis Polk & Wardwell LLP 450 Lexington Avenue New York, New York 10017 Tel: (212) 450-4000 |
Martin A. Wellington Joshua G. DuClos Sara Garcia Duran Sidley Austin LLP 1001 Page Mill Road, Building 1 Palo Alto, California 94304 Tel: (650) 565-7000 |
Large accelerated filer |
☐ |
Accelerated filer |
☐ | |||
☒ |
Smaller reporting company |
|||||
Emerging growth company |
| ||||||||
Title of Each Class of Securities to be Registered |
Amount to be Registered(6) |
Proposed Maximum Offering Price Per Share |
Proposed Maximum Aggregate Offering Price |
Amount of Registration Fee | ||||
New Grove Class A Common Stock(1) |
50,312,500 |
$9.88(7) |
$497,087,500.00 |
$46,080.01(10) | ||||
Warrants to purchase New Grove Class A Common Stock(2) |
14,750,000 |
$0.74(9) |
$10,915,000.00 |
$1,011.82(10) | ||||
New Grove Class A Common Stock(3) |
14,750,000 |
$11.50(8) |
$169,625,000.00 |
$15,724.24(10) | ||||
New Grove Class B Common Stock(4) |
174,073,129 |
$9.88(9) |
$1,719,842,514.52 |
$159,429.40(10) | ||||
New Grove Class A Common Stock(5) |
174,073,129 |
— | ||||||
Total |
$222,245.47 | |||||||
| ||||||||
|
(1) |
Based on the maximum number of shares of Class A common stock, par value $0.0001 per share, of New Grove (as defined below) (the “ New Grove Class A Common Stock ”) to be issued in connection with the Domestication (as defined below). This number is based on shares of New Grove Class A Common Stock to be issued in respect of (A) 40,250,000 Class A ordinary shares underlying units issued in VGAC II’s initial public offering and (B) 10,062,500 Class B ordinary shares held by VG Acquisition Sponsor II LLC. |
(2) |
The number of warrants to acquire shares of New Grove Class A Common Stock being registered represents (i) 8,050,000 warrants to purchase Class A ordinary shares underlying units issued in VGAC II’s initial public offering (“ public warrants ”) and (ii) 6,700,000 warrants to purchase Class A ordinary shares issued to VG Acquisition Sponsor II LLC in a private placement simultaneously with the closing of VGAC II’s initial public offering (“private placement warrants ” and, together with the public warrants, the “warrants ”). The warrants will convert into warrants to acquire shares of New Grove Class A Common Stock in the Domestication (as defined below). |
(3) |
The number of shares of New Grove Class A Common Stock to be issued upon the exercise of (i) 8,050,000 public warrants and (ii) 6,700,000 private warrants. |
(4) |
Based on the maximum number of shares of Class B common stock, par value $0.0001 per share, of New Grove (the “ New Grove Class B Common Stock ”) to be issued in connection with the business combination described herein (the “Business Combination ”). This number includes (a) shares of New Grove Class B Common Stock to be issued in connection with the Merger (as defined below), (b) the product of (i) shares of Grove Collaborative capital stock reserved for issuance as of [●] under Grove’s 2016 Equity Incentive Plan (as defined below) and that may be issued after such date pursuant to the terms of the Merger Agreement (as defined below) and (ii) the Exchange Ratio (as defined below), and (c) the product of (i) shares of Grove Collaborative capital stock that may be reserved for issuance under Grove’s 2016 Equity Incentive Plan and that may be issued after such date pursuant to the terms of the Merger Agreement and (ii) the Exchange Ratio. |
(5) |
Represents shares of New Grove Class A Common Stock issuable upon conversion (on a one-for-one |
(6) |
Pursuant to Rule 416(a) of the Securities Act of 1933, as amended (the “ Securities Act ”), there are also being registered an indeterminable number of additional securities as may be issued to prevent dilution resulting from stock splits, stock dividends, or similar transactions. |
(7) |
Estimated solely for the purpose of calculating the registration fee, based on the average of the high and low prices of the Class A ordinary shares of VGAC II on the New York Stock Exchange (“ NYSE ”) on January 11, 2022 ($9.88 per Class A ordinary share). This calculation is in accordance with Rule 457(f)(1) of the Securities Act. |
(8) |
Represents the exercise price of the public warrants and private warrants. |
(9) |
Estimated solely for the purpose of calculating the registration fee, based on the average of the high and low prices of the VGAC II public warrants on the NYSE on January 13, 2022 ($0.74 per warrant). This calculation is in accordance with Rule 457(f)(1) of the Securities Act. |
(10) |
Determined in accordance with Section 6(b) of the Securities Act at a rate equal to $92.70 per $1,000,000 of the proposed maximum aggregate offering price. |
* |
At least one day prior to the consummation of the Business Combination, Virgin Group Acquisition Corp. II, a Cayman Islands exempted company (“ VGAC II ”), intends to effect a deregistration and a transfer by way of continuation to Delaware pursuant to Part XII of the Companies Act (As Revised) of the Cayman Islands and Section 388 of the Delaware General Corporation Law, pursuant to which VGAC II’s jurisdiction of incorporation will be changed from the Cayman Islands to the State of Delaware (the “Domestication ”). All securities being registered will be issued by the continuing entity following the Domestication, which will be renamed “Grove Collaborative Holdings, Inc.” upon the consummation of the Domestication. As used herein, “New Grove ” refers to VGAC II after giving effect to the Domestication. |
(a) | At least one day prior to the Closing Date, VGAC II will change its jurisdiction of incorporation by deregistering as a Cayman Islands exempted company and continuing and domesticating as a public benefit corporation incorporated under the laws of the State of Delaware (the “ Domestication ”), upon which VGAC II will change its name to “Grove Collaborative Holdings, Inc.” (“New Grove ”) (for further details, see “Proposal No. 2—The Domestication Proposal |
(b) | On the Closing Date, VGAC II Merger Sub will merge with and into Grove (the “ Merger ”), with Grove as the surviving company and, after giving effect to such Merger, Grove shall be a wholly owned direct subsidiary of New Grove. In accordance with the terms and subject to the conditions of the Merger Agreement, at the time at which the Merger becomes effective (the “Effective Time ”), based on an implied equity value of $1.4 billion: (a) each share of Grove common stock and preferred stock (on an |
as-converted to common stock basis) (other than dissenting shares) will be canceled and converted into the right to receive (i) a number of shares of New Grove Class B common stock, par value $0.0001 per share, of New Grove (the “New Grove Class B Common Stock ”), as determined pursuant to an exchange ratio set forth in the Merger Agreement (the “Exchange Ratio ”) and (ii) a number of restricted shares of New Grove Class B Common Stock that will vest upon the achievement of certain earnout thresholds prior to the tenth anniversary of the Closing, as more fully described in the accompanying proxy statement/consent solicitation statement/prospectus (such shares, the “Grove Earnout Shares ”); (b) each outstanding option to purchase Grove common stock (whether vested or unvested) will be assumed by New Grove and converted into (i) comparable options that are exercisable for shares of New Grove Class B Common Stock, with a value determined in accordance with the Exchange Ratio (and, with regard to options that are intended to qualify as “incentive stock options” under Section 422 of the Code, in a manner compliant with Section 424(a) of the Code) and (ii) the right to receive a number of Grove Earnout Shares; (c) each award of restricted stock units to acquire Grove common stock (collectively, “Grove RSUs ”) will be assumed by New Grove and converted into (i) a comparable award of restricted stock units to acquire shares of New Grove Class B Common Stock and (ii) the right to receive a number of Grove Earnout Shares; and (d) each warrant to acquire shares of Grove common stock or Grove preferred stock will be assumed by New Grove and converted into (i) a comparable warrant to acquire shares of New Grove Class B Common Stock and (ii) the right to receive a number of Grove Earnout Shares. The implied equity value of $1.4 billion includes the value of the options exercisable for shares of New Grove Class B Common Stock that are issued and outstanding in respect of options (whether vested or unvested) to purchase Grove common stock but excludes the value of the options exercisable for shares of New Grove Class B Common Stock that are issued and outstanding in respect of options to purchase Grove common stock granted since January 1, 2021 under Grove’s 2016 Equity Incentive Plan that have not yet vested as of immediately prior to the Closing (the “Company Unvested 2021 Options ”). |
Sincerely, |
|
Josh Bayliss |
Chief Executive Officer and Director |
• | Proposal No. 1—The Business Combination Proposal—RESOLVED Merger Agreement ”), by and among VGAC II, Treehouse Merger Sub, Inc., a Delaware corporation and wholly owned direct subsidiary of VGAC II (“VGAC II Merger Sub ”), and Grove Collaborative, Inc., a Delaware corporation (“Grove ”), a copy of which is attached to the proxy statement/consent solicitation statement/prospectus as Annex A, be approved, pursuant to which, among other things, at least one day following the de-registration of VGAC II as an exempted company in the Cayman Islands and the continuation and domestication of VGAC II as a public benefit corporation in the State of Delaware with the name “Grove Collaborative Holdings, Inc., ” (a) VGAC II Merger Sub will merge with and into Grove (the “Merger ”), with Grove as the surviving company in the Merger and, after giving effect to such Merger, Grove shall be a wholly owned direct subsidiary of New Grove, and (b) in accordance with the terms and subject to the conditions of the Merger Agreement, at the time at which the Merger becomes effective (the “Effective Time ”), based on an implied equity value of $1.4 billion: (a) each share of Grove common stock and preferred stock (on an as-converted to common stock basis) (other than dissenting shares) will be canceled and converted into the right to receive (i) a number of shares of New Grove Class B common stock, par value $0.0001 per share, of New Grove (the “New Grove Class B Common Stock ”), as determined pursuant to an exchange ratio set forth in the Merger Agreement (the “Exchange Ratio ”) and (ii) a number of restricted shares of New Grove Class B Common Stock that will vest upon the achievement of certain earnout thresholds prior to the tenth anniversary of the Closing, as more fully described in the accompanying proxy statement/consent solicitation statement/prospectus (such shares, the “Grove Earnout Shares ”); (b) each outstanding option to purchase Grove common stock (whether vested or unvested) will be assumed by New Grove and converted into (i) comparable options that are exercisable for shares of New Grove Class B Common Stock, with a value determined in accordance with the Exchange Ratio (and, with regard to options that are intended to qualify as “incentive stock options” under Section 422 of the Code, in a manner compliant with Section 424(a) of the Code) and (ii) the right to receive a number of Grove Earnout Shares; (c) each award of restricted stock units to acquire Grove common stock (collectively, “Grove RSUs ”) will be assumed by New Grove and converted into (i) a comparable award of restricted stock units to acquire shares of New Grove Class B Common Stock and (ii) the right to receive a |
number of Grove Earnout Shares; and (d) each warrant to acquire shares of Grove common stock or Grove preferred stock will be assumed by New Grove and converted into (i) a comparable warrant to acquire shares of New Grove Class B Common Stock and (ii) the right to receive a number of Grove Earnout Shares. The implied equity value of $1.4 billion includes the value of the options exercisable for shares of New Grove Class B Common Stock that are issued and outstanding in respect of options (whether vested or unvested) to purchase Grove common stock but excludes the value of the options exercisable for shares of New Grove Class B Common Stock that are issued and outstanding in respect of options to purchase Grove common stock granted since January 1, 2021 under Grove’s 2016 Equity Incentive Plan that have not yet vested as of immediately prior to the Closing (the “ Company Unvested 2021 Options ”). |
• | Proposal No. 2—The Domestication Proposal—RESOLVED DGCL ”) and, immediately upon being de-registered in the Cayman Islands, VGAC II be continued and domesticated as a public benefit corporation under the laws of the State of Delaware and, conditioned upon, and with effect from, the registration of VGAC II as a corporation in the State of Delaware, the name of VGAC II be changed from “Virgin Group Acquisition Corp. II” to “Grove Collaborative Holdings, Inc.” and the registered office of the Company be changed to 3500 South DuPont Highway, City of Dover, County of Kent, Delaware, be approved. |
• | Proposal No. 3—Charter Amendment Proposal—RESOLVED Existing Governing Documents ”) be amended and restated by the deletion in their entirety and the substitution in their place of the proposed new certificate of incorporation, a copy of which is attached to the proxy statement/consent solicitation statement/prospectus as Annex C (the “Proposed Certificate of Incorporation ”) and the proposed new bylaws, a copy of which is attached to the proxy statement/consent solicitation statement/prospectus as Annex D (the “Proposed Bylaws ”) of “Grove Collaborative Holdings, Inc.” upon the Domestication, be approved as the certificate of incorporation and bylaws, respectively, of Grove Collaborative Holdings, Inc., effective upon the effectiveness of the Domestication. |
• | Governing Documents Proposals non-binding, advisory resolutions to approve certain features of the Proposed Certificate of Incorporation and Proposed Bylaws (such proposals, collectively, the “Governing Documents Proposals ”): |
• | Proposal No. 4—Governing Documents Proposal A—RESOLVED non-binding, advisory resolution, that the change in the authorized share capital of VGAC II from (i) US$22,100 divided into 200,000,000 Class A ordinary shares, par value $0.0001 per share, (ii) 20,000,000 Class B ordinary shares, par value $0.0001 per share, and (iii) 1,000,000 preference shares, par value $0.0001 per share, to (a) 600,000,000 shares of New Grove Class A Common Stock, (b) 200,000,000 shares of New Grove Class B Common Stock, and (c) 100,000,000 shares of preferred stock, par value $0.0001 per share, of New Grove (the “New Grove Preferred Stock ”) be approved. |
• | Proposal No. 5—Governing Documents Proposal B—RESOLVED non-binding, advisory resolution, that the amendment and restatement of the Existing Governing Documents be approved and that all other immaterial changes necessary or, as mutually agreed in good faith by VGAC II and Grove, desirable in connection with the replacement of the Existing Governing Documents with the Proposed Certificate of Incorporation and Proposed Bylaws as part of the Domestication (copies of which are attached to the accompanying proxy statement/consent solicitation statement/prospectus as Annex C and Annex D, respectively), including (i) changing the corporate name from “Virgin Group Acquisition Corp. II” to “Grove Collaborative Holdings, Inc.” (which is expected to occur upon the consummation of the Domestication), (ii) making New Grove’s corporate existence perpetual, (iii) adopting Delaware as the exclusive forum for litigation arising out of the Securities Act of 1933, as amended and (iv) removing certain provisions related to our status as a blank check company that will no longer be applicable upon consummation of the Business Combination be approved. |
• | Proposal No. 6—Governing Documents Proposal C—RESOLVED non-binding, advisory resolution, that the issuance of shares of New Grove Class B Common Stock, which will allow holders of New Grove Class B Common Stock to cast ten votes per share of New Grove Class B Common Stock be approved. |
• | Proposal No. 7—The NYSE Proposal—RESOLVED NYSE ”) Listing Rule 312.03, the issuance of shares of New Grove Class A Common Stock and shares of New Grove Class B Common Stock be approved. |
• | Proposal No. 8—The Incentive Equity Plan Proposal—RESOLVED |
• | Proposal No. 9—The ESPP Proposal—RESOLVED |
• | Proposal No. 10—The Director Election Proposal—RESOLVED |
• | Proposal No. 11—The Adjournment Proposal—RESOLVED Subscription Agreements ”) with certain investors (the “PIPE Investors ”), for aggregate gross proceeds of $87,075,000 (the “PIPE Financing ”), equal no less than $175,000,000 after deducting any amounts paid to VGAC II shareholders that exercise their redemption rights in connection with the Business Combination would not be satisfied, at the extraordinary general meeting be approved. |
(i) | (a) hold public shares, or (b) hold public shares through units and elect to separate your units into the underlying public shares and warrants prior to exercising your redemption rights with respect to the public shares; |
(ii) | submit a written request to Continental Stock Transfer & Trust Company (“ Continental ”), VGAC II’s transfer agent, in which you (a) request that New Grove redeem all or a portion of your public shares for cash, and (b) identify yourself as the beneficial holder of the public shares and provide your legal name, phone number and address; and |
(iii) | deliver your share certificates (if any) and other redemption forms (as applicable) to Continental physically or electronically through The Depository Trust Company. |
iii | ||||
iii | ||||
iv | ||||
viii | ||||
x | ||||
1 | ||||
27 | ||||
75 | ||||
83 | ||||
123 | ||||
127 | ||||
130 | ||||
132 | ||||
136 | ||||
137 | ||||
139 | ||||
148 | ||||
153 | ||||
155 | ||||
157 | ||||
175 | ||||
177 | ||||
192 | ||||
209 | ||||
214 | ||||
247 | ||||
270 | ||||
290 | ||||
293 | ||||
307 | ||||
308 | ||||
309 | ||||
310 |
• | “ Articles of Association ” are to the amended and restated articles of association of VGAC II; |
• | “ Available Cash ” are an amount equal to the sum of, immediately prior to the Closing, (i) the amount of cash available to be released from the trust account (after giving effect to all payments to VGAC II shareholders that exercise their redemption rights in connection with the Business Combination), plus (ii) the net amount of proceeds actually received by VGAC II pursuant to the PIPE Financing. |
• | “ Business Combination ” are to the Merger and other transactions contemplated by the Merger Agreement, other than the Domestication, collectively, including the PIPE Financing; |
• | “ Cayman Islands Companies Act ” are to the Companies Act (As Revised) of the Cayman Islands; |
• | “ Class A ordinary shares ” are to the Class A ordinary shares, par value $0.0001 per share, of VGAC II prior to the Domestication, which will automatically convert, on a one-for-one |
• | “ Class B ordinary shares ” or “founder shares ” are to the 10,062,500 Class B ordinary shares, par value $0.0001 per share, of VGAC II outstanding as of the date of this proxy statement/consent solicitation statement/prospectus that were issued to the Sponsor in a private placement prior to the initial public offering (as defined below), and, in connection with the Domestication, will automatically convert, on a one-for-one |
• | “ Closing ” are to the closing of the Business Combination; |
• | “ Closing Date ” are to that date that is in no event later than the third business day, following the satisfaction (or, to the extent permitted by applicable law, waiver) of the conditions described under the section entitled “Business Combination Proposal—Conditions to Closing of the Business Combination |
• | “ Condition Precedent Proposals ” are to the Business Combination Proposal, the Domestication Proposal, the Charter Amendment Proposal, the NYSE Proposal, the Incentive Equity Plan Proposal, the ESPP Proposal, and the Director Election Proposal, collectively; |
• | “ Continental ” are to Continental Stock Transfer & Trust Company; |
• | “ COVID-19 COVID-19 pandemic(SARS-CoV-2 COVID-19), and any evolutions, mutations, or variations thereof or any other related or associated public health condition, emergency, epidemics, pandemics, or disease outbreaks; |
• | “ Domestication ” are to VGAC II’s domestication, at least one day prior to the Closing, upon the terms and subject to the conditions of the Merger Agreement, as a Delaware corporation in accordance with the DGCL and the Cayman Islands Companies Act; |
• | “ Effective Time ” are to the time at which the Merger becomes effective; |
• | “ ESPP ” are to the Grove Collaborative Holdings, Inc. Employee Stock Purchase Plan to be considered for adoption and approval by VGAC II shareholders pursuant to the ESPP Proposal; |
• | “ Existing Governing Documents ” are to the Memorandum of Association and the Articles of Association; |
• | “ extraordinary general meeting ” are to the extraordinary general meeting of VGAC II to be held at the offices of Davis Polk & Wardwell LLP located at 450 Lexington Avenue, New York, New York 10017 |
and virtually via the Internet at [●], Eastern Time, on [●], 2022, or at such other time, on such other date and at such other place to which the meeting may be adjourned; |
• | “ Governing Documents Proposals ” are to Governing Documents Proposal A, Governing Documents Proposal B, and Governing Documents Proposal C; |
• | “ Grove ” are to Grove Collaborative, Inc., a Delaware corporation, prior to the consummation of the Business Combination; |
• | “ Grove Board ” are to the Board of Directors of Grove; |
• | “ Grove Common Stock ” are to the shares of common stock, par value $0.0001 per share, of Grove; |
• | “ Grove Equityholders ” are to the holders of Grove equity interests; |
• | “ Grove Preferred Stock ” are the shares of (i) Series Seed preferred stock; (ii) Series A preferred stock, par value $0.0001 per share, of Grove, (iii) Series B preferred stock, par value $0.0001 per share, of Grove, (iv) Series C preferred stock, par value $0.0001 per share, of Grove, (v) Series C-1 preferred stock, par value $0.0001 per share, of Grove, (vi) Series D preferred stock, par value $0.0001 per share, of Grove, (vii) Series D-1 preferred stock, par value $0.0001 per share, of Grove, (viii) Series D-2 preferred stock, par value $0.0001 per share, of Grove, and (ix) Series E preferred stock, par value $0.0001 per share, of Grove; |
• | “ Grove Stockholders ” are to holders of Grove Common Stock and Grove Preferred Stock; |
• | “ Incentive Equity Plan ” are to the Grove Collaborative Holdings, Inc. 2022 Incentive Equity Plan to be considered for adoption and approval by VGAC II shareholders pursuant to the Incentive Equity Plan Proposal; |
• | “ initial public offering ” are to VGAC II’s initial public offering that was consummated on March 25, 2021; |
• | “ Memorandum of Association ” are to the amended and restated memorandum of association of VGAC II; |
• | “ Merger ” are to the merger of VGAC II Merger Sub with and into Grove pursuant to the Merger Agreement, with Grove as the surviving company in the Merger and, after giving effect to such Merger, Grove becoming a wholly owned direct subsidiary of New Grove; |
• | “ Merger Agreement ” are to that certain Agreement and Plan of Merger, dated December 7, 2021, by and among VGAC II, VGAC II Merger Sub, and Grove; |
• | “ Minimum Available Cash Condition ” are to the condition that Available Cash shall be greater than or equal to $175,000,000; |
• | “ New Grove ” are to Grove Collaborative Holdings, Inc. (f.k.a. Virgin Group Acquisition Corp. II) upon and after the Domestication; |
• | “ New Grove Board ” are to the board of directors of New Grove; |
• | “ New Grove Class A Common Stock ” are to the shares of Class A common stock, par value $0.0001 per share, of New Grove; |
• | “ New Grove Class B Common Stock ” are to the shares of Class B common stock, par value $0.0001 per share, of New Grove; |
• | “ New Grove Common Stock ” are to the shares New Grove Class A Common Stock and New Grove Class B Common Stock; |
• | “ New Grove Preferred Stock ” are to the shares of preferred stock, par value $0.0001 per share, of New Grove; |
• | “ New Grove Public Warrants ” are to warrants included in the public units issued in the initial public offering that will be exercisable for shares of New Grove Class A Common Stock after the Closing; |
• | “ NYSE ” are to the New York Stock Exchange; |
• | “ ordinary shares ” are to VGAC II Class A ordinary shares and Class B ordinary shares; |
• | “ PIPE Financing ” are to the transactions contemplated by the Subscription Agreements, pursuant to which the PIPE Investors have collectively committed to subscribe for an aggregate of 8,707,500 shares of New Grove Class A Common Stock for an aggregate purchase price of $87,075,000 to be consummated in connection with the Closing; |
• | “ PIPE Investors ” are to the investors participating in the PIPE Financing, collectively; |
• | “ private placement warrants ” are to the 6,700,000 private placement warrants outstanding as of the date of this proxy statement/consent solicitation statement/prospectus that were issued to and held by the Sponsor in private placements simultaneously with the closing of the initial public offering, which are substantially identical to the public warrants sold as part of the units in the initial public offering, subject to certain limited exceptions; |
• | “ pro forma ” are to giving pro forma effect to the Business Combination, including the Merger and the PIPE Financing; |
• | “ Proposed Bylaws ” are to the proposed bylaws of New Grove to be effective upon the Domestication attached to this proxy statement/consent solicitation statement/prospectus as Annex D; |
• | “ Proposed Certificate of Incorporation ” are to the proposed certificate of incorporation of New Grove to be effective upon the Domestication attached to this proxy statement/consent solicitation statement/prospectus as Annex C; |
• | “ Proposed Governing Documents ” are to the Proposed Certificate of Incorporation and the Proposed Bylaws; |
• | “ public shareholders ” are to holders of public shares, whether acquired in the initial public offering or acquired in the secondary market; |
• | “ public shares ” are to the currently outstanding 40,250,000 Class A ordinary shares of VGAC II, whether acquired in VGAC II’s initial public offering or acquired in the secondary market; |
• | “ public warrants ” are to the currently outstanding 8,050,000 redeemable warrants to purchase Class A ordinary shares of VGAC II that were issued by VGAC II in the initial public offering; |
• | “ redemption ” are to each redemption of public shares for cash pursuant to the Existing Governing Documents; |
• | “ redemption rights ” are to the redemption rights of VGAC II shareholders; |
• | “ SEC ” are to the U.S. Securities and Exchange Commission; |
• | “ Securities Act ” are to the Securities Act of 1933, as amended; |
• | “ Sponsor ” are to VG Acquisition Sponsor II LLC, a Cayman Islands limited liability company; |
• | “ Sponsor Agreement ” are to the Sponsor Letter Agreement, dated as of December 7, 2021, entered into by Grove, the Sponsor, VGAC II, Credit Suisse Securities (USA) LLC as the underwriter, the Insiders (as defined therein) and the Holders (as defined therein); |
• | “ Subscription Agreements ” are to the subscription agreements, entered into by VGAC II and each of the PIPE Investors in connection with the PIPE Financing; |
• | “ transfer agent ” are to Continental, VGAC II’s transfer agent; |
• | “ trust account ” are to the account established by VGAC II for the benefit of its public shareholders pursuant to the Investment Management Trust Agreement, dated as of March 22, 2021, by and between VGAC II and Continental; |
• | “ Trust Agreement ” are to the Investment Management Trust Agreement, dated as of March 22, 2021, between VGAC II and Continental; |
• | “ trust fund ” are to the trust fund established by VGAC II for the benefit of its public shareholders; |
• | “ VGAC II ” are to Virgin Group Acquisition Corp. II, a Cayman Islands exempted company, prior to the Domestication; |
• | “ VGAC II Board ” are to VGAC II’s board of directors; |
• | “ VGAC II meeting website ” are to [●], the Internet address of the extraordinary general meeting; |
• | “ VGAC II Merger Sub ” are to Treehouse Merger Sub, Inc., a Delaware corporation and wholly owned direct subsidiary of VGAC II prior to the consummation of the Business Combination; |
• | “ VGAC II Parties ” are to VGAC II and VGAC II Merger Sub; |
• | “ VGAC II units ” are to the units of VGAC II, each unit representing one Class A ordinary share and one-fifth of one warrant to acquire one Class A ordinary share, that were offered and sold by VGAC II in the initial public offering; |
• | “ VGAC II shareholders ” are to holders of VGAC II ordinary shares; |
• | “ VGAC II Warrant Agreement ” are to the warrant agreement, dated March 22, 2021, between VGAC II and Continental, as warrant agent; |
• | “ VGAC II warrantholders ” are to holders of VGAC II warrants (as defined below); |
• | “ VGAC II warrants ” are to the public warrants and the private placement warrants; and |
• | “ Virgin Group ” are to the Virgin Group, an affiliate of the Sponsor, and its affiliates where applicable. |
• | VGAC II’s ability to complete the Business Combination with Grove and the timing thereof or, if VGAC II does not consummate such Business Combination, any other initial business combination; |
• | satisfaction or waiver of the conditions to the Business Combination including, among others: (i) the approval by VGAC II shareholders of the Condition Precedent Proposals; (ii) the expiration or termination of the applicable waiting period under the Hart-Scott-Rodino Act of 1976 (the “ HSR Act ”) relating to the Merger Agreement; (iii) VGAC II having at least $5,000,001 of net tangible assets (as determined in accordance with Rule 3a51-1(g)(1) of the Exchange Act) after giving effect to the transactions contemplated by the Merger Agreement and the PIPE Financing; (iv) the Minimum Available Cash Condition; and (v) the approval by the NYSE of VGAC II’s initial listing application in connection with the Business Combination; |
• | statements regarding estimates and forecasts of other financial and performance metrics and projections of market opportunity; |
• | references with respect to the anticipated benefits of the Business Combination and the projected future financial performance of New Grove or New Grove’s operating companies following the Business Combination; |
• | changes in the market for Grove’s products, and expansion plans and opportunities; |
• | anticipated customer retention by Grove; |
• | the extent to which Grove is able to protect Grove’s intellectual property and not infringe on the intellectual property rights of others; |
• | the sources and uses of cash of the Business Combination; |
• | new or adverse regulatory developments relating to automatic renewal laws; |
• | the effect of COVID-19 on the foregoing, including VGAC II’s ability to consummate the Business Combination due to the uncertainty resulting from the recent COVID-19 pandemic; and |
• | other factors detailed under the section entitled “ Risk Factors |
Q: |
Why am I receiving this proxy statement/consent solicitation statement/prospectus? |
A: | VGAC II shareholders are being asked to consider and vote upon, among other proposals, a proposal to approve and adopt the Merger Agreement and approve the transactions contemplated thereby, including the Business Combination. In accordance with the terms and subject to the conditions of the Merger Agreement, among other things, in connection with the Merger, based on an implied equity value of $1.4 billion: (a) each share of Grove Common Stock and Grove Preferred Stock (on an as-converted to common stock basis) (other than dissenting shares) will be canceled and converted into the right to receive (i) a number of shares of New Grove Class B Common Stock, as determined pursuant to an exchange ratio set forth in the Merger Agreement (the “Exchange Ratio ”) and (ii) a number of restricted shares of New Grove Class B Common Stock that will vest upon the achievement of certain earnout thresholds prior to the tenth anniversary of the Closing, as more fully described in the accompanying proxy statement/consent solicitation statement/prospectus (such shares, the “Grove Earnout Shares ”); (b) each outstanding option to purchase Grove Common Stock (whether vested or unvested) will be assumed by New Grove and converted into (i) comparable options that are exercisable for shares of New Grove Class B Common Stock, with a value determined in accordance with the Exchange Ratio (and, with regard to options that are intended to qualify as “incentive stock options” under Section 422 of the Code, in a manner compliant with Section 424(a) of the Code) and (ii) the right to receive a number of Grove Earnout Shares; (c) each award of restricted stock units to acquire Grove Common Stock (collectively, “Grove RSUs ”) will be assumed by New Grove and converted into (i) a comparable award of restricted stock units to acquire shares of New Grove Class B Common Stock and (ii) the right to receive a number of Grove Earnout Shares; and (d) each warrant to acquire shares of Grove Common Stock or Grove Preferred Stock will be assumed by New Grove and converted into (i) a comparable warrant to acquire shares of New Grove Class B Common Stock and (ii) the right to receive a number of Grove Earnout Shares. The implied equity value of $1.4 billion includes the value of the options exercisable for shares of New Grove Class B Common Stock that are issued and outstanding in respect of options (whether vested or unvested) to purchase Grove Common Stock but excludes the value of the options exercisable for shares of New Grove Class B Common Stock that are issued and outstanding in respect of options to purchase Grove common stock granted since January 1, 2021 under Grove’s 2016 Equity Incentive Plan that have not yet vested as of immediately prior to the Closing (the “Company Unvested 2021 Options ”). |
Q: |
What proposals are shareholders of VGAC II being asked to vote upon? |
A: | At the extraordinary general meeting, VGAC II is asking holders of its ordinary shares to consider and vote upon eleven separate proposals: |
• | a proposal to approve and adopt by ordinary resolution the Merger Agreement, including the Merger, and the transactions contemplated thereby; |
• | a proposal to approve by special resolution the Domestication; |
• | a proposal to approve by special resolution the adoption and approval of the proposed new certificate of incorporation (the “ Proposed Certificate of Incorporation ”) and bylaws (the “Proposed Bylaws, ” and together with the Proposed Certificate of Incorporation, the “Proposed Governing Documents ”) of New Grove, copies of which are attached to the accompanying proxy statement/consent solicitation statement/prospectus as Annexes D and E, respectively; |
• | the following five separate non-binding, advisory proposals to approve by ordinary resolution the following material differences between the Existing Governing Documents and the Proposed Governing Documents: |
• | to authorize the change in the authorized share capital of VGAC II from (i) US$22,100 divided into 200,000,000 Class A ordinary shares, par value $0.0001 per share, 20,000,000 Class B ordinary shares, par value $0.0001 per share, and 1,000,000 preference shares, par value $0.0001 per share, to (ii) 600,000,000 shares of New Grove Class A Common Stock, 200,000,000 shares of New Grove Class B Common Stock, and 100,000,000 shares of New Grove Preferred Stock; |
• | to amend and restate the Existing Governing Documents and authorize all other immaterial changes necessary or, as mutually agreed in good faith by VGAC II and Grove, desirable in connection with the replacement of the Existing Governing Documents with the Proposed Governing Documents as part of the Domestication; |
• | to authorize the issuance of shares of New Grove Class B Common Stock, which will allow holders of New Grove Class B Common Stock to cast ten votes per share of New Grove Class B Common Stock; and |
• | a proposal to approve by ordinary resolution the issuance of shares of New Grove Class A Common Stock and shares of New Grove Class B Common Stock in connection with the Business Combination and the PIPE Financing pursuant to NYSE Listing Rules; |
• | a proposal to approve and adopt by ordinary resolution the Incentive Equity Plan; |
• | a proposal to approve and adopt by ordinary resolution the ESPP; |
• | a proposal to elect the directors to the New Grove Board; and |
• | a proposal to approve by ordinary resolution the adjournment of the extraordinary general meeting to a later date or dates, if necessary, to, among other things, permit further solicitation and vote of proxies in the event that there are insufficient votes for the approval of one or more proposals at the extraordinary general meeting. |
Q: |
Why is VGAC II proposing the Business Combination? |
A: | VGAC II is a blank check company incorporated on January 13, 2021 as a Cayman Islands exempted company and incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. Although VGAC II may pursue an acquisition opportunity in any business, industry, sector, or geographical location for purposes of consummating an initial business combination, VGAC II has focused on companies in the travel & leisure, financial services, health & wellness, technology & internet-enabled, music & entertainment, media & mobile, and renewable energy/resource efficiency sectors. VGAC II is not permitted |
under the Existing Governing Documents to effect a business combination with a blank check company or a similar type of company with nominal operations. |
Q: |
Did the VGAC II Board obtain a third-party valuation or fairness opinion in determining whether or not to proceed with the Business Combination? |
A: | Yes. Although the Existing Governing Documents do not require VGAC II to seek an opinion from an independent investment banking firm or another valuation or appraisal firm that regularly renders fairness opinions unless it pursues a business combination with an affiliated company, the board of directors of VGAC II received an opinion dated December 6, 2021, of Houlihan Lokey Capital, Inc. (“ Houlihan Lokey ”) to the effect that, as of such date and on the basis of and subject to the qualifications, limitations and assumptions set forth in Houlihan Lokey’s written opinion, the merger consideration, excluding the Grove Earnout Shares, to be issued by VGAC II in the Business Combination pursuant to the Merger Agreement (the “Closing Payment Shares ”) was fair, from a financial point of view, to VGAC II. See the section entitled “BCA Proposal — Opinion of Houlihan Lokey |
Q: |
What will Grove’s equityholders receive in return for the Business Combination with VGAC II? |
A: | On the date of Closing, VGAC II Merger Sub will merge with and into Grove, with Grove as the surviving company in the Merger and, after giving effect to such Merger, Grove shall be a wholly owned direct subsidiary of New Grove. In accordance with the terms and subject to the conditions of the Merger Agreement, at the time at which the Merger becomes effective (the “ Effective Time ”), based on an implied equity value of $1.4 billion: (a) each share of Grove Common Stock and Grove Preferred Stock (on an as-converted to common stock basis) (other than dissenting shares) will be canceled and converted into the right to receive (i) a number of shares of New Grove Class B Common Stock, as determined pursuant to an exchange ratio set forth in the Merger Agreement and (ii) a number of shares of Grove Earnout Shares, as more fully described in the accompanying proxy statement/consent solicitation statement/prospectus; (b) each outstanding option to purchase Grove Common Stock (whether vested or unvested) will be assumed by New Grove and converted into (i) comparable options that are exercisable for shares of New Grove Class B Common Stock, with a value determined in accordance with the Exchange Ratio (and, with |
regard to options that are intended to qualify as “incentive stock options” under Section 422 of the Code, in a manner compliant with Section 424(a) of the Code) and (ii) the right to receive a number of Grove Earnout Shares; (c) each award of Grove RSUs will be assumed by New Grove and converted into (i) a comparable award of restricted stock units to acquire shares of New Grove Class B Common Stock and (ii) the right to receive a number of Grove Earnout Shares; and (d) each warrant to acquire shares of Grove Common Stock or Grove Preferred Stock will be assumed by New Grove and converted into (i) a comparable warrant to acquire shares of New Grove Class B Common Stock and (ii) the right to receive a number of Grove Earnout Shares. The implied equity value of $1.4 billion includes the value of the options exercisable for shares of New Grove Class B Common Stock that are issued and outstanding in respect of options (whether vested or unvested) to purchase Grove Common Stock but excludes the value of the options exercisable for shares of New Grove Class B Common Stock that are issued and outstanding in respect of Company Unvested 2021 Options. |
Q: |
How will the combined company be managed following the Business Combination? |
A: | Following the Closing, it is expected that the current management of Grove will become the management of New Grove, and the New Grove Board will consist of nine directors. If the Director Election Proposal is approved, the New Grove Board will consist of Stuart Landesberg, Christopher Clark, Catherine Beaudoin, David Glazer, John Replogle, [●], [●], [●] and [●]. Please see the section entitled “ Management of New Grove Following the Business Combination Director Election Proposal |
Q: |
What equity stake will current VGAC II shareholders and current equityholders of Grove hold in New Grove immediately after the consummation of the Business Combination? |
A: | As of the date of this proxy statement/consent solicitation statement/prospectus, there are (i) 40,250,000 Class A ordinary shares outstanding underlying units issued in the initial public offering and (ii) 10,062,500 Class B ordinary shares outstanding held by the Sponsor. As of the date of this proxy statement/consent solicitation statement/prospectus, there are 6,700,000 private placement warrants outstanding and held by the Sponsor and 8,050,000 public warrants. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share and, following the Domestication, will entitle the holder thereof to purchase one share of New Grove Class A Common Stock. Therefore, as of the date of this proxy statement/consent solicitation statement/prospectus (without giving effect to the Business Combination and assuming that none of VGAC II’s outstanding public shares are redeemed in connection with the Business Combination), VGAC II’s fully diluted share capital, giving effect to the exercise of all of the private placement warrants and public warrants, would be 65,062,500 ordinary shares. |
Share Ownership in New Grove(1) |
||||||||
No Redemptions |
Maximum redemptions(2) |
|||||||
Percentage of Outstanding Shares |
Percentage of Outstanding Shares |
|||||||
VGAC II Shareholders |
22.4 | % | 5.9 | % | ||||
Sponsor(2) |
3.7 | % | 4.4 | % | ||||
PIPE Investors |
4.8 | % | 83.8 | % | ||||
Grove Stockholders(3) |
69.1 | % | 5.9 | % |
(1) | As of January 14, 2022. Percentages may not add to 100% due to rounding. |
(2) | Assumes that 31,459,600 of VGAC II’s Class A ordinary share are redeemed for an aggregate payment of $314.6 million (which is the maximum number of redemptions that would still allow the Minimum Cash Condition to be satisfied). |
(3) | Excludes equity awards issued at Closing upon rollover of vested and unvested Grove equity awards and new awards issued under the proposed New Grove Incentive Equity Plan. |
Q: |
What percentage of voting power will current VGAC II shareholders and current equityholders of Grove hold in New Grove immediately after the consummation of the Business Combination? |
A: | The following table illustrates the estimated voting power in New Grove immediately following the consummation of the Business Combination, based on the varying levels of redemptions by the public shareholders and the following additional assumptions: |
Voting Power in New Grove(1) |
||||||||
No Redemptions |
Maximum redemptions(2) |
|||||||
Percentage of Voting Power of Outstanding Shares |
Percentage of Voting Power of Outstanding Shares |
|||||||
VGAC II Shareholders |
[ | ●]% | [ | ●]% | ||||
Sponsor |
[ | ●]% | [ | ●]% | ||||
PIPE Investors |
[ | ●]% | [ | ●]% | ||||
Grove Class A Stockholders(3) |
[ | ●]% | [ | ●]% | ||||
Grove Class B Stockholders(3)(4) |
[ | ●]% | [ | ●]% |
(1) | As of [●], 2022. Percentages may not add to 100% due to rounding. |
(2) | Assumes that 31,459,600 of VGAC II’s Class A ordinary share are redeemed for an aggregate payment of $314.6 million (which is the maximum number of redemptions that would still allow the Minimum Cash Condition to be satisfied). |
(3) | Excludes equity awards issued at Closing upon rollover of vested and unvested Grove equity awards under the proposed New Grove’s Incentive Equity Plan. |
(4) | Each share of New Grove Class B Common Stock will have ten (10) votes per share, while each share of New Grove Class A Common Stock will have one (1) vote per share. |
Q: |
Why is VGAC II proposing the Domestication? |
A: | The VGAC II Board believes that there are significant advantages to VGAC II that will arise as a result of a change of its domicile to Delaware. Further, the VGAC II Board believes that any direct benefit that the Delaware General Corporation Law (the “ DGCL ”) provides to a corporation also indirectly benefits its stockholders, who are the owners of the corporation. The VGAC II Board believes that there are several reasons why transfer by way of continuation to Delaware is in the best interests of VGAC II and the VGAC II shareholders, including (i) the prominence, predictability, and flexibility of the DGCL, (ii) Delaware’s well-established principles of corporate governance, and (iii) the increased ability for Delaware corporations |
to attract and retain qualified directors. Each of the foregoing reasons are discussed in greater detail in the section entitled “ Domestication Proposal—Reasons for the Domestication |
Q: |
What amendments will be made to the current constitutional documents of VGAC II? |
A: | The Closing is conditional, among other things, on the Domestication. Accordingly, in addition to voting on the Business Combination, VGAC II shareholders also are being asked to consider and vote upon a proposal to approve the Domestication, and replace the Existing Governing Documents, in each case, under Cayman Islands law with the Proposed Governing Documents, in each case, under the DGCL, which differ from the Existing Governing Documents in the following material respects: |
Existing Governing Documents |
Proposed Governing Documents | |||
Authorized Shares ( Governing Documents Proposal A |
The share capital under the Existing Governing Documents is US$22,100 divided into 200,000,000 Class A ordinary shares of par value US$0.0001 per share, 20,000,000 Class B ordinary shares of par value US$0.0001 per share, and 1,000,000 preference shares of par value US$0.0001 per share. | The Proposed Governing Documents authorize 600,000,000 shares of New Grove Class A Common Stock, 200,000,000 shares of New Grove Class B Common Stock, and 100,000,000 shares of New Grove Preferred Stock. | ||
See paragraph 5 of the Memorandum of Association. |
See Article IV of the Proposed Certificate of Incorporation. | |||
Corporate Name Governing Documents Proposal B |
The Existing Governing Documents provide the name of the company is “Virgin Group Acquisition Corp. II” | The Proposed Governing Documents will provide that the name of the corporation will be “Grove Collaborative Holdings, Inc.” | ||
See paragraph 1 of VGAC II’s Memorandum of Association. |
See Article I of the Proposed Certificate of Incorporation. | |||
Perpetual Existence Governing Documents Proposal B |
The Existing Governing Documents provide that if VGAC II does not consummate a business combination (as defined in the | The Proposed Governing Documents do not include any provisions relating to New Grove’s ongoing existence; the |
Existing Governing Documents |
Proposed Governing Documents | |||
Existing Governing Documents) by March 25, 2023 (twenty-four months after the closing of the initial public offering), VGAC II will cease all operations except for the purposes of winding up and will redeem the shares issued in the initial public offering and liquidate its trust account. | default under the DGCL will make New Grove’s existence perpetual. | |||
See Article 49 of VGAC II’s Articles of Association. |
This is the default rule under the DGCL. | |||
Exclusive Forum Governing Documents Proposal B |
The Existing Governing Documents do not contain a provision adopting an exclusive forum for certain shareholder litigation. | The Proposed Governing Documents adopt Delaware as the exclusive forum for certain stockholder litigation and the federal district courts of the United States as the exclusive forum for litigation arising out of the Securities Act. | ||
Provisions Related to Status as Blank Check Company Governing Documents Proposal B |
The Existing Governing Documents set forth various provisions related to VGAC II’s status as a blank check company prior to the consummation of a business combination. | The Proposed Governing Documents do not include such provisions related to VGAC II’s status as a blank check company, which no longer will apply upon consummation of the Business Combination, as VGAC II will cease to be a blank check company at such time. | ||
See Article 49 of VGAC II’s Amended and Restated Articles of Association. |
||||
Voting Rights of Common Stock Governing Documents Proposal C |
The Existing Governing Documents provide that the holders of each ordinary share of VGAC II is entitled to one vote for each share on each matter properly submitted to the VGAC II shareholders entitled to vote. | The Proposed Governing Documents provide that holders of shares of New Grove Class A Common Stock will be entitled to cast one (1) vote per share of New Grove Class A Common Stock, and holders of shares of New Grove Class B Common Stock will be entitled to cast ten (10) votes per share of New Grove Class B Common Stock on each matter properly submitted to the stockholders entitled to vote. | ||
See Article 23 of VGAC II’s Articles of Association. |
See Article IV of the Proposed Certificate of Incorporation. |
Q: |
How will the Domestication affect my ordinary shares, warrants, and units? |
A: | In connection with the Domestication, at least one day prior to the Closing Date, (i) each issued and outstanding Class A ordinary share and each issued and outstanding Class B ordinary share of VGAC II will convert automatically, on a one-for-one one-fifth of one warrant representing the right to purchase one share of New Grove Class A Common Stock at an exercise price of $11.50 per share on the terms and conditions set forth in the VGAC II Warrant Agreement. See “Domestication Proposal. |
Q: |
What effect will New Grove being a public benefit corporation under Delaware law have on New Grove’s public stockholders? |
A: | Unlike traditional corporations, which have a fiduciary duty to focus exclusively on maximizing stockholder value, as a Delaware public benefit corporation, New Grove’s directors will have a fiduciary duty to consider not only the stockholders’ interests, but also the company’s specific public benefit and the interests of other stakeholders affected by New Grove’s actions. Therefore, New Grove may take actions that its directors believes will be in the best interests of those stakeholders materially affected by its specific benefit purpose, even if those actions do not maximize New Grove’s financial results. While New Grove intends for this public benefit designation and obligation to provide an overall net benefit to New Grove and its stakeholders, it could instead cause New Grove to make decisions and take actions without seeking to maximize the income generated from its business, and hence available for distribution to its stockholders. |
Q: |
What are the U.S. federal income tax consequences of the Domestication Proposal? |
A: | The Domestication should constitute a tax-free reorganization within the meaning of Section 368(a)(1)(F) of the Internal Revenue Code of 1986, as amended (the “Code ”). Assuming that the Domestication so qualifies, the following summarizes the consequences to U.S. Holders (as defined in “U.S. Federal Income Tax Considerations ” below) of the Domestication: |
• | Subject to the discussion below concerning PFICs, a U.S. Holder of Class A ordinary shares whose ordinary shares have a fair market value of less than $50,000 on the date of the Domestication and who does not own actually and/or constructively 10% or more of the total combined voting power of all classes of VGAC II shares entitled to vote or 10% or more of the total value of all classes of VGAC II shares (that is, who is not a “ 10% shareholder ”) will not recognize any gain or loss and will not be required to include any part of VGAC II’s earnings in income. |
• | Subject to the discussion below concerning PFICs, a U.S. Holder of Class A ordinary shares whose ordinary shares have a fair market value of $50,000 or more, but who is not a 10% shareholder will generally recognize gain (but not loss) on the deemed receipt of New Grove Class A Common Stock in the Domestication. As an alternative to recognizing gain as a result of the Domestication, such U.S. Holder may file an election to include in income, as a dividend, the “ all earnings and profits amount ” (as defined in the regulations promulgated under the Code (the “Treasury Regulations ”) under Section 367 of the Code) attributable to its Class A ordinary shares provided certain other requirements are satisfied. |
• | Subject to the discussion below concerning PFICs, a U.S. Holder of Class A ordinary shares who on the date of the Domestication is a 10% shareholder will generally be required to include in income, as a dividend, the “ all earnings and profits amount ” (as defined in the Treasury Regulations under Section 367 of the Code) attributable to its Class A ordinary shares provided certain other requirements are satisfied. |
• | As discussed further under “ U.S. Federal Income Tax Considerations ” below, VGAC II believes that it is (and has been) treated as a PFIC for U.S. federal income tax purposes. In the event that VGAC II is (or in some cases has been) treated as a PFIC, notwithstanding the foregoing, proposed Treasury Regulations under Section 1291(f) of the Code (which have a retroactive effective date), if finalized in their current form, generally would require a U.S. Holder to recognize gain as a result of the Domestication unless the U.S. Holder makes (or has made) certain elections discussed further under “U.S. Federal Income Tax Considerations—The Domestication. ” The tax on any such gain would be imposed at the rate applicable to ordinary income and an interest charge would apply based on a complex set of rules. It is difficult to predict whether such proposed regulations will be finalized and whether, in what form, and with what effective date, other final Treasury Regulations under Section 1291(f) of the Code will be adopted. Further, it is not clear how any such regulations would apply to the warrants. For a more complete discussion of the potential application of the PFIC rules to U.S. Holders as a result of the Domestication, see the section entitled “U.S. Federal Income Tax Considerations. ” Each U.S. Holder of Class A ordinary shares or warrants is urged to consult its own tax advisor concerning the application of the PFIC rules to the exchange of Class A ordinary shares for New Grove Class A Common Stock and public warrants for New Grove warrants pursuant to the Domestication. |
Q: |
Do I have redemption rights? |
A: | If you are a holder of public shares, you have the right to request that VGAC II redeems all or a portion of your public shares for cash provided that you follow the procedures and deadlines described elsewhere in this proxy statement/consent solicitation statement/prospectus. Public shareholders may elect to redeem all or a portion of the public shares held by them regardless of if or how they vote in respect of the Business Combination Proposal. If you wish to exercise your redemption rights, please see the answer to the next question: “ How do I exercise my redemption rights? |
Q: |
How do I exercise my redemption rights? |
A: | If you are a public shareholder and wish to exercise your right to redeem the public shares, you must: |
(i) | (a) hold public shares, or (b) hold public shares through units and elect to separate your units into the underlying public shares and public warrants prior to exercising your redemption rights with respect to the public shares; |
(ii) | submit a written request to Continental, VGAC II’s transfer agent, in which you (a) request that VGAC II redeem all or a portion of your public shares for cash, and (b) identify yourself as the beneficial holder of the public shares and provide your legal name, phone number, and address; and |
(iii) | deliver your share certificates (if any) and other redemption forms (as applicable) to Continental physically or electronically through The Depository Trust Company (“ DTC” ). |
Q: |
If I am a holder of units, can I exercise redemption rights with respect to my units? |
A: | No. Holders of issued and outstanding units must elect to separate the units into the underlying public shares and public warrants prior to exercising redemption rights with respect to the public shares. If you hold your units in an account at a brokerage firm or bank, you must notify your broker or bank that you elect to separate the units into the underlying public shares and public warrants, or if you hold units registered in your own name, you must contact Continental directly and instruct them to do so. The redemption rights include the requirement that a holder must identify itself in writing as a beneficial holder and provide its |
legal name, phone number, and address to Continental in order to validly redeem its shares. You are requested to cause your public shares to be separated and delivered to Continental by 5:00 PM, Eastern Time, on [●], 2022 (two business days before the extraordinary general meeting) in order to exercise your redemption rights with respect to your public shares. |
Q: |
What are the U.S. federal income tax consequences of exercising my redemption rights? |
A: | A U.S. Holder (as defined in “ U.S. Federal Income Tax Considerations ” below) of Class A ordinary shares (if the Domestication does not occur) or New Grove Class A Common Stock (if the Domestication occurs) as the case may be, that exercises its redemption rights to receive cash from the trust account in exchange for such ordinary shares or common stock may (subject to the application of the PFIC rules) be treated as selling such ordinary shares or common stock, resulting in the recognition of capital gain or capital loss. There may be certain circumstances in which the redemption may be treated as a distribution for U.S. federal income tax purposes depending on the amount of ordinary shares or common stock, as the case may be, that a U.S. Holder owns or is deemed to own (including through the ownership of warrants). For a more complete discussion of the U.S. federal income tax considerations of an exercise of redemption rights by a U.S. Holder, see the sections entitled “U.S. Federal Income Tax Considerations – Tax Consequences of the Ownership and Disposition of Class A Ordinary Shares and Warrants if the Domestication Does Not Occur – U.S. Holders – Redemption of Class A Ordinary Shares” and “U.S. Federal Income Tax Considerations – The Domestication – Tax Consequences of a Redemption of New Grove Class A Common Stock.” |
Q: |
What happens to the funds deposited in the trust account after consummation of the Business Combination? |
A: | Following the closing of the initial public offering, an amount equal to $402,500,000 ($10.00 per unit) of the net proceeds from the initial public offering and the sale of the private placement warrants was placed in the trust account. As of September 30, 2021, funds in the trust account totaled approximately $402,520,541 and were held in money market funds. These funds will remain in the trust account, except for the withdrawal of interest to pay taxes, if any, until the earliest of (i) the completion of a business combination (including the Closing) or (ii) the redemption of all of the public shares if VGAC II is unable to complete a business combination by March 25, 2023 (unless such date is extended in accordance with the Existing Governing Documents), subject to applicable law. |
Q: |
What happens if a substantial number of the public shareholders vote in favor of the Business Combination Proposal and exercise their redemption rights? |
A: | VGAC II’s public shareholders are not required to vote in respect of the Business Combination in order to exercise their redemption rights. Accordingly, the Business Combination may be consummated even though the funds available from the trust account and the number of public shareholders are reduced as a result of redemptions by public shareholders. |
Q: |
What conditions must be satisfied to complete the Business Combination? |
A: | The consummation of the Business Combination is conditioned upon, among other things: (i) the approval by VGAC II shareholders of the Condition Precedent Proposals; (ii) the expiration or termination of the applicable waiting period under the HSR Act relating to the Merger Agreement; (iii) VGAC II having at least $5,000,001 of net tangible assets (as determined in accordance with Rule 3a51-1(g)(1) of the Exchange Act) after giving effect to the transactions contemplated by the Merger Agreement and the PIPE Financing; (iv) the Minimum Available Cash Condition; (v) the approval by NYSE of VGAC II’s initial listing application in connection with the Business Combination; and (vi) the consummation of the Domestication. Therefore, unless these conditions are waived by the applicable parties to the Merger Agreement, the Merger Agreement could terminate and the Business Combination may not be consummated. |
Q: |
When do you expect the Business Combination to be completed? |
A: | It is currently expected that the Business Combination will be consummated in late first quarter or early second quarter 2022. This date depends on, among other things, the approval of the proposals to be voted on by VGAC II shareholders at the extraordinary general meeting. However, such extraordinary general meeting could be adjourned if the Adjournment Proposal is adopted by VGAC II shareholders at the extraordinary general meeting and VGAC II elects to adjourn the extraordinary general meeting to a later date or dates (i) to the extent necessary to ensure that any required supplement or amendment to the accompanying proxy statement/consent solicitation statement/prospectus is provided to VGAC II shareholders, (ii) in order to solicit additional proxies from VGAC II shareholders in favor of one or more of the proposals at the extraordinary general meeting, (iii) if, as of the time for which the extraordinary general meeting is scheduled, there are insufficient VGAC II ordinary shares represented (either in person or by proxy) to constitute a quorum necessary to conduct the business to be conducted at the extraordinary general meeting, or (iv) if VGAC II shareholders redeem an amount of public shares such that the Minimum Available Cash Condition would not be satisfied. For a description of the conditions for the completion of the Business Combination, see “ Business Combination Proposal—Conditions to Closing of the Business Combination |
Q: |
What happens if the Business Combination is not consummated? |
A: | VGAC II will not complete the Domestication unless all other conditions to the Closing have been satisfied or waived by the parties in accordance with the terms of the Merger Agreement. If VGAC II is not able to consummate the Business Combination with Grove nor able to complete another business combination by March 25, 2023, in each case, as such date may be extended pursuant to the Existing Governing Documents, VGAC II will: (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest earned on the funds held in the trust account (less taxes payable and up to $100,000 of interest income to pay dissolution expenses), divided by the number of then-outstanding public shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of VGAC II’s remaining shareholders and the VGAC II Board, liquidate and dissolve, subject in the case of clauses (ii) and (iii) to VGAC II’s obligations under Cayman Islands law to provide for claims of creditors and in all cases subject to the other requirements of applicable law. |
Q: |
Do I have appraisal rights in connection with the proposed Business Combination and the proposed Domestication? |
A: | Neither VGAC II shareholders nor VGAC II warrantholders have appraisal rights in connection with the Business Combination or the Domestication under the Cayman Islands Companies Act or under the DGCL. |
Q: |
What do I need to do now? |
A: | VGAC II urges you to read this proxy statement/consent solicitation statement/prospectus, including the Annexes hereto and the documents referred to herein, carefully and in their entirety and to consider how the Business Combination will affect you as a VGAC II shareholder and/or a VGAC II warrantholder. VGAC II shareholders should then vote as soon as possible in accordance with the instructions provided in this proxy statement/consent solicitation statement/prospectus and on the enclosed proxy card. |
Q: |
What do I need in order to vote and ask questions at the extraordinary general meeting via the Internet? |
A: | To attend the extraordinary general meeting via the Internet, you must register at [●]. Upon completing your registration, you will receive further instructions via email, including a unique link that will allow you access to the extraordinary general meeting and to vote and submit questions during the extraordinary general meeting. As part of the registration process, you must enter the control number located on your proxy card or voting instruction form. If you hold your shares in “street name,” which means your shares are held of record by a broker, bank, or nominee, you will also need to provide the registered name on your account and the name of your broker, bank or other nominee as part of the registration process. On the day of the extraordinary general meeting, you may begin to log in to the extraordinary general meeting fifteen (15) minutes prior to the extraordinary general meeting. We will have technicians ready to assist you with any technical difficulties you may have accessing the extraordinary general meeting. If you encounter any difficulties accessing the extraordinary general meeting platform, including any difficulties voting or submitting questions, you may call the technical support number that will be posted in your instructional email. |
Q: |
How do I vote my shares at the extraordinary general meeting? |
A: | Shares Held of Record |
Q: |
If my shares are held in “street name,” will my broker, bank, or nominee automatically vote my shares for me? |
A: | No. If your shares are held in a stock brokerage account or by a bank or other nominee, you are considered the “beneficial holder” of the shares held for you in what is known as “street name.” If this is the case, this proxy statement/consent solicitation statement/prospectus may have been forwarded to you by your brokerage firm, bank, or other nominee, or its agent. As the beneficial holder, you have the right to direct your broker, bank, or other nominee as to how to vote your shares. If you do not provide voting instructions to your broker on a particular proposal on which your broker does not have discretionary authority to vote, your shares will not be voted on that proposal. This is called a “broker non-vote.” Abstentions and broker non-votes, while considered present for the purposes of establishing a quorum, will not count as votes cast at the extraordinary general meeting, and otherwise will have no effect on a particular proposal. If you decide to vote, you should provide instructions to your broker, bank, or other nominee on how to vote in accordance with the information and procedures provided to you by your broker, bank, or other nominee. |
Q: |
When and where will the extraordinary general meeting be held? |
A: | The extraordinary general meeting will be held at the offices of Davis Polk & Wardwell LLP located at 450 Lexington Avenue, New York, New York 10017 and virtually via the Internet at [●], Eastern Time, on [●], 2022, unless the extraordinary general meeting is adjourned. |
Q: |
How will the COVID-19 pandemic impact in-person voting at the General Meeting? |
A: | VGAC II intends to hold the extraordinary general meeting both in person and virtually via the Internet. Because VGAC II is sensitive to the public health and travel concerns our shareholders may have and recommendations that public health officials may issue in light of the evolving nature of COVID-19 situation, VGAC II encourages VGAC II shareholders to attend the extraordinary general meeting virtually via the Internet. Additionally, VGAC II may impose additional procedures or limitations on VGAC II shareholders who wish to attend the extraordinary general meeting in person. VGAC II plans to announce any such updates in a press release filed with the SEC and on its proxy website, [●], and VGAC II encourages VGAC II shareholders to check this website prior to the meeting if they plan to attend. |
Q: |
What impact will the COVID-19 pandemic have on the Business Combination? |
A: | Given the ongoing and dynamic nature of the circumstances, it is difficult to predict the impact of COVID-19 on the businesses of VGAC II and Grove, and there is no guarantee that efforts by VGAC II and Grove to address the adverse impacts of COVID-19 will be effective. The extent of such impact will depend on future developments, which are highly uncertain and cannot be predicted, including new information which may emerge concerning the severity of COVID-19 and actions taken to contain COVID-19 or its impact, among others. If VGAC II or Grove are unable to recover from a business disruption on a timely basis, the Business Combination and/or New Grove’s business, financial condition, and results of operations following the completion of the Business Combination, would be adversely affected. The Business Combination may also be delayed and adversely affected by COVID-19 and become more costly. Each of VGAC II and Grove may also incur additional costs to remedy damages caused by any such disruptions, which could adversely affect their respective financial condition and results of operations. |
Q: |
Who is entitled to vote at the extraordinary general meeting? |
A: | VGAC II has fixed [●], 2022 as the record date for the extraordinary general meeting. If you were a shareholder of VGAC II at the close of business on the record date, you are entitled to vote on matters that come before the extraordinary general meeting. However, a VGAC II shareholder may only vote his or her shares if he or she is present in person or is represented by proxy at the extraordinary general meeting. |
Q: |
How many votes do I have? |
A: | VGAC II shareholders are entitled to one vote at the extraordinary general meeting for each ordinary share held of record as of the record date. As of the close of business on the record date for the extraordinary general meeting, there were 50,312,500 ordinary shares issued and outstanding, of which 40,250,000 were issued and outstanding public shares. |
Q: |
What constitutes a quorum? |
A: | A quorum of VGAC II shareholders is necessary to hold a valid meeting. A quorum will be present at the extraordinary general meeting if one (1) or more VGAC II shareholders who together hold not less than a majority of the issued and outstanding ordinary shares as of the record date entitled to vote at the extraordinary general meeting are represented in person or by proxy at the extraordinary general meeting. As of the record date for the extraordinary general meeting, [●] ordinary shares would be required to achieve a quorum. |
Q: |
What vote is required to approve each proposal at the extraordinary general meeting? |
A: | The following votes are required for each proposal at the extraordinary general meeting: |
(i) | Business Combination Proposal |
(ii) | Domestication Proposal two-thirds of the ordinary shares who, being present in person or represented by proxy and entitled to vote at the extraordinary general meeting, vote at the extraordinary general meeting. |
(iii) | Charter Amendment Proposal two-thirds of the ordinary shares who, being present in person or represented by proxy and entitled to vote at the extraordinary general meeting, vote at the extraordinary general meeting. |
(iv) | Governing Documents Proposals : |
(v) | NYSE Proposal |
(vi) | Incentive Equity Plan Proposal |
(vii) | ESPP Proposal |
(viii) | Director Election Proposal |
(ix) | Adjournment Proposal |
Q: |
What are the recommendations of the VGAC II Board? |
A: | The VGAC II Board believes that the Business Combination Proposal and the other proposals to be presented at the extraordinary general meeting are in the best interest of VGAC II and VGAC II shareholders and unanimously recommends that its shareholders vote “FOR” the Business Combination Proposal, “FOR” the Domestication Proposal, “FOR” the Charter Amendment Proposal, “FOR” the Governing Documents Proposals, “FOR” the NYSE Proposal, “FOR” the Incentive Equity Plan Proposal, “FOR” the ESPP Proposal, “FOR” the Director Election Proposal, and “FOR” the Adjournment Proposal, in each case, if presented at the extraordinary general meeting. |
Q: |
How does the Sponsor intend to vote its shares? |
A: | The Sponsor has agreed to vote all its shares in favor of all the proposals being presented at the extraordinary general meeting. As of the date of this proxy statement/consent solicitation statement/prospectus, the Sponsor owns approximately 20.0% of the issued and outstanding ordinary shares. |
Q: |
What happens if I sell my VGAC II ordinary shares before the extraordinary general meeting? |
A: | The record date for the extraordinary general meeting is earlier than the date of the extraordinary general meeting and earlier than the date that the Business Combination is expected to be completed. If you transfer your public shares after the applicable record date, but before the extraordinary general meeting, unless you grant a proxy to the transferee, you will retain your right to vote at the extraordinary general meeting. |
Q: |
May I change my vote after I have mailed my signed proxy card? |
A: | Yes. Shareholders may send a later-dated, signed proxy card to VGAC II’s Chief Financial Officer at VGAC II’s address set forth below so that it is received by VGAC II’s Chief Financial Officer prior to the vote at the extraordinary general meeting (which is scheduled to take place on [●], 2022) or attend the extraordinary general meeting in person and vote. Shareholders also may revoke their proxy by sending a notice of revocation to VGAC II’s Chief Financial Officer, which must be received by VGAC II’s Chief Financial Officer prior to the vote at the extraordinary general meeting. However, if your shares are held in |
“street name” by your broker, bank, or another nominee, you must contact your broker, bank, or other nominee to change your vote. |
Q: |
What happens if I fail to take any action with respect to the extraordinary general meeting? |
A: | If you fail to vote with respect to the extraordinary general meeting and the Business Combination is approved by VGAC II shareholders and the Business Combination is consummated, you will become a stockholder and/or warrantholder of New Grove. If you fail to vote with respect to the extraordinary general meeting and the Business Combination is not approved, you will remain a shareholder and/or warrantholder of VGAC II. However, if you fail to vote with respect to the extraordinary general meeting, you will nonetheless be able to elect to redeem your public shares in connection with the Business Combination. |
Q: |
What should I do if I receive more than one set of voting materials? |
A: | Shareholders may receive more than one set of voting materials, including multiple copies of this proxy statement/consent solicitation statement/prospectus and multiple proxy cards or voting instruction cards. For example, if you hold your shares in more than one brokerage account, you will receive a separate voting instruction card for each brokerage account in which you hold shares. If you are a holder of record and your shares are registered in more than one name, you will receive more than one proxy card. Please complete, sign, date, and return each proxy card and voting instruction card that you receive in order to cast a vote with respect to all of your ordinary shares. |
Q: |
Who will solicit and pay the cost of soliciting proxies for the extraordinary general meeting? |
A: | VGAC II will pay the cost of soliciting proxies for the extraordinary general meeting. VGAC II has engaged [●] (“[●]”) to assist in the solicitation of proxies for the extraordinary general meeting. VGAC II has agreed to pay [●] a fee of $[●], plus disbursements, and will reimburse [●] for its reasonable out-of-pocket |
Q: |
Where can I find the voting results of the extraordinary general meeting? |
A: | The preliminary voting results will be announced at the extraordinary general meeting. VGAC II will publish final voting results of the extraordinary general meeting in a Current Report on Form 8-K within four business days after the extraordinary general meeting. |
Q: |
Who can help answer my questions? |
A: | If you have questions about the Business Combination or if you need additional copies of the proxy statement/consent solicitation statement/prospectus or the enclosed proxy card you should contact: |
Q: |
Who is entitled to give a written consent for Grove? |
A: | The holders representing a majority of the outstanding Grove Common Stock and Grove Preferred Stock (on an as-converted basis) will be entitled to give consent using the form of written consent furnished with this proxy statement/consent solicitation statement/prospectus. |
Q: |
What approval is required by the Grove Stockholders to adopt the Merger Agreement? |
A: | The Merger cannot be completed unless stockholders of Grove adopt the Merger Agreement and thereby approve the Business Combination and the other transactions contemplated by the Merger Agreement. Adoption of the Merger Agreement requires the approval of the written consent of the holders of Grove Common Stock and Grove Preferred Stock representing the requisite vote required under the certificate of incorporation of Grove. As of the close of business on [●], 2022, there were approximately [●] shares of Grove Common Stock (including the shares of Grove Preferred Stock on an as-converted basis) outstanding and entitled to vote. |
Q: |
Do any of Grove’s directors or officers have interests in the Merger that may differ from or be in addition to the interests of Grove stockholders? |
A: | Grove’s executive officers and certain non-employee directors may have interests in the Merger that may be different from, or in addition to, the interests of Grove stockholders generally, including (i) the fact that a director of Grove will become a director of New Grove after the closing of the Merger and, as such, in the future such director will receive any cash fees, stock options or stock awards that the New Grove Board determines to pay to its non-executive directors; (ii) the fact that Grove has entered into employment agreements with certain of its named executive officers (please see “Grove—Executive Compensation |
current directors and officers and the continuation of directors’ and officers’ liability insurance. The Grove Board was aware of and considered these interests to the extent such interests existed at the time, among other matters, in approving the Merger Agreement and in recommending that the Merger Agreement be approved by the Grove stockholders. |
Q: |
I am an employee of Grove who holds equity awards of Grove. How will my equity awards be treated in the Merger? |
A: | As of the effective time of the Merger, each outstanding option to purchase Grove Common Stock (whether vested or unvested) will be assumed by New Grove and converted into (i) comparable options that are exercisable for shares of New Grove Class B Common Stock, with a value determined in accordance with the Exchange Ratio (and, with regard to options that are intended to qualify as “incentive stock options” under Section 422 of the Code, in a manner compliant with Section 424(a) of the Code) and (ii) the right to receive a number of Grove Earnout Shares. |
Q: |
How can I return my written consent? |
A: | If you hold shares of Grove Common Stock and you wish to submit your consent, you must fill out the enclosed written consent, date, and sign it, and promptly return it to Grove. Once you have completed, dated and signed your written consent, deliver it to Grove by emailing a .pdf copy of your written consent to [dcostin@grove.co] or by mailing your written consent to Grove at [1301 Sansome Street, San Francisco, CA 94111], Attention: [Delida Costin]. Grove does not intend to hold a stockholders’ meeting to consider the Business Combination Proposal, and, unless Grove decides to hold a stockholders’ meeting for such purposes, you will be unable to vote in person or virtually by attending a stockholders’ meeting. |
Q: |
What is the deadline for returning my written consent? |
A: | The Grove Board has set [●] Eastern Time, on [●], 2022 as the targeted final date for the receipt of written consents. Grove reserves the right to extend the final date for the receipt of written consents beyond [●], 2022. Any such extension may be made without notice to Grove stockholders. Once a sufficient number of consents to adopt the Merger Agreement have been received, the consent solicitation will conclude. |
Q: |
What options do I have with respect to the proposed Merger? |
A: | With respect to the shares of Grove Common Stock and Grove Preferred Stock that you hold, you may execute a written consent to approve the Business Combination Proposal. If you fail to execute and return your written consent, or otherwise withhold your written consent, it has the same effect as voting against the Business Combination Proposal. You may also dissent and demand appraisal of your shares. See “—Can I Dissent and Require Appraisal of My Shares? |
Q: |
Can I dissent and require appraisal of my shares? |
A: | If you are a Grove stockholder who does not approve the Merger by delivering a written consent adopting the Merger Agreement, you will, by complying with Section 262 of the DGCL, be entitled to appraisal rights. Section 262 of the DGCL is attached to this proxy statement/consent solicitation statement/prospectus as Annex K. Failure to follow any of the statutory procedures set forth in Annex K may result in the loss or waiver of appraisal rights under Delaware law. Delaware law requires that, among other things, you send a written demand for appraisal to Grove after receiving a notice that appraisal rights are available to you, which notice will be sent to non-consenting Grove stockholders in the future. This proxy statement/consent solicitation statement/prospectus is not intended to constitute such a notice. Do not send in your demand before the date of such notice because any demand for appraisal made prior to your receipt of such notice may not be effective to perfect your rights. See the section titled “Appraisal Rights |
Q: |
Should Grove stockholders send in their stock certificates now? |
A: | No. Grove stockholders SHOULD NOT send in any stock certificates now. If the Merger Agreement is adopted and the Merger is consummated, transmittal materials, with instructions for their completion, will be provided under separate cover to Grove stockholders who hold physical stock certificates and the stock certificates should be sent at that time in accordance with such instructions. |
Q: |
Whom should I contact if I have any questions about the consent solicitation? |
A: | If you have any questions about the merger or how to return your written consent or letter of transmittal, or if you need additional copies of this proxy statement/consent solicitation statement/prospectus or a replacement written consent or letter of transmittal, you should contact Delida Costin at legal@grove.co. |
• | Charter Amendment Proposal |
• | Governing Documents Proposal A |
• | Governing Documents Proposal B |
• | Governing Documents Proposal C |
• | Grove’s sustainability-first mindset and ability to innovate quickly; |
• | scale of the addressable market for home and personal care in the U.S.; |
• | the proven ability to drive growth of Grove; |
• | Grove’s strong and increasing margins; |
• | Grove’s strong and loyal direct-to-consumer DTC ”) customer base; |
• | the financial condition of Grove; |
• | the proven track record of Grove’s management team, which will remain in place following the Business Combination; |
• | the continued ownership of Grove equity holders and the significant investments from PIPE Investors in the PIPE Financing; |
• | the terms of the Merger Agreement; |
• | the results of its review of several alternative transactions; |
• | the results of due diligence conducted by VGAC II’s management and its legal and financial advisors; and |
• | Grove’s attractive valuation. |
• | risks associated with the Business Combination, including the possibility that the Business Combination may not be completed; |
• | risks associated with sourcing, manufacturing, warehousing, distribution and logistics to third-party providers; |
• | risks associated with being subject to increased derivative litigation concerning duty to balance stockholder and public benefit interests as a public benefit corporation; |
• | risks related to the post-Business Combination corporate governance of New Grove; |
• | the limited review undertaken by the VGAC II Board; and |
• | the interests of the VGAC II Board and VGAC II’s executive officers. |
Share Ownership in New Grove(1) |
Voting Power in New Grove |
|||||||||||||||
No Redemptions |
Maximum redemptions(2) |
No Redemptions |
Maximum redemptions(2) |
|||||||||||||
Percentage of Outstanding Shares |
Percentage of Outstanding Shares |
Percentage of Voting Power of Outstanding Shares |
Percentage of Voting Power of Outstanding Shares |
|||||||||||||
VGAC II Shareholders |
22.4 | % | 5.9 | % | [ | ●]% | [ | ●]% | ||||||||
Sponsor |
3.7 | % | 4.4 | % | [ | ●]% | [ | ●]% | ||||||||
PIPE Investors |
4.8 | % | 5.9 | % | [ | ●]% | [ | ●]% | ||||||||
Grove Class A Stockholders(3) |
[● | ]% | [● | ]% | [ | ●]% | [ | ●]% | ||||||||
Grove Class B Stockholders(3) |
[● | ]% | [● | ]% | [ | ●]% | [ | ●]% |
(1) | As of [●], 2022. Percentages may not add to 100% due to rounding. |
(2) | Assumes that 31,459,600 of VGAC II’s Class A ordinary share are redeemed for an aggregate payment of $314.6 million (which is the maximum number of redemptions that would still allow the Minimum Cash Condition to be satisfied). |
(3) | Excludes equity awards issued at Closing upon rollover of vested and unvested Grove equity awards under the proposed New Grove Incentive Equity Plan. |
(4) | Each share of New Grove Class B Common Stock will have ten (10) votes per share, while each share of New Grove Class A Common Stock will have one (1) vote per share. |
(i) | Business Combination Proposal |
(ii) | Domestication Proposal two-thirds of the ordinary shares who, being present in person or represented by proxy and entitled to vote at the extraordinary general meeting, vote at the extraordinary general meeting. |
(iii) | Charter Amendment Proposal : two-thirds of the ordinary shares who, being present in person or represented by proxy and entitled to vote at the extraordinary general meeting, vote at the extraordinary general meeting. |
(iv) | Governing Documents Proposals : |
(v) | NYSE Proposal |
(vi) | Incentive Equity Plan Proposal |
(vii) | ESPP Proposal |
(viii) | Director Election Proposal |
(ix) | Adjournment Proposal |
shares who, being present in person or represented by proxy and entitled to vote at the extraordinary general meeting, vote at the extraordinary general meeting. |
(i) | (a) hold public shares, or (b) if you hold public shares through units, you elect to separate your units into the underlying public shares and warrants prior to exercising your redemption rights with respect to the public shares; |
(ii) | submit a written request to Continental, VGAC II’s transfer agent, in which you (a) request that New Grove redeem all or a portion of your public shares for cash, and (b) identify yourself as the beneficial holder of the public shares and provide your legal name, phone number, and address; and |
(iii) | deliver your share certificates (if any) and other redemption forms (as applicable) to Continental physically or electronically through DTC. |
• | the fact that the Sponsor has agreed not to redeem any Class A ordinary shares held by it in connection with a shareholder vote to approve a proposed initial business combination; |
• | the fact that the Sponsor paid an aggregate of $25,000 for 10,062,500 Class B ordinary shares, of which the Sponsor currently owns 9,972,500 Class B ordinary shares and each of the three independent directors owns 30,000 Class B ordinary shares, and such securities will have a significantly higher value at the time of the Business Combination; as described further below: |
Shares of Class B ordinary shares(1) |
Value of Class B ordinary shares implied by the Business Combination(3) |
Value of Class B ordinary shares based on recent trading price(4) |
||||||||||
Sponsor(2) |
9,972,500 | $ | 99,725,000 | $ | ||||||||
Chris Burggraeve |
30,000 | $ | 300,000 | $ | ||||||||
Elizabeth Nelson |
30,000 | $ | 300,000 | $ | ||||||||
Latif Peracha |
30,000 | $ | 300,000 | $ |
(1) | Interests shown consist solely of founder shares. Such shares will automatically convert into shares of New Grove Class A Common Stock upon Domestication on a one-for-one |
(2) | VG Acquisition Sponsor II LLC is the record holder of the shares reported herein. |
(3) | Assumes a value of $10.00 per share, the deemed value of the Class B ordinary shares in the Business Combination. |
(4) | Assumes a value of $ per share, the closing price of the Class B ordinary shares on |
• | the fact that each of Mr. Bayliss and Mr. Lovell invested $300,000 in the Sponsor and hold interests in the Sponsor that represent an indirect interest in 1,246,600 Class B ordinary shares and 197,939 private placement warrants, and the fact that Mr. Burggraeve, Ms. Nelson and Mr. Peracha each invested $100,000, in the Sponsor indirectly through an investment in VG Acquisition Holdings II LLC, an affiliate of the Sponsor, and each holds interests in VG Acquisition Holdings II LLC that represent an indirect interest in 70,216 Class B ordinary shares, and 66,550 private placement warrants, and all of such securities would be worthless if a business combination is not consummated by March 25, 2023 (unless such date is extended in accordance with the Existing Governing Documents); |
• | the fact that given the differential in the purchase price that the Sponsor paid for the founder shares as compared to the price of the public shares sold in the initial public offering, the Sponsor and its affiliates may earn a positive rate of return on their investment even if the Class A ordinary shares trades below the price initially paid for the public shares in the initial public offering and the public shareholders experience a negative rate of return following the completion of the Business Combination; |
• | the fact that the Sponsor will benefit from the completion of a business combination and may be incentivized to complete an acquisition of a less favorable target company or on terms less favorable to shareholders rather than liquidate; |
• | the fact that if a business combination is not consummated by March 25, 2023 (unless such date is extended in accordance with the Existing Governing Documents), our Sponsor and VGAC II’s officers and directors will lose their entire investment in VGAC II, which investment included a capital contribution of $25,000 for the Sponsor’s Class B ordinary shares and $10,050,000 for the Sponsor’s private placement warrants, and will not be reimbursed for any out-of-pocket |
• | the fact that the Sponsor and VGAC II’s other current officers and directors have agreed to waive their rights to liquidating distributions from the trust account with respect to any ordinary shares (other than public shares) held by them if VGAC II fails to complete an initial business combination by March 25, 2023; |
• | the fact that the Registration Rights Agreement will be entered into by the Sponsor; |
• | the fact that the Sponsor transferred 30,000 Class B ordinary shares to each of VGAC II’s three independent directors prior to the initial public offering, and such securities would be worthless if a business combination is not consummated by March 25, 2023 (unless such date is extended in accordance with the Existing Governing Documents); |
• | the fact that the Sponsor entered into the Sponsor Agreement pursuant to which the Sponsor has agreed that the Sponsor Earnout Shares will be subject to certain earn-out provisions set forth in the Sponsor Agreement, with such shares vesting effective (i) with respect to 50% of the Sponsor Earnout Shares, if the daily volume weighted average price of the shares of New Grove Class A Common Stock is greater than or equal to $12.50 for any 20 trading days (which may be consecutive or not consecutive) within any 30-trading-day period that occurs after the Closing Date and prior to the expiration of the Sponsor Earnout Period and (ii) with respect to the other 50% of the Sponsor Earnout Shares, if the daily volume weighted average price of the shares of New Grove Class A Common Stock is greater than or equal to $15.00 for any 20 trading days (which may be consecutive or not consecutive) within any 30-trading-day |
expiration of the Sponsor Earnout Period, any Sponsor Earnout Shares shall have not vested, then such Sponsor Earnout Shares shall be automatically forfeited by the Sponsor and canceled by New Grove; |
• | the continued indemnification of VGAC II’s directors and officers and the continuation of VGAC II’s directors’ and officers’ liability insurance after the Business Combination ( i.e. |
• | the fact that if the trust account is liquidated, including in the event VGAC II is unable to complete an initial business combination by March 25, 2023, the Sponsor has agreed to indemnify VGAC II to ensure that the proceeds in the trust account are not reduced below $10.00 per public share, or such lesser per public share amount as is in the trust account on the liquidation date, by the claims of prospective target businesses with which VGAC II has entered into an acquisition agreement or claims of any third party for services rendered or products sold to VGAC II, but only if such a vendor or target business has not executed a waiver of any and all rights to seek access to the trust account; |
• | the fact that [●], [●] of the Sponsor is expected to be director of New Grove after the consummation of the Business Combination and as such, in the future, he may receive cash fees, stock options, stock awards or other remuneration that the New Grove Board determines to pay to him and any other applicable compensation; and |
• | the fact that the Virgin Group and the Sponsor will collectively own 6,572,125 shares of New Grove Class A Common Stock, which collectively will represent up to approximately 4.4% outstanding shares of New Grove Common Stock and approximately [●]% of the voting power of New Grove Common Stock assuming that 100% of VGAC II Class A ordinary shares are redeemed. |
Source of Funds(1) (in thousands) |
Uses(1) (in thousands) |
|||||||||
Existing Cash held in trust account(2) |
$ | 402,521 | Merger Consideration to Grove Equityholders(3) |
$ | 1,400,000 | |||||
Merger Consideration to Grove Equityholders(3) |
$ | 1,400,000 | Transaction Fees and Expenses |
$ | 50,000 | |||||
PIPE Financing(3) |
$ | 87,075 | Remaining Cash to Balance Sheet |
$ | 439,596 | |||||
|
|
|
|
|||||||
Total Sources |
$ |
1,889,596 |
Total Uses |
$ |
1,889,596 |
|||||
|
|
|
|
(1) | Totals might be affected by rounding. |
(2) | As of September 30, 2021. |
(3) | Shares issued to Grove Equityholders and PIPE Investors are at a deemed value of $10.00 per share. |
Source of Funds(1) (in thousands) |
Uses(1) (in thousands) |
|||||||||
Existing Cash held in trust account(2) |
$ | 402,521 | Merger Consideration to Grove Equityholders(3) |
$ | 1,400,000 | |||||
Merger Consideration to Grove |
Transaction Fees and Expenses |
$ | 50,000 | |||||||
Equityholders(3) |
$ | 1,400,000 | VGAC II public shareholder redemptions |
$ | 314,596 | |||||
Pipe Financing(3) |
$ | 87,075 | Remaining Cash to Balance Sheet |
$ | 125,000 | |||||
|
|
|
|
|||||||
Total Sources |
$ |
1,889,596 |
Total Uses |
$ |
1,889,596 |
|||||
|
|
|
|
(1) | Totals might be affected by rounding. |
(2) | As of September 30, 2021. |
(3) | Shares issued to Grove Equityholders and PIPE Investors are at a deemed value of $10.00 per share. |
For the Period from January 13, 2021 to September 30, 2021 |
||||
Statement of Operations Data |
||||
Formation and operating costs |
$ | 1,485,953 | ||
|
|
|||
Loss from operations |
(1,485,953 | ) | ||
Other income (expense): |
||||
Interest earned on investments held in trust account |
20,541 | |||
Offering costs allocated to warrants |
(570,496 | ) | ||
Change in fair value of warranty liability |
6,496,009 | |||
|
|
|||
Total other income (expense) |
5,946,054 | |||
|
|
|||
Net Loss |
$ |
4,460,101 |
||
|
|
|||
Weighted average shares outstanding of Class A redeemable ordinary shares |
28,918,582 | |||
|
|
|||
Basic and diluted net income per share, Class A |
$ |
0.12 |
||
|
|
|||
Weighted average shares outstanding of Class B non-redeemable ordinary shares |
9,640,625 | |||
|
|
|||
Basic and diluted net loss per share, Class B |
$ |
0.12 |
||
|
|
As of September 30, 2021 |
||||
Balance Sheet Data |
||||
Total Current Assets |
$ | 687,978 | ||
Prepaid expenses—non-current portion |
299,902 | |||
Cash and investments held in trust account |
402,520,541 | |||
|
|
|||
Total Assets |
403,508,421 | |||
|
|
|||
Total Liabilities |
28,786,992 | |||
Class A ordinary shares, $0.0001 par value; 200,000,000 shares authorized; 40,250,000 shares subject to possible redemption at a redemption value of $10.00 per share |
402,500,000 | |||
Shareholders’ Deficit: |
||||
Class B ordinary shares, $0.0001 par value; 20,000,000 shares authorized; 10,062,500 shares issued and outstanding |
1,006 | |||
Additional paid-in capital |
— | |||
Accumulated deficit |
(27,779,577 | ) | ||
|
|
|||
Total Shareholders’ deficit |
(27,778,571 | ) | ||
|
|
|||
Total Liabilities and Shareholders’ deficit |
403,508,421 | |||
|
|
Year Ended December 31, |
Nine Months Ended September 30, |
|||||||||||||||||||
2018 |
2019 |
2020 |
2020 |
2021 |
||||||||||||||||
(in thousands) |
||||||||||||||||||||
Statement of Operations Data: |
||||||||||||||||||||
Revenue, net |
$ | 104,928 | $ | 233,116 | $ | 364,271 | $ | 271,233 | $ | 296,421 | ||||||||||
Cost of goods sold |
68,502 | 149,681 | 188,267 | 141,683 | 147,179 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Gross profit |
36,426 | 83,435 | 176,004 | 129,550 | 149,242 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Operating expenses: |
||||||||||||||||||||
Advertising |
32,095 | 77,842 | 55,547 | 43,816 | 90,611 | |||||||||||||||
Product development |
5,581 | 13,604 | 18,655 | 13,855 | 16,436 | |||||||||||||||
Selling, general and administrative |
79,486 | 155,158 | 168,295 | 126,427 | 140,609 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Operating loss |
(80,736 | ) | (163,169 | ) | (66,493 | ) | (54,548 | ) | (98,414 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Interest expense |
619 | 2,052 | 5,607 | 4,568 | 3,272 | |||||||||||||||
Loss on extinguishment of debt |
— | — | — | — | 1,027 | |||||||||||||||
Other expense (income), net |
339 | (3,763 | ) | 119 | (204 | ) | 1,157 | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Interest and other expense (income), net |
958 | (1,711 | ) | 5,726 | 4,364 | 5,456 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Loss before provision for income taxes |
(81,694 | ) | (161,458 | ) | (72,219 | ) | (58,912 | ) | (103,870 | ) | ||||||||||
Provision for income taxes |
1 | 12 | 41 | 31 | 39 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net loss |
$ | (81,695 | ) | $ | (161,470 | ) | $ | (72,260 | ) | $ | (58,943 | ) | $ | (103,909 | ) | |||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Deemed dividend due to the exchange of Series Seed convertible preferred stock and Series A convertible preferred stock for Series D convertible preferred stock |
— | (1,801 | ) | — | — | — | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net loss attributable to common stockholders, basic and diluted |
$ | (81,695 | ) | $ | (163,271 | ) | $ | (72,260 | ) | $ | (58,943 | ) | $ | (103,909 | ) | |||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net loss per share attributable to common stockholders, basic and diluted |
$ | (21.13 | ) | $ | (43.37 | ) | $ | (15.82 | ) | $ | (14.29 | ) | $ | (14.61 | ) | |||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted |
3,865,812 | 3,764,374 | 4,568,540 | 4,125,470 | 7,114,091 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
December 31, |
September 30, 2021 |
|||||||||||
2019 |
2020 |
|||||||||||
(in thousands) |
||||||||||||
Balance Sheet Data: |
||||||||||||
Cash and cash equivalents |
$ | 36,829 | $ | 176,523 | $ | 109,217 | ||||||
Working capital (deficit) (1) |
(14,345 | ) | 164,793 | 101,177 | ||||||||
Total assets |
87,703 | 269,718 | 216,929 | |||||||||
Debt, current |
18,800 | 1,918 | 1,265 | |||||||||
Debt, noncurrent |
2,463 | 29,782 | 55,981 | |||||||||
Total liabilities |
90,843 | 121,441 | 157,729 | |||||||||
Convertible preferred stock |
273,412 | 487,918 | 487,918 | |||||||||
Accumulated deficit |
(281,987 | ) | (354,247 | ) | (458,156 | ) | ||||||
Total stockholders’ deficit |
(276,552 | ) | (339,641 | ) | (428,718 | ) |
(1) |
Working capital (deficit) is defined as current assets less current liabilities. See the financial statements and the related notes included elsewhere in this proxy statement/prospectus/information statement for further details regarding Grove’s current assets and current liabilities. |
• | No Redemption Scenario: |
• | Maximum Redemption Scenario: |
No Redemption |
Maximum Redemption |
|||||||||||||||
Number of Shares |
% Ownership |
Number of Shares |
% Ownership |
|||||||||||||
Former VGII shareholders |
40,250,000 | 22.4 | % | 40,250,000 | 22.4 | % | ||||||||||
Less: VGII Class A shares redeemed |
— | — | % | (31,459,600 | ) | (16.5 | )% | |||||||||
|
|
|
|
|
|
|
|
|||||||||
Total held by former VGII shareholders |
40,250,000 | 22.4 | % | 8,790,400 | 5.9 | % | ||||||||||
Sponsor |
6,572,125 | 3.7 | % | 6,572,125 | 4.4 | % | ||||||||||
Grove Shareholders |
124,056,114 | 69.1 | % | 124,056,114 | 83.8 | % | ||||||||||
PIPE Investors |
8,707,500 | 4.8 | % | 8,707,500 | 5.9 | % | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Pro forma shares outstanding |
179,585,739 | 100.0 | % | 148,126,139 | 100.0 | % | ||||||||||
|
|
|
|
|
|
|
|
Pro Forma Combined |
||||||||
No Redemption |
Maximum Redemption |
|||||||
(in thousands, except per share data) |
||||||||
Selected Unaudited Pro Forma Condensed Combined Statement of Operations Data—Nine Months Ended September 30, 2021 |
||||||||
Revenue |
$ | 296,421 | $ | 296,421 | ||||
Operating loss |
(99,900 | ) | (99,900 | ) | ||||
Net loss |
(97,943 | ) | (97,943 | ) | ||||
Net loss per share, basic and diluted |
$ | (0.55 | ) | $ | (0.67 | ) | ||
Weighted average shares, basic and diluted |
178,598,507 | 147,138,907 | ||||||
Selected Unaudited Pro Forma Condensed Combined Statement of Operations Data—Year Ended December 31, 2020 |
||||||||
Revenue |
$ | 364,271 | $ | 364,271 | ||||
Operating loss |
(68,640 | ) | (68,640 | ) | ||||
Net loss |
(73,443 | ) | (73,443 | ) | ||||
Net loss per share, basic and diluted |
$ | (0.47 | ) | $ | (0.58 | ) | ||
Weighted average shares, basic and diluted |
157,126,637 | 125,667,037 | ||||||
Selected Unaudited Pro Forma Condensed Combined Balance Sheet Data—As of September 30, 2021 |
||||||||
Total current assets |
$ | 624,534 | $ | 309,938 | ||||
Total assets |
664,879 | 350,283 | ||||||
Total current liabilities |
74,445 | 74,445 | ||||||
Total liabilities |
314,134 | 314,134 | ||||||
Total stockholders’ equity |
350,745 | 36,149 |
• | The FDA regulates product labels and other product claims for the consumer products subject to its jurisdiction and has the authority to challenge product labels and claims that it believes are non-compliant or false or misleading, through the use of a variety of enforcement tools (e.g., Warning Letters, untitled letters, and seizure actions). In limited circumstances, the FDA has taken regulatory action against products labeled “natural” but that nonetheless contain synthetic ingredients or components. |
• | The FTC has the authority to challenge claims made in product advertising and requires that such claims are adequately substantiated prior to use. The FTC similarly has enforcement tools that it uses to challenge advertising claims that it deems non-compliant with the law. |
• | The USDA enforces federal standards for organic production and use of the term “organic” on product labeling. These laws prohibit a company from selling or labeling products as organic unless they are produced and handled in accordance with the applicable federal law. Failure to comply with these requirements may subject us to liability or regulatory enforcement. Consumers may also pursue state law claims challenging use of the organic label as being intentionally mislabeled or misleading or deceptive to consumers. |
• | In addition, certain products, including the disinfectant products, we sell may require approval from and registration with the EPA and state regulatory agencies prior to sale. Products that expressly or impliedly claim to control microorganisms that pose a threat to human health may be subject by additional regulatory scrutiny and need to be supported by additional efficacy data. Should we advertise or market these regulated products with claims that are not permitted by the terms of their registration or are otherwise false or misleading, the EPA and states may be authorized to take enforcement action to prevent the sale or distribution of disinfectant products. |
• | the fact that the Sponsor has agreed not to redeem any Class A ordinary shares held by it in connection with a shareholder vote to approve a proposed initial business combination; |
• | the fact that the Sponsor paid an aggregate of $25,000 for 10,062,500 Class B ordinary shares, of which the Sponsor currently owns 9,972,500 Class B ordinary shares and each of the three independent directors owns 30,000 Class B ordinary shares, and such securities will have a significantly higher value at the time of the Business Combination; as described further below: |
Shares of Class B ordinary shares (1) |
Value of Class B ordinary shares implied by the Business Combination (3) |
Value of Class B ordinary shares based on recent trading price (4) |
||||||||||
Sponsor(2) |
9,972,500 | $ | 99,725,000 | $ | ||||||||
Chris Burggraeve |
30,000 | $ | 300,000 | $ | ||||||||
Elizabeth Nelson |
30,000 | $ | 300,000 | $ | ||||||||
Latif Peracha |
30,000 | $ | 300,000 | $ |
(1) | Interests shown consist solely of founder shares. Such shares will automatically convert into shares of New Grove Class A Common Stock upon Domestication on a one-for-one |
(2) | VG Acquisition Sponsor II LLC is the record holder of the shares reported herein. |
(3) | Assumes a value of $10.00 per share, the deemed value of the Class B ordinary shares in the Business Combination. |
(4) | Assumes a value of $ per share, the closing price of the Class B ordinary shares on |
• | the fact that each of Mr. Bayliss and Mr. Lovell invested $300,000 in the Sponsor and hold interests in the Sponsor that represent an indirect interest in 1,246,600 Class B ordinary shares and 197,939 private placement warrants, and the fact that Mr. Burggraeve, Ms. Nelson and Mr. Peracha each invested $100,000, in the Sponsor indirectly through an investment in VG Acquisition Holdings II LLC, an affiliate of the Sponsor, and each holds interests in VG Acquisition Holdings II LLC that represent an indirect interest in 70,216 Class B ordinary shares, and 66,550 private placement warrants, and all of such securities would be worthless if a business combination is not consummated by March 25, 2023 (unless such date is extended in accordance with the Existing Governing Documents); |
• | the fact that given the differential in the purchase price that the Sponsor paid for the founder shares as compared to the price of the public shares sold in the initial public offering, the Sponsor and its affiliates may earn a positive rate of return on their investment even if the Class A ordinary shares trades below the price initially paid for the public shares in the initial public offering and the public shareholders experience a negative rate of return following the completion of the Business Combination; |
• | the fact that the Sponsor will benefit from the completion of a business combination and may be incentivized to complete an acquisition of a less favorable target company or on terms less favorable to shareholders rather than liquidate; |
• | the fact that if a business combination is not consummated by March 25, 2023 (unless such date is extended in accordance with the Existing Governing Documents), our Sponsor and VGAC II’s officers and directors will lose their entire investment in VGAC II, which investment included a capital contribution of $25,000 for the Sponsor’s Class B ordinary shares and $10,050,000 for the Sponsor’s private placement warrants, and will not be reimbursed for any out-of-pocket |
• | the fact that the Sponsor and VGAC II’s other current officers and directors have agreed to waive their rights to liquidating distributions from the trust account with respect to any ordinary shares (other than public shares) held by them if VGAC II fails to complete an initial business combination by March 25, 2023; |
• | the fact that the Registration Rights Agreement will be entered into by the Sponsor; |
• | the fact that the Sponsor transferred 30,000 Class B ordinary shares to each of VGAC II’s three independent directors prior to the initial public offering, and such securities would be worthless if a business combination is not consummated by March 25, 2023 (unless such date is extended in accordance with the Existing Governing Documents); |
• | the fact that the Sponsor entered into the Sponsor Agreement pursuant to which the Sponsor has agreed that the Sponsor Earnout Shares will be subject to certain earn-out provisions set forth in the Sponsor Agreement, with such shares vesting effective (i) with respect to 50% of the Sponsor Earnout Shares, if the daily volume weighted average price of the shares of New Grove Class A Common Stock is greater than or equal to $12.50 for any 20 trading days (which may be consecutive or not consecutive) within any 30-trading-day 30-trading-day |
assignment for the benefit of creditors or similar event with respect to New Grove after the Closing Date and prior to the expiration of the Sponsor Earnout Period, the Sponsor Earnout Shares will vest (to the extent such Sponsor Earnout Shares have not already vested in accordance with the Sponsor Agreement). If, upon the expiration of the Sponsor Earnout Period, any Sponsor Earnout Shares shall have not vested, then such Sponsor Earnout Shares shall be automatically forfeited by the Sponsor and canceled by New Grove; |
• | the continued indemnification of VGAC II’s directors and officers and the continuation of VGAC II’s directors’ and officers’ liability insurance after the Business Combination ( i.e. |
• | the fact that if the trust account is liquidated, including in the event VGAC II is unable to complete an initial business combination by March 25, 2023, the Sponsor has agreed to indemnify VGAC II to ensure that the proceeds in the trust account are not reduced below $10.00 per public share, or such lesser per public share amount as is in the trust account on the liquidation date, by the claims of prospective target businesses with which VGAC II has entered into an acquisition agreement or claims of any third party for services rendered or products sold to VGAC II, but only if such a vendor or target business has not executed a waiver of any and all rights to seek access to the trust account; |
• | the fact that [●], [●] of the Sponsor is expected to be director of New Grove after the consummation of the Business Combination and as such, in the future, he may receive cash fees, stock options, stock awards or other remuneration that the New Grove Board determines to pay to him and any other applicable compensation; and |
• | the fact that the Virgin Group and the Sponsor will collectively own 6,572,125 shares of New Grove Class A Common Stock, which collectively will represent up to approximately 4.4% outstanding shares of New Grove Common Stock and approximately [●]% of the voting power of New Grove Common Stock assuming that 100% of VGAC II Class A ordinary shares are redeemed. |
• | changes in the industries in which New Grove and its customers operate; |
• | variations in its operating performance and the performance of its competitors in general; |
• | any material and adverse impact of the COVID-19 pandemic on the markets and the broader global economy; |
• | actual or anticipated fluctuations in New Grove’s quarterly or annual results of operation; |
• | publication of research reports by securities analysts about New Grove or its competitors or its industry; |
• | the public’s reaction to New Grove’s press releases, its other public announcements, and its filings with the SEC; |
• | New Grove’s failure or the failure of its competitors to meet analysts’ projections or guidance that New Grove or its competitors may give to the market; |
• | additions and departures of key personnel; |
• | changes in laws and regulations affecting its business; |
• | commencement of, or involvement in, litigation involving New Grove; |
• | changes in New Grove’s capital structure, such as future issuances of securities or the incurrence of additional debt; |
• | the volume of shares of New Grove Class A Common Stock available for public sale; |
• | sales of shares of New Grove Class A Common Stock by the PIPE Investors; and |
• | general economic and political conditions such as recessions, interest rates, fuel prices, foreign currency fluctuations, international tariffs, social, political, and economic risks, and acts of war or terrorism. |
• | a limited availability of market quotations for New Grove’s securities; |
• | reduced liquidity for New Grove’s securities; |
• | a determination that New Grove Class A Common Stock is a “penny stock” which will require brokers trading in New Grove Class A Common Stock to adhere to more stringent rules and possibly result in a reduced level of trading activity in the secondary trading market for New Grove’s securities; |
• | a limited amount of news and analyst coverage; and |
• | a decreased ability to issue additional securities or obtain additional financing in the future. |
• | Subject to the discussion below concerning PFICs, a U.S. Holder of Class A ordinary shares whose ordinary shares have a fair market value of less than $50,000 on the date of the Domestication and who is not a 10% shareholder (as defined above) will not recognize any gain or loss and will not be required to include any part of VGAC II’s earnings in income. |
• | Subject to the discussion below concerning PFICs, a U.S. Holder of Class A ordinary shares whose ordinary shares have a fair market value of $50,000 or more, but who is not a 10% shareholder will generally recognize gain (but not loss) on the deemed receipt of New Grove Class A Common Stock in the Domestication. As an alternative to recognizing gain as a result of the Domestication, such U.S. Holder may file an election to include in income, as a dividend, the “all earnings and profits amount” (as defined in the Treasury Regulations under Section 367 of the Code) attributable to its Class A ordinary shares provided certain other requirements are satisfied. |
• | Subject to the discussion below concerning PFICs, a U.S. Holder of Class A ordinary shares who on the date of the Domestication is a 10% shareholder will generally be required to include in income, as a dividend, the “all earnings and profits amount” (as defined in the Treasury Regulations under Section 367 of the Code) attributable to its VGAC II shares provided certain other requirements are satisfied. |
• | As discussed further under “ U.S. Federal Income Tax Considerations |
• | a classified board of directors; |
• | the dual-class structure that provides for New Grove Class B Common Stock being entitled to ten (10) votes per share; |
• | the ability of the New Grove Board to issue shares of preferred stock, including “blank check” preferred stock and to determine the price and other terms of those shares, including preferences and voting rights, without stockholder approval, which could be used to significantly dilute the ownership of a hostile acquirer; |
• | the limitation of the liability of, and the indemnification of, New Grove’s directors and officers; |
• | the requirement that a special meeting of stockholders may only be called by a majority of the entire New Grove Board, the Chairman of the New Grove Board, or the Chief Executive Officer of New Grove, which could delay the ability of stockholders to force consideration of a proposal or to take action, including the removal of directors; |
• | controlling the procedures for the conduct and scheduling of board of directors and stockholder meetings; |
• | the ability of the New Grove Board to amend the bylaws, which may allow the New Grove Board to take additional actions to prevent an unsolicited takeover and inhibit the ability of an acquirer to amend the bylaws to facilitate an unsolicited takeover attempt; and |
• | advance notice procedures with which stockholders must comply to nominate candidates to the New Grove Board or to propose matters to be acted upon at a stockholders’ meeting, which could preclude stockholders from bringing matters before annual or special meetings of stockholders and delay changes in the New Grove Board, and also may discourage or deter a potential acquirer from conducting a solicitation of proxies to elect the acquirer’s own slate of directors or otherwise attempting to obtain control of New Grove. |
• | a proposal to approve by ordinary resolution the Merger Agreement, including the Merger, and the transactions contemplated thereby; |
• | a proposal to approve by special resolution the Domestication; |
• | a proposal to approve by special resolution the adoption and approval of the Proposed Certificate of Incorporation and the Proposed Bylaws; |
• | the following five separate non-binding, advisory proposals to approve by ordinary resolution the following material differences between the Existing Governing Documents and the Proposed Governing Documents: |
• | to authorize the change in the authorized share capital of VGAC II from (i) US$22,100 divided into 200,000,000 Class A ordinary shares, par value $0.0001 per share, 20,000,000 Class B ordinary shares, par value $0.0001 per share, and 1,000,000 preference shares, par value $0.0001 per share, to (ii) 600,000,000 shares of New Grove Class A Common Stock, 200,000,000 shares of New Grove Class B Common Stock, and 100,000,000 shares of New Grove Preferred Stock; |
• | to amend and restate the Existing Governing Documents and authorize all other immaterial changes in connection with the replacement of the Existing Governing Documents with the Proposed Governing Documents as part of the Domestication, including (i) changing the post-Business Combination corporate name from “Virgin Group Acquisition Corp. II” to “Grove Collaborative Holdings, Inc.” (which is expected to occur upon the effectiveness of the Domestication), (ii) making New Grove’s corporate existence perpetual, (iii) adopting Delaware as the exclusive forum for certain stockholder litigation and the federal district courts of the United States as the exclusive forum for litigation arising out of the Securities Act and (iv) removing certain provisions related to VGAC II’s status as a blank check company that will no longer be applicable upon consummation of the Business Combination, all of which the VGAC II Board believes is necessary to adequately address the needs of New Grove after the Business Combination; |
• | to authorize the issuance of shares of New Grove Class B Common Stock, which will allow holders of New Grove Class B Common Stock to cast ten votes per share of New Grove Class B Common Stock; and |
• | a proposal to approve by ordinary resolution the issuance of shares of New Grove Class A Common Stock and shares of New Grove Class B Common Stock in connection with the Business Combination and the PIPE Financing pursuant to NYSE Listing Rule 312.03; |
• | a proposal to approve and adopt by ordinary resolution the Incentive Equity Plan; |
• | a proposal to approve and adopt by ordinary resolution the ESPP; |
• | a proposal to elect Stuart Landesberg, Christopher Clark, Catherine Beaudoin, David Glazer, John Replogle, [●], [●], [●] and [●], in each case, to serve as directors of New Grove until their respective successors are duly elected and qualified, or until their earlier death, resignation, or removal; and |
• | a proposal to approve by ordinary resolution the adjournment of the extraordinary general meeting to a later date or dates, if necessary, to, among other things, permit further solicitation and vote of proxies in the event that there are insufficient votes for the approval of one or more proposals at the extraordinary general meeting. |
(i) | Business Combination Proposal |
(ii) | Domestication Proposal two-thirds of the ordinary shares who, being present in person or represented by proxy and entitled to vote at the extraordinary general meeting, vote at the extraordinary general meeting. |
(iii) | Charter Amendment Proposal two-thirds of the ordinary shares who, being present in person or represented by proxy and entitled to vote at the extraordinary general meeting, vote at the extraordinary general meeting. |
(iv) | Governing Documents Proposals : |
(v) | NYSE Proposal |
(vi) | Incentive Equity Plan Proposal |
(vii) | ESPP Proposal |
present in person or represented by proxy and entitled to vote at the extraordinary general meeting, vote at the extraordinary general meeting. |
(viii) | Director Election Proposal |
(ix) | Adjournment Proposal |
• | you may send another proxy card with a later date; |
• | you may notify VGAC II’s Chief Financial Officer in writing that you have revoked your proxy, such written notification must be received by 11:59 PM, Eastern Time, on [●], 2022; or |
• | you may attend the extraordinary general meeting, revoke your proxy, and vote in person, as indicated above. |
(i) | (a) hold public shares or (b) hold public shares through units and elect to separate your units into the underlying public shares and warrants prior to exercising your redemption rights with respect to the public shares; |
(ii) | submit a written request to Continental, VGAC II’s transfer agent, in which you (a) request that New Grove redeem all or a portion of your public shares for cash, and (b) identify yourself as the beneficial holder of the public shares and provide your legal name, phone number, and address; and |
(iii) | deliver your share certificates (if any) and other redemption forms (as applicable) to Continental physically or electronically through DTC. |
(a) | If the daily volume weighted average price of the shares of New Grove Class A Common Stock is greater than or equal to $12.50 per share for any 20 trading days (which may be consecutive or not consecutive) within any 30-trading-day $12.50 Share Price Milestone ”), 7,000,000 of the Grove Earnout Shares (the “$12.50 Grove Earnout Shares ”) will automatically vest; and |
(b) | If the daily volume weighted average price of the shares of New Grove Class A Common Stock is greater than or equal to $15.00 per share for any 20 trading days (which may be consecutive or not consecutive) within any 30-trading-day $15.00 Share Price Milestone ”), 7,000,000 of the Grove Earnout Shares (the “$15.00 Grove Earnout Shares ”) will automatically vest. |
(a) | any person or any “group” of persons acting together which would constitute a “group” for purposes of Section 13(d) of the Exchange Act or any successor provisions thereto (excluding a corporation or other entity owned, directly or indirectly, by the stockholders of New Grove in substantially the same proportions as their ownership of stock of New Grove) (x) is or becomes the beneficial owner, directly or indirectly, of securities of New Grove representing more than fifty percent (50%) of the combined voting power of New Grove’s then outstanding voting securities or (y) has or acquires control of the New Grove Board; |
(b) | a merger, consolidation, reorganization or similar business combination transaction involving New Grove, and, immediately after the consummation of such transaction or series of transactions, either (x) the New Grove Board immediately prior to the merger or consolidation does not constitute at least a majority of the board of directors of the company surviving the merger or, if the surviving company is a subsidiary, the ultimate parent thereof, or (y) the voting securities of New Grove immediately prior to such merger or consolidation do not continue to represent or are not converted into more than fifty percent (50%) of the combined voting power of the then outstanding voting securities of the person resulting from such transaction or series of transactions or, if the surviving company is a subsidiary, the ultimate parent thereof; or |
(c) | the sale, lease or other disposition, directly or indirectly, by New Grove of all or substantially all of the assets of New Grove and its subsidiaries, taken as a whole, other than such sale or other disposition by VGAC II of all or substantially all of the assets of New Grove and its subsidiaries, taken as a whole, to an entity at least a majority of the combined voting power of the voting securities of which are owned by the stockholders of New Grove. |
• | organization and qualification to do business, subsidiaries; |
• | organizational documents; |
• | capitalization; |
• | authority to enter into the Merger Agreement; |
• | no conflicts and required filings and consents; |
• | permits and compliance; |
• | financial statements; |
• | absence of certain changes or events; |
• | absence of litigation; |
• | employee benefit plans; |
• | labor and employment matters; |
• | real property and title to assets; |
• | intellectual property and data security; |
• | regulatory compliance; |
• | taxes; |
• | environmental matters; |
• | material contracts; |
• | insurance; |
• | approval of the Grove board and Grove stockholder vote required; |
• | certain business practices; |
• | interested party transactions; |
• | customers and vendors; |
• | exchange act; |
• | brokers; |
• | the information set forth in this proxy statement/consent solicitation statement/prospectus; and |
• | exclusivity of the representations and warranties made by Grove. |
• | corporate organization; |
• | organizational documents; |
• | capitalization; |
• | authority to enter into the Merger Agreement; |
• | no conflicts and required filings and consents; |
• | compliance; |
• | SEC filings, financial statements and Sarbanes-Oxley Act; |
• | absence of certain changes or events; |
• | absence of litigation; |
• | approval of the VGAC II Board and VGAC II shareholder vote required; |
• | brokers; |
• | the Fairness Opinion; |
• | the trust account; |
• | employees; |
• | taxes; |
• | registration and listing of VGAC II Class A ordinary shares, VGAC II warrants and VGAC II units; |
• | material contracts; |
• | properties; |
• | affiliate transactions; |
• | the PIPE Financing; |
• | certain business practices and anti-corruption; |
• | the information set forth in the proxy statement/consent solicitation statement/prospectus; |
• | investigation and reliance; and |
• | exclusivity of the representations and warranties made by VGAC II and VGAC II Merger Sub. |
• | amend or otherwise change its certificate of incorporation or bylaws or equivalent organizational documents; |
• | issue, sell, pledge, dispose of, grant or encumber, or authorize the issuance, sale, pledge, disposition, grant or encumbrance of, (any shares of any class of capital stock of Grove or any of its subsidiaries, or any options, warrants, restricted stock units, convertible securities or other rights of any kind to acquire any shares of such capital stock, or any other ownership interest (including any phantom interest), of Grove or any of its subsidiaries, other than (A) issuances of Grove warrants in connection with drawdowns in the ordinary course of business pursuant to its existing credit agreement, (B) issuances of Grove securities or other equity securities in connection with acquisitions by Grove or any of its subsidiaries of any corporation, partnership, other business organization or any division or assets thereof in the ordinary course of business, (C) issuances or grants made under the Grove’s 2016 Equity Incentive Plan, (D) the exercise or settlement of any Grove options or Grove warrants or (E) the conversion of any shares of capital stock in accordance with their terms; |
• | sell, lease, license, sublicense, exchange, mortgage, pledge, create any liens (other than permitted liens or liens created in connection with indebtedness incurred in compliance with the seventh bullet) on, transfer or otherwise dispose of any material tangible assets of Grove or its subsidiaries outside of the ordinary course of business; |
• | declare, set aside, make or pay any dividend or other distribution, payable in cash, stock, property or otherwise, with respect to any of its capital stock, except dividends and distributions by a wholly-owned subsidiary of Grove to another wholly-owned subsidiary; |
• | reclassify, combine, split, subdivide or redeem, or purchase or otherwise acquire, directly or indirectly, any of its capital stock, other than (a) redemptions of equity securities from former employees upon the terms set forth in the underlying agreements governing such equity securities, (b) the withholding of equity securities to satisfy the exercise price or the applicable tax withholding requirements upon the exercise or vesting of any equity-based compensation award or (c) transactions between Grove and any wholly-owned subsidiary of Grove or between wholly-owned subsidiaries of Grove; |
• | (a) acquire any equity interest or other interest in any other entity or enter into a joint venture or business association with any other entity or (b) acquire (including by merger, consolidation, or acquisition of stock or substantially all of the assets or any other business combination) any corporation, partnership, other business organization or any division thereof, in each case, if such acquisition exceeds $10,000,000; |
• | (a) other than drawdowns under its existing credit agreement in the ordinary course of business, incur or assume any indebtedness for borrowed money or indebtedness evidenced by any note, bond, debenture, mortgage or other debt instrument or debt security or similar instrument in excess of $18,000,000 in the aggregate, (B) cancel or forgive any material debts or other material amounts owed to Grove or any of its subsidiaries other than in the ordinary course of business or (C) make any loans, advances to, or guarantees for the benefit of, any person other than any wholly-owned subsidiary of Grove, except for loans and advances to customers, suppliers or vendors in the ordinary course of business; |
• | merge or consolidate itself with any person or authorize, recommend, propose or announce an intention to adopt, or otherwise effect, a plan of complete or partial liquidation, dissolution, restructuring, recapitalization, reorganization or similar transaction involving Grove or any of its subsidiaries (other than the Merger); |
• | hire, terminate (other than for cause) or change the material compensation terms of any officer of Grove or any of its subsidiaries who will become subject to Section 16 of the Exchange Act as a result of the transactions contemplated by the Merger Agreement; |
• | change any of its or its subsidiaries’ accounting methods, policies or procedures, other than reasonable and usual amendments in the ordinary course of business as required by GAAP or applicable law or to obtain compliance with the auditing standards of the Public Company Accounting Oversight Board and any division or subdivision thereof; |
• | (a) make or change any material tax election, (b) adopt or change any material tax accounting method, (c) settle or compromise any material tax liability, (d) enter into any closing agreement within the meaning of Section 7121 of the Code (or any corresponding or similar provision of state, local or foreign tax law), (e) file any amended material tax return, (f) consent to any extension or waiver of the statute of limitations regarding any material amount of taxes, or (g) settle or consent to any claim or assessment relating to any material amount of taxes; |
• | (a) commence, waive, release, assign, settle, satisfy or compromise any litigation, suit, claim, action, proceeding, audit or investigation by or before any governmental authority, other than waivers, releases, assignments, settlements or compromises that are solely monetary in nature and do not involve an admission of wrongdoing, do not result in any material restriction on Grove or its subsidiaries and do not exceed $10,000,000 individually or in the aggregate or (B) other than in the ordinary course of business, waive, release or assign any claims or rights of Grove or its subsidiaries; |
• | other than in the ordinary course of business (including, in the case of clause (b) below, upon any expiration of the term of any material contract or as needed to continue conducting its business in the ordinary course of business), (a) modify, voluntarily terminate, permit to lapse, waive, or fail to enforce any material right or remedy under any material contract, (b) materially amend, extend or renew any material contract or (c) enter into any material contract; |
• | except for non-exclusive licenses granted in the ordinary course of business, assign, transfer or dispose of, license, abandon, sell, lease, sublicense, modify, terminate, permit to lapse, create or incur any lien (other than a permitted lien or liens incurred in connection with indebtedness permitted to be incurred under the Merger Agreement) on, or otherwise fail to take any action necessary to maintain, enforce or protect any material intellectual property owned or licensed by Grove or any of its subsidiaries; |
• | permit any specified insurance policies to be canceled or terminated in a manner that would be adverse or detrimental to Grove or its business, other than if, in connection with such cancellation or |
termination, a replacement policy having comparable deductions and providing coverage substantially similar to the coverage under the lapsed policy for substantially similar premiums or less is in full force and effect; |
• | make any commitments for capital expenditures that would reasonably be expected to require payments during fiscal years 2021 or 2022 in excess of $10,000,000 in the aggregate; |
• | fail to maintain or timely obtain any franchise, grant, authorization, license, permit, easement, variance, exception, consent, certificate, approval or order that is material to the ongoing operations of Grove and its subsidiaries; or |
• | enter into any binding formal or informal agreement or otherwise make a binding commitment to do any of the foregoing. |
• | amend or otherwise change (a) the organizational documents of VGAC II or VGAC II Merger Sub or (b) the Trust Agreement or any other agreement related to the Trust Agreement; |
• | declare, set aside, make or pay any dividend or other distribution, payable in cash, stock, property or otherwise, with respect to any of its capital stock, other than redemptions from the trust fund that are required pursuant to the Existing Governing Documents; |
• | reclassify, combine, split, subdivide or redeem, or purchase or otherwise acquire, directly or indirectly, any of the Class A ordinary shares, Class B ordinary shares or VGAC II warrants other than (A) any redemption from the trust fund] that is required pursuant to the Existing Governing Documents or (B) as otherwise required by the Existing Governing Documents in order to consummate the Business Combination; |
• | issue, sell, pledge, dispose of, grant or encumber, or authorize the issuance, sale, pledge, disposition, grant or encumbrance of, any shares of any class of capital stock or other securities of VGAC II or VGAC II Merger Sub, or any options, warrants, convertible securities or other rights of any kind to acquire any shares of such capital stock, or any other ownership interest (including any phantom interest), of VGAC II or VGAC II Merger Sub other than in connection with the exercise of any VGAC II warrants outstanding on the date hereof; |
• | (a) acquire any equity interest or other interest in any other entity or enter into a joint venture, partnership, alliance or business association with any other entity or (b) acquire (including by merger, consolidation, or acquisition of stock or assets or any other business combination) any corporation, partnership, other business organization; |
• | other than working capital loans from the Sponsor to fund operating expenses, incur or assume any indebtedness for borrowed money or guarantee any such indebtedness of another person or persons, issue or sell any debt securities or options, warrants, calls or other rights to acquire any debt securities of VGAC II, as applicable, enter into any “keep well” or other agreement to maintain any financial statement condition or enter into any arrangement having the economic effect of any of the foregoing; |
• | make any change in any method of financial accounting or financial accounting principles, policies, procedures or practices, except as required by a concurrent amendment in GAAP or applicable law; |
• | (a) make or change any material tax election, (b) adopt or change any material tax accounting method, (c) settle or compromise any material tax liability, (d) enter into any closing agreement within the meaning of Section 7121 of the Code (or any corresponding or similar provision of state, local or foreign Tax Law), (e) file any amended material tax return, (f) consent to any extension or waiver of the statute of limitations regarding any material amount of taxes, or (g) settle or consent to any claim or assessment relating to any material amount of Taxes; |
• | merge or consolidate itself with any person or authorize, recommend, propose or announce an intention to adopt, or otherwise effect, a plan of complete or partial liquidation, dissolution, restructuring, recapitalization, reorganization or similar transaction involving VGAC II or any of its subsidiaries (other than the Merger); |
• | (a) enter into any material contract or, other than in the ordinary course of business, (1) modify, voluntarily terminate, permit to lapse, waive, or fail to enforce any material right or remedy under any material contract or (2) materially amend, extend or renew any material contract, or (b) amend, modify, terminate, supplement or waive any of the conditions or contingencies to funding set forth in the Subscription Agreements or any other provision of, or remedies under, the Subscription Agreements, other than to reflect any permitted assignments or transfers of the Subscription Agreements by the applicable PIPE Investors pursuant to the Subscription Agreements; |
• | hire any employees or adopt any benefit plans; |
• | make any loans, advances or capital contributions to, or investments in, any other person; |
• | (a) waive, release, assign, settle or compromise any litigation, suit, claim, action, proceeding, audit or investigation by or before any governmental authority, other than waivers, releases, assignments, settlements or compromises that are solely monetary in nature and do not involve an admission of wrongdoing, do not result in any material restriction on VGAC II or New Grove, as applicable, or the Surviving Corporation and do not exceed $50,000 individually or in the aggregate or (B) waive, release or assign any claims or rights of VGAC II or VGAC II Merger Sub; |
• | sell, lease, license, sublicense, exchange, mortgage, pledge, create any liens (other than permitted liens) on, transfer or otherwise dispose of any material tangible or intangible assets of VGAC II or VGAC II Merger Sub; |
• | change any of VGAC II’s or VGAC II Merger Sub’s accounting policies or procedures, other than as required by GAAP or applicable law; |
• | pay or make any commitments for capital expenditures; or |
• | enter into any binding formal or informal agreement or otherwise make a binding commitment to do any of the foregoing. |
• | Grove and VGAC II providing access to books and records and furnishing relevant information to the other party, subject to certain limitations and confidentiality provisions; |
• | certain employee benefit matters; |
• | director and officer indemnification; |
• | prompt notification of certain matters; |
• | Grove and VGAC II using reasonable best efforts to consummate the Business Combination; |
• | public announcements relating to the Business Combination; |
• | agreement relating to the intended tax treatment of the Business Combination; |
• | cooperation regarding any filings required under the HSR Act; and |
• | VGAC II making disbursements from the trust account. |
(a) | the Grove Stockholder Approval will have been obtained and such approval shall remain in full force and effect; |
(b) | the Condition Precedent Proposals will have been approved and adopted by the requisite affirmative vote of the shareholders of VGAC II in accordance with this proxy statement/consent solicitation statement/prospectus and such approval shall remain in full force and effect; |
(c) | VGAC II shall have approved and adopted the Merger Agreement and approved the Merger and the other transactions contemplated by the Merger Agreement in its capacity as the sole stockholder of VGAC II Merger Sub and such approval shall remain in full force and effect; |
(d) | no governmental authority will have enacted, issued, promulgated, enforced or entered any law, rule, regulation or other judgment which is then in effect and has the effect of making the Business Combination illegal or otherwise prohibits the Business Combination; |
(e) | all required filings under the HSR Act, will have been completed and any applicable waiting period (and any extension thereof) applicable to the consummation of the Business Combination under the HSR Act will have expired or been terminated; |
(f) | the registration statement, of which this proxy statement/consent solicitation statement/prospectus forms a part, will have been declared effective under the Securities Act; no stop order suspending the effectiveness of such registration statement will be in effect; and no proceedings for purposes of suspending the effectiveness of such registration statement will have been initiated or be threatened by the SEC; |
(g) | the Domestication will have been consummated; |
(h) | VGAC II will have at least $5,000,001 of net tangible assets following the consummation of the PIPE Financing and the closing of the redemption rights in accordance with the Existing Governing Documents; and |
(i) | Grove will have delivered to VGAC II the financial statements required to be included in the Current Report on Form 8-K to be filed in connection with the Closing. |
(a) | (x) the representations and warranties of Grove contained in (i) the sections of the Merger Agreement titled (A) Organization and Qualification; Subsidiaries, (B) Certificate of Incorporation and Bylaws, (C) Capitalization, (D) Authority Relative to the Merger Agreement and (E) Brokers (without giving any effect to any limitation as to “materiality” or “Company Material Adverse Effect” (as defined in the Merger Agreement) or any similar limitation set forth therein) will each be true and correct in all material respects as of the Closing as though made on the Closing Date, except to the extent that any such representation and warranty expressly speaks as of an earlier date, in which case such representation and warranty will be true and correct as of such earlier date; and (ii) clause (c) of the section of the Merger Agreement titled Absence of Certain Changes or Events will be true and correct in all respects as of the Closing as though made on the Closing Date; and (y) all other representations and warranties of Grove contained in the Merger Agreement will be true and correct (without giving any effect to any limitation as to “materiality” or “Company Material Adverse Effect” or any similar limitation set forth therein) in all respects as of the Closing, as though made on and as of the Closing Date, except, in the case of this clause (y), (1) to the extent that any such representation and warranty expressly speaks as of an earlier date, in which case such representation and warranty will be true and correct as of such earlier date and (2) where the failure of such representations and warranties to be true and correct (whether as of the Closing Date or such earlier date), taken as a whole, does not result in a Company Material Adverse Effect; |
(b) | Grove will have performed or complied in all material respects with all agreements and covenants required by the Merger Agreement to be performed or complied with by it on or prior to the Effective Time; |
(c) | Grove will have delivered to VGAC II a customary officer’s certificate, dated the Closing Date, certifying as to the satisfaction of certain conditions; |
(d) | no Company Material Adverse Effect will have occurred and be continuing since the date of the Merger Agreement; |
(e) | other than those persons identified as continuing directors and officers in the Merger Agreement, all members of the board of directors and all officers of Grove, as required pursuant to the Merger Agreement, will have executed written resignations effective as of the Effective Time; |
(f) | all parties to the Registration Rights Agreement (other than VGAC II) will have delivered, or cause to be delivered, to VGAC II copies of the Registration Rights Agreement duly executed by all such parties; and |
(g) | Grove will have delivered to VGAC II a certification satisfying the requirements of Treasury Regulations Sections 1.897-2(h) and 1.1445-2(c)(3), that Grove is not, nor has it been within the period described in Section 897(c)(1)(A)(ii) of the Code, a “United States real property holding corporation” as defined in Section 897(c)(2) of the Code and an accompanying notice to the Internal Revenue Service satisfying the requirements of Treasury Regulations Section 1.897-2(h)(2); provided |
(a) | (x) the representations and warranties of VGAC II and VGAC II Merger Sub contained in the sections of the Merger Agreement titled (A) Corporate Organization, (B) Governing Documents, (C) Capitalization, (D) Authority Relative to the Merger Agreement and (E) Brokers (without giving effect to any limitation as to “materiality” or “Parent Material Adverse Effect” (as defined in the Merger Agreement) or any similar limitation set forth therein) will each be true and correct in all material respects as of the Closing as though made on the Closing Date, except to the extent that any such representation and warranty expressly speaks as of an earlier date, in which case such representation and warranty will be true and correct in all material respects as of such earlier date; and (y) all other representations and warranties of VGAC II and VGAC II Merger Sub contained in the Merger Agreement will be true and correct (without giving any effect to any limitation as to “materiality” or “Parent Material Adverse Effect” or any similar limitation set forth therein) in all respects as of the Closing Date, as though made on and as of the Closing Date, except, in the case of this clause (y) (1) to the extent that any such representation and warranty expressly speaks as of an earlier date, in which case such representation and warranty will be true and correct as of such earlier date and (2) where the failure of such representations and warranties to be true and correct (whether as of the Closing Date or such earlier date), taken as a whole, does not result in a Parent Material Adverse Effect; |
(b) | VGAC II and VGAC II Merger Sub will have performed or complied in all material respects with all agreements and covenants required by the Merger Agreement to be performed or complied with by it on or prior to the Effective Time; |
(c) | VGAC II will have delivered to Grove a customary officer’s certificate, dated the Closing Date, certifying as to the satisfaction of certain conditions; |
(d) | no Parent Material Adverse Effect will have occurred and be continuing since the date of the Merger Agreement; |
(e) | the Minimum Available Cash Condition will have been satisfied; |
(f) | the Class A ordinary shares will be listed on the NYSE as of the Closing Date and a supplemental listing will have been filed with the NYSE as of the Closing Date to list the shares constituting the merger consideration contemplated to be listed pursuant to the Merger Agreement, and VGAC II will not have received any notice of non-compliance with any applicable initial and continuing listing requirements of the NYSE; |
(g) | VGAC II will have delivered a copy of the Registration Rights Agreement duly executed by VGAC II; and |
(h) | other than those persons identified as continuing directors or officers in the Merger Agreement, all members of the VGAC II Board and all officers of VGAC II, as required pursuant to the Merger Agreement, will have executed written resignations effective as of the Effective Time. |
(a) | by mutual written consent of VGAC II and Grove; |
(b) | by VGAC II or Grove, if the Effective Time has not occurred prior to July 31, 2022 (the “Outside Date”); provided however |
breach or violation of any representation, warranty, covenant, agreement or obligation contained in the Merger Agreement and such breach or violation is the principal cause of the failure of any of the conditions precedent to the Merger on or prior to the Outside Date; |
(c) | by VGAC II or Grove, if any governmental authority has enacted, issued, promulgated, enforced or entered any injunction, order, decree or ruling (whether temporary, preliminary or permanent) which has become final and nonappealable and has the effect of making consummation of the Business Combination, including the Merger, illegal or otherwise preventing or prohibiting consummation of the Business Combination; |
(d) | by VGAC II or Grove, if any of the Conditions Precedent Proposals fail to receive the requisite vote for approval at the extraordinary general meeting (subject to any permitted or required adjournment or postponement of the extraordinary general meeting); |
(f) | by VGAC II if there is an occurrence of a breach of any representation, warranty, covenant or agreement on the part of Grove set forth in the Merger Agreement, or if any representation or warranty of Grove will have become untrue, in either case such that the conditions described in subsections (a) and (b) under the heading “Conditions to Closing; VGAC II and VGAC II Merger Sub” would not be satisfied (a “ Terminating Grove Breach ”); provided provided further |
(e) | by Grove if there is an occurrence of a breach of any representation, warranty, covenant or agreement on the part of VGAC II or VGAC II Merger Sub set forth in the Merger Agreement, or if any representation or warranty of VGAC II or VGAC II Merger Sub will have become untrue, in either case such that the conditions described in subsections (a) and (b) under the heading “ Conditions to Closing; Grove Terminating VGAC II Breach ”); provided provided further |
• | would perform well in the public markets over the long term and offer attractive returns to VGAC II shareholders; |
• | would uniquely benefit from an association with a trusted name like Virgin through brand enhancement and improved operational performance; |
• | could be sourced through VGAC II’s extensive proprietary networks so as to avoid broadly marketed processes; |
• | generate stable free cashflows or that have a clear near-term path to produce healthy free cashflows; |
• | have the ability to provide a strong consumer experience that is meaningfully differentiated from competitors; |
• | have a strong and experienced management team that VGAC II could work alongside and augment as the business scales; and |
• | are prepared from a management, corporate governance, and reporting perspective to become a publicly traded company and can benefit from the access to the broader capital markets that this will provide. |
• | developed an initial list of potential business combination candidates, which were primarily identified through VGAC II’s and Virgin’s respective knowledge and network and the knowledge and network of VGAC II’s financial advisors; |
• | considered and conducted analyses of approximately 441 potential business combination candidates; and |
• | engaged in preliminary, high-level discussions of illustrative transaction structure to effect an initial business combination with 69 potential business combination candidates or their representatives. |
• | Company A (Media & entertainment company): Discussions between VGAC II and Company A regarding a potential business combination did not progress in any material respect following the signing of a non-disclosure agreement between VGAC II and Company A on March 31, 2021. |
• | Company B (Digital advertising company): After evaluating the competitive outlook for the industry as well as public investor appetite in the industry and Company B’s product and technology differentiation, VGAC II determined that Company B would find it difficult to perform in the public markets. Accordingly, VGAC II terminated discussions with Company B regarding a potential business combination on June 11, 2021. |
• | Company C (Agriculture technology company): VGAC II reviewed the business model provided by Company C in detail and determined that the execution risk in the business could result in significant risk to the future profitability of its business. Additionally, the amount of capital required to reach cash flow breakeven could materially increase should Company C not be able to meet the projections as outlined in its business model. For these reasons, VGAC II terminated discussions with Company C regarding a potential business combination on June 8, 2021. |
• | Company D (Travel & leisure company): VGAC II determined that the public markets would be unlikely to support the proposed use of proceeds from the SPAC transaction given the large proportion of secondary proceeds that Company D’s ownership was seeking from the de-SPAC transaction. Furthermore, VGAC II believed that the growth plans that Company D’s management had proposed were not compelling. As a result, VGAC II terminated discussions with Company D regarding a potential business combination on June 7, 2021. |
• | Company E (Packaging manufacturing company): After detailed diligence of Company E, VGAC II determined that it was not prepared to underwrite the projected financial performance outlined in the business plan provided by Company E, particularly given that achieving the business plan outlined would require the installation of new manufacturing equipment that had not been tested at scale and there was therefore, in VGAC II’s view, an insufficient track record to prove the projected run-rate unit economics. VGAC II terminated discussions with Company E regarding a potential business combination on June 15, 2021. |
• | an equity value of Grove between $1,913,000,000 and $2,365,000,000; |
• | a PIPE financing of $200,000,000, with at least $25,000,000 and up to $50,000,000 funded by the Sponsor; |
• | a lock-up/earn-out |
• | mutual exclusivity provisions for a period ending 45-days following the execution of the non-binding letter of intent, subject to Grove’s right to terminate such exclusivity period if VGAC II proposed a reduction in equity value at any time or other adverse change to the material terms; and |
• | certain conditions to the consummation of the business combination including shareholder approval and other customary matters, including the receipt of all applicable regulatory and stock exchange clearances and a $350,000,000 minimum cash condition to be agreed by the parties |
• | an equity value of Grove between $2,000,000,000 and $2,500,000,000; |
• | a PIPE financing of $200,000,000, with at least $25,000,000 and up to $50,000,000 funded by the Sponsor; |
• | a lock-up/earn-out |
• | mutual exclusivity provisions for a period ending 45-days following the execution of the non-binding letter of intent, subject to Grove’s right to terminate such exclusivity period if VGAC II proposed a reduction in equity value at any time or other adverse change to the material terms; and |
• | certain conditions to the consummation of the business combination including shareholder approval and other customary matters, including the receipt of all applicable regulatory and stock exchange clearances and a $350,000,000 minimum cash condition to be agreed by the parties |
• | an equity value of Grove equal to $1,720,000,000; |
• | a PIPE financing of $150,000,000, with at least $25,000,000 and up to $50,000,000 funded by the Sponsor; |
• | a lock-up/earn-out |
• | an agreement to transfer up to 50% of VGAC II private placement warrants held by the Sponsor to certain PIPE investors, in a manner to be agreed by Sponsor and Grove, if such transfer is needed to reach the PIPE financing amount; |
• | mutual exclusivity provisions for a period ending on September 12, 2021, subject to Grove’s right to terminate such exclusivity period if VGAC II proposed a reduction in equity value at any time or other adverse change to the material terms; and |
• | certain conditions to the consummation of the business combination including shareholder approval and other customary matters, including the receipt of all applicable regulatory and stock exchange clearances and a $200,000,000 minimum cash condition to be agreed by the parties |
• | extensive meetings with Grove’s management team regarding operations and forecasts; |
• | research on the DTC, HPC and consumer packaged goods industries, including historical growth trends and market share information as well as end-market size and growth projections; |
• | analysis of Grove’s historical and projected financials to understand and validate the key assumptions underpinning the financial projections prepared by Grove management; |
• | multiple expert calls with professionals in the HPC sector regarding the competitive landscape, benefits and effectiveness of Grove’s positioning in the HPC sector; |
• | discussions with Grove’s management team to assess their product development track record, current product development pipeline and strategy for building the company’s business moving forward; |
• | discussions with Grove’s management team to assess their strategic plans for the retail channel, performance to date in that channel, and team capabilities to execute on their retail strategy; |
• | review of Grove’s material contracts regarding financials, tax, legal, accounting, information technology, security, insurance and intellectual property; |
• | financial and valuation analyses of Grove and the Business Combination; |
• | Grove’s historical financial statements; |
• | reports related to tax and legal diligence prepared by external advisors; and |
• | assessment of Grove’s public company readiness. |
• | will perform well in the public markets over the long term and offer attractive returns to shareholders; |
• | would uniquely benefit from an association with a trusted name like the Virgin Group through brand enhancement and improved operational performance; |
• | can be sourced through the Virgin Group’s extensive proprietary networks so as to avoid broadly marketed processes; |
• | generate stable free cashflows or that have a clear near-term path to produce healthy free cashflows; |
• | have the ability to provide a strong consumer experience that is meaningfully differentiated from competitors; |
• | have a strong and experienced management team that VGAC II can work alongside and augment as the business scales; and |
• | are prepared from a management, corporate governance, and reporting perspective to become a publicly traded company and can benefit from the access to the broader capital markets that this will provide. |
• | Commercial Rationale |
• | Investing in a sustainable future for consumer packaged goods purpose-led brand with an ambitious goal of becoming 100% plastic free by 2025, Grove is poised to capitalize on this demand. |
• | Scale Opportunity |
• | Rapid Growth and Broad Consumer Adoption |
• | Strong and Increasing Margins |
• | Retail Strategy Offers Significant Upside |
• | Financial Condition |
• | Opinion of Financial Advisor The Business Combination Proposal— Opinion of the Financial Advisor to VGAC II. |
• | Proven Existing Management Team |
• | Strong Sponsorship |
• | Significant Equity Investment |
• | Terms of the Merger Agreement arm’s-length negotiations among the parties. |
• | Shareholder Approval |
• | Independent Director Role |
• | Other Alternatives |
• | Risks Associated with the Business Combination. |
• | The risk that the Business Combination might not be consummated in a timely manner or that the Closing might not occur despite the companies’ efforts, including by reason of a failure to obtain the approval of VGAC II shareholders. |
• | The significant fees and expenses associated with completing the Business Combination and related transactions and the substantial time and effort of management required to complete the Business Combination. |
• | The possibility of litigation challenging the Business Combination. |
• | The risk that VGAC II does not obtain the PIPE Financing or otherwise retain sufficient cash in the trust account or find replacement cash to meet the requirements of the Merger Agreement. |
• | The fact that the PIPE Financing is being provided largely by the Sponsor and existing equityholders of Grove, each of whom may have interest in the transaction that are different from, or in addition to, the interests of VGAC II shareholders in general, and the resulting risk that the value at which the PIPE Investors were willing to invest in the combined company may not be reflecting of the price at which other public market investors are willing to invest. |
• | The fact that the Merger Agreement does not permit our board of directors to change, withdraw, withhold, qualify or modify, or publicly propose to change, withdraw, withhold, qualify or modify its recommendation to approve the proposals contained in this proxy statement/consent solicitation statement/prospectus, unless our board of directors determines, upon the advice of counsel, that a Company Material Adverse Effect (as defined in the Merger Agreement) has occurred and making such a change in recommendation is required in order to comply with its fiduciary duties. |
• | Risks Associated with Grove’s Business. |
• | The risks associated with macroeconomic uncertainty and the effects it could have on Grove’s revenues. |
• | The risks associated with Grove’s ability to maintain and grow its customer base. |
• | The fact that Grove has incurred significant losses since inception, expects to incur losses in the future, and may not be able to reach a sufficient margin profile to achieve and maintain profitability. |
• | The risks associated with the DTC, HPC and consumer packaged goods industries in general, including the development, effects and enforcement of laws and regulations with respect to the industry. |
• | The risk that key employees of Grove might not remain with New Grove following the Closing. |
• | The challenge of attracting and retaining senior management personnel. |
• | The risk that Grove might not be able to protect its trade secrets or maintain its trademarks, patents and other intellectual property consistent with historical practice. |
• | The risk associated with sourcing, manufacturing, warehousing, distribution and logistics to third-party providers. |
• | Risks Related to Grove’s Governmental Regulation and Litigation. |
• | The risk of being subject to increased derivative litigation concerning duty to balance stockholder and public benefit interests as a public benefit corporation. |
• | Risks Associated with Post-Closing Corporate Governance. The dual-class structure of New Grove’s common stock will have the effect of concentrating voting power with the existing holders of Grove Class B Common Stock, which will limit an investor’s ability to influence the outcome of important transactions, including a change in control. |
• | The other risks described in the section entitled “ Risk Factors |
1. | reviewed a draft, dated December 5, 2021, of the Merger Agreement; |
2. | reviewed certain publicly available business and financial information relating to VGAC II and Grove that Houlihan Lokey deemed to be relevant; |
3. | reviewed certain information relating to the historical, current and future operations, financial condition and prospects of Grove made available to Houlihan Lokey by Grove and VGAC II, including financial projections prepared by the management of Grove relating to Grove (the “ Projections ”); |
4. | spoke with certain members of the managements of VGAC II and Grove and certain of their respective representatives and advisors regarding the business, operations, financial condition and prospects of Grove, the Business Combination, the Domestication and related matters; |
5. | compared the financial and operating performance of Grove with that of companies with publicly traded equity securities that Houlihan Lokey deemed to be relevant; and |
6. | conducted such other financial studies, analyses and inquiries and considered such other information and factors as Houlihan Lokey deemed appropriate. |
• | Enterprise value as a multiple of estimated net revenue for the 2021 calendar year, or “CY 2021E” net revenue; and |
• | Enterprise value as a multiple of estimated net revenue for the 2022 calendar year, or “CY 2022E” net revenue. |
• | Church & Dwight Co., Inc. |
• | The Clorox Company |
• | Colgate-Palmolive Company |
• | Kimberly-Clark Corporation |
• | The Procter & Gamble Company |
• | Reckitt Benckiser Group plc |
• | Unilever PLC |
• | Beyond Meat, Inc. |
• | Fevertree Drinks Plc |
• | Freshpet, Inc. |
• | The Honest Company, Inc. |
• | Lululemon Athletica Inc. |
• | Peloton Interactive, Inc. |
• | The Simply Good Foods Company |
• | Vital Farms, Inc. |
Enterprise Value to Net Revenue |
||||||||
CY 2021E |
CY 2022E |
|||||||
Low |
2.25x | 1.91x | ||||||
High |
10.03x | 8.22x | ||||||
Median |
4.09x | 3.98x | ||||||
Mean |
5.14x | 4.45x |
• | the fact that the Sponsor has agreed not to redeem any Class A ordinary shares held by it in connection with a shareholder vote to approve a proposed initial business combination; |
• | the fact that the Sponsor paid an aggregate of $25,000 for 10,062,500 Class B ordinary shares, of which the Sponsor currently owns 9,972,500 Class B ordinary shares and each of the three independent directors owns 30,000 Class B ordinary shares, and such securities will have a significantly higher value at the time of the Business Combination; as described further below: |
Shares of Class B ordinary shares(1) |
Value of Class B ordinary shares implied by the Business Combination(3) |
Value of Class B ordinary shares based on recent trading price(4) |
||||||||||
Sponsor(2) |
9,972,500 | $ | 99,725,000 | $ | ||||||||
Chris Burggraeve |
30,000 | $ | 300,000 | $ | ||||||||
Elizabeth Nelson |
30,000 | $ | 300,000 | $ | ||||||||
Latif Peracha |
30,000 | $ | 300,000 | $ |
(1) | Interests shown consist solely of founder shares. Such shares will automatically convert into shares of New Grove Class A Common Stock upon Domestication on a one-for-one |
(2) | VG Acquisition Sponsor II LLC is the record holder of the shares reported herein. |
(3) | Assumes a value of $10.00 per share, the deemed value of the Class B ordinary shares in the Business Combination. |
(4) | Assumes a value of $ per share, the closing price of the Class B ordinary shares on |
• | the fact that each of Mr. Bayliss and Mr. Lovell invested $300,000 in the Sponsor and hold interests in the Sponsor that represent an indirect interest in 1,246,600 Class B ordinary shares and 197,939 private placement warrants, and the fact that Mr. Burggraeve, Ms. Nelson and Mr. Peracha each invested $100,000, in the Sponsor indirectly through an investment in VG Acquisition Holdings II LLC, an |
affiliate of the Sponsor, and each holds interests in VG Acquisition Holdings II LLC that represent an indirect interest in 70,216 Class B ordinary shares, and 66,550 private placement warrants, respectively, and all of such securities would be worthless if a business combination is not consummated by March 25, 2023 (unless such date is extended in accordance with the Existing Governing Documents); |
• | the fact that given the differential in the purchase price that the Sponsor paid for the founder shares as compared to the price of the public shares sold in the initial public offering, the Sponsor and its affiliates may earn a positive rate of return on their investment even if the Class A ordinary shares trades below the price initially paid for the public shares in the initial public offering and the public shareholders experience a negative rate of return following the completion of the Business Combination; |
• | the fact that the Sponsor will benefit from the completion of a business combination and may be incentivized to complete an acquisition of a less favorable target company or on terms less favorable to shareholders rather than liquidate; |
• | the fact that if a business combination is not consummated by March 25, 2023 (unless such date is extended in accordance with the Existing Governing Documents), our Sponsor and VGAC II’s officers and directors will lose their entire investment in VGAC II, which investment included a capital contribution of $25,000 for the Sponsor’s Class B ordinary shares and $10,050,000 for the Sponsor’s private placement warrants, and will not be reimbursed for any out-of-pocket |
• | the fact that the Sponsor and VGAC II’s other current officers and directors have agreed to waive their rights to liquidating distributions from the trust account with respect to any ordinary shares (other than public shares) held by them if VGAC II fails to complete an initial business combination by March 25, 2023; |
• | the fact that the Registration Rights Agreement will be entered into by the Sponsor; |
• | the fact that the Sponsor transferred 30,000 Class B ordinary shares to each of VGAC II’s three independent directors prior to the initial public offering, and such securities would be worthless if a business combination is not consummated by March 25, 2023 (unless such date is extended in accordance with the Existing Governing Documents); |
• | the fact that the Sponsor entered into the Sponsor Agreement pursuant to which the Sponsor has agreed that the Sponsor Earnout Shares will be subject to certain earn-out provisions set forth in the Sponsor Agreement, with such shares vesting effective (i) with respect to 50% of the Sponsor Earnout Shares, if the daily volume weighted average price of the shares of New Grove Class A Common Stock is greater than or equal to $12.50 for any 20 trading days (which may be consecutive or not consecutive) within any 30-trading-day 30-trading-day |
• | the continued indemnification of VGAC II’s directors and officers and the continuation of VGAC II’s directors’ and officers’ liability insurance after the Business Combination ( i.e. |
• | the fact that if the trust account is liquidated, including in the event VGAC II is unable to complete an initial business combination by March 25, 2023, the Sponsor has agreed to indemnify VGAC II to ensure that the proceeds in the trust account are not reduced below $10.00 per public share, or such lesser per public share amount as is in the trust account on the liquidation date, by the claims of prospective target businesses with which VGAC II has entered into an acquisition agreement or claims of any third party for services rendered or products sold to VGAC II, but only if such a vendor or target business has not executed a waiver of any and all rights to seek access to the trust account; |
• | the fact that [●], [●] of the Sponsor is expected to be director of New Grove after the consummation of the Business Combination and as such, in the future, he may receive cash fees, stock options, stock awards or other remuneration that the New Grove Board determines to pay to him and any other applicable compensation; and |
• | the fact that the Virgin Group and the Sponsor will collectively own 6,572,125 shares of New Grove Class A Common Stock, which collectively will represent up to approximately 4.4% outstanding shares of New Grove Common Stock and approximately [●]% of the voting power of New Grove Common Stock assuming that 100% of VGAC II Class A ordinary shares are redeemed. |
• | Prominence, Predictability, and Flexibility of Delaware Law |
adopting, construing, and implementing comprehensive, flexible corporate laws responsive to the legal and business needs of corporations organized under its laws. Many corporations have chosen Delaware initially as a state of incorporation or have subsequently changed corporate domicile to Delaware. Because of Delaware’s prominence as the state of incorporation for many major corporations, both the legislature and courts in Delaware have demonstrated the ability and a willingness to act quickly and effectively to meet changing business needs. The DGCL is frequently revised and updated to accommodate changing legal and business needs and is more comprehensive, widely used and interpreted than other state corporate laws. This favorable corporate and regulatory environment is attractive to businesses such as VGAC II. |
• | Well-Established Principles of Corporate Governance |
• | Increased Ability to Attract and Retain Qualified Directors |
• | In the judgement of the VGAC II Board, the Proposed Certificate of Incorporation is necessary to address the needs of New Grove. The purpose of the new public entity reflects its designation as a public benefit corporation under Delaware law. |
Existing Governing Documents |
Proposed Governing Documents | |||
Authorized Shares (Governing Documents Proposal A) |
The share capital under the Existing Governing Documents is US$22,100 divided into 200,000,000 Class A ordinary shares of par value US$0.0001 per share, 20,000,000 Class B ordinary shares of par value US$0.0001 per share, and 1,000,000 preference shares of par value US$0.0001 per share. | The Proposed Governing Documents authorize 600,000,000 shares of New Grove Class A Common Stock, 200,000,000 shares of New Grove Class B Common Stock, and 100,000,000 shares of New Grove Preferred Stock. | ||
See paragraph 5 of the Memorandum of Association. |
See Article IV of the Proposed Certificate of Incorporation. | |||
Authorize the Board of Directors to Issue Preferred Stock Without Stockholder Consent (Governing Documents Proposal B) |
The Existing Governing Documents authorize the issuance of 1,000,000 preference shares with such designation, rights, and preferences as may be determined from time to time by the VGAC II Board. Accordingly, VGAC II Board is empowered under the Existing Governing Documents, without shareholder approval, to issue preference shares with dividend, liquidation, redemption, voting, or other rights, provided | The Proposed Governing Documents authorize the board of directors to issue all or any shares of preferred stock in one or more series and to fix for each such series such voting powers, full or limited, and such designations, preferences and relative, participating, optional or other special rights and such qualifications, limitations, or restrictions thereof, as the New Grove Board may determine. |
Existing Governing Documents |
Proposed Governing Documents | |||
that the issuance of such preference shares does not materially adversely affect the rights attached to the other shareholders of VGAC II. | ||||
See paragraph 5 of the Memorandum of Association and Articles 3 and 10 of the Articles of Association. |
See Article IV subsection 2 of the Proposed Certificate of Incorporation. | |||
Corporate Name (Governing Documents Proposal B) |
The Existing Governing Documents provide the name of the company is “Virgin Group Acquisition Corp. II” | The Proposed Governing Documents will provide that the name of the corporation will be “Grove Collaborative Holdings, Inc.” | ||
See paragraph 1 of VGAC II’s Memorandum of Association. |
See Article I of the Proposed Certificate of Incorporation. | |||
Perpetual Existence (Governing Documents Proposal B) |
The Existing Governing Documents provide that if VGAC II does not consummate a business combination (as defined in the Existing Governing Documents) by March 25, 2023 (twenty-four months after the closing of the initial public offering), VGAC II will cease all operations except for the purposes of winding up and will redeem the shares issued in the initial public offering and liquidate its trust account. | The Proposed Governing Documents do not include any provisions relating to New Grove’s ongoing existence; the default under the DGCL will make New Grove’s existence perpetual. | ||
See Article 49 of VGAC II’s Articles of Association. |
This is the default rule under the DGCL. | |||
Exclusive Forum (Governing Documents Proposal B) |
The Existing Governing Documents do not contain a provision adopting an exclusive forum for certain shareholder litigation. | The Proposed Governing Documents adopt Delaware as the exclusive forum for certain stockholder litigation and the federal district courts of the United States as the exclusive forum for litigation arising out of the Securities Act and the Exchange Act. | ||
See Article XI of the Proposed Certificate of Incorporation. | ||||
Provisions Related to Status as Blank Check Company (Governing Documents Proposal B) |
The Existing Governing Documents set forth various provisions related to VGAC II’s status as a blank check company | The Proposed Governing Documents do not include such provisions related to VGAC II’s status as a blank check company, which no longer will apply upon |
Existing Governing Documents |
Proposed Governing Documents | |||
prior to the consummation of a business combination. | consummation of the Business Combination, as VGAC II will cease to be a blank check company at such time. | |||
See Article 49 of VGAC II’s Amended and Restated Articles of Association. |
||||
Voting Rights of Common Stock (Governing Documents Proposal C) |
The Existing Governing Documents provide that the holders of each ordinary share of VGAC II is entitled to one vote for each share on each matter properly submitted to the shareholders entitled to vote. | The Proposed Governing Documents provide that holders of shares of New Grove Class A Common Stock will be entitled to cast one vote per share of New Grove Class A Common Stock, and holders of shares of New Grove Class B Common Stock will be entitled to cast ten votes per share of New Grove Class B Common Stock on each matter properly submitted to the stockholders entitled to vote. | ||
See Article 23 of VGAC II’s Articles of Association. |
See Article IVof the Proposed Certificate of Incorporation. |
• | Non-qualified stock options; |
• | Incentive stock options (within the meaning of Section 422 of the Code); |
• | Stock appreciation rights (“ SARs ”); |
• | Restricted stock, restricted stock units and other stock awards (collectively, “ Stock Awards ”); and |
• | Performance awards. |
Name of Director |
Class of Director | |
[●] |
Class I | |
[●] |
Class I | |
[●] |
Class I | |
[●] |
Class II | |
[●] |
Class II | |
[●] |
Class II | |
Stuart Landesberg |
Class III |
Name of Director |
Class of Director | |
[●] |
Class III | |
[●] |
Class III |
• | our sponsor; |
• | financial institutions or financial services entities; |
• | broker-dealers; |
• | taxpayers that are subject to the mark-to-market |
• | tax-exempt entities; |
• | governments or agencies or instrumentalities thereof; |
• | insurance companies; |
• | regulated investment companies; |
• | real estate investment trusts; |
• | expatriates or former long-term residents of the United States; |
• | “controlled foreign corporations,” PFICs, and corporations that accumulate earnings to avoid U.S. federal income tax; |
• | foreign corporations with respect to which there are one or more United States shareholders within the meaning of Treasury Regulation Section 1.367(b)-3(b)(1)(ii); |
• | persons that actually or constructively own 10 percent or more of VGAC II shares, by vote or value; |
• | persons that acquired our securities as compensation; |
• | persons that hold our securities as part of a straddle, constructive sale, hedge, conversion or other integrated or similar transaction; or |
• | U.S. Holders whose functional currency is not the U.S. dollar. |
• | the U.S. Holder’s gain or excess distribution will be allocated ratably over the U.S. Holder’s holding period for the Class A ordinary shares or warrants; |
• | the amount allocated to the U.S. Holder’s taxable year in which the U.S. Holder recognized the gain or received the excess distribution, or to the period in the U.S. Holder’s holding period before the first day of VGAC II’s first taxable year in which VGAC II is a PFIC, will be taxed as ordinary income; |
• | the amount allocated to other taxable years (or portions thereof) of the U.S. Holder and included in its holding period will be taxed at the highest tax rate in effect for that year and applicable to the U.S. Holder; and |
• | an additional tax equal to the interest charge generally applicable to underpayments of tax will be imposed on the U.S. Holder with respect to the tax attributable to each such other taxable year of the U.S. Holder. |
• | U.S. Holders generally will not recognize taxable gain or loss as a result of the Domestication for U.S. federal income tax purposes, |
• | the tax basis of a share of New Grove Class A Common Stock or New Grove warrant received by a U.S. Holder in the Domestication will equal the U.S. Holder’s tax basis in the Class A ordinary share or public warrant, as the case may be, surrendered in exchange therefor, increased by any amount included in the income of such U.S. Holder as a result of Section 367 of the Code (as discussed below), and |
• | the holding period for a share of New Grove Class A common stock or a New Grove warrant received by a U.S. Holder will include such U.S. Holder’s holding period for the Class A ordinary share or public warrant surrendered in exchange therefor. |
• | the gain is effectively connected with the conduct of a trade or business by the Non-U.S. Holder within the United States; |
• | New Grove is or has been a “United States real property holding corporation” (“ USRPHC ”) for U.S. federal income tax purposes at any time during the shorter of the five-year period ending on the date of disposition or the Non-U.S. Holder’s holding period for such securities disposed of, and either (i) the New Grove Class A Common Stock and New Grove warrants have ceased to be regularly traded on an established securities market or (ii) the Non-U.S. Holder has owned, actually or constructively, more than five percent (5%) of such securities, as applicable, at any time during the shorter of the five-year period ending on the date of disposition or the Non-U.S. Holder’s holding period for the security disposed of. |
• | the historical unaudited condensed financial statements of VGAC II as of September 30, 2021 and for the period from January 13, 2021 (inception) to September 30, 2021; |
• | the (a) historical audited financial statements of Grove as of and for the year ended December 31, 2020 and 2019, and (b) historical unaudited condensed financial statements of Grove as of September 30, 2021 and for the nine months ended September 30, 2021 and 2020, and |
• | other information relating to Grove and VGAC II included in this proxy statement/consent solicitation statement/prospectus, including the Merger Agreement and the description of certain terms thereof set forth under the section titled “Business Combination Proposal.” |
(A) | VGAC II’s name will be changed to “Grove Collaborative Holdings, Inc.” (“ New Grove ”), |
(B) | each then-issued and outstanding Class A ordinary share of VGAC II will convert automatically into one share of Class A Common Stock of New Grove (the “ New Grove Class A Common Stock ”), |
(C) | each then-issued and outstanding Class B ordinary share of VGAC II will convert automatically into one share of New Grove Class A Common Stock, |
(D) | each then-issued and outstanding warrant to purchase Class A ordinary shares of VGAC II (“ Public Warrant ”) will convert automatically into one warrant to purchase one share of New Grove Class A Common Stock, and |
(E) | each then-issued and outstanding sponsor warrant of VGAC II (“ Private Placement Warrant ”) will convert automatically into one warrant to purchase one share of New Grove Class A Common Stock. |
(A) | the conversion of all outstanding shares of Grove’s convertible preferred stock into shares of Grove’s common stock at the then-effective conversion rate as calculated pursuant to Grove’s certificate of incorporation; |
(B) | the conversion of each issued and outstanding share of Grove’s common stock (including shares of Grove common stock resulting from the conversion of all outstanding shares of Grove’s convertible preferred stock) to a number of shares of New Grove Class B Common Stock equal to the Exchange Ratio; |
(C) | the conversion of all outstanding shares of Grove’s restricted stock into shares of New Grove Class B Common Stock at the Exchange Ratio, which shares will continue to be governed by the same terms and conditions (including vesting and repurchase terms) effective immediately prior to the Business Combination; |
(D) | the conversion of all outstanding Grove warrants, excluding 266,660 warrants to purchase Grove common stock that will be net settled or canceled prior to the consummation of the Business Combination, into warrants exercisable for shares of New Grove Class B Common Stock with the same terms except for the number of shares exercisable and the exercise price, each of which will be adjusted using the Exchange Ratio; |
(E) | the conversion of all outstanding vested and unvested Grove stock options into New Grove stock options exercisable for shares of New Grove Class B Common Stock with the same terms except for the number of shares exercisable and the exercise price, each of which will be adjusted using the Exchange Ratio; and |
(F) | the conversion of all outstanding Grove restricted stock units into New Grove restricted stock units with the same terms that each represent the right to receive the number of shares of New Grove Class B Common Stock adjusted using the Exchange Ratio. |
• | 7,000,000 shares earned if the share price of New Grove Class A Common Stock is greater than or equal to $12.50 over any 20 trading days within any consecutive 30 trading day period during the Earnout Period; |
• | 7,000,000 shares earned, including the shares subject to the $12.50 threshold if not previously vested, if the share price of New Grove Class A Common Stock is greater than or equal to $15.00 over any 20 trading days within any 30 consecutive trading day period during the Earnout Period; and |
• | If, during the Earnout Period, there is a Change of Control Transaction (as defined in the Merger Agreement), then all remaining triggering events that have not previously occurred and the related vesting conditions shall be deemed to have occurred. |
• | 50% of the Sponsor Earnout Shares will vest if the share price of New Grove Class A Common Stock is greater than or equal to $12.50 over any 20 trading days within any consecutive 30 trading day period during the Earnout Period. |
• | 50% of the Sponsor Earnout Shares, including the shares subject to the $12.50 threshold if not previously vested, will vest if the share price of New Grove Class A Common Stock is greater than or equal to $15.00 over any 20 trading days within any 30 consecutive trading day period during the Earnout Period. |
• | If, during the Earnout Period, there is a Change of Control Transaction, then all remaining triggering events that have not previously occurred shall be deemed to have occurred. |
• | Current Grove stockholders will have a relative majority of the voting power of New Grove; |
• | The New Grove Board will have nine members of whom one individual shall be designated by VGAC II and of whom eight individuals shall be designated by Grove; |
• | Grove’s senior management will comprise the senior management roles of New Grove and be responsible for the day-to-day operations; |
• | New Grove will assume the Grove name; and |
• | The intended strategy and operations of New Grove will continue Grove’s current strategy. |
• | Sponsor and Grove Earnout Shares – The Earnout Shares, excluding those allocated to the unvested Grove options and restricted stock units, are expected to be accounted for as liability classified equity instruments that are earned upon achieving the triggering events, which include events that are not indexed to the common stock of New Grove, and if the arrangements should be recorded as long term. The Company has preliminarily concluded that liability classification for these Earnout Shares is appropriate and as such, the liability will be recognized at fair value upon the Merger closing and remeasured in future reporting periods through the statement of operations The preliminary fair value of the Earnout Shares was determined using the most reliable information currently available. The actual fair value could change materially once the final valuation is determined upon consummation of the Business Combination. The Earnout Shares attributed to the unvested Grove options and restricted stock units are expected to be accounted for as stock-based compensation due to the continued service requirement and will be equity-classified. Compensation expense, if any, related to such Earnout Shares has not been reflected in the unaudited pro forma condensed combined statement of operations. |
• | Public Warrants and Private Placement Warrants –The Company has preliminarily concluded that liability classification for the Public Warrants and Private Placement Warrants is appropriate and as such, the liability will be recognized at fair value upon the Merger closing and remeasured in future reporting periods through the statement of operations. |
• | Direct and Incremental Transaction Costs—Estimates are necessary to finalize the allocation of direct and incremental transaction costs between instruments issued or assumed in the Business Combination. The Company has preliminarily allocated such costs on a relative fair value basis between the VGAC II ordinary shares, PIPE Shares, Sponsor Earnout Shares, the Public Warrants and the Private Placement Warrants based on estimates that are available. Direct and incremental transaction costs allocated to equity-classified instruments have been preliminarily recorded within equity in the unaudited pro forma condensed combined financial statements. Direct and incremental transaction costs allocated to liability-classified equity instruments were expensed in the unaudited pro forma condensed combined financial statements. |
• | Assuming no redemptions: This scenario assumes that no shares of VGAC II Class A ordinary shares are redeemed. |
• | Assuming maximum redemptions: This scenario assumes 31,459,600 of VGAC II’s Class A ordinary shares are redeemed for an aggregate payment of $314.6 million, which is derived from the number of shares that could be redeemed in connection with the Business Combination at an assumed redemption price of approximately $10.00 per share based on funds held in the trust account as of September 30, 2021 and still satisfy the Minimum Cash Condition required to consummate the Business Combination of at least $175.0 million, after giving effect to the proceeds from the PIPE Investment. |
No Redemption |
Maximum Redemption |
|||||||||||||||
Number of Shares |
% Ownership |
Number of Shares |
% Ownership |
|||||||||||||
Former VGAC II shareholders |
40,250,000 | 40,250,000 | ||||||||||||||
Less: VGAC II Class A shares redeemed |
— | (31,459,600 | ) | |||||||||||||
|
|
|
|
|||||||||||||
Total held by former VGAC II shareholders |
40,250,000 | 22.4 | % | 8,790,400 | 5.9 | % | ||||||||||
Sponsor |
6,572,125 | 3.7 | % | 6,572,125 | 4.4 | % | ||||||||||
Grove Stockholders |
124,056,114 | 69.1 | % | 124,056,114 | 83.8 | % | ||||||||||
PIPE Investors |
8,707,500 | 4.8 | % | 8,707,500 | 5.9 | % | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Pro forma shares outstanding |
179,585,739 | 100.0 | % | 148,126,139 | 100.0 | % | ||||||||||
|
|
|
|
|
|
|
|
No Redemptions Scenario |
Maximum Redemptions Scenario |
|||||||||||||||||||||||||||||||
VGAC II (Historical) |
Grove (Historical) |
Transaction Accounting Adjustments (Note 3) |
Notes |
Pro Forma Combined |
Transaction Accounting Adjustments (Note 3) |
Notes |
Pro Forma Combined |
|||||||||||||||||||||||||
ASSETS |
||||||||||||||||||||||||||||||||
Current assets: |
||||||||||||||||||||||||||||||||
Cash and cash equivalents |
$ | 59 | $ | 109,217 | $ | 402,521 | A |
$ | 557,499 | $ | (314,596 | ) | F |
$ | 242,903 | |||||||||||||||||
87,075 | B |
|||||||||||||||||||||||||||||||
(14,088 | ) | C |
||||||||||||||||||||||||||||||
(27,285 | ) | D |
||||||||||||||||||||||||||||||
Inventory, net |
— | 59,466 | — | 59,466 | — | 59,466 | ||||||||||||||||||||||||||
Prepaid expenses and other current assets |
629 | 6,940 | — | 7,569 | — | 7,569 | ||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Total current assets |
688 | 175,623 | 448,223 | 624,534 | (314,596 | ) | 309,938 | |||||||||||||||||||||||||
Prepaid expenses – noncurrent portion |
300 | — | — | 300 | — | 300 | ||||||||||||||||||||||||||
Cash and investments held in trust account |
402,521 | — | (402,521 | ) | A |
— | — | — | ||||||||||||||||||||||||
Property and equipment, net |
— | 15,800 | — | 15,800 | — | 15,800 | ||||||||||||||||||||||||||
Operating lease right-of-use |
— | 22,040 | — | 22,040 | — | 22,040 | ||||||||||||||||||||||||||
Other long-term assets |
— | 3,466 | (1,261 | ) | D |
2,205 | — | 2,205 | ||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Total assets |
$ | 403,509 | $ | 216,929 | $ | 44,441 | $ | 664,879 | $ | (314,596 | ) | $ | 350,283 | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
LIABILITIES, CONVERTIBLE PREFERRED STOCK, AND STOCKHOLDERS’ (DEFICIT) EQUITY |
||||||||||||||||||||||||||||||||
Current liabilities: |
||||||||||||||||||||||||||||||||
Accounts payable |
$ | — | $ | 31,126 | $ | — | $ | 31,126 | $ | — | $ | 31,126 | ||||||||||||||||||||
Accrued expenses |
983 | 26,267 | (1,046 | ) | D |
26,204 | — | 26,204 | ||||||||||||||||||||||||
Due to related party |
62 | — | — | 62 | — | 62 | ||||||||||||||||||||||||||
Deferred revenue |
— | 11,278 | — | 11,278 | — | 11,278 | ||||||||||||||||||||||||||
Operating lease liabilities, current |
— | 3,493 | — | 3,493 | — | 3,493 | ||||||||||||||||||||||||||
Other current liabilities |
— | 1,017 | — | 1,017 | — | 1,017 | ||||||||||||||||||||||||||
Debt, current |
— | 1,265 | — | 1,265 | — | 1,265 | ||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Total current liabilities |
1,045 | 74,446 | (1,046 | ) | 74,445 | — | 74,445 | |||||||||||||||||||||||||
Debt, noncurrent |
— | 55,981 | — | 55,981 | — | 55,981 | ||||||||||||||||||||||||||
Operating lease liabilities, noncurrent |
— | 20,909 | — | 20,909 | — | 20,909 | ||||||||||||||||||||||||||
Other long-term liabilities |
— | 6,393 | (5,079 | ) | K |
1,314 | — | 1,314 | ||||||||||||||||||||||||
Warrant liability |
13,655 | — | — | 13,655 | — | 13,655 | ||||||||||||||||||||||||||
Earnout liabilities |
— | — | 147,830 | G |
147,830 | — | 147,830 | |||||||||||||||||||||||||
Deferred underwriters’ discount |
14,088 | — | (14,088 | ) | C |
— | — | — | ||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Total liabilities |
28,788 | 157,729 | 127,617 | 314,134 | — | 314,134 | ||||||||||||||||||||||||||
Convertible preferred stock |
— | 487,918 | (487,918 | ) | I |
— | — | — | ||||||||||||||||||||||||
VGAC II Class A ordinary shares subject to redemption |
402,500 | — | (402,500 | ) | E |
— | — | — | ||||||||||||||||||||||||
Stockholders‘ equity (deficit): |
||||||||||||||||||||||||||||||||
Grove common stock |
— | 1 | (1 | ) | J |
— | — | — | ||||||||||||||||||||||||
VGAC II Class A ordinary shares |
— | — | — | — | — | — | ||||||||||||||||||||||||||
VGAC II Class B ordinary shares |
1 | — | (1 | ) | E |
— | — | — | ||||||||||||||||||||||||
New Grove Class A common stock |
— | — | 1 | B |
6 | (3 | ) | F |
3 | |||||||||||||||||||||||
5 | E |
|||||||||||||||||||||||||||||||
New Grove Class B common stock |
— | — | 1 | J |
11 | — | 11 | |||||||||||||||||||||||||
10 | I |
|||||||||||||||||||||||||||||||
Additional paid-in capital |
— | 29,437 | 87,074 | B |
811,031 | (314,593 | ) | F |
496,438 | |||||||||||||||||||||||
(25,353 | ) | D |
||||||||||||||||||||||||||||||
402,496 | E |
|||||||||||||||||||||||||||||||
(147,830 | ) | G |
||||||||||||||||||||||||||||||
(27,780 | ) | H |
||||||||||||||||||||||||||||||
487,908 | I |
|||||||||||||||||||||||||||||||
5,079 | K |
|||||||||||||||||||||||||||||||
Accumulated deficit |
(27,780 | ) | (458,156 | ) | 27,780 | H |
(460,303 | ) | — | (460,303 | ) | |||||||||||||||||||||
(2,147 | ) | D |
||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Total stockholders’ equity (deficit) |
(27,779 | ) | (428,718 | ) | 807,242 | 350,745 | (314,596 | ) | 36,149 | |||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Total liabilities, convertible preferred stock, and stockholders’ equity (deficit) |
$ | 403,509 | $ | 216,929 | $ | 44,441 | $ | 664,879 | $ | (314,596 | ) | $ | 350,283 | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
For the period from January 13, 2021 (inception) to September 30, 2021 VGAC II |
For the Nine Months Ended September 30, 2021 Grove (Historical) |
No Redemptions Scenario |
Maximum Redemptions Scenario |
|||||||||||||||||||||||||||||
Transaction Accounting Adjustments (Note 3) |
Notes |
Pro Forma Combined |
Transaction Accounting Adjustments (Note 3) |
Notes |
Pro Forma Combined |
|||||||||||||||||||||||||||
Revenue, net |
$ | — | $ | 296,421 | $ | — | $ | 296,421 | $ | — | $ | 296,421 | ||||||||||||||||||||
Cost of goods sold |
— | 147,179 | — | 147,179 | — | 147,179 | ||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Gross profit |
— | 149,242 | — | 149,242 | — | 149,242 | ||||||||||||||||||||||||||
Operating expenses: |
||||||||||||||||||||||||||||||||
Advertising |
— | 90,611 | — | 90,611 | — | 90,611 | ||||||||||||||||||||||||||
Product development |
— | 16,436 | — | 16,436 | — | 16,436 | ||||||||||||||||||||||||||
Selling, general and administrative |
— | 140,609 | — | 140,609 | — | 140,609 | ||||||||||||||||||||||||||
Formation and operating costs |
1,486 | — | — | 1,486 | — | 1,486 | ||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Operating loss |
(1,486 | ) | (98,414 | ) | — | (99,900 | ) | — | (99,900 | ) | ||||||||||||||||||||||
Interest income earned on investments held in Trust Account |
(21 | ) | — | 21 | DD |
— | — | — | ||||||||||||||||||||||||
Offering costs allocated to warrants |
570 | — | — | 570 | — | 570 | ||||||||||||||||||||||||||
Change in fair value of warrant liabilities |
(6,496 | ) | — | — | (6,496 | ) | — | (6,496 | ) | |||||||||||||||||||||||
Interest expense |
— | 3,272 | — | 3,272 | — | 3,272 | ||||||||||||||||||||||||||
Loss on extinguishment of debt |
— | 1,027 | — | 1,027 | — | 1,027 | ||||||||||||||||||||||||||
Other expense (income), net |
— | 1,157 | (1,526 | ) | EE |
(369 | ) | — | (369 | ) | ||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Interest and other expense (income), net |
(5,947 | ) | 5,456 | (1,505 | ) | (1,996 | ) | — | (1,996 | ) | ||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Income (loss) before provision for income taxes |
4,461 | (103,870 | ) | 1,505 | (97,904 | ) | — | (97,904 | ) | |||||||||||||||||||||||
Provision for income taxes |
— | 39 | — | 39 | — | 39 | ||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Net income (loss) |
$ | 4,461 | $ | (103,909 | ) | $ | 1,505 | $ | (97,943 | ) | $ | — | $ | (97,943 | ) | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Net loss attributable to common stockholders, basic and diluted |
$ | 4,461 | $ | (103,909 | ) | $ | 1,505 | $ | (97,943 | ) | $ | — | $ | (97,943 | ) | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Weighted average shares outstanding of New Grove Class A and B Common Stock—basic and diluted |
FF |
178,598,507 | FF |
147,138,907 | ||||||||||||||||||||||||||||
|
|
|
|
|||||||||||||||||||||||||||||
Net loss per share of New Grove Class A and B Common Stock—basic and diluted |
$ | (0.55 | ) | $ | (0.67 | ) | ||||||||||||||||||||||||||
|
|
|
|
|||||||||||||||||||||||||||||
Weighted average shares outstanding of Grove common stock—basic and diluted |
7,114,091 | |||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||
Net loss per share of Grove common stock—basic and diluted |
$ | (14.61 | ) | |||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||
Weighted average shares outstanding of VGAC II Class A ordinary shares—basic and diluted |
28,918,582 | |||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||
Net loss per share of VGAC II Class A ordinary shares—basic and diluted |
$ | 0.12 | ||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||
Weighted average shares outstanding of VGAC II Class B ordinary shares—basic and diluted |
9,640,625 | |||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||
Net loss per share of VGAC II Class B ordinary shares—basic and diluted |
$ | 0.12 | ||||||||||||||||||||||||||||||
|
|
Grove (Historical) |
No Redemptions Scenario |
Maximum Redemptions Scenario |
||||||||||||||||||||||||||
Transaction Accounting Adjustments (Note 3) |
Notes |
Pro Forma Combined |
Transaction Accounting Adjustments (Note 3) |
Notes |
Pro Forma Combined |
|||||||||||||||||||||||
Revenue, net |
$ | 364,271 | $ | — | $ | 364,271 | $ | — | $ | 364,271 | ||||||||||||||||||
Cost of goods sold |
188,267 | — | 188,267 | — | 188,267 | |||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Gross profit |
176,004 | — | 176,004 | — | 176,004 | |||||||||||||||||||||||
Operating expenses: |
||||||||||||||||||||||||||||
Advertising |
55,547 | — | 55,547 | — | 55,547 | |||||||||||||||||||||||
Product development |
18,655 | — | 18,655 | — | 18,655 | |||||||||||||||||||||||
Selling, general and administrative |
168,295 | 2,147 | CC |
170,442 | — | 170,442 | ||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Operating loss |
(66,493 | ) | (2,147 | ) | (68,640 | ) | — | (68,640 | ) | |||||||||||||||||||
Interest expense |
5,607 | — | 5,607 | — | 5,607 | |||||||||||||||||||||||
Other expense (income), net |
119 | (964 | ) | AA |
(845 | ) | — | (845 | ) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Interest and other expense (income), net |
5,726 | (964 | ) | 4,762 | — | 4,762 | ||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Loss before provision for income taxes |
(72,219 | ) | (1,183 | ) | (73,402 | ) | — | (73,402 | ) | |||||||||||||||||||
Provision for income taxes |
41 | — | 41 | — | 41 | |||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Net loss |
$ | (72,260 | ) | $ | (1,183 | ) | $ | (73,443 | ) | $ | — | $ | (73,443 | ) | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Net loss attributable to common stockholders, basic and diluted |
$ | (72,260 | ) | $ | (1,183 | ) | $ | (73,443 | ) | $ | — | $ | (73,443 | ) | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Weighted average shares outstanding of New Grove Class A and Class B Common Stock—basic and diluted |
BB |
157,126,637 | BB |
125,667,037 | ||||||||||||||||||||||||
|
|
|
|
|||||||||||||||||||||||||
Net loss per share of New Grove Class A and Class B Common Stock—basic and diluted |
$ | (0.47 | ) | $ | (0.58 | ) | ||||||||||||||||||||||
|
|
|
|
|||||||||||||||||||||||||
Weighted average shares outstanding of Grove common stock—basic and diluted |
4,568,540 | |||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||
Net loss per share of Grove common stock—basic and diluted |
$ | (15.82 | ) | |||||||||||||||||||||||||
|
|
• | the historical unaudited financial statements of VGAC II as of September 30, 2021 and for the period from January 13, 2021 (inception) to September 30, 2021; |
• | the (a) historical audited financial statements of Grove as of and for the year ended December 31, 2020, and (b) historical unaudited condensed financial statements of Grove as of and for the nine months ended September 30, 2021, and |
• | other information relating to Grove and VGAC II included in this proxy statement/consent solicitation statement/prospectus, including the Merger Agreement and the description of certain terms thereof set forth under the section titled “Business Combination.” |
(A) | The reclassification of $402.5 million of cash and investments held in the VGAC II Trust Account that becomes available at closing of the Business Combination. |
(B) | In connection with the signing of the Merger Agreement, VGAC II entered into subscription agreements with certain investors (the “ PIPE Investors ”). Pursuant to the Subscription Agreements, the PIPE Investors agreed to subscribe for and purchase, and VGAC II agreed to issue and sell to such investors 8.7 million shares of New Grove Class A Common Stock with par value of $0.0001, resulting in gross proceeds of $87.1 million. The costs related to the issuance of the PIPE Financing are adjusted against additional paid in capital (see adjustment D below). |
(C) | Reflects the cash settlement of the $14.1 million liability for VGAC II’s deferred underwriting commissions related to its initial public offering. |
(D) | Represents the preliminary estimated direct and incremental transaction costs incurred by Grove related to the Business Combination, including underwriting/banking, legal, accounting and other fees for both the no redemption and maximum redemption scenarios, of which $25.4 million is allocated to the VGAC II ordinary shares, excluding those subject to the Sponsor Earnout, and PIPE Shares and reflected in the unaudited pro forma condensed combined balance sheet as a direct reduction to New Grove’s additional paid-in capital and are assumed to be cash settled. The direct and incremental costs related to liability-classified instruments totaling $2.1 million is expensed as of January 1, 2021 (see adjustment CC below). As of September 30, 2021, Grove had deferred transaction costs incurred of $1.3 million, of which $1.0 million was unpaid. |
(E) | Reflects the recapitalization of VGAC II Class A ordinary shares subject to possible redemption and VGAC II Class B ordinary shares into New Grove Class A Common Stock at $0.0001 par value. |
(F) | Represents the maximum redemptions scenario in which approximately 31,459,600 shares of VGAC II Class A ordinary shares are redeemed for $314.6 million, using a par value of $0.0001 per share at a redemption price of approximately $10.00 per share. |
(G) | Reflects the preliminary estimated fair value of contingently issuable Sponsor Earnout Shares and Grove Earnout Shares, excluding those allocated to the unvested Grove options and restricted stock units, that are expected to be accounted for as liability classified equity instruments that are earned upon achieving the triggering events, which include events that are not indexed to the common stock of New Grove. The preliminary fair value of these Earnout Shares was determined using the most reliable information currently available. The actual fair value could change materially once the final valuation is determined upon Closing. Refer to Note 5 for more information. Subsequent to the consummation of the Business Combination, this liability will be remeasured to its fair value at the end of each reporting period and subsequent changes in the fair value will be recognized in New Grove’s statement of operations within other income/expense. |
(H) | Reflects the elimination of VGAC II’s historical accumulated deficit with a corresponding adjustment to additional paid-in capital for New Grove in connection with the reverse recapitalization upon closing of the Business Combination. |
(I) | Reflects the conversion of Grove convertible preferred stock into shares of Grove common stock, and such shares will be converted into the right to receive shares of New Grove Class B Common Stock pursuant to the Exchange Ratio concurrent with the closing of the Business Combination. |
(J) | Reflects the conversion of Grove Common Stock into shares of New Grove Class B Common Stock pursuant to the Exchange Ratio concurrent with the closing of the Business Combination. |
(K) | Reflects the reclassification of Grove warrants from liability to equity classification as the warrants will become exercisable for shares of New Grove Class B Common Stock rather than Grove convertible preferred stock upon closing of the Business Combination. |
(AA) | Reflects the elimination of remeasurement losses on the Grove convertible preferred stock warrant liability. |
(BB) | As the Business Combination is being reflected as if it had occurred at the beginning of the earliest period presented, the calculation of weighted average shares outstanding for pro forma basic and |
diluted net income per share assumes that the shares issuable in connection with the Business Combination and the PIPE Financing have been outstanding for the entirety of the periods presented. If the maximum number of shares are redeemed, this calculation is retroactively adjusted to eliminate such shares for the entire period. |
(CC) | Represents the preliminary estimated direct and incremental transaction costs incurred by Grove related to the Business Combination, including underwriting/banking, legal, accounting and other fees for both the no redemption and maximum redemption scenarios, of which $2.1 million is allocated to the Sponsor Earnout Shares, Public Warrants, and Private Placement Warrants that are expected to be liability-classified and expensed. |
(DD) | Reflects the elimination of interest income related to the investments held in the VGAC II trust account. |
(EE) | Reflects the elimination of remeasurement losses on the Grove convertible preferred stock warrant liability. |
(FF) | As the Business Combination is being reflected as if it had occurred at the beginning of the earliest period presented, the calculation of weighted average shares outstanding for pro forma basic and diluted net income per share assumes that the shares issuable in connection with the Business Combination and the PIPE Financing have been outstanding for the entirety of the periods presented. If the maximum number of shares are redeemed, this calculation is retroactively adjusted to eliminate such shares for the entire period. |
Year Ended December 31, 2020 |
Nine Months Ended September 30, 2021 |
|||||||||||||||
No Redemption |
Maximum Redemption |
No Redemption |
Maximum Redemption |
|||||||||||||
Pro forma net loss |
$ | (73,443 | ) | $ | (73,443 | ) | $ | (97,943 | ) | $ | (97,943 | ) | ||||
Weighted average shares outstanding of New Grove Class A and Class B Common Stock—basic and diluted |
157,126,637 | 125,667,037 | 178,598,507 | 147,138,907 | ||||||||||||
Net loss per share of New Grove Class A and Class B Common Stock—basic and diluted |
$ | (0.47 | ) | $ | (0.58 | ) | $ | (0.55 | ) | $ | (0.67 | ) |
Year Ended December 31, 2020 |
Nine Months Ended September 30, 2021 |
|||||||||||||||
No Redemption |
Maximum Redemption |
No Redemption |
Maximum Redemption |
|||||||||||||
Private Placement Warrants (1) |
6,700,000 | 6,700,000 | 6,700,000 | 6,700,000 | ||||||||||||
Public Warrants |
8,050,000 | 8,050,000 | 8,050,000 | 8,050,000 | ||||||||||||
Sponsor Earnout Shares (2) |
3,490,375 | 3,490,375 | 3,490,375 | 3,490,375 | ||||||||||||
Grove common stock options (3) |
18,641,090 | 18,641,090 | 27,587,267 | 27,587,267 | ||||||||||||
Grove restricted stock units (3) |
— | — | 637,327 | 637,327 | ||||||||||||
Grove common stock warrants |
1,389,924 | 1,389,924 | 1,105,274 | 1,105,274 | ||||||||||||
Grove common stock issued early exercise of options |
1,227,876 | 1,227,876 | 197,476 | 197,476 | ||||||||||||
Grove Earnout Shares (4) |
14,000,000 | 14,000,000 | 14,000,000 | 14,000,000 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
53,499,265 | 53,499,265 | 61,767,719 | 61,767,719 | ||||||||||||
|
|
|
|
|
|
|
|
(1) | One whole warrant entitles the holder to purchase one share of New Grove Class A Common Stock at a price of $11.50 per share. New Grove’s warrants are anti-dilutive on a pro forma basis and have been excluded from the diluted number of New Grove’s shares outstanding at the time of closing. |
(2) | Sponsor Earnout Shares vest upon the achievement of the Share Price Milestones. Upon the closing of the Business Combination, these shares remain outstanding and unvested. |
(3) | All outstanding Grove options and restricted stock units at the closing, whether vested or unvested, will convert into options or rights to purchase a number of shares of New Grove Class B Common Stock, determined in accordance with the Exchange Ratio. Additionally, holders of Grove options and restricted stock units will receive a pro rata share of the Grove Earnout Shares. |
(4) | Grove Earnout Shares are contingently issuable upon the achievement of the Share Price Milestones. |
• | subject VGAC II to negative economic, competitive, and regulatory developments, any or all of which may have a substantial adverse impact on the particular industry in which VGAC II operates after an initial business combination; and |
• | cause VGAC II to depend on the marketing and sale of a single product or limited number of products or services. |
Name |
Age |
Position | ||||
Josh Bayliss |
48 | Chief Executive Officer and Director | ||||
Evan Lovell |
52 | Chief Financial Officer and Director | ||||
Rayhan Arif |
34 | Chief Operating Officer | ||||
Latif Peracha |
41 | Director | ||||
Elizabeth Nelson |
61 | Director | ||||
Chris Burggraeve |
57 | Director |
• | assisting board oversight of (1) the integrity of VGAC II’s financial statements, (2) VGAC II’s compliance with legal and regulatory requirements, (3) VGAC II’s independent registered public accounting firm’s qualifications and independence, and (4) the performance of VGAC II’s internal audit function and independent registered public accounting firm; the appointment, compensation, retention, replacement, and oversight of the work of the independent registered public accounting firm and any other independent registered public accounting firm engaged by VGAC II; |
• | pre-approving all audit and non-audit services to be provided by the independent registered public accounting firm or any other registered public accounting firm engaged by us, and establishing pre-approval policies and procedures; |
• | reviewing and discussing with the independent registered public accounting firm all relationships the registered public accounting firm have with VGAC II in order to evaluate their continued independence; |
• | setting clear policies for audit partner rotation in compliance with applicable laws and regulations; obtaining and reviewing a report, at least annually, from the independent registered public accounting firm describing (1) the independent registered public accounting firm’s internal quality-control procedures and (2) any material issues raised by the most recent internal quality-control review, or peer review, of the registered public accounting firm, or by any inquiry or investigation by governmental or professional authorities, within the preceding five years respecting one or more independent audits carried out by the firm and any steps taken to deal with such issues; |
• | meeting to review and discuss VGAC II’s annual audited financial statements and quarterly financial statements with management and the independent registered public accounting firm, including reviewing VGAC II’s specific disclosures under “Management’s Discussion and Analysis of Financial Condition and Results of Operations”; |
• | reviewing and approving any related party transaction required to be disclosed pursuant to Item 404 of Regulation S-K promulgated by the SEC prior to VGAC II entering into such transaction; and |
• | reviewing with management, the independent registered public accounting firm, and VGAC II’s legal advisors, as appropriate, any legal, regulatory, or compliance matters, including any correspondence with regulators or government agencies and any employee complaints or published reports that raise material issues regarding VGAC II’s financial statements or accounting policies and any significant changes in accounting standards or rules promulgated by the Financial Accounting Standards Board, the SEC, or other regulatory authorities. |
• | identifying, screening, and reviewing individuals qualified to serve as directors, consistent with criteria approved by the VGAC II Board, and recommending to the VGAC II Board candidates for nomination for appointment at the annual general meeting or to fill vacancies on the VGAC II Board; |
• | developing and recommending to the VGAC II Board and overseeing implementation of VGAC II’s corporate governance guidelines; |
• | coordinating and overseeing the annual self-evaluation of the VGAC II Board, its committees, individual directors, and management in the governance of VGAC II; and |
• | reviewing on a regular basis VGAC II’s overall corporate governance and recommending improvements as and when necessary. |
• | reviewing and approving on an annual basis the corporate goals and objectives relevant to VGAC II’s chief executive officer’s compensation; |
• | evaluating VGAC II’s chief executive officer’s performance in light of such goals and objectives and determining and approving the remuneration (if any) of VGAC II’s chief executive officer’s based on such evaluation; |
• | reviewing and making recommendations to the VGAC II Board with respect to the compensation, and any incentive compensation and equity based plans that are subject to VGAC II Board approval of all of VGAC II’s other officers; |
• | reviewing VGAC II’s executive compensation policies and plans; |
• | implementing and administering VGAC II’s incentive compensation equity-based remuneration plans; |
• | assisting management in complying with VGAC II’s proxy statement and annual report disclosure requirements; |
• | approving all special perquisites, special cash payments, and other special compensation and benefit arrangements for VGAC II’s officers and employees; |
• | producing a report on executive compensation to be included in VGAC II’s annual proxy statement; and |
• | reviewing, evaluating, and recommending changes, if appropriate, to the remuneration for directors. |
• | duty to act in good faith in what the director or officer believes to be in the best interests of the company as a whole; |
• | duty to exercise powers for the purposes for which those powers were conferred and not for a collateral purpose; |
• | directors should not improperly fetter the exercise of future discretion; |
• | duty to exercise powers fairly as between different sections of shareholders; |
• | duty not to put themselves in a position in which there is a conflict between their duty to the company and their personal interests; and |
• | duty to exercise independent judgment. |
Individual |
Entity |
Entity’s Business |
Affiliation | |||
Josh Bayliss | Virgin Group Virgin Group Holdings Limited Corvina Holdings Limited Virgin Investments Limited Virgin Entertainment Holdings, Inc. Virgin Red Limited |
Investment Firm Investment Firm Investment Firm Investment Firm Investment Firm Loyalty/Rewards |
Chief Executive Officer Director Director Director Director Director | |||
Evan Lovell | Virgin Group Virgin Galactic Holdings, Inc. VO Holdings, Inc. Virgin Hotels, LLC Virgin Cruises Limited Sport Group Limited BMR Energy Ltd. BMR Energy LLC 23andMe Holding Co. |
Investment Firm Space Space Hospitality Travel Health & Wellness Energy Energy Personal genomics and biotechnology |
Chief Investment Officer Director Director Director Director Director Director Director Director | |||
Rayhan Arif | BMR Energy Virgin Mobile LATAM |
Energy Wireless Communications |
Director Director | |||
Latif Peracha | M13 Feelmore Labs Rho Technologies Emerge |
Venture Capital Health & Wellness FinTech Technology |
General Partner Director Director Director | |||
Elizabeth Nelson | Nokia Corporation Upwork Inc. Berkeley Lights Inc. |
Wireless Communications Technology Healthcare |
Director Director Director | |||
Chris Burggraeve | Vicomte LLC Seaters A.I. Toast Holdings AYR Wellness, Inc. |
Marketing Marketing Consumer Goods Medicinal |
Founder & Chief Executive Officer Director Director Director |
• | VGAC II’s officers and directors are not required to, and will not, commit their full-time to VGAC II’s affairs, which may result in a conflict of interest in allocating their time between VGAC II’s operations and VGAC II’s search for a business combination and their other businesses. VGAC II currently does not have and does not intend to have any full-time employees prior to the completion of an initial business combination. Each of VGAC II’s officers is engaged in several other business endeavors for which he may be entitled to substantial compensation, and VGAC II’s officers are not obligated to contribute any specific number of hours per week to VGAC II’s affairs. |
• | VGAC II’s initial shareholders purchased founder shares prior to the date of the initial public offering and purchased private placement warrants in a transaction that closed simultaneously with the closing of the initial public offering. The Sponsor, officers, and directors have entered into a letter agreement with VGAC II, pursuant to which they have agreed to waive their redemption rights with respect to |
their founder shares and public shares in connection with the completion of an initial business combination. Additionally, the Sponsor, officers, and directors have agreed to waive their rights to liquidating distributions from the trust account with respect to their founder shares if VGAC II fails to complete an initial business combination within the prescribed time frame. If VGAC II does not complete an initial business combination within the prescribed time frame, the private placement warrants will expire worthless. Furthermore, the Sponsor, officers, and directors have agreed not to transfer, assign, or sell any of their founder shares and any Class A ordinary shares issuable upon conversion thereof until the earlier to occur of: (i) one year after the completion of an initial business combination or (ii) the date following the completion of an initial business combination on which VGAC II completes a liquidation, merger, share exchange or other similar transaction that results in all of VGAC II shareholders having the right to exchange their ordinary shares for cash, securities, or other property. Notwithstanding the foregoing, if the closing price of VGAC II Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading-day |
• | The private placement warrants (including the Class A ordinary shares issuable upon exercise of the private placement warrants) will not be transferable until 30 days following the completion of an initial business combination. Because each of VGAC II’s officers and directors will own ordinary shares or warrants directly or indirectly, they may have a conflict of interest in determining whether a particular target business is an appropriate business with which to effectuate an initial business combination. |
• | Each of Mr. Bayliss and Mr. Lovell invested $300,000 in the Sponsor and hold interests in the Sponsor that represent an indirect interest in 1,246,600 Class B ordinary shares and 197,939 private placement warrants. Mr. Arif, Mr. Burggraeve, Ms. Nelson and Mr. Peracha invested $50,000, $100,000, $100,000 and $100,000, respectively, in the Sponsor indirectly through an investment in VG Acquisition Holdings II LLC (an affiliate of the Sponsor), and hold interests in VG Acquisition Holdings II LLC that represent an indirect interest in 73,341, 70,216, 70,216 and 70,216 Class B ordinary shares, respectively, and 33,212, 66,550, 66,550 and 66,550 private placement warrants, respectively. All of such securities would be worthless if a business combination is not consummated by March 25, 2023 (unless such date is extended in accordance with the Existing Governing Documents). |
• | The fact that the Virgin Group and the Sponsor will collectively own 6,572,125 shares of New Grove Class A Common Stock, which collectively will represent up to approximately 4.4% of outstanding shares of New Grove Common Stock and approximately [●]% of the voting power of New Grove Common Stock assuming that 100% of VGAC II Class A ordinary shares are redeemed. |
• | We have implemented procedures intended to ensure that we identify and apply the applicable accounting guidance to all complex transactions. |
• | We are establishing additional monitoring and oversight controls designed to ensure the accuracy and completeness of our financial statements and related disclosures. |
• | Gross margin increased by 1,400 basis points from 36% in 2019 to 50% in the twelve months ended September 30, 2021; |
• | Gross profit increased from $83 million in 2019 to $196 million in the twelve months ended September 30, 2021; and |
• | We significantly improved Adjusted EBITDA from ($145) million in 2019 to ($92) million in the twelve months ended September 30, 2021, marking a $53 million improvement. |
• | #1 brand in units per store per trip: |
• | #1 brand in repeat sales: |
• | #1 brand in % of basket: |
• | We can test market acceptance of product attributes prior to or as part of product launch, including fragrance, price point, marketing messaging, sustainability and more. We can assess market acceptance of products on our DTC platform prior to a product ready date to determine consumer interest via our waitlist feature. |
• | We can quickly gather consumer feedback by including samples in existing shipments, conducting online focus groups, and asking our consumers directly. We can then improve the products where possible and relaunch or drop underperforming SKUs at very little cost. |
• | We can launch products on our DTC platform at any point, without the constraints of retailer shelf reset timelines. |
• | We have a deep understanding of our consumers based on historical purchasing behavior, demographic information, and the ways in which they engage with our community and platform. |
I. |
Plastic single-use plastic packaging. As consumers awaken to the reality of the plastic pollution crisis, they are urgently and increasingly demanding bold new solutions. |
○ |
Plastic Neutral: |
term plastic-free solutions. We work with two partners, rePurpose Global and Plastic Bank, to fund plastic pollution collection and infrastructure development in the Philippines, India, Kenya and Colombia. |
○ |
Plastic-Free by the End of 2025: |
II. |
Forests: |
○ |
One Million Trees: |
○ |
Tree-Free Paper: ® |
III. |
Carbon : |
○ |
CarbonNeutral ® Certified Company: ® company as of 2021—meaning that we have purchased carbon offsets to neutralize all of the emissions related to the business activities that are under our direct control, which excludes manufacturing and supply chain. In order to maintain this certification, we are required to continue to reduce or offset the carbon emissions generated by our business activities, consumer shipments and several other areas of our company indicated by the CarbonNeutral® protocol. This codifies our commitment to maintain our values as our business grows. |
○ |
Net Zero by 2030 |
○ |
Science-Based Targets: |
• | DTC |
• | Retail brick-and-mortar exclusive-for-Target |
1. | Build a vibrant and engaged online community of consumers who care deeply about both home and planet. In our customer insights surveys, we found that while 61% of consumers self-identify as buying some natural products (across home, personal care, beauty and food), many are unfamiliar with natural and sustainable brands and are only buying products from a small handful of brands, or in one or two categories. They are early on in their journey of switching to natural and sustainable products, and recommendations from friends, family, influencers and other shoppers are especially powerful. On an average day, our community will comment, share or post thousands of times. This vibrant and ever-evolving dialogue has been instrumental in breaking down barriers to trial. |
2. | Efficiently acquire new customers using performance marketing across a wide variety of digital and offline marketing channels. We pair insights and content sourced directly from our community with sophisticated in-house media measurement and optimization capabilities. This combination has enabled us to efficiently acquire a large customer base and build both interest and desire for our Grove Brands and product lines. |
3. | Enable customers to try a variety of natural and/or sustainable products, starting with their first order. This emphasis on product and brand discovery differentiates us from many other brands in the natural |
and sustainable market who offer a limited selection, or only have a presence in one part of the home. The natural and sustainable products industry is highly fragmented, with no clear market leader, forcing consumers to spend time and energy to research and discover new products. By moving beyond a single category, we provide our customers with a whole-home solution that not only matches their values, but is also easy, affordable, and low-risk (due to our price matching policy and 100% Happiness Guarantee, in which we commit to respond to customer service inquiries within 24 hours, and allow customers to return products within 30 days of delivery, or cancel their subscriptions at any time if they are not completely satisfied). |
• | Large & Unique Data Asset speed-to-insight brick-and-mortar |
• | The Right People on-site buying trends in near real time, and modify on-site presentation of products to drive success in key campaigns. |
• | Pragmatic Algorithms on-site and in-app recommendations to encourage product discovery and drive higher average order value. |
• | Data Privacy and Cybersecurity |
corporate networks. We strive to ensure ongoing compliance with the requirements under relevant standards including PCI and the Sarbanes-Oxley Act of 2002 (SOX). Additionally, our teams use the standards, guidelines, and practices from the NIST Cybersecurity Framework to understand and manage cybersecurity risk. We continually monitor and proactively address identified cyber security risks through a combination of automated tools, external audits, and recurring review from our internal cybersecurity working group and report any material findings and incidents to the audit committee. Our data privacy practices are designed to ensure security, compliance, and privacy while collecting, storing, and creating insights from the data. |
• | Subscription Engine |
• | Flexible Monthly Shipments Feature |
• | Marketing Campaigns Software-as-a-Service |
• | Gross margin increased by 1,400 basis points from 36% in 2019 to 50% in the twelve months ended September 30, 2021; |
• | Gross profit increased from $83 million in 2019 to $196 million in the twelve months ended September 30, 2021; and |
• | We significantly improved Adjusted EBITDA from ($145) million in 2019 to ($92) million in the twelve months ended September 30, 2021, marking a $53 million improvement. |
(in thousands , except DTC Net Revenue Per Order and percentages) |
Years Ended December 31, |
Nine Months Ended September 30, |
||||||||||||||||||
2018 |
2019 |
2020 |
2020 |
2021 |
||||||||||||||||
Financial and Operating Data |
||||||||||||||||||||
Grove Brands % Net Revenue |
28 | % | 37 | % | 45 | % | 44 | % | 49 | % | ||||||||||
DTC Total Orders |
2,833 | 5,618 | 6,860 | 5,226 | 5,152 | |||||||||||||||
DTC Active Customers |
959 | 1,696 | 1,732 | 1,807 | 1,707 | |||||||||||||||
DTC Net Revenue Per Order |
$ | 37 | $ | 41 | $ | 53 | $ | 52 | $ | 56 |
Year Ended December 31, |
Nine Months Ended September 30, |
|||||||||||||||||||
2018 |
2019 |
2020 |
2020 |
2021 |
||||||||||||||||
Reconciliation of Net Loss to Adjusted EBITDA |
(in thousands) |
|||||||||||||||||||
Net loss |
$ | (81,695 | ) | $ | (161,470 | ) | $ | (72,260 | ) | $ | (58,943 | ) | $ | (103,909 | ) | |||||
Stock-based compensation |
1,593 | 11,960 | 7,762 | 5,474 | 10,858 | |||||||||||||||
Depreciation and amortization |
571 | 2,361 | 4,115 | 3,028 | 3,633 | |||||||||||||||
Remeasurement of convertible preferred stock warrant liability |
651 | 430 | 964 | 453 | 1,526 | |||||||||||||||
Interest expense |
619 | 2,052 | 5,607 | 4,568 | 3,272 | |||||||||||||||
Loss on extinguishment of debt |
— | — | — | — | 1,027 | |||||||||||||||
Provision for income taxes |
1 | 12 | 41 | 31 | 39 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total Adjusted EBITDA |
$ | (78,260 | ) | $ | (144,655 | ) | $ | (53,771 | ) | $ | (45,389 | ) | $ | (83,554 | ) | |||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Adjusted EBITDA margin |
(75 | )% | (62 | )% | (15 | )% | (17 | )% | (28 | )% |
Year Ended December 31, |
Nine Months Ended September 30, |
|||||||||||||||
2019 |
2020 |
2020 |
2021 |
|||||||||||||
(in thousands) |
||||||||||||||||
Revenue, net |
$ | 233,116 | $ | 364,271 | $ | 271,233 | $ | 296,421 | ||||||||
Cost of goods sold |
149,681 | 188,267 | 141,683 | 147,179 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Gross profit |
83,435 | 176,004 | 129,550 | 149,242 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Operating expenses: |
||||||||||||||||
Advertising |
77,842 | 55,547 | 43,816 | 90,611 | ||||||||||||
Product development |
13,604 | 18,655 | 13,855 | 16,436 | ||||||||||||
Selling, general and administrative |
155,158 | 168,295 | 126,427 | 140,609 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Operating loss |
(163,169 | ) | (66,493 | ) | (54,548 | ) | (98,414 | ) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Interest expense |
2,052 | 5,607 | 4,568 | 3,272 | ||||||||||||
Loss on extinguishment of debt |
— | — | — | 1,027 | ||||||||||||
Other expense (income), net |
(3,763 | ) | 119 | (204 | ) | 1,157 | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Interest and other expense (income), net |
(1,711 | ) | 5,726 | 4,364 | 5,456 | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Loss before provision for income taxes |
(161,458 | ) | (72,219 | ) | (58,912 | ) | (103,870 | ) | ||||||||
Provision for income taxes |
12 | 41 | 31 | 39 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net loss |
$ | (161,470 | ) | $ | (72,260 | ) | $ | (58,943 | ) | $ | (103,909 | ) | ||||
|
|
|
|
|
|
|
|
Year Ended December 31, |
Nine Months Ended September 30, |
|||||||||||||||
2019 |
2020 |
2020 |
2021 |
|||||||||||||
(as a percentage of revenue) |
||||||||||||||||
Revenue, net |
100 | % | 100 | % | 100 | % | 100 | % | ||||||||
Cost of goods sold |
64 | 52 | 52 | 50 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Gross profit |
36 | 48 | 48 | 50 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Operating expenses: |
||||||||||||||||
Advertising |
33 | 15 | 16 | 31 | ||||||||||||
Product development |
6 | 5 | 5 | 6 | ||||||||||||
Selling, general and administrative |
67 | 46 | 47 | 47 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Operating loss |
(70 | ) | (18 | ) | (20 | ) | (34 | ) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Interest expense |
1 | 2 | 2 | 1 | ||||||||||||
Loss on extinguishment of debt |
— | — | — | — | ||||||||||||
Other expense (income), net |
(2 | ) | — | — | — | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Interest and other expense (income), net |
(1 | ) | 2 | 2 | 1 | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Loss before provision for income taxes |
(69 | ) | (20 | ) | (22 | ) | (35 | ) | ||||||||
Provision for income taxes |
— | — | — | — | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net loss |
(69 | )% | (20 | )% | (22 | )% | (35 | )% | ||||||||
|
|
|
|
|
|
|
|
Nine Months Ended September 30, |
Change |
|||||||||||||||
2020 |
2021 |
Amount |
% |
|||||||||||||
(in thousands) |
||||||||||||||||
Revenue, net: |
||||||||||||||||
Grove Brands |
$ | 120,139 | $ | 145,516 | $ | 25,377 | 21 | % | ||||||||
Third-party products |
151,094 | 150,905 | (189 | ) | — | % | ||||||||||
|
|
|
|
|
|
|||||||||||
Total revenue, net |
$ | 271,233 | $ | 296,421 | $ | 25,188 | 9 | % | ||||||||
|
|
|
|
|
|
Nine Months Ended September 30, |
Change |
|||||||||||||||
2020 |
2021 |
Amount |
% |
|||||||||||||
(in thousands) |
||||||||||||||||
Cost of goods sold |
$ | 141,683 | $ | 147,179 | $ | 5,496 | 4 | % | ||||||||
Gross profit |
129,550 | 149,242 | 19,692 | 15 | % | |||||||||||
Gross margin |
48 | % | 50 | % | 2 | % |
Nine Months Ended September 30, |
Change |
|||||||||||||||
2020 |
2021 |
Amount |
% |
|||||||||||||
(in thousands) |
||||||||||||||||
Advertising |
$ | 43,816 | $ | 90,611 | $ | 46,795 | 107 | % |
Nine Months Ended September 30, |
Change |
|||||||||||||||
2020 |
2021 |
Amount |
% |
|||||||||||||
(in thousands) |
||||||||||||||||
Product development |
$ | 13,855 | $ | 16,436 | $ | 2,581 | 19 | % |
Nine Months Ended September 30, |
Change |
|||||||||||||||
2020 |
2021 |
Amount |
% |
|||||||||||||
(in thousands) |
||||||||||||||||
Selling, general and administrative |
$ | 126,427 | $ | 140,609 | $ | 14,182 | 11 | % |
Nine Months Ended September 30, |
Change |
|||||||||||||||
2020 |
2021 |
Amount |
% |
|||||||||||||
(in thousands) |
||||||||||||||||
Interest expense |
$ | 4,568 | $ | 3,272 | $ | (1,296 | ) | (28 | )% |
Nine Months Ended September 30, |
Change | |||||||||||||
2020 |
2021 |
Amount |
% | |||||||||||
(in thousands) |
||||||||||||||
Loss on extinguishment of debt |
$ | — | $ | 1,027 | $ | 1,027 | * |
* | Percentage change not meaningful. |
Nine Months Ended September 30, |
Change | |||||||||||||
2020 |
2021 |
Amount |
% | |||||||||||
(in thousands) |
||||||||||||||
Other expense (income), net |
$ | (204 | ) | $ | 1,157 | $ | 1,361 | * |
* | Percentage change not meaningful. |
Year Ended December 31, |
Change |
|||||||||||||||
2019 |
2020 |
Amount |
% |
|||||||||||||
(in thousands) |
||||||||||||||||
Revenue, net: |
||||||||||||||||
Grove Brands |
$ | 86,717 | $ | 164,372 | $ | 77,655 | 90 | % | ||||||||
Third-party products |
146,399 | 199,899 | 53,500 | 37 | % | |||||||||||
|
|
|
|
|
|
|||||||||||
Total revenue, net |
$ | 233,116 | $ | 364,271 | $ | 131,155 | 56 | % | ||||||||
|
|
|
|
|
|
Year Ended December 31, |
Change |
|||||||||||||||
2019 |
2020 |
Amount |
% |
|||||||||||||
(in thousands) |
||||||||||||||||
Cost of goods sold |
$ | 149,681 | $ | 188,267 | $ | 38,586 | 26 | % | ||||||||
Gross profit |
83,435 | 176,004 | 92,569 | 111 | % | |||||||||||
Gross margin |
36 | % | 48 | % | 12 | % |
Year Ended December 31, |
Change |
|||||||||||||||
2019 |
2020 |
Amount |
% |
|||||||||||||
(in thousands) |
||||||||||||||||
Advertising |
$ | 77,842 | $ | 55,547 | $ | (22,295 | ) | (29 | )% |
Year Ended December 31, |
Change |
|||||||||||||||
2019 |
2020 |
Amount |
% |
|||||||||||||
(in thousands) |
||||||||||||||||
Product development |
$ | 13,604 | $ | 18,655 | $ | 5,051 | 37 | % |
Year Ended December 31, |
Change |
|||||||||||||||
2019 |
2020 |
Amount |
% |
|||||||||||||
(in thousands) |
||||||||||||||||
Selling, general and administrative |
$ | 155,158 | $ | 168,295 | $ | 13,137 | 8 | % |
Year Ended December 31, |
Change |
|||||||||||||||
2019 |
2020 |
Amount |
% |
|||||||||||||
(in thousands) |
||||||||||||||||
Interest expense |
$ | 2,052 | $ | 5,607 | $ | 3,555 | 173 | % |
Year Ended December 31, |
Change |
|||||||||||||||
2019 |
2020 |
Amount |
% |
|||||||||||||
(in thousands) |
||||||||||||||||
Other expense (income), net |
$ | (3,763 | ) | $ | 119 | $ | 3,882 | (103 | )% |
Year Ended December 31, |
Nine Months Ended September 30, |
|||||||||||||||
2019 |
2020 |
2020 |
2021 |
|||||||||||||
(in thousands) |
||||||||||||||||
Net cash used in operating activities |
$ | (124,805 | ) | $ | (83,656 | ) | $ | (54,004 | ) | $ | (88,753 | ) | ||||
Net cash used in investing activities |
(12,307 | ) | (4,820 | ) | (3,370 | ) | (4,268 | ) | ||||||||
Net cash provided by financing activities |
107,447 | 228,170 | 102,148 | 25,715 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net increase (decrease) in cash and cash equivalents |
$ | (29,665 | ) | $ | 139,694 | $ | 44,774 | $ | (67,306 | ) | ||||||
|
|
|
|
|
|
|
|
• | independent third-party valuations of our common stock; |
• | the rights, preferences and privileges of our redeemable convertible preferred stock relative to our common stock; |
• | our operating results, financial position and capital resources; |
• | our stage of development and current business conditions and projections, including the introduction of new products; |
• | the lack of marketability of our common stock; |
• | the hiring of key personnel and the experience of our management; |
• | the likelihood of achieving a liquidity event, such as an initial public offering or a sale of our company given the prevailing market conditions; |
• | and the nature and history of our business; |
• | industry trends and competitive environment; |
• | trends in consumer spending, including consumer confidence; and |
• | the overall economic, regulatory and capital market conditions. |
• | Stu Landesberg, Chief Executive Officer; |
• | Delida Costin, Chief Legal and People Officer; and |
• | Jennie Perry, Chief Marketing Officer |
Name and Principal Position |
Year |
Salary ($) (1) |
Bonus ($) |
Option Awards ($) (2) |
Stock Awards ($) (3) |
Non-Equity Incentive Plan Compensation ($) |
All Other Compensation ($) |
Total ($) |
||||||||||||||||||||||||
Stuart Landesberg |
2021 | 255,000 | — | 18,387,940 | — | — | — | 18,642,940 | ||||||||||||||||||||||||
Chief Executive Officer and President |
||||||||||||||||||||||||||||||||
Delida Costin |
2022 | 425,000 | — | 1,854,572 | 436,500 | — | — | 2,716,072 | ||||||||||||||||||||||||
Chief Legal and People Officer |
||||||||||||||||||||||||||||||||
Jennie Perry |
2022 | 404,134 | — | 2,897,846 | — | — | — | 3,301,980 | ||||||||||||||||||||||||
Chief Marketing Officer |
(1) | Ms. Perry jointed Grove on February 8, 2021. Amounts reported in this column for Ms. Perry reflect a base salary of $450,000 prorated to her start date. |
(2) | Amounts reported in this column for Mr. Landesberg and Mses. Costin and Perry reflect the aggregate grant date fair value of stock options awarded in 2021, computed in accordance with FASB ASC Topic 718, Compensation—Stock Compensation based on the following assumptions: risk-free interest rate of 0.67% - 0.69%; expected volatility of 73.66% - 73.74%; expected term of 6.0 – 6.1 years; and expected dividend rate of 0.00%. As noted above, 864,910 of the stock options granted to Mr. Landesberg vest based on market conditions. The fair value for Mr. Landesberg’s stock options with a market based vesting condition was determined using the probability weighted expected term method (“PWERM”), which involves the estimation of future potential outcomes as well as values and probabilities associated with each potential outcome. Two potential scenarios were used in the PWERM that utilized 1) the value of the Company’s common equity, and 2) a Monte Carlo simulation to specifically value the award. The total grant date fair value of the award, based on the probable satisfaction of the market-based vesting conditions, was determined to be $5.5 million. Under FASB ASC Topic 718, due to the vesting conditions related to Mr. Landesberg’s 864,910 stock options, there is no grant date fair value below or in excess of the amount reflected in the table above for Mr. Landesberg that could be calculated and disclosed based on the achievement of the underlying conditions. |
(3) | The amount reported in this column for Ms. Costin reflects the grant date fair value of $8.73 for her RSUs, computed in accordance with FASB ASC Topic 718, calculated based on the Company’s most recent Section 409A valuation available prior to the grant date. |
Option Awards |
Equity Incentive Plan Awards |
|||||||||||||||||||||||||||||||||||
Name |
Grant Date |
Vesting Commencement Date |
Number of Securities Underlying Unexercised Options (#) Exercisable |
Number of Securities Underlying Unexercised Options (#) Unexercisable |
Equity Incentive Plan Awards: Number of Securities Underlying Unexercised Unearned Options (#) |
Option Exercise Price ($) |
Option Expiration Date |
Number of Unearned Shares, Units or Other Rights That Have Not Vested (#) |
Market or Payout Value of Unearned Shares, Units or Other Rights That Have Not Vested ($) |
|||||||||||||||||||||||||||
Stuart Landesberg |
3/30/2018 | (2) | 12/18/2017 | 2,256,324 | — | — | 0.75 | 3/29/2028 | — | — | ||||||||||||||||||||||||||
5/31/2019 | (3) | 12/21/2018 | 3,638,130 | — | — | 2.25 | 5/30/2029 | — | — | |||||||||||||||||||||||||||
2/15/2021 | (4) | 1/1/2021 | 586,309 | 2,540,673 | — | 4.43 | 2/14/2031 | — | — | |||||||||||||||||||||||||||
2/15/2021 | (5) | (5 | ) | — | — | 864,910 | 4.43 | 2/14/2031 | — | — | ||||||||||||||||||||||||||
Delida Costin |
5/31/2019 | (6) | 5/20/2019 | 205,000 | 150,000 | — | 2.25 | 5/30/2029 | — | — | ||||||||||||||||||||||||||
1/15/2020 | (7) | 1/7/2020 | 110,000 | — | — | 2.25 | 1/14/2030 | — | — | |||||||||||||||||||||||||||
2/15/2021 | (8) | 1/1/2021 | 84,375 | 365,625 | — | 4.43 | 2/14/2031 | — | — | |||||||||||||||||||||||||||
9/22/2021 | (9) | N/A | — | — | — | — | — | 50,000 | 436,500 | |||||||||||||||||||||||||||
Jennie Perry |
2/15/2021 | (10) | 2/8/2021 | — | 700,000 | — | 4.43 | 2/14/2031 | — | — |
(1) | As of December 31, 2021, Grove’s equity was not publicly traded and, therefore, there was no ascertainable public market value for the equity on such date. The market value reported in this table is based upon a Section 409A valuation analysis of Grove’s equity as of August 31, 2021, the most recent report available. |
(2) | This option vests 25% on the first anniversary of the vesting commencement date and then vests quarterly for the next 36 months, subject to Mr. Landesberg’s continuous employment through each applicable vesting date, with accelerated vesting if Mr. Landesberg’s employment is terminated by Grove without cause or he resigns for good reason. Because these options may be early exercised for restricted stock, they are reported in this table as “Exercisable.” |
(3) | This option vests 25% on the first anniversary of the vesting commencement date and then vests quarterly for the next 36 months, subject to Mr. Landesberg’s continuous employment through each applicable vesting date, with accelerated vesting if Mr. Landesberg’s employment is terminated by Grove without cause or he resigns for good reason. Because these options may be early exercised for restricted stock, they are reported in this table as “Exercisable.” |
(4) | This option vests on the earlier of (i) if Grove’s shares are not publicly traded, such time as Grove closes a preferred or common equity financing in the amount of at least $25.0 million at a price per share of at least $15.03, (ii) if Grove’s shares (or its successor’s shares) are publicly traded, such time as the 20-day trading day volume-weighted average price is at least $15.03 per share, or (iii) immediately prior to the consummation of certain corporate transactions in which the holders of shares of Grove common stock will receive, in exchange for such shares, cash or other consideration the aggregate amount of $15.03 per share, subject to Mr. Landesberg’s continuous employment on the date of such milestone. |
(5) | This option vests 25% on the first anniversary of the vesting commencement date and then vests quarterly for the next 36 months, subject to Ms. Costin’s continuous employment through each applicable vesting |
date, with accelerated vesting following a change in control if Ms. Costin’s employment is terminated by Grove without cause or she resigns for good reason. |
(6) | This option vests 25% on the first anniversary of the vesting commencement date and then vests quarterly for the next 36 months, subject to Ms. Costin’s continuous employment through each applicable vesting date, with accelerated vesting following a change in control if Ms. Costin’s employment is terminated by Grove without cause or she resigns for good reason. Because these options may be early exercised for restricted stock, they are reported in this table as “Exercisable.” |
(7) | This option vests 25% on the first anniversary of the vesting commencement date and then vests quarterly for the next 36 months, subject to Ms. Costian’s continuous employment through each applicable vesting date, with accelerated vesting following a change in control if Ms. Costian’s employment is terminated by Grove without cause or she resigns for good reason. Because these options may be early exercised for restricted stock, they are reported in this table as “Exercisable.” |
(8) | This option vests quarterly for 48 months starting with the first quarter following the vesting commencement date, subject to Ms. Costin’s continuous employment through each applicable vesting date, with accelerated vesting following a change in control if Ms. Costin’s employment is terminated by Grove without cause or she resigns for good reason. |
(9) | The vesting the RSUs requires the satisfaction of both of two conditions: an event condition and a service condition. The event condition will be satisfied if a liquidity event occurs prior to the expiration date (five years from the grant date) subject to Ms. Costin’s continuous employment through the date of such liquidity event. The service condition is satisfied with respect to 1/8th of the RSUs on the date of the liquidity event and quarterly for the next 18 months, subject to Ms. Costin’s continuous employment through the applicable vesting date. Any RSU for which both conditions are satisfied shall become vested. The vesting of the RSUs accelerate following a change in control if Ms. Costin’s employment is terminated by Grove without cause or she resigns for good reason. |
(10) | This option vests 25% on the first anniversary of the vesting commencement date and then vests quarterly for the next 36 months, with accelerated vesting following a change in control if Ms. Perry’s employment is terminated by Grove without cause or she resigns for good reason. |
Name |
Stock Awards($)(1) |
Option Awards($)(2) |
Total($) |
|||||||||
Catherine Beaudoin |
||||||||||||
David Glazer |
||||||||||||
John Replogle |
(1) | The amount reported in this column for Messrs. Glazer and Replogle reflects the grant date fair value of $ |
(2) | Amounts reported in this column for Ms. Beaudoin and Messrs. Glazer and Replogle reflect the aggregate grant date fair value of stock options awarded in 2021, computed in accordance with FASB ASC Topic 718, Compensation—Stock Compensation based on the following assumptions: risk-free interest rate of |
Name |
Age |
Position | ||||
Executive Officers |
||||||
Stuart Landesberg |
36 | Chief Executive Officer and Director | ||||
Christopher Clark |
36 | Chief Technology Officer and Director | ||||
Delida Costin |
52 | Chief Legal and People Officer; Secretary | ||||
Janae De Crescenzo |
37 | Interim Co-Chief Financial Officer | ||||
Phil Moon |
36 | Interim Co-Chief Financial Officer | ||||
Jennie Perry |
55 | Chief Marketing Officer | ||||
Andrew Rendich |
54 | Chief Operating Officer | ||||
Jon Silverman |
48 | Senior Vice President, Physical Goods | ||||
Non-Employee Directors |
||||||
Catherine Beaudoin |
58 | Director | ||||
David Glazer |
38 | Director | ||||
John Replogle |
55 | Director |
• | each person known by VGAC II to be the beneficial owner of more than 5% of VGAC II’s outstanding ordinary shares on the record date ([●], 2022) or the beneficial owner of more than 5% of the shares of the Company’s common stock upon completion of the Business Combination; |
• | each person known by VGAC II who may become beneficial owner of more than 5% of New Grove outstanding Common Stock immediately following the Business Combination; |
• | each of VGAC II’s current executive officers and directors; |
• | each person who will become an executive officer or a director of New Grove upon consummation of the Business Combination; |
• | all of VGAC II’s current executive officers and directors as a group; and |
• | all of New Grove executive officers and directors as a group after the consummation of the Business Combination. |
Prior to Business Combination(2) |
After Business Combination |
|||||||||||||||||||||||||||||||||||||||
Assuming No Redemptions(3) |
Assuming Maximum Redemptions(4) |
|||||||||||||||||||||||||||||||||||||||
Name and Address of Beneficial Owners |
Number of Ordinary Shares |
% |
Number of Shares of New Grove Collaborative Class A Common Stock |
% |
Number of Shares of New Grove Collaborative Class B Common Stock |
% |
Number of Shares of New Grove Collaborative Class A Common Stock |
% |
Number of Shares of New Grove Collaborative Class B Common Stock |
% |
||||||||||||||||||||||||||||||
Directors and executive officers prior to the Business Combination(1): |
||||||||||||||||||||||||||||||||||||||||
Rayhan Arif |
— | — | — | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||
Josh Bayliss |
— | — | — | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||
Chris Burggraeve |
30,000 | * | 30,000 | * | — | — | 30,000 | * | — | — | ||||||||||||||||||||||||||||||
Evan Lovell |
— | — | — | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||
Elizabeth Nelson |
30,000 | * | 30,000 | * | — | — | 30,000 | * | — | — | ||||||||||||||||||||||||||||||
Latif Peracha |
30,000 | * | 30,000 | * | — | — | 30,000 | * | — | — |
Prior to Business Combination(2) |
After Business Combination |
|||||||||||||||||||||||||||||||||||||||
Assuming No Redemptions(3) |
Assuming Maximum Redemptions(4) |
|||||||||||||||||||||||||||||||||||||||
Name and Address of Beneficial Owners |
Number of Ordinary Shares |
% |
Number of Shares of New Grove Collaborative Class A Common Stock |
% |
Number of Shares of New Grove Collaborative Class B Common Stock |
% |
Number of Shares of New Grove Collaborative Class A Common Stock |
% |
Number of Shares of New Grove Collaborative Class B Common Stock |
% |
||||||||||||||||||||||||||||||
All directors and executive officers prior to the Business Combination (6 persons) |
90,000 | * | 90,000 | * | — | — | 90,000 | * | — | — | ||||||||||||||||||||||||||||||
Directors and executive officers after the Business Combination(5): |
||||||||||||||||||||||||||||||||||||||||
Stu Landesberg(6) |
— | — | 8,740,169 | (7) | 8,737,669 | 8,740,169 | (7) | 8,737,669 | ||||||||||||||||||||||||||||||||
Janae De Crescenzo(8) |
— | — | 202,900 | 202,900 | 202,900 | 202,900 | ||||||||||||||||||||||||||||||||||
Phil Moon(9) |
— | — | 548,415 | 548,415 | 548,415 | 548,415 | ||||||||||||||||||||||||||||||||||
Chris Clark(10) |
— | — | 1,478,527 | 1,478,527 | 1,478,527 | 1,478,527 | ||||||||||||||||||||||||||||||||||
Delida Costin(11)(12) |
— | — | 533,810 | 533,810 | 533,810 | 533,810 | ||||||||||||||||||||||||||||||||||
Andrew Rendich(13) |
— | — | 1,168,569 | 1,168,569 | 1,168,569 | 1,168,569 | ||||||||||||||||||||||||||||||||||
Jon Silverman(14) |
— | — | 653,988 | 653,988 | 653,988 | 653,988 | ||||||||||||||||||||||||||||||||||
Jennie Perry(15) |
— | — | 204,750 | 204,750 | 204,750 | 204,750 | ||||||||||||||||||||||||||||||||||
Cathy Beaudoin(16) |
— | — | 506,945 | 506,945 | 506,945 | 506,945 | ||||||||||||||||||||||||||||||||||
David Glazer(17) |
— | — | 5,119 | 5,119 | 5,119 | 5,119 | ||||||||||||||||||||||||||||||||||
John Replogle(18)(19) |
— | — | 225,306 | 225,306 | 225,306 | 225,306 | ||||||||||||||||||||||||||||||||||
[●] |
||||||||||||||||||||||||||||||||||||||||
[●] |
||||||||||||||||||||||||||||||||||||||||
[●] |
||||||||||||||||||||||||||||||||||||||||
All directors and executive officers after the Business Combination as a group ( persons) |
||||||||||||||||||||||||||||||||||||||||
Five Percent Holders: |
||||||||||||||||||||||||||||||||||||||||
Entities associated with Mayfield(20) |
— | — | 14,506,518 | (21) | 14,306,518 | 14,506,518 | (21) | 14,306,518 | ||||||||||||||||||||||||||||||||
Norwest Venture Partners XIII, LP(22) |
— | — | 14,644,569 | (23) | 14,144,569 | 14,644,569 | (23) | 14,144,569 | ||||||||||||||||||||||||||||||||
General Atlantic (GC), L.P.(24) |
— | — | 12,313,290 | (25) | 11,813,290 | 12,313,290 | (25) | 11,813,290 |
* | Less than 1% |
(1) | The business address of each of VGAC II directors and executive officers prior to the Business Combination is 65 Bleecker Street, 6th Floor, New York, New York 10012. |
(2) | Prior to the Business Combination, the percentage of beneficial ownership of VGAC II on the record date is calculated based on (i) [●] Class A ordinary shares and (ii) [●] Class B ordinary shares, in each case, outstanding as of such date. |
(3) | The expected beneficial ownership of New Grove immediately upon consummation of the Business Combination, assuming no holders of public shares exercise their redemption rights in connection therewith |
and the Closing occurs on , 2022, is based on (A) shares of New Grove Class A Common Stock outstanding as of such date, and consists of (i) [●] Class A ordinary shares and [●] Class B ordinary shares that will convert into a like number of shares of New Grove Class A Common Stock and (ii) (A) 8,700,000 shares of New Grove Class A Common Stock that will be issued in the PIPE Financing and (B) shares of Grove capital stock that will be exchanged for New Grove Class B Common Stock as determined pursuant to the exchange ratio in the Merger Agreement. For purposes of this table the exchange ratio has been estimated as of December 7, 2021 at 1.17. |
(4) | The expected beneficial ownership of New Grove immediately upon consummation of the Business Combination, assuming holders of VGAC II’s public shares exercise their redemption rights in connection therewith and the Closing occurs on , 2022, is based on (A) shares of New Grove Class A Common Stock outstanding as of such date, and consists of (i) Class A ordinary shares and Class B ordinary shares that will convert into a like number of shares of New Grove Class A Common Stock and (ii) (A) 8,700,000 shares of New Grove Class A Common Stock that will be issued in the PIPE Financing and (B) shares of Grove Collaborative’s capital stock will be exchanged for New Grove Class B Common Stock as determined pursuant to the exchange ratio in the Merger Agreement. For purposes of this table the exchange ratio has been estimated as of December 7, 2021 at 1.17. |
(5) | The business address of each of Stuart Landesberg, Janae De Crescenzo, Phil Moon, Chris Clark, Delida Costin, Andrew Rendich, Jon Silverman, Jennie Perry, Cathy Beaudoin, David Glazer, and John Replogle is 1301 Sansome Street, San Francisco, CA 94111. |
(6) | Includes 8,737,669 shares of New Grove Class B Common Stock that are convertible into shares of New Grove Class A Common Stock on a one-for-one basis. |
(7) | Includes 2,500 shares of New Grove Class A Common Stock to be bought in the PIPE Financing by Stuart Landesberg. |
(8) | Includes 202,900 shares of New Grove Class B Common Stock that are convertible into shares of New Grove Class A Common Stock on a one-for-one basis. |
(9) | Includes 548,415 shares of New Grove Class B Common Stock that are convertible into shares of New Grove Class A Common Stock on a one-for-one basis. |
(10) | Includes 1,478,527 shares of New Grove Class B Common Stock that are convertible into shares of New Grove Class A Common Stock on a one-for-one basis. |
(11) | Consists of 16,085 shares of New Grove Class B Common Stock that are held by the Weatherspoon Costin Family Trust. Ms. Costin may be deemed to have voting and dispositive investment power with respect to the shares held by the Weatherspoon Costin Family Trust. |
(12) | Includes 533,810 shares of New Grove Class B Common Stock that are convertible into shares of New Grove Class A Common Stock on a one-for-one basis |
(13) | Includes 1,168,569 shares of New Grove Class B Common Stock that are convertible into shares of New Grove Class A Common Stock on a one-for-one basis. |
(14) | Includes 653,988 shares of New Grove Class B Common Stock that are convertible into shares of New Grove Class A Common Stock on a one-for-one basis. |
(15) | Includes 204,750 shares of New Grove Class B Common Stock that are convertible into shares of New Grove Class A Common Stock on a one-for-one basis. |
(16) | Includes 506,945 shares of New Grove Class B Common Stock that are convertible into shares of New Grove Class A Common Stock on a one-for-one basis. |
(17) | Includes 5,119 shares of New Grove Class B Common Stock that are convertible into shares of New Grove Class A Common Stock on a one-for-one basis. |
(18) | Consists of 227 shares of New Grove Class B Common Stock that are held by the Replogle Family Trust. Mr. Replogle may be deemed to have voting and dispositive investment power with respect to the shares held by the Replogle Family Trust. |
(19) | Includes 225,306 shares of New Grove Class B Common Stock that are convertible into shares of New Grove Class A Common Stock on a one-for-one basis. |
(20) | Consists of 12,156,141 shares of New Grove Class B Common Stock held by Mayfield XV, a Cayman Islands Exempted Limited Partnership (“ MF XV ”) and 2,150,377 shares of New Grove Class B Common Stock held by Mayfield Select, a Cayman Islands Exempted Limited Partnership (“MF Select ”). Mayfield |
XV Management (UGP), Ltd., a Cayman Islands Exempted Company (“ MF XV UGP ” is the general partner of Mayfield XV Management (EGP), L.P., a Cayman Islands Exempted Limited Partnership, which is the general partner of MF XV. Rajeev Batra, Navin Chaddha and Urshit Parikh are the directors of MF XV UGP. As a result, each of the foregoing entities and individuals may be deemed to share beneficial ownership of the shares owned by MF XV, but each of the individuals disclaims such beneficial ownership. Mayfield Select Management (UGP), Ltd., a Cayman Islands Exempted Company (“MF Select UGP ) is the general partner of Mayfield Select Management (EGP), L.P., a Cayman Islands Exempted Limited Partnership, which is the general partner of MF Select. Rajeev Batra, Navin Chaddha and Urshit Parikh are the directors of MF Select UGP. As a result, each of the foregoing entities and individuals may be deemed to share beneficial ownership of the shares owned by MF Select, but each of the individuals disclaims such beneficial ownership. The address for each of these entities and individuals is c/o Mayfield, 2484 Sand Hill Road, Menlo Park, CA 94025 |
(21) | Includes 200,000 shares of New Grove Class A Common Stock to be bought in the PIPE Financing by MF Select. |
(22) | Includes 14,144,569 shares of New Grove Class B Common Stock held of record by Norwest Venture Partners XIII, LP that are convertible into shares of New Grove Class A Common Stock on a one-for-one basis. Genesis VC Partners XIII, LLC is the general partner of Norwest Venture Partners XIII, LP, and NVP Associates, LLC is the managing member of Genesis VC Partners XIII, LLC. Each of Promod Haque, Jeffrey Crowe, and Jon Kossow, who are co-chief executive officers of NVP Associates, LLC, may be deemed to share voting and dispositive power over the shares held by Norwest Venture Partners XIII, LP. Mr. Crowe disclaims beneficial ownership of all such shares, except to the extent of his pecuniary interest therein, if any. The address for each of these entities and individuals is c/o 525 University Avenue, #800, Palo Alto, California 94301. |
(23) | Includes 500,000 shares of New Grove Class A Common Stock to be bought in the PIPE Financing by Norwest Venture Partners XIII, LP. |
(24) | Includes 11,813,290 shares of New Grove Class B Common Stock held of record by General Atlantic (GC), L.P. (“ GA GC ”) that are convertible into shares of New Grove Class A Common Stock on a one-for-one basis. The limited partners that share beneficial ownership of the shares held by GA GC are the following General Atlantic investment funds (the “GA Funds ”): General Atlantic Partners 100, L.P. (“GAP 100 ”), General Atlantic Partners (Bermuda) EU, L.P. (“GAP Bermuda EU ”), GAP Coinvestments III, LLC (“GAPCO III ”), GAP Coinvestments IV, LLC (“GAPCO IV ”), GAP Coinvestments V, LLC (“GAPCO V ”) and GAP Coinvestments CDA, L.P. (“GAPCO CDA”). The general partner of GA GC is General Atlantic (SPV) GP, LLC (“GA SPV ”). The general partner of GAP 100 is ultimately controlled by General Atlantic, L.P. (“GA LP ”), which is controlled by the Management Committee of GASC MGP, LLC (the “Management Committee ”). The general partner of GAP Bermuda EU is ultimately controlled by GAP (Bermuda) L.P. (“GAP Bermuda ”), which is also controlled by the Management Committee. GA LP is the managing member of GAPCO III, GAPCO IV and GAPCO V, the general partner of GAPCO CDA and is the sole member of GA SPV. There are nine members of the Management Committee. GA GC, GA LP, GAP Bermuda, GA SPV and the GA Funds (collectively, the “GA Group ”) are a “group” within the meaning of Rule 13d-5 of the Securities Exchange Act of 1934, as amended. The mailing address of the foregoing General Atlantic entities, other than GAP Bermuda EU and GAP Bermuda, is c/o General Atlantic Service Company, L.P., 55 East 52nd Street, 33rd Floor, New York, NY 10055. The mailing address of GAP Bermuda EU and GAP Bermuda is Clarendon House, 2 Church Street, Hamilton HM 11, Bermuda. Each of the members of the Management Committee disclaims ownership of the shares except to the extent that he has a pecuniary interest therein. |
(25) | Includes 500,000 shares of New Grove Class A Common Stock to be bought in the PIPE Financing by GA GC. |
• | Grove Collaborative has been or is to be a participant; |
• | the amount involved exceeded or will exceed $120,000; and |
• | any of Grove Collaborative’s directors or executive officers that are expected to continue as directors or executive officers following the Business Combination or holders of more than 5% of Grove Collaborative’s capital stock, or any immediate family member of, or person sharing the household with, any of these individuals, had or will have a direct or material interest. |
Name |
Number of Shares of Series E Preferred Stock |
Aggregate Purchase Price ($) |
||||||
SCM GC Investments Limited*(1) |
5,021,189 | $ | 49,999,995.83 |
* | Owners, together with their affiliates, of more than 5% of Grove Collaborative capital stock |
(1) | Additional details regarding this stockholder and its equity holdings are provided in this proxy statement/consent solicitation statement/prospectus under the section “ Beneficial Ownership of Securities |
Name |
Number of Shares of Series D-2 Preferred Stock |
Aggregate Purchase Price ($) |
||||||
SCM GC Investments Limited*(1) |
2,749,595 | $ | 20,000,004.11 | |||||
General Atlantic (GC), L.P. *(1) |
1,374,798 | $ | 10,000,005.69 | |||||
Norwest Venture Partners XIII, LP*(1) |
1,374,798 | $ | 10,000,005.69 | |||||
Lone Cypress, Ltd. *(1) |
766,175 | $ | 5,573,003.72 | |||||
Lone Cascade, L.P. *(1) |
528,610 | $ | 3,845,003.42 | |||||
Mayfield Select, a Cayman Islands Exempted Partnership*(1) |
274,960 | $ | 2,000,004.05 | |||||
MHS Capital Partners II, L.P. *(1) |
137,480 | $ | 1,000,002.02 | |||||
Lone Monterey Master Fund, Ltd. *(1) |
38,219 | $ | 277,997.37 | |||||
Lone Sierra, L.P. *(1) |
26,809 | $ | 195,003.31 | |||||
Lone Spruce, L.P. *(1) |
14,985 | $ | 108,997.90 | |||||
Weatherspoon Costin Family Trust (2) |
13,748 | $ | 100,000.20 | |||||
Andy Rendich |
6,874 | $ | 50,000.10 |
* | Owners, together with their affiliates, of more than 5% of Grove Collaborative capital stock |
(1) | Additional details regarding this stockholder and its equity holdings are provided in this proxy statement/consent solicitation statement/prospectus under the section “ Beneficial Ownership of Securities |
(2) | Weatherspoon Costin Family Trust is an affiliate of Delida Costin, Grove Collaborative’s Secretary and Chief Legal and People Officer. |
Name |
Number of Shares of Series D-1 Preferred Stock |
Aggregate Purchase Price ($) |
||||||
General Atlantic (GC), L.P. *(1) |
937,180 | $ | 9,999,991.76 | |||||
Norwest Ventures Partners XIII, LP*(1) |
374,872 | $ | 3,999,996.72 | |||||
Lone Cypress, Ltd. *(1) |
349,716 | $ | 3,731,574.64 | |||||
Mayfield Select, a Cayman Islands Exempted Limited Partnership*(1) |
93,718 | $ | 999,999.18 | |||||
Lone Spruce, L.P.*(1) |
6,410 | $ | 68,396.63 |
* | Owners, together with their affiliates, of more than 5% of Grove Collaborative capital stock |
(1) | Additional details regarding this stockholder and its equity holdings are provided in this proxy statement/consent solicitation statement/prospectus under the section “ Beneficial Ownership of Securities |
Name |
Number of Shares of Series D Preferred Stock |
Aggregate Purchase Price ($) |
||||||
Lone Cypress, Ltd. *(1) |
6,534,759 | $ | 53,899,999.19 | |||||
General Atlantic (GC), L.P. *(1) |
5,823,008 | $ | 48,029,994.45 | |||||
Norwest Venture Partners XIII, LP*(1) |
1,382,119 | $ | 11,399,993.93 | |||||
MHS Capital Partners G2, LLC*(1) |
373,414 | $ | 3,079,993.37 | |||||
Mayfield Select, a Cayman Islands Exempted Limited Partnership*(1) |
121,238 | $ | 999,995.28 | |||||
OBV Rooted, LLC(2) |
50,920 | $ | 419,998.35 | |||||
MHS Capital Partners II, L.P. *(1) |
26,672 | $ | 219,996.00 |
* | Owners, together with their affiliates, of more than 5% of Grove Collaborative capital stock |
(1) | Additional details regarding this stockholder and its equity holdings are provided in this proxy statement/consent solicitation statement/prospectus under the section “ Beneficial Ownership of Securities |
(2) | OBV Rooted, LLC is an affiliate of John Replogle, a member of Grove Collaborative’s board of directors. |
Delaware |
Cayman Islands | |||
Stockholder/Shareholder Approval of Business Combinations |
Mergers generally require approval of a majority of all outstanding shares. Mergers in which less than 20% of the acquirer’s stock is issued generally do not require acquirer stockholder approval. Mergers in which one corporation owns 90% or more of a second corporation may be completed without the vote of the second corporation’s board of directors or stockholders. |
Mergers require a special resolution, and any other authorization as may be specified in the relevant articles of association. Parties holding certain security interests in the constituent companies must also consent. All mergers (other than parent/ subsidiary mergers) require shareholder approval. Where a bidder has acquired 90% or more of the shares in a Cayman Islands company, it can compel the acquisition of the shares of the remaining shareholders and thereby become the sole shareholder. A Cayman Islands company may also be acquired through a “scheme of arrangement” sanctioned by a Cayman Islands court and approved by 50%+1 in number and 75% in value of shareholders in attendance and voting at a shareholders’ meeting. | ||
Stockholder/Shareholder Votes for Routine Matters |
Generally, approval of routine corporate matters that are put to a stockholder vote require the affirmative vote of the majority of shares present in person or represented by proxy at the | Under Cayman Islands law and the Existing Governing Documents, routine corporate matters may be approved by an ordinary resolution (being the affirmative vote of at least a majority of shareholders present in |
Delaware |
Cayman Islands | |||
meeting and entitled to vote on the subject matter. | person or represented by proxy at the extraordinary general meeting and entitled to vote on such matter). | |||
Appraisal Rights |
Generally, a stockholder of a publicly traded corporation does not have appraisal rights in connection with a merger. Stockholders of a publicly traded corporation do, however, generally have appraisal rights in connection with a merger if they are required by the terms of a merger agreement to accept for their shares: (a) shares or depository receipts of the corporation surviving or resulting from such merger; (b) shares of stock or depository receipts that will be either listed on a national securities exchange or held of record by more than 2,000 holders; (c) cash in lieu of fractional shares or fractional depository receipts described in (a) and (b) above; or (d) any combination of the shares of stock, depository receipts and cash in lieu of fractional shares or fractional depository receipts described in (a), (b), and (c) above. | Pursuant to the Cayman Islands Companies Act, shareholders that dissent from a merger are entitled to be paid the fair market value of their shares, which if necessary may ultimately be determined by the court. | ||
Inspection of Books and Records |
Any stockholder may inspect the corporation’s books and records for a proper purpose during the usual hours for business. | Shareholders generally do not have any rights to inspect or obtain copies of the register of shareholders or other corporate records of a company. | ||
Stockholder/Shareholder Lawsuits |
A stockholder may bring a derivative suit subject to procedural requirements (including adopting Delaware as the exclusive forum as per Governing Documents Proposal C). | In the Cayman Islands, the decision to institute proceedings on behalf of a company is generally taken by the company’s board of directors. A shareholder may be entitled to bring a derivative action on behalf of the company, but only in certain limited circumstances. |
Delaware |
Cayman Islands | |||
Fiduciary Duties of Directors |
Directors must exercise a duty of care and duty of loyalty and good faith to the company and its stockholders. | A director owes fiduciary duties to a company, including to exercise loyalty, honesty, and good faith to the company as a whole. In addition to fiduciary duties, directors owe a duty of care, diligence, and skill. Such duties are owed to the company but may be owed direct to creditors or shareholders in certain limited circumstances. | ||
Indemnification of Directors and Officers |
A corporation is generally permitted to indemnify its directors and officers acting in good faith. | A Cayman Islands company generally may indemnify its directors or officers except with regard to fraud, dishonesty, or willful default or to protect from the consequences of committing a crime. | ||
Limited Liability of Directors |
Permits limiting or eliminating the monetary liability of a director to a corporation or its stockholders, except with regard to breaches of duty of loyalty, intentional misconduct, unlawful repurchases or dividends, or improper personal benefit. | Liability of directors may be limited, except with regard to their own fraud or willful default. |
(1) | the board of directors approves the acquisition of stock or the merger transaction before the time that the person becomes an interested stockholder; |
(2) | the interested stockholder owns at least 85% of the outstanding voting stock of the corporation at the time the merger transaction commences (excluding voting stock owned by directors who are also officers and certain employee stock plans); or |
(3) | the merger transaction is approved by the board of directors and at a meeting of stockholders, not by written consent, by the affirmative vote of 2/3 of the outstanding voting stock which is not owned by the interested stockholder. |
• | in whole and not in part; |
• | at a price of $0.01 per warrant; |
• | upon not less than 30 days’ prior written notice of redemption to each warrantholder; and |
• | if, and only if, the last reported sale price of the New Grove Class A Common Stock for any 20 trading days within a 30-trading-day Reference Value ”) equals or exceeds $18.00 per share (as adjusted for share splits, share capitalizations, reorganizations, recapitalizations, and the like). |
• | in whole and not in part; |
• | at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption, provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined by reference to the table below, based on the redemption date and the “fair market value” of New Grove Class A Common Stock (as defined below); |
• | if, and only if, the Reference Value (as defined above under “Redemption of Warrants When the Price per New Grove Class A Common Stock Equals or Exceeds $18.00”) equals or exceeds $10.00 per share (as adjusted per share sub-divisions, share dividends, reorganizations, reclassifications, recapitalizations, and the like); and |
• | if the Reference Value is less than $18.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations, and the like) the private placement warrants must also be concurrently called for redemption on the same terms as the outstanding public warrants, as described above. |
Redemption Date (period to expiration of warrants) |
$Fair Market Value of Class A Ordinary Shares |
|||||||||||||||||||||||||||||||||||
³ $10.00 |
$11.00 |
$12.00 |
$13.00 |
$14.00 |
$15.00 |
$16.00 |
$17.00 |
³ $18.00 |
||||||||||||||||||||||||||||
60 months |
0.261 | 0.281 | 0.297 | 0.311 | 0.324 | 0.377 | 0.348 | 0.358 | 0.361 | |||||||||||||||||||||||||||
57 months |
0.257 | 0.277 | 0.294 | 0.310 | 0.324 | 0.337 | 0.348 | 0.358 | 0.365 | |||||||||||||||||||||||||||
54 months |
0.252 | 0.272 | 0.291 | 0.307 | 0.322 | 0.335 | 0.347 | 0.357 | 0.365 | |||||||||||||||||||||||||||
51 months |
0.246 | 0.268 | 0.287 | 0.304 | 0.320 | 0.333 | 0.346 | 0.357 | 0.365 | |||||||||||||||||||||||||||
48 months |
0.241 | 0.263 | 0.283 | 0.301 | 0.317 | 0.332 | 0.344 | 0.356 | 0.365 | |||||||||||||||||||||||||||
45 months |
0.235 | 0.258 | 0.279 | 0.298 | 0.315 | 0.330 | 0.343 | 0.356 | 0.365 | |||||||||||||||||||||||||||
42 months |
0.228 | 0.252 | 0.274 | 0.294 | 0.312 | 0.328 | 0.342 | 0.355 | 0.364 | |||||||||||||||||||||||||||
39 months |
0.221 | 0.246 | 0.269 | 0.290 | 0.309 | 0.325 | 0.340 | 0.354 | 0.364 | |||||||||||||||||||||||||||
36 months |
0.213 | 0.239 | 0.263 | 0.285 | 0.305 | 0.323 | 0.339 | 0.353 | 0.364 | |||||||||||||||||||||||||||
33 months |
0.205 | 0.232 | 0.257 | 0.280 | 0.301 | 0.320 | 0.337 | 0.352 | 0.364 | |||||||||||||||||||||||||||
30 months |
0.196 | 0.224 | 0.250 | 0.274 | 0.297 | 0.316 | 0.335 | 0.351 | 0.364 | |||||||||||||||||||||||||||
27 months |
0.185 | 0.214 | 0.242 | 0.268 | 0.291 | 0.313 | 0.332 | 0.350 | 0.364 | |||||||||||||||||||||||||||
24 months |
0.173 | 0.204 | 0.233 | 0.260 | 0.285 | 0.308 | 0.329 | 0.348 | 0.364 | |||||||||||||||||||||||||||
21 months |
0.161 | 0.193 | 0.223 | 0.252 | 0.279 | 0.304 | 0.326 | 0.347 | 0.364 | |||||||||||||||||||||||||||
18 months |
0.146 | 0.179 | 0.211 | 0.242 | 0.271 | 0.298 | 0.322 | 0.345 | 0.363 | |||||||||||||||||||||||||||
15 months |
0.130 | 0.164 | 0.197 | 0.230 | 0.262 | 0.291 | 0.317 | 0.342 | 0.363 | |||||||||||||||||||||||||||
12 months |
0.111 | 0.146 | 0.181 | 0.216 | 0.250 | 0.282 | 0.312 | 0.339 | 0.363 | |||||||||||||||||||||||||||
9 months |
0.090 | 0.125 | 0.162 | 0.199 | 0.237 | 0.272 | 0.305 | 0.336 | 0.362 | |||||||||||||||||||||||||||
6 months |
0.065 | 0.099 | 0.137 | 0.178 | 0.219 | 0.259 | 0.296 | 0.331 | 0.362 | |||||||||||||||||||||||||||
3 months |
0.034 | 0.065 | 0.104 | 0.150 | 0.197 | 0.243 | 0.286 | 0.326 | 0.361 | |||||||||||||||||||||||||||
0 months |
— | — | 0.042 | 0.115 | 0.179 | 0.233 | 0.281 | 0.323 | 0.361 |
• | 1% of the total number of New Grove Class A Common Stock then-outstanding; or |
• | the average weekly reported trading volume of the New Grove Class A Common Stock during the four calendar weeks preceding the filing of a notice on Form 144 with respect to the sale. |
• | the issuer of the securities that was formerly a shell company has ceased to be a shell company; |
• | the issuer of the securities is subject to the reporting requirements of Section 13 or 15(d) of the Exchange Act; |
• | the issuer of the securities has filed all Exchange Act reports and material required to be filed, as applicable, during the preceding twelve months (or such shorter period that the issuer was required to file such reports and materials), other than Current Reports on Form 8-K; and |
• | at least one year has elapsed from the time that the issuer filed current Form 10 type information with the SEC reflecting its status as an entity that is not a shell company. |
• | not later than the close of business on the 90th day; and |
• | not earlier than the close of business on the 120th day before the one-year anniversary of the preceding year’s annual meeting. |
Page |
||||
Virgin Group Acquisition Corp. II - Index to Financial Statements |
||||
F-2 | ||||
Financial Statements: |
||||
F-3 | ||||
F-4 | ||||
F-5 | ||||
F-6 | ||||
F-7 | ||||
F-17 | ||||
F-18 | ||||
F-19 | ||||
F-20 | ||||
Grove Collaborative, Inc. - Index to Financial Statements |
||||
F-37 | ||||
Financial Statements: |
||||
F-38 | ||||
F-39 | ||||
F-40 | ||||
F-41 | ||||
F-42 | ||||
Unaudited Condensed Financial Statements: |
||||
F-68 | ||||
F-69 | ||||
F-70 | ||||
F-71 | ||||
F-73 |
ASSETS |
||||
Deferred offering costs |
$ | |||
|
|
|||
TOTAL ASSETS |
$ |
|||
|
|
|||
LIABILITIES AND SHAREHOLDER’S EQUITY |
||||
Liabilities |
||||
Current Liabilities |
||||
Accounts payable and accrued expenses |
$ | |||
Total Current Liabilities |
||||
|
|
|||
Commitments and Contingencies |
||||
Shareholder’s Equity |
||||
Preference shares, $ |
||||
Class A ordinary shares, $ |
||||
Class B ordinary shares, $ (1) |
||||
Additional paid in capital |
||||
Accumulated deficit |
( |
) | ||
|
|
|||
Total Shareholder’s Equity |
||||
|
|
|||
TOTAL LIABILITIES AND SHAREHOLDER’S EQUITY |
$ |
|||
|
|
(1) | Includes an aggregate of up to 33-for-25 35-for-33 per-share amounts have been retroactively restated to reflect the share capitalizations (see Note 4). |
Formation costs |
$ | |||
|
|
|||
Net Loss |
$ |
( |
) | |
|
|
|||
Weighted average ordinary shares outstanding, basic and diluted (1) |
||||
|
|
|||
Basic and diluted net loss per ordinary share |
$ |
( |
) | |
|
|
(1) | Excludes an aggregate of up to per-share amounts have been retroactively restated to reflect the share capitalizations (see Note 4). |
Class B Ordinary Shares (1) |
Additional Paid in Capital |
Accumulated Deficit |
Total Shareholder’s Equity |
|||||||||||||||||
Shares |
Amount |
|||||||||||||||||||
Balance — January 13, 2021 (inception) |
$ |
$ |
$ |
$ |
||||||||||||||||
Issuance of Class B ordinary shares to Sponsor (1) |
||||||||||||||||||||
Net loss |
— | — | ( |
) | ( |
) | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Balance — January 26, 2021 |
$ |
$ |
$ |
( |
) |
$ |
||||||||||||||
|
|
|
|
|
|
|
|
|
|
(1) | Includes an aggregate of up to per-share amounts have been retroactively restated to reflect the share capitalizations (see Note 4). |
Cash Flows from Operating Activities: |
||||
Net loss |
$ | ( |
) | |
Adjustments to reconcile net loss to net cash used in operating activities: |
||||
Formation costs paid by Sponsor in consideration for issuance of Class B ordinary shares |
||||
|
|
|||
Net cash used in operating activities |
||||
|
|
|||
Net Change in Cash |
||||
Cash — Beginning of period |
||||
|
|
|||
Cash — End of period |
$ |
|||
|
|
|||
Non-cash investing and financing activities: |
||||
Deferred offering costs included in accounts payable and accrued expenses |
$ | |||
|
|
|||
Deferred offering cost paid by Sponsor in consideration for Class B ordinary shares |
$ | |||
|
|
• | in whole and not in part; |
• | at a price of $ |
• | upon not less than |
• | to each warrant holder; and |
• | if, and only if, the reported closing price of the ordinary shares equals or exceeds $ |
ASSETS: |
||||
Current Assets: |
||||
Cash |
$ | |||
Prepaid expenses |
||||
|
|
|||
Total current assets |
||||
Prepaid expenses — non-current portion |
||||
Cash and investments held in trust account |
||||
|
|
|||
TOTAL ASSETS |
$ |
|||
|
|
|||
LIABILITIES AND SHAREHOLDER’S DEFICIT |
||||
Current liabilities: |
||||
Accrued costs and expenses |
$ | |||
Due to related party |
||||
|
|
|||
Total current liabilities |
||||
Warrant liability |
||||
Deferred underwriters’ discount |
||||
|
|
|||
Total liabilities |
||||
Commitments and Contingencies |
||||
Class A Ordinary shares, $ Shares subject to possible redemption at a redemption value of per share |
||||
Shareholders’ Deficit: |
||||
Preference shares, $ |
||||
Class B ordinary shares, $ |
||||
Additional paid-in capital |
||||
Accumulated deficit |
( |
) | ||
|
|
|||
Total Shareholders’ deficit |
( |
) | ||
|
|
|||
TOTAL LIABILITIES AND SHAREHOLDER’S DEFICIT |
$ |
|||
|
|
For the three months ended September 30, 2021 |
For the period from January 13, 2021 (inception) to September 30, 2021 |
|||||||
Formation and operating costs |
$ | $ | ||||||
|
|
|
|
|||||
Loss from operations |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Other income (expense) |
||||||||
Interest income earned on investments held in trust account |
||||||||
Offering costs allocated to warrants |
( |
) | ||||||
Change in fair value of warrant liabilities |
||||||||
|
|
|
|
|||||
Total other income |
||||||||
|
|
|
|
|||||
Net income |
$ |
$ |
||||||
|
|
|
|
|||||
Basic and diluted weighted average shares outstanding, Class A ordinary shares |
||||||||
|
|
|
|
|||||
Basic and diluted net income per ordinary share, Class A |
$ | $ | ||||||
|
|
|
|
|||||
Basic and diluted weighted average shares outstanding, Class B ordinary shares |
||||||||
|
|
|
|
|||||
Basic and diluted net income per ordinary share, Class B |
$ | $ | ||||||
|
|
|
|
Class B Ordinary Shares |
Additional Paid In Capital |
Accumulated Deficit |
Total Shareholders’ Deficit |
|||||||||||||||||
Shares |
Amount |
|||||||||||||||||||
Balance as of January 13, 2021 (inception) |
$ |
$ |
$ |
$ |
||||||||||||||||
Issuance of Class B Ordinary shares to Sponsor |
||||||||||||||||||||
Accretion for Class A Ordinary Shares to redemption amount |
( |
) | ( |
) | ( |
) | ||||||||||||||
Net loss |
— | — | ( |
) | ( |
) | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Balance as of June 30, 2021 |
$ |
$ |
$ |
( |
) |
$ |
( |
) | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net income |
— | — | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Balance as of September 30, 2021 |
$ |
$ |
$ |
( |
) |
$ |
( |
) | ||||||||||||
|
|
|
|
|
|
|
|
|
|
Cash flows from operating activities: |
||||
Net income |
$ | |||
Adjustments to reconcile net income to net cash used in operating activities: |
||||
Interest income on cash and investments held in Trust Account |
( |
) | ||
Offering costs allocated to warrant liability |
||||
Change in fair value of warrant liability |
( |
) | ||
Changes in operating assets and liabilities: |
||||
Prepaid assets |
( |
) | ||
Accrued costs and expenses |
||||
Due to related party |
||||
|
|
|||
Net cash used in operating activities |
( |
) | ||
|
|
|||
Cash Flows from Investing Activities: |
||||
Investment of cash in Trust Account |
( |
) | ||
|
|
|||
Net cash used in investing activities |
( |
) | ||
Cash flows from financing activities: |
||||
Proceeds from purchase of Class B shares by initial shareholder |
||||
Proceeds from initial public offering, net of underwriters’ discount |
||||
Proceeds from private placement |
||||
Payment of offering costs |
( |
) | ||
|
|
|||
Net cash provided by financing activities |
||||
|
|
|||
Net change in cash |
||||
Cash, beginning of the period |
||||
|
|
|||
Cash, end of the period |
$ | |||
|
|
|||
Supplemental disclosure of cash flow information: |
||||
Deferred underwriting commissions charged to temporary equity |
$ | |||
|
|
As Reported |
Adjustment |
As Restated |
||||||||||
Balance Sheet as of March 25, 2021 |
||||||||||||
Class A ordinary shares subject to possible redemption |
$ |
$ |
$ |
|||||||||
|
|
|
|
|
|
|||||||
Class A ordinary shares, $ |
( |
) |
||||||||||
Additional Paid-in Capital |
( |
) |
||||||||||
Accumulated Deficit |
( |
) |
( |
) |
( |
) | ||||||
|
|
|
|
|
|
|||||||
Total Shareholders’ Equity (Deficit) |
$ |
$ |
( |
) |
$ |
( |
) | |||||
|
|
|
|
|
|
|||||||
Number of shares subject to redemption |
||||||||||||
|
|
|
|
|
|
|||||||
Balance Sheet as of March 31, 2021 (unaudited) |
||||||||||||
Class A ordinary shares subject to possible redemption |
$ | $ | $ | |||||||||
|
|
|
|
|
|
|||||||
Class A ordinary shares, $ |
( |
) | ||||||||||
Class B ordinary shares, $ |
||||||||||||
Additional Paid-in Capital |
( |
) | ||||||||||
Accumulated Deficit |
( |
) | ( |
) | ( |
) | ||||||
|
|
|
|
|
|
|||||||
Total Shareholders’ Equity (Deficit) |
$ | $ | ( |
) | $ | ( |
) | |||||
|
|
|
|
|
|
|||||||
Number of shares subject to redemption |
||||||||||||
|
|
|
|
|
|
|||||||
Statement of operations for the period from January 13, 2021 (inception) through March 31, 2021 (unaudited) |
| |||||||||||
Basic and diluted net loss per ordinary share, Class A |
$ | $ | ( |
) | $ | ( |
) | |||||
Basic and diluted net loss per ordinary share, Class B |
$ | ( |
) | $ | $ | ( |
) | |||||
Statement of Cash Flows for the period from January 13, 2021 (inception) through March 31, 2021 (unaudited) |
| |||||||||||
Initial classification of Class A ordinary shares subject to possible redemption |
$ | $ | ( |
) | $ | |||||||
Change in value of Class A ordinary shares subject to possible redemption |
$ | ( |
) | $ | $ | |||||||
Balance Sheet as of June 30, 2021 (unaudited) |
| |||||||||||
Class A ordinary shares subject to possible redemption |
$ | $ | $ | |||||||||
|
|
|
|
|
|
|||||||
Class A ordinary shares, $ |
( |
) | ||||||||||
Class B ordinary shares, $ |
||||||||||||
Additional Paid-in Capital |
( |
) | ||||||||||
Accumulated Deficit |
( |
) | ( |
) | ( |
) | ||||||
|
|
|
|
|
|
|||||||
Total Shareholders’ Equity (Deficit) |
$ | $ | ( |
) | $ | ( |
) | |||||
|
|
|
|
|
|
|||||||
Number of shares subject to redemption |
||||||||||||
|
|
|
|
|
|
Statement of operations (unaudited) |
||||||||||||
For the three months ended June 30, 2021 |
||||||||||||
Basic and diluted net loss per ordinary share, Class A |
$ | ( |
) | ( |
) | |||||||
Basic and diluted net loss per ordinary share, Class B |
$ | ( |
) | ( |
) | |||||||
For |
||||||||||||
Basic and diluted net loss per ordinary share, Class A |
$ | ( |
) | ( |
) | |||||||
Basic and diluted net loss per ordinary share, Class B |
$ | ( |
) | ( |
) | |||||||
Statement through June 30, 2021 (unaudited) |
| |||||||||||
Initial classification of Class A ordinary shares subject to possible redemption |
$ | $ | ( |
) | $ | |||||||
Change in value of Class A ordinary shares subject to possible redemption |
$ | $ | ( |
) | $ |
Gross Proceeds |
$ |
|||
Less: Proceeds allocated to Public Warrants |
( |
) | ||
Less: Issuance costs related to Class A ordinary shares |
( |
) | ||
Plus: Accretion of carrying value to redemption value |
||||
|
|
|||
Class A ordinary shares subject to possible redemption |
$ |
• |
Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; |
• |
Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and |
• |
Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. |
For the Three Months ended September 30, 2021 |
For the period from January 13, 2021 (inception) to September 30, 2021 |
|||||||
Ordinary shares subject to possible redemption |
||||||||
Numerator: |
||||||||
Net redemption |
$ | $ | ||||||
Denominator: |
||||||||
Weighted Average Redeemable Class A Ordinary shares, Basic and Diluted |
||||||||
|
|
|
|
|||||
Basic and Diluted net income per share, Redeemable Class A Ordinary shares |
$ | $ | ||||||
|
|
|
|
|||||
Non-Redeemable Ordinary shares |
||||||||
Numerator: |
||||||||
Net income allocable to Class B ordinary shares not subject to redemption |
$ | $ | ||||||
Denominator: |
||||||||
Weighted Average Non-Redeemable Ordinary shares, Basic and Diluted |
||||||||
|
|
|
|
|||||
Basic and diluted net income per share, ordinary shares |
$ | $ | ||||||
|
|
|
|
September 30, 2021 |
Quoted Prices In Active Markets (Level 1) |
Significant Other Observable Inputs (Level 2) |
Significant Other Unobservable Inputs (Level 3) |
|||||||||||||
Assets: |
||||||||||||||||
Mutual Fund held in Trust Account |
$ | $ | $ | — | $ | — | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Liabilities: |
||||||||||||||||
Warrant liability — Public Warrants |
$ | $ | — |
— | ||||||||||||
Warrant liability — Private Warrants |
— | — |
||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Warrant Liability |
$ | $ | $ | — | $ | |||||||||||
|
|
|
|
|
|
|
|
September 30, 2021 |
||||
Strike price |
$ | |
||
Share price |
$ | |||
Volatility |
% | |||
Risk-free rate |
% | |||
Expected term (years) |
• |
in whole and not in part; |
• | |
at a price of $ |
• | |
upon not less than (the “30-day redemption period”) to each warrant holder; and |
• | |
if, and only if, the reported closing price of the Class A ordinary shares equals or exceeds $ a day period ending three business days before the Company sends the notice of redemption to the warrant holders. |
Private Placement Warrants |
Public Warrants |
Warrant Liabilities |
||||||||||
January 13, 2021 |
$ |
$ |
$ |
|||||||||
Initial measurement on March 25, 2021 |
||||||||||||
Change in fair value |
||||||||||||
|
|
|
|
|
|
|||||||
Fair value as of March 31, 2021 |
||||||||||||
Initial measurement on April 13, 2021 of over-allotment |
||||||||||||
Change in fair value |
( |
) |
( |
) | ||||||||
Transfer to Level 1 |
( |
) |
( |
) | ||||||||
|
|
|
|
|
|
|||||||
Fair value as of June 30, 2021 |
||||||||||||
( |
) | ( |
) | |||||||||
|
|
|
|
|
|
|||||||
Fair Value as of September 30, 2021 |
||||||||||||
|
|
|
|
|
|
December 31, |
||||||||
2019 |
2020 |
|||||||
Assets |
||||||||
Current assets: |
||||||||
Cash and cash equivalents |
$ | 36,829 | $ | 176,523 | ||||
Inventory, net |
29,722 | 46,580 | ||||||
Prepaid expenses and other current assets |
3,193 | 4,828 | ||||||
|
|
|
|
|||||
Total current assets |
69,744 | 227,931 | ||||||
Property and equipment, net |
14,707 | 15,100 | ||||||
Operating lease right-of-use |
— | 24,234 | ||||||
Other long-term assets |
3,252 | 2,453 | ||||||
|
|
|
|
|||||
Total assets |
$ | 87,703 | $ | 269,718 | ||||
|
|
|
|
|||||
Liabilities, Convertible Preferred Stock and Stockholders’ Deficit |
||||||||
Current liabilities: |
||||||||
Accounts payable |
$ | 40,269 | $ | 23,814 | ||||
Accrued expenses |
14,062 | 19,810 | ||||||
Deferred revenue |
9,017 | 11,119 | ||||||
Operating lease liabilities, current |
— | 2,955 | ||||||
Other current liabilities |
1,941 | 3,522 | ||||||
Debt, current |
18,800 | 1,918 | ||||||
|
|
|
|
|||||
Total current liabilities |
84,089 | 63,138 | ||||||
Debt, noncurrent |
2,463 | 29,782 | ||||||
Operating lease liabilities, noncurrent |
— | 23,579 | ||||||
Other long-term liabilities |
4,291 | 4,942 | ||||||
|
|
|
|
|||||
Total liabilities |
90,843 | 121,441 | ||||||
|
|
|
|
|||||
Commitments and contingencies (Note 8) |
||||||||
Convertible preferred stock, $0.0001 par value – 74,393,493 and 98,234,236 shares authorized at December 31, 2019 and 2020, respectively; 72,685,196 and 97,611,343 shares issued and outstanding at December 31, 2019 and December 31, 2020, respectively |
273,412 | 487,918 | ||||||
Stockholders’ deficit: |
||||||||
Common stock, $0.0001 par value –100,000,000 and 165,000,000 shares authorized at December 31, 2019 and 2020, respectively; 3,936,839 and 7,200,243 shares issued and outstanding at December 31, 2019 and December 31, 2020, respectively |
— | 1 | ||||||
Additional paid-in capital |
5,435 | 14,605 | ||||||
Accumulated deficit |
(281,987 | ) | (354,247 | ) | ||||
|
|
|
|
|||||
Total stockholders’ deficit |
(276,552 | ) | (339,641 | ) | ||||
|
|
|
|
|||||
Total liabilities, convertible preferred stock and stockholders’ deficit |
$ | 87,703 | $ | 269,718 | ||||
|
|
|
|
Year Ended December 31, |
||||||||
2019 |
2020 |
|||||||
Revenue, net |
$ | 233,116 | $ | 364,271 | ||||
Cost of goods sold |
149,681 | 188,267 | ||||||
|
|
|
|
|||||
Gross profit |
83,435 | 176,004 | ||||||
Operating expenses: |
||||||||
Advertising |
77,842 | 55,547 | ||||||
Product development |
13,604 | 18,655 | ||||||
Selling, general and administrative |
155,158 | 168,295 | ||||||
|
|
|
|
|||||
Operating loss |
(163,169 | ) | (66,493 | ) | ||||
Interest expense |
2,052 | 5,607 | ||||||
Other expense (income), net |
(3,763 | ) | 119 | |||||
|
|
|
|
|||||
Interest and other expense (income), net |
(1,711 | ) | 5,726 | |||||
|
|
|
|
|||||
Loss before provision for income taxes |
(161,458 | ) | (72,219 | ) | ||||
Provision for income taxes |
12 | 41 | ||||||
|
|
|
|
|||||
Net loss |
$ | (161,470 | ) | $ | (72,260 | ) | ||
Deemed dividend due to the exchange of Series Seed convertible preferred stock and Series A convertible preferred stock for Series D convertible preferred stock (Note 9) |
(1,801 | ) | — | |||||
|
|
|
|
|||||
Net loss attributable to common stockholders, basic and diluted |
$ | (163,271 | ) | $ | (72,260 | ) | ||
|
|
|
|
|||||
Net loss per share attributable to common stockholders, basic and diluted |
$ | (43.37 | ) | $ | (15.82) | |||
|
|
|
|
|||||
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted |
3,764,374 | 4,568,540 | ||||||
|
|
|
|
Convertible Preferred Stock |
Common Stock |
Additional Paid-In Capital |
Accumulated Deficit |
Total Stockholders’ Deficit |
||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
|||||||||||||||||||||||||
Balance at December 31, 2018 |
61,010 | $ | 167,675 | 4,657 | $ | — | $ | 1,585 | $ | (120,301 | ) | $ | (118,716 | ) | ||||||||||||||
Issuance of Series D convertible preferred stock, net of issuance costs of $50 |
5,887 | 48,505 | — | — | — | — | — | |||||||||||||||||||||
Issuance of Series D-1 convertible preferred stock, net of issuance costs of $70 |
4,519 | 48,146 | — | — | — | — | — | |||||||||||||||||||||
Exchange of common stock, Series Seed convertible preferred stock and Series A convertible preferred stock for Series D convertible preferred stock, inclusive of deemed dividend of $1,801 |
43 | 1,801 | (43 | ) | — | (1,585 | ) | (216 | ) | (1,801 | ) | |||||||||||||||||
Exchange of common stock for Series D convertible preferred stock, inclusive of stock-based compensation of $7,285 |
1,226 | 7,285 | (1,228 | ) | — | — | — | — | ||||||||||||||||||||
Issuance of common stock for business and asset acquisitions |
— | — | 178 | — | 530 | — | 530 | |||||||||||||||||||||
Issuance of common stock upon exercise of stock options |
— | — | 373 | — | 140 | — | 140 | |||||||||||||||||||||
Vesting of early exercise of options |
— | — | — | — | 49 | — | 49 | |||||||||||||||||||||
Stock-based compensation associated with stock options |
— | — | — | — | 4,716 | — | 4,716 | |||||||||||||||||||||
Net loss |
— | — | — | — | — | (161,470 | ) | (161,470 | ) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance at December 31, 2019 |
72,685 | 273,412 | 3,937 | — | 5,435 | (281,987 | ) | (276,552 | ) | |||||||||||||||||||
Issuance of Series D-2 convertible preferred stock, net of issuance costs of $362 |
12,373 | 89,638 | — | — | — | — | — | |||||||||||||||||||||
Issuance of Series E convertible preferred stock, net of issuance costs of $132 |
12,553 | 124,868 | — | — | — | — | — | |||||||||||||||||||||
Issuance of common stock for an asset acquisition |
— | — | 30 | — | 67 | — | 67 | |||||||||||||||||||||
Issuance of common stock upon exercise of stock options, net of amount related to early exercised options of $2,080 |
— | — | 3,233 | 1 | 1,183 | — | 1,184 | |||||||||||||||||||||
Vesting of early exercise of options |
— | — | — | — | 68 | — | 68 | |||||||||||||||||||||
Stock-based compensation |
— | — | — | — | 7,852 | — | 7,852 | |||||||||||||||||||||
Net loss |
— | — | — | — | — | (72,260 | ) | (72,260 | ) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance at December 31, 2020 |
97,611 | $ | 487,918 | 7,200 | $ | 1 | $ | 14,605 | $ | (354,247 | ) | $ | (339,641 | ) | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, |
||||||||
2019 |
2020 |
|||||||
Cash Flows from Operating Activities |
||||||||
Net loss |
$ | (161,470 | ) | $ | (72,260 | ) | ||
Adjustments to reconcile net loss to net cash used in operating activities: |
||||||||
Remeasurement of convertible preferred stock warrant liability |
430 | 964 | ||||||
Stock-based compensation |
11,960 | 7,762 | ||||||
Depreciation and amortization |
2,361 | 4,115 | ||||||
Non-cash interest expense |
848 | 917 | ||||||
Gain on purchase of a business |
(2,670 | ) | — | |||||
Inventory reserve expense |
349 | 1,820 | ||||||
Other non-cash expenses |
215 | 401 | ||||||
Changes in operating assets and liabilities: |
||||||||
Inventory |
(1,661 | ) | (18,611 | ) | ||||
Other assets |
(194 | ) | (1,437 | ) | ||||
Accounts payable |
19,286 | (16,250 | ) | |||||
Accrued expenses |
(1,829 | ) | 5,582 | |||||
Deferred revenue |
4,603 | 2,102 | ||||||
Operating lease right-of-use |
— | 278 | ||||||
Other liabilities |
2,967 | 961 | ||||||
|
|
|
|
|||||
Net cash used in operating activities |
(124,805 | ) | (83,656 | ) | ||||
|
|
|
|
|||||
Cash Flows from Investing Activities |
||||||||
Purchase of investments |
(8,640 | ) | — | |||||
Proceeds from sale of investments |
— | — | ||||||
Proceeds from maturities of investments |
8,700 | — | ||||||
Purchase of property and equipment |
(10,744 | ) | (4,820 | ) | ||||
Purchase of intangible assets |
(873 | ) | — | |||||
Acquisition of a business |
(750 | ) | — | |||||
|
|
|
|
|||||
Net cash used in investing activities |
(12,307 | ) | (4,820 | ) | ||||
|
|
|
|
|||||
Cash Flows from Financing Activities |
||||||||
Proceeds from issuance of convertible preferred stock, net of issuance costs |
96,529 | 214,790 | ||||||
Proceeds from issuance of debt |
17,172 | 43,513 | ||||||
Repayment of debt |
(6,029 | ) | (33,118 | ) | ||||
Payment of debt issuance costs |
(365 | ) | (279 | ) | ||||
Proceeds from exercise of stock options |
140 | 3,264 | ||||||
Repurchase of common stock |
— | — | ||||||
|
|
|
|
|||||
Net cash provided by financing activities |
107,447 | 228,170 | ||||||
|
|
|
|
|||||
Net increase (decrease) in cash and cash equivalents |
(29,665 | ) | 139,694 | |||||
Cash and cash equivalents at beginning of year |
66,494 | 36,829 | ||||||
|
|
|
|
|||||
Cash and cash equivalents at end of year |
$ | 36,829 | $ | 176,523 | ||||
|
|
|
|
|||||
Supplemental Disclosure |
||||||||
Cash paid for income taxes |
$ | 1 | $ | 4 | ||||
Cash paid for interest |
1,153 | 3,887 | ||||||
Supplemental Disclosure of Non-Cash Investing and Financing Activities |
||||||||
Purchases of property and equipment included in accounts payable and accrued liabilities |
$ | 408 | $ | 86 | ||||
Issuance of common stock for business and asset acquisitions |
530 | 67 | ||||||
Debt issuance costs recorded with an offset to convertible preferred stock warrant liability |
374 | 323 | ||||||
Convertible preferred stock issuance costs included in accrued liabilities |
— | 284 |
Computer equipment |
3 - 5 years | |||
Furniture and fixtures |
5 years | |||
Machinery and warehouse equipment |
7 - 10 years | |||
Leasehold improvements |
|
Shorter of 10 years or lease term |
|
December 31, 2019 |
||||||||||||||||
Level 1 |
Level 2 |
Level 3 |
Total |
|||||||||||||
Financial Assets: |
||||||||||||||||
Cash equivalents: |
||||||||||||||||
Money market funds |
$ | 13,071 | $ | — | $ | — | $ | 13,071 | ||||||||
Repurchase agreement |
— | 10,000 | — | 10,000 | ||||||||||||
Commercial paper |
— | 1,000 | — | 1,000 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
$ | 13,071 | $ | 11,000 | $ | — | $ | 24,071 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Financial Liabilities: |
||||||||||||||||
Convertible preferred stock warrant liability |
$ | — | $ | — | $ | 2,266 | $ | 2,266 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
$ | — | $ | — | $ | 2,266 | $ | 2,266 | ||||||||
|
|
|
|
|
|
|
|
December 31, 2020 |
||||||||||||||||
Level 1 |
Level 2 |
Level 3 |
Total |
|||||||||||||
Financial Assets: |
||||||||||||||||
Cash equivalents: |
||||||||||||||||
Money market funds |
$ | 173,315 | $ | — | $ | — | $ | 173,315 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
$ | 173,315 | $ | — | $ | — | $ | 173,315 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Financial Liabilities: |
||||||||||||||||
Convertible preferred stock warrant liability |
$ | — | $ | — | $ | 3,553 | $ | 3,553 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
$ | — | $ | — | $ | 3,553 | $ | 3,553 | ||||||||
|
|
|
|
|
|
|
|
Balance at December 31, 2019 |
$ | 2,266 | ||
Initial measurement of warrants issued |
323 | |||
Change in fair value |
964 | |||
|
|
|||
Balance at December 31, 2020 |
$ | 3,553 | ||
|
|
December 31, 2019 |
||||||||||||||||
Series A Convertible Preferred Stock Warrants |
Series B Convertible Preferred Stock Warrants |
Series C Convertible Preferred Stock Warrants |
Series D Convertible Preferred Stock Warrants |
|||||||||||||
Expected term (in years) |
2.0 | 2.0 | 2.0 | 2.0 | ||||||||||||
Fair value of underlying shares |
$ | 6.02 | $ | 6.17 | $ | 6.50 | $ | 9.05 | ||||||||
Volatility |
64.87 | % | 64.87 | % | 64.87 | % | 64.87 | % | ||||||||
Risk-free interest rate |
1.58 | % | 1.58 | % | 1.58 | % | 1.58 | % | ||||||||
Dividend yield |
— | — | — | — | ||||||||||||
December 31, 2020 |
||||||||||||||||
Series A Convertible Preferred Stock Warrants |
Series B Convertible Preferred Stock Warrants |
Series C Convertible Preferred Stock Warrants |
Series D Convertible Preferred Stock Warrants |
|||||||||||||
Expected term (in years) |
2.0 | 2.0 | 2.0 | 2.0 | ||||||||||||
Fair value of underlying shares |
$ | 7.43 | $ | 7.63 | $ | 7.97 | $ | 9.82 | ||||||||
Volatility |
88.04 | % | 88.04 | % | 88.04 | % | 88.04 | % | ||||||||
Risk-free interest rate |
0.13 | % | 0.13 | % | 0.13 | % | 0.13 | % | ||||||||
Dividend yield |
— | — | — | — |
December 31, |
||||||||
2019 |
2020 |
|||||||
Machinery and warehouse equipment |
$ | 6,377 | $ | 7,133 | ||||
Internally developed software |
5,129 | 8,044 | ||||||
Computer equipment |
2,634 | 2,880 | ||||||
Leasehold Improvements |
1,977 | 1,763 | ||||||
Furniture and fixtures |
1,294 | 1,241 | ||||||
Construction in progress |
51 | 471 | ||||||
|
|
|
|
|||||
Total property and equipment |
17,462 | 21,532 | ||||||
Less: accumulated depreciation |
(2,755 | ) | (6,432 | ) | ||||
|
|
|
|
|||||
Property and equipment, net |
$ | 14,707 | $ | 15,100 | ||||
|
|
|
|
December 31, |
||||||||
2019 |
2020 |
|||||||
Inventory purchases |
$ | 3,624 | $ | 6,285 | ||||
Sales taxes |
1,924 | 1,999 | ||||||
Advertising costs |
3,235 | 1,936 | ||||||
Compensation and benefits |
944 | 1,545 | ||||||
Fulfillment costs |
729 | 1,156 | ||||||
Other accrued expenses |
3,606 | 6,889 | ||||||
|
|
|
|
|||||
Total accrued expenses |
$ | 14,062 | $ | 19,810 | ||||
|
|
|
|
December 31, |
||||||||
2019 |
2020 |
|||||||
Silicon Valley Bank Loan Revolver |
$ | 12,171 | $ | 5,947 | ||||
Silicon Valley Bank Term Loan |
3,219 | 2,586 | ||||||
Triplepoint Loan Facility 2 |
4,888 | — | ||||||
Triplepoint Loan Facility 4 |
— | 19,933 | ||||||
Atel Loan Facility Draw 1 |
684 | 358 | ||||||
Atel Loan Facility Draw 2 |
301 | 165 | ||||||
Atel Loan Facility Draw 3 |
— | 2,315 | ||||||
Atel Loan Facility Draw 4 |
— | 396 | ||||||
|
|
|
|
|||||
Total debt |
21,263 | 31,700 | ||||||
Less: debt, current |
(18,800 | ) | (1,918 | ) | ||||
|
|
|
|
|||||
Total debt, noncurrent |
$ | 2,463 | $ | 29,782 | ||||
|
|
|
|
Year Ended December 31, |
||||
2021 |
$ | 22,798 | ||
2022 |
8,428 | |||
2023 |
576 | |||
2024 |
— | |||
2025 |
— | |||
Thereafter |
— | |||
|
|
|||
Total principal debt payments |
31,802 | |||
Less: debt discount |
(102 | ) | ||
|
|
|||
Total debt |
$ | 31,700 | ||
|
|
December 31, 2020 | ||||||||||||
Lenders |
Exercise Price Per Share |
Number of Shares |
Expiration Date | |||||||||
Series A warrants |
SVB | $ | 0.62 | 51,617 | December 2026 | |||||||
Series B warrants |
SVB | 1.46 | 107,093 | July to November 2027 | ||||||||
Series C warrants |
TriplePoint | 2.84 | 264,140 | April 2028 | ||||||||
Series D warrants |
TriplePoint | 8.25 | 200,043 | June 2026 to May 2029 |
Year Ended December 31, |
Operating Lease Commitments |
|||
2021 |
$ | 6,724 | ||
2022 |
6,823 | |||
2023 |
6,546 | |||
2024 |
5,881 | |||
2025 |
5,371 | |||
Thereafter |
9,890 | |||
|
|
|||
Total undiscounted lease payments |
41,235 | |||
Less: Imputed interest |
(14,701 | ) | ||
|
|
|||
Present value of lease liabilities |
26,534 | |||
Less: Operating lease liabilities, current |
(2,955 | ) | ||
|
|
|||
Operating lease liabilities, noncurrent |
$ | 23,579 | ||
|
|
Year Ended December 31, |
||||
2020 |
$ | 7,047 | ||
2021 |
7,112 | |||
2022 |
7,222 | |||
2023 |
6,957 | |||
2024 |
6,125 | |||
Thereafter |
15,261 | |||
|
|
|||
Total |
$ | 49,724 | ||
|
|
December 31, 2020 |
||||||||||||||||||||
Original Issue Price |
Shares Authorized |
Shares Outstanding |
Net Carrying Value |
Liquidation Preference |
||||||||||||||||
Series Seed |
$ | 0.6168 | 8,242,152 | 8,242,152 | $ | 3,943 | $ | 5,084 | ||||||||||||
Series A |
0.6168 | 12,015,184 | 11,963,567 | 5,240 | 7,379 | |||||||||||||||
Series B |
1.4642 | 10,789,890 | 10,682,797 | 15,545 | 15,642 | |||||||||||||||
Series C |
2.8394 | 13,295,062 | 13,030,922 | 36,917 | 37,000 | |||||||||||||||
Series C-1 |
3.7244 | 7,273,640 | 7,273,640 | 27,003 | 27,090 | |||||||||||||||
Series D |
8.2482 | 17,173,437 | 16,973,394 | 136,618 | 140,000 | |||||||||||||||
Series D-1 |
10.6703 | 4,518,724 | 4,518,724 | 48,146 | 48,216 | |||||||||||||||
Series D-2 |
7.2738 | 12,373,174 | 12,373,174 | 89,638 | 90,000 | |||||||||||||||
Series E |
9.9578 | 12,552,973 | 12,552,973 | 124,868 | 125,000 | |||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Total |
98,234,236 | 97,611,343 | $ | 487,918 | $ | 495,411 | ||||||||||||||
|
|
|
|
|
|
|
|
Options Outstanding |
||||||||||||||||
Number of Options |
Weighted– Average Exercise Price |
Weighted- Average Remaining Contractual Life (years) |
Aggregate Intrinsic Value |
|||||||||||||
Balance – December 31, 2019 |
15,466,163 | $ | 1.62 | 8.72 | $ | 34,315 | ||||||||||
Granted |
4,668,449 | 2.85 | ||||||||||||||
Exercised |
(3,233,562 | ) | 1.01 | |||||||||||||
Forfeited and expired |
(975,058 | ) | 2.24 | |||||||||||||
|
|
|||||||||||||||
Balance – December 31, 2020 |
15,925,992 | $ | 1.74 | 8.15 | $ | 52,909 | ||||||||||
|
|
|||||||||||||||
Options vested and exercisable – December 31, 2020 |
7,075,932 | $ | 1.40 | 7.51 | $ | 25,908 | ||||||||||
|
|
Number of Options |
Weighted– Average Exercise Price |
|||||||
Outstanding and unvested as of December 31, 2019 |
22,300 | $ | 0.44 | |||||
Issued |
1,170,448 | 1.78 | ||||||
Vested |
(143,714 | ) | 0.47 | |||||
|
|
|||||||
Outstanding and unvested as of December 31, 2020 |
1,049,034 | $ | 1.93 | |||||
|
|
Year Ended December 31, |
||||||||
2019 |
2020 |
|||||||
Fair value of common stock |
$ | 3.41 – 3.84 | $ | 3.48 – 4.15 | ||||
Expected term (in years) |
5.00 – 6.11 | 5.00 – 6.11 | ||||||
Volatility |
58.49% – 59.39 | % | 61.12% – 74.34 | % | ||||
Risk-free interest rate |
1.72% – 1.98 | % | 0.21% – 1.66 | % | ||||
Dividend yield |
— | % | — | % |
Years Ended December 31, |
||||||||
2019 |
2020 |
|||||||
Federal statutory rate |
21.0 | % | 21.0 | % | ||||
Change in valuation allowance |
(19.5 | )% | (19.5 | )% | ||||
Stock-based compensation |
(1.4 | )% | (1.7 | )% | ||||
Other |
(0.1 | )% | (0.2 | )% | ||||
|
|
|
|
|||||
Provision for income taxes |
— | % | — | % | ||||
|
|
|
|
December 31, |
||||||||
2019 |
2020 |
|||||||
Deferred tax assets: |
||||||||
Net operating loss carryforwards |
$ | 57,170 | $ | 69,486 | ||||
Deferred revenue |
2,049 | 2,532 | ||||||
Inventory reserve and uniform capitalization |
1,119 | 2,067 | ||||||
Operating lease liabilities |
— | 6,042 | ||||||
Accruals and other reserves |
1,545 | 1,794 | ||||||
Stock-based compensation |
264 | 240 | ||||||
Other |
344 | 1,637 | ||||||
|
|
|
|
|||||
Total deferred tax assets |
62,491 | 83,798 | ||||||
Less: valuation allowance |
59,634 | 75,061 | ||||||
|
|
|
|
|||||
Total deferred tax assets, net of valuation allowance |
2,857 | 8,737 | ||||||
|
|
|
|
|||||
Deferred tax liabilities: |
||||||||
Operating lease right-of-use |
(5,518 | ) | ||||||
Depreciation and amortization |
(2,857 | ) | (3,219 | ) | ||||
|
|
|
|
|||||
Total deferred tax liabilities |
(2,857 | ) | (8,737 | ) | ||||
|
|
|
|
|||||
Net deferred tax assets |
$ | — | $ | — | ||||
|
|
|
|
December 31, |
||||||||
2019 |
2020 |
|||||||
Valuation allowance, as of beginning of year |
$ | 25,780 | $ | 59,634 | ||||
Valuation allowance established |
33,977 | 15,499 | ||||||
Changes to existing valuation allowances |
(123 | ) | (72 | ) | ||||
|
|
|
|
|||||
Valuation allowance, as of end of year |
$ | 59,634 | $ | 75,061 | ||||
|
|
|
|
December 31, |
||||||||
2019 |
2020 |
|||||||
Balance at beginning of year |
$ | 513 | $ | 530 | ||||
Decrease related to prior period tax positions |
— | (505 | ) | |||||
Increase related to current year tax positions |
17 | 10 | ||||||
|
|
|
|
|||||
Balance at end of year |
$ | 530 | $ | 35 | ||||
|
|
|
|
Year Ended December 31, |
||||||||
2019 |
2020 |
|||||||
Convertible preferred stock |
72,685,196 | 98,029,647 | ||||||
Common stock options |
15,466,163 | 15,925,992 | ||||||
Convertible preferred stock warrants |
561,851 | 625,629 | ||||||
Common stock warrants |
531,965 | 561,851 | ||||||
Shares subject to repurchase |
22,300 | 1,049,034 | ||||||
|
|
|
|
|||||
Total |
89,267,475 | 116,192,153 | ||||||
|
|
|
|
December 31, 2020 |
September 30, 2021 |
|||||||
(Unaudited) |
||||||||
Assets |
||||||||
Current assets: |
||||||||
Cash and cash equivalents |
$ | 176,523 | $ | 109,217 | ||||
Inventory, net |
46,580 | 59,466 | ||||||
Prepaid expenses and other current assets |
4,828 | 6,940 | ||||||
|
|
|
|
|||||
Total current assets |
227,931 | 175,623 | ||||||
Property and equipment, net |
15,100 | 15,800 | ||||||
Operating lease right-of-use |
24,234 | 22,040 | ||||||
Other long-term assets |
2,453 | 3,466 | ||||||
|
|
|
|
|||||
Total assets |
$ | 269,718 | $ | 216,929 | ||||
|
|
|
|
|||||
Liabilities, Convertible Preferred Stock, and Stockholders’ Deficit |
||||||||
Current liabilities: |
||||||||
Accounts payable |
$ | 23,814 | $ | 31,126 | ||||
Accrued expenses |
19,810 | 26,267 | ||||||
Deferred revenue |
11,119 | 11,278 | ||||||
Operating lease liabilities, current |
2,955 | 3,493 | ||||||
Other current liabilities |
3,522 | 1,017 | ||||||
Debt, current |
1,918 | 1,265 | ||||||
|
|
|
|
|||||
Total current liabilities |
63,138 | 74,446 | ||||||
Debt, noncurrent |
29,782 | 55,981 | ||||||
Operating lease liabilities, noncurrent |
23,579 | 20,909 | ||||||
Other long-term liabilities |
4,942 | 6,393 | ||||||
|
|
|
|
|||||
Total liabilities |
121,441 | 157,729 | ||||||
|
|
|
|
|||||
Commitments and contingencies (Note 6) |
||||||||
Convertible preferred stock, $0.0001 par value – 98,234,236 shares authorized at December 31, 2020 and September 30, 2021; 97,611,343 shares issued and outstanding at December 31, 2020 and September 30, 2021 |
487,918 | 487,918 | ||||||
Stockholders’ deficit: |
||||||||
Common stock, $0.0001 par value – 165,000,000 shares authorized at December 31, 2020 and September 30, 2021; 7,200,243 and 7,809,002 shares issued and outstanding at December 31, 2020 and September 30, 2021, respectively |
1 | 1 | ||||||
Additional paid-in capital |
14,605 | 29,437 | ||||||
Accumulated deficit |
(354,247 | ) | (458,156 | ) | ||||
|
|
|
|
|||||
Total stockholders’ deficit |
(339,641 | ) | (428,718 | ) | ||||
|
|
|
|
|||||
Total liabilities, convertible preferred stock, and stockholders’ deficit |
$ | 269,718 | $ | 216,929 | ||||
|
|
|
|
Nine Months Ended September 30, |
||||||||
2020 |
2021 |
|||||||
Revenue, net |
$ | 271,233 | $ | 296,421 | ||||
Cost of goods sold |
141,683 | 147,179 | ||||||
|
|
|
|
|||||
Gross profit |
129,550 | 149,242 | ||||||
|
|
|
|
|||||
Operating expenses: |
||||||||
Advertising |
43,816 | 90,611 | ||||||
Product development |
13,855 | 16,436 | ||||||
Selling, general and administrative |
126,427 | 140,609 | ||||||
|
|
|
|
|||||
Operating loss |
(54,548 | ) | (98,414 | ) | ||||
Interest expense |
4,568 | 3,272 | ||||||
Loss on extinguishment of debt |
— | 1,027 | ||||||
Other expense (income), net |
(204 | ) | 1,157 | |||||
|
|
|
|
|||||
Interest and other expense, net |
4,364 | 5,456 | ||||||
|
|
|
|
|||||
Loss before provision for income taxes |
(58,912 | ) | (103,870 | ) | ||||
Provision for income taxes |
31 | 39 | ||||||
|
|
|
|
|||||
Net loss |
$ | (58,943 | ) | $ | (103,909 | ) | ||
|
|
|
|
|||||
Net loss per share attributable to common stockholders, basic and diluted |
$ | (14.29 | ) | $ | (14.61 | ) | ||
|
|
|
|
|||||
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted |
4,125,470 | 7,114,091 | ||||||
|
|
|
|
Convertible Preferred Stock |
Common Stock |
Additional Paid-In Capital |
Accumulated Deficit |
Total Stockholders’ Deficit |
||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
|||||||||||||||||||||||||
Balance at December 31, 2019 |
72,685 | $ | 273,412 | 3,937 | $ | — | $ | 5,435 | $ | (281,987 | ) | $ | (276,552 | ) | ||||||||||||||
Issuance of common stock upon asset acquisition |
— | — | 30 | — | 67 | — | 67 | |||||||||||||||||||||
Issuance of Series D-2 convertible preferred stock, net of issuance costs of $362 |
12,373 | 89,638 | — | — | — | — | — | |||||||||||||||||||||
Issuance of common stock upon exercise of stock options, net of amount related to early exercised options of $1,805 |
— | — | 922 | — | 271 | — | 271 | |||||||||||||||||||||
Vesting of early exercise of options |
— | — | — | — | 23 | — | 23 | |||||||||||||||||||||
Stock-based compensation |
— | — | — | — | 5,539 | — | 5,539 | |||||||||||||||||||||
Net loss |
— | — | — | — | — | (58,943 | ) | (58,943 | ) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance at September 30, 2020 (Unaudited) |
85,058 | $ | 363,050 | 4,889 | $ | — | $ | 11,335 | $ | (340,930 | ) | $ | (329,595 | ) | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Convertible Preferred Stock |
Common Stock |
Additional Paid-In Capital |
Accumulated Deficit |
Total Stockholders’ Deficit |
||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
|||||||||||||||||||||||||
Balance at December 31, 2020 |
97,611 | $ | 487,918 | 7,200 | $ | 1 | $ | 14,605 | $ | (354,247 | ) | $ | (339,641 | ) | ||||||||||||||
Issuance of common stock for services |
— | — | 4 | — | 49 | — | 49 | |||||||||||||||||||||
Issuance of common stock warrants |
— | — | — | — | 1,622 | — | 1,622 | |||||||||||||||||||||
Issuance of common stock upon exercise of warrants |
— | — | 243 | — | 150 | — | 150 | |||||||||||||||||||||
Issuance of common stock upon exercise of stock options, net of amount related to early exercise options of $8 |
— | — | 493 | — | 591 | — | 591 | |||||||||||||||||||||
Vesting of early exercise of options |
— | — | — | — | 1,413 | — | 1,413 | |||||||||||||||||||||
Repurchase of early exercised options |
— | — | (131 | ) | — | — | — | — | ||||||||||||||||||||
Stock-based compensation |
— | — | — | — | 11,007 | — | 11,007 | |||||||||||||||||||||
Net loss |
— | — | — | — | — | (103,909 | ) | (103,909 | ) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance at September 30, 2021 (Unaudited) |
97,611 | $ | 487,918 | 7,809 | $ | 1 | $ | 29,437 | $ | (458,156 | ) | $ | (428,718 | ) | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine Months Ended September 30, |
||||||||
2020 |
2021 |
|||||||
Cash Flows from Operating Activities |
||||||||
Net loss |
$ | (58,943 | ) | $ | (103,909 | ) | ||
Adjustments to reconcile net loss to net cash used in operating activities: |
||||||||
Remeasurement of convertible preferred stock warrant liability |
453 | 1,526 | ||||||
Stock-based compensation |
5,474 | 10,858 | ||||||
Depreciation and amortization |
3,028 | 3,633 | ||||||
Non-cash interest expense |
819 | 509 | ||||||
Loss on extinguishment of debt |
— | 1,027 | ||||||
Inventory reserve |
485 | 1,933 | ||||||
Other non-cash expenses |
353 | 396 | ||||||
Changes in operating assets and liabilities: |
||||||||
Inventory |
(3,012 | ) | (14,819 | ) | ||||
Prepaids and other assets |
(4,106 | ) | (2,081 | ) | ||||
Accounts payable |
(11,057 | ) | 7,400 | |||||
Accrued expenses |
8,310 | 5,431 | ||||||
Deferred revenue |
2,449 | 159 | ||||||
Operating lease right-of-use |
229 | 62 | ||||||
Other liabilities |
1,514 | (878 | ) | |||||
|
|
|
|
|||||
Net cash used in operating activities |
(54,004 | ) | (88,753 | ) | ||||
|
|
|
|
|||||
Cash Flows from Investing Activities |
||||||||
Purchase of property and equipment |
(3,370 | ) | (4,268 | ) | ||||
|
|
|
|
|||||
Net cash used in investing activities |
(3,370 | ) | (4,268 | ) | ||||
|
|
|
|
|||||
Cash Flows from Financing Activities |
||||||||
Proceeds from issuance of convertible preferred stock, net of issuance costs |
89,971 | — | ||||||
Payment of deferred offering and convertible preferred stock issuance costs |
— | (340 | ) | |||||
Proceeds from issuance of debt |
43,513 | 50,000 | ||||||
Payment of debt issuance costs |
(279 | ) | (375 | ) | ||||
Repayment of debt |
(32,561 | ) | (21,523 | ) | ||||
Payment for debt extinguishment |
— | (2,499 | ) | |||||
Proceeds from exercise of stock options and warrants |
1,504 | 749 | ||||||
Repurchase of early exercised common stock |
— | (297 | ) | |||||
|
|
|
|
|||||
Net cash provided by financing activities |
102,148 | 25,715 | ||||||
|
|
|
|
|||||
Net increase (decrease) in cash and cash equivalents |
44,774 | (67,306 | ) | |||||
Cash and cash equivalents at beginning of period |
36,829 | 176,523 | ||||||
|
|
|
|
|||||
Cash and cash equivalents at end of period |
$ | 81,603 | $ | 109,217 | ||||
|
|
|
|
Nine Months Ended September 30, |
||||||||
2020 |
2021 |
|||||||
Supplemental Disclosure |
||||||||
Cash paid for taxes |
$ | 4 | $ | 52 | ||||
Cash paid for interest |
3,140 | 3,285 | ||||||
Supplemental Disclosure of Non-Cash Investing and Financing Activities |
||||||||
Purchases of property and equipment included in accounts payable and accrued liabilities |
$ | 40 | $ | 102 | ||||
Deferred offering and convertible preferred stock issuance costs included in accounts payable and accrued liabilities |
332 | 1,198 | ||||||
Debt issuance costs recorded with an offset to convertible preferred stock warrant liability |
323 | — | ||||||
Initial measurement of common stock warrants recorded as debt fees |
— | 1,622 | ||||||
Issuance of common stock for business and asset acquisitions |
67 | — | ||||||
Vesting of early exercised stock options |
23 | 1,413 |
Nine Months Ended September 30, |
||||||||
2020 |
2021 |
|||||||
Revenue, net: |
||||||||
Grove Brands |
$ | 120,139 | $ | 145,516 | ||||
Third-party products |
151,094 | 150,905 | ||||||
|
|
|
|
|||||
Total revenue, net |
$ | 271,233 | $ | 296,421 | ||||
|
|
|
|
December 31, 2020 |
||||||||||||||||
Level 1 |
Level 2 |
Level 3 |
Total |
|||||||||||||
Financial Assets: |
||||||||||||||||
Cash equivalents: |
||||||||||||||||
Money market funds |
$ | 173,315 | $ | — | $ | — | $ | 173,315 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
$ | 173,315 | $ | — | $ | — | $ | 173,315 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Financial Liabilities: |
||||||||||||||||
Convertible preferred stock warrant liability |
$ | — | $ | — | $ | 3,553 | $ | 3,553 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
$ | — | $ | — | $ | 3,553 | $ | 3,553 | ||||||||
|
|
|
|
|
|
|
|
September 30, 2021 |
||||||||||||||||
Level 1 |
Level 2 |
Level 3 |
Total |
|||||||||||||
Financial Assets: |
||||||||||||||||
Cash equivalents: |
||||||||||||||||
Money market funds |
$ | 105,636 | $ | — | $ | — | $ | 105,636 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
$ | 105,636 | $ | — | $ | — | $ | 105,636 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Financial Liabilities: |
||||||||||||||||
Convertible preferred stock warrant liability |
$ | — | $ | — | $ | 5,079 | $ | 5,079 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
$ | — | $ | — | $ | 5,079 | $ | 5,079 | ||||||||
|
|
|
|
|
|
|
|
Balance at December 31, 2020 |
$ | 3,553 | ||
Change in fair value |
1,526 | |||
|
|
|||
Balance at September 30, 2021 |
$ | 5,079 | ||
|
|
December 31, 2020 |
||||||||||||||||
Series A Convertible Preferred Stock Warrants |
Series B Convertible Preferred Stock Warrants |
Series C Convertible Preferred Stock Warrants |
Series D Convertible Preferred Stock Warrants |
|||||||||||||
Expected term (in years) |
2.0 | 2.0 | 2.0 | 2.0 | ||||||||||||
Fair value of underlying preferred stock |
$ | 7.43 | $ | 7.63 | $ | 7.97 | $ | 9.82 | ||||||||
Volatility |
88.04 | % | 88.04 | % | 88.04 | % | 88.04 | % | ||||||||
Risk-free interest rate |
0.13 | % | 0.13 | % | 0.13 | % | 0.13 | % | ||||||||
Dividend yield |
— | — | — | — |
September 30, 2021 |
||||||||||||||||
Series A Convertible Preferred Stock Warrants |
Series B Convertible Preferred Stock Warrants |
Series C Convertible Preferred Stock Warrants |
Series D Convertible Preferred Stock Warrants |
|||||||||||||
Expected term (in years) |
4.02 | 4.44 | 4.95 | 3.65 | ||||||||||||
Fair value of underlying preferred stock |
$ | 10.49 | $ | 10.55 | $ | 10.65 | $ | 11.36 | ||||||||
Volatility |
67.79 | % | 67.68 | % | 67.81 | % | 67.97 | % | ||||||||
Risk-free interest rate |
0.75 | % | 0.82 | % | 0.91 | % | 0.68 | % | ||||||||
Dividend yield |
— | — | — | — |
December 31, 2020 |
September 30, 2021 |
|||||||
Inventory purchases |
$ | 6,285 | $ | 4,953 | ||||
Sales taxes |
1,999 | 2,178 | ||||||
Advertising costs |
1,936 | 7,156 | ||||||
Compensation and benefits |
1,545 | 2,196 | ||||||
Fulfillment costs |
1,156 | 1,353 | ||||||
Other accrued expenses |
6,889 | 8,431 | ||||||
|
|
|
|
|||||
Total accrued expenses |
$ | 19,810 | $ | 26,267 | ||||
|
|
|
|
December 31, 2020 |
September 30, 2021 |
|||||||
Silicon Valley Bank Loan Revolver |
$ | 5,947 | $ | 5,947 | ||||
Silicon Valley Bank Term Loan |
2,586 | — | ||||||
Silicon Valley Bank and Hercules Mezzanine Term Loan |
— | 49,144 | ||||||
Triplepoint Loan Facility 4 |
19,933 | — | ||||||
Atel Loan Facility Draw 1 |
358 | 105 | ||||||
Atel Loan Facility Draw 2 |
165 | 44 | ||||||
Atel Loan Facility Draw 3 |
2,315 | 1,711 | ||||||
Atel Loan Facility Draw 4 |
396 | 295 | ||||||
|
|
|
|
|||||
Total debt |
31,700 | 57,246 | ||||||
Less: debt, current |
(1,918 | ) | (1,265 | ) | ||||
|
|
|
|
|||||
Total debt, noncurrent |
$ | 29,782 | $ | 55,981 | ||||
|
|
|
|
September 30, 2021 | ||||||||||||
Lenders |
Exercise Price Per Share |
Number of Shares |
Expiration Date | |||||||||
Series A warrants |
SVB | $ | 0.62 | 51,617 | December 2026 | |||||||
Series B warrants |
SVB | 1.46 | 107,093 | July to November 2027 | ||||||||
Series C warrants |
TriplePoint | 2.84 | 264,140 | April 2028 | ||||||||
Series D warrants |
TriplePoint | 8.25 | 200,043 | June 2026 to May 2029 |
Original Issue Price |
Shares Authorized |
Shares Outstanding |
Net Carrying Value |
Liquidation Preference |
||||||||||||||||
Series Seed |
$ | 0.6168 | 8,242,152 | 8,242,152 | $ | 3,943 | $ | 5,084 | ||||||||||||
Series A |
0.6168 | 12,015,184 | 11,963,567 | 5,240 | 7,379 | |||||||||||||||
Series B |
1.4642 | 10,789,890 | 10,682,797 | 15,545 | 15,642 | |||||||||||||||
Series C |
2.8394 | 13,295,062 | 13,030,922 | 36,917 | 37,000 | |||||||||||||||
Series C-1 |
3.7244 | 7,273,640 | 7,273,640 | 27,003 | 27,090 | |||||||||||||||
Series D |
8.2482 | 17,173,437 | 16,973,394 | 136,618 | 140,000 | |||||||||||||||
Series D-1 |
10.6703 | 4,518,724 | 4,518,724 | 48,146 | 48,216 | |||||||||||||||
Series D-2 |
7.2738 | 12,373,174 | 12,373,174 | 89,638 | 90,000 | |||||||||||||||
Series E |
9.9578 | 12,552,973 | 12,552,973 | 124,868 | 125,000 | |||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Total |
98,234,236 | 97,611,343 | $ | 487,918 | $ | 495,411 | ||||||||||||||
|
|
|
|
|
|
|
|
Options Outstanding |
||||||||||||||||
Number of Options |
Weighted– Average Exercise Price |
Weighted- Average Remaining Contractual Life (years) |
Aggregate Intrinsic Value |
|||||||||||||
Balance – December 31, 2020 |
15,925,992 | $ | 1.74 | 8.15 | $ | 52,909 | ||||||||||
Granted |
9,360,770 | 4.86 | ||||||||||||||
Exercised |
(493,622 | ) | 1.25 | |||||||||||||
Forfeited and expired |
(1,223,994 | ) | 2.65 | |||||||||||||
|
|
|||||||||||||||
Balance – September 30, 2021 |
23,569,146 | $ | 2.94 | 8.13 | $ | 136,492 | ||||||||||
|
|
|||||||||||||||
Options vested and exercisable – September 30, 2021 |
10,315,191 | $ | 1.75 | 7.14 | $ | 71,992 | ||||||||||
|
|
Number of Options |
Weighted– Average Exercise Price |
|||||||
Outstanding and unvested as of December 31, 2020 |
1,049,034 | $ | 1.93 | |||||
Issued |
9,375 | 0.89 | ||||||
Vested |
(757,877 | ) | 1.86 | |||||
Repurchased |
(131,819 | ) | 2.25 | |||||
|
|
|||||||
Outstanding and unvested as of September 30, 2021 |
168,713 | $ | 1.90 | |||||
|
|
Nine Months Ended September 30, | ||||
2020 |
2021 | |||
Fair value of common stock |
$3.48 – 3.84 | $5.95 – 8.13 | ||
Expected term (in years) |
5.00 – 6.11 | 5.00 – 6.28 | ||
Volatility |
61.12% –73.60% | 62.33% – 75.19% | ||
Risk-free interest rate |
0.21% – 1.66% | 0.50% – 1.16% | ||
Dividend yield |
— | — |
Nine Months Ended September 30, |
||||||||
2020 |
2021 |
|||||||
Convertible preferred stock |
85,461,450 | 98,029,647 | ||||||
Common stock options |
18,335,669 | 23,569,146 | ||||||
Restricted stock units |
— | 544,500 | ||||||
Convertible preferred stock warrants |
625,629 | 625,629 | ||||||
Common stock warrants |
561,851 | 585,321 | ||||||
Shares subject to repurchase |
701,939 | 168,713 | ||||||
|
|
|
|
|||||
Total |
105,686,538 | 123,522,956 | ||||||
|
|
|
|
Page |
||||||
A-2 | ||||||
SECTION 1.01 |
A-2 | |||||
SECTION 1.02 |
A-11 | |||||
SECTION 1.03 |
A-14 | |||||
A-15 | ||||||
SECTION 2.01 |
A-15 | |||||
SECTION 2.02 |
A-15 | |||||
SECTION 2.03 |
A-15 | |||||
SECTION 2.04 |
A-15 | |||||
SECTION 2.05 |
A-15 | |||||
SECTION 2.06 |
A-16 | |||||
SECTION 2.07 |
A-16 | |||||
SECTION 2.08 |
A-16 | |||||
SECTION 2.09 |
A-17 | |||||
SECTION 2.10 |
A-17 | |||||
A-18 | ||||||
SECTION 3.01 |
A-18 | |||||
SECTION 3.02 |
A-19 | |||||
SECTION 3.03 |
A-20 | |||||
SECTION 3.04 |
A-20 | |||||
SECTION 3.05 |
A-21 | |||||
SECTION 3.06 |
A-21 | |||||
A-22 | ||||||
SECTION 4.01 |
A-22 | |||||
SECTION 4.02 |
A-22 | |||||
SECTION 4.03 |
A-22 | |||||
SECTION 4.04 |
A-24 | |||||
SECTION 4.05 |
A-25 | |||||
SECTION 4.06 |
A-25 | |||||
SECTION 4.07 |
A-26 | |||||
SECTION 4.08 |
A-27 | |||||
SECTION 4.09 |
A-27 | |||||
SECTION 4.10 |
A-28 | |||||
SECTION 4.11 |
A-30 | |||||
SECTION 4.12 |
A-30 | |||||
SECTION 4.13 |
A-31 |
Page |
||||||
SECTION 4.14 |
A-33 | |||||
SECTION 4.15 |
A-34 | |||||
SECTION 4.16 |
A-36 | |||||
SECTION 4.17 |
A-36 | |||||
SECTION 4.18 |
A-38 | |||||
SECTION 4.19 |
A-38 | |||||
SECTION 4.20 |
A-39 | |||||
SECTION 4.21 |
A-39 | |||||
SECTION 4.22 |
A-40 | |||||
SECTION 4.23 |
A-40 | |||||
SECTION 4.24 |
A-40 | |||||
SECTION 4.25 |
A-40 | |||||
SECTION 4.26 |
A-40 | |||||
SECTION 4.27 |
A-41 | |||||
A-41 | ||||||
SECTION 5.01 |
A-41 | |||||
SECTION 5.02 |
A-42 | |||||
SECTION 5.03 |
A-42 | |||||
SECTION 5.04 |
A-43 | |||||
SECTION 5.05 |
A-43 | |||||
SECTION 5.06 |
A-44 | |||||
SECTION 5.07 |
A-44 | |||||
SECTION 5.08 |
A-45 | |||||
SECTION 5.09 |
A-45 | |||||
SECTION 5.10 |
A-46 | |||||
SECTION 5.11 |
A-46 | |||||
SECTION 5.12 |
A-46 | |||||
SECTION 5.13 |
A-47 | |||||
SECTION 5.14 |
A-47 | |||||
SECTION 5.15 |
A-47 | |||||
SECTION 5.16 |
A-48 | |||||
SECTION 5.17 |
A-49 | |||||
SECTION 5.18 |
A-49 | |||||
SECTION 5.19 |
A-50 | |||||
SECTION 5.20 |
A-50 | |||||
SECTION 5.21 |
A-50 | |||||
SECTION 5.22 |
A-51 | |||||
SECTION 5.23 |
A-51 |
Page |
||||||
SECTION 5.24 |
A-51 | |||||
SECTION 5.25 |
A-52 | |||||
A-52 | ||||||
SECTION 6.01 |
A-52 | |||||
SECTION 6.02 |
A-55 | |||||
SECTION 6.03 |
A-56 | |||||
A-57 | ||||||
SECTION 7.01 |
A-57 | |||||
SECTION 7.02 |
A-58 | |||||
SECTION 7.03 |
A-59 | |||||
SECTION 7.04 |
A-59 | |||||
SECTION 7.05 |
A-60 | |||||
SECTION 7.06 |
A-61 | |||||
SECTION 7.07 |
A-61 | |||||
SECTION 7.08 |
A-62 | |||||
SECTION 7.09 |
A-63 | |||||
SECTION 7.10 |
A-63 | |||||
SECTION 7.11 |
A-64 | |||||
SECTION 7.12 |
A-65 | |||||
SECTION 7.13 |
A-65 | |||||
SECTION 7.14 |
A-65 | |||||
SECTION 7.15 |
A-66 | |||||
SECTION 7.16 |
A-66 | |||||
SECTION 7.17 |
A-66 | |||||
A-66 | ||||||
SECTION 8.01 |
A-66 | |||||
SECTION 8.02 |
A-67 | |||||
SECTION 8.03 |
A-68 | |||||
A-69 | ||||||
SECTION 9.01 |
A-69 | |||||
SECTION 9.02 |
A-70 | |||||
SECTION 9.03 |
A-70 | |||||
SECTION 9.04 |
A-70 | |||||
A-71 | ||||||
SECTION 10.01 |
A-71 | |||||
SECTION 10.02 |
A-72 | |||||
SECTION 10.03 |
A-72 | |||||
SECTION 10.04 |
A-72 |
Page |
||||||
SECTION 10.05 |
A-72 | |||||
SECTION 10.06 |
A-72 | |||||
SECTION 10.07 |
A-73 | |||||
SECTION 10.08 |
A-73 | |||||
SECTION 10.09 |
A-73 | |||||
SECTION 10.10 |
A-73 | |||||
SECTION 10.11 |
A-74 | |||||
SECTION 10.12 |
A-74 | |||||
SECTION 10.13 |
A-74 | |||||
SECTION 10.14 |
A-74 |
Annex I | Earnout Merger Consideration |
Exhibit A | Form of Newco Certificate of Incorporation |
Exhibit B | Form of Newco Bylaws |
Exhibit C | Form of Amended and Restated Registration Rights Agreement |
Exhibit D | Form of New Incentive Plan |
Exhibit E | Form of New Stock Purchase Plan |
Defined Term |
Location of Definition | |
$12.50 Earnout Shares | Annex I | |
$12.50 Share Price Milestone | Annex I | |
$15.00 Earnout Shares | Annex I | |
$15.00 Share Price Milestone | Annex I | |
Agreement | Preamble | |
Alternative Transaction | § 7.05 | |
Amended and Restated Registration Rights Agreement | Recitals | |
Anti-Money Laundering Laws | § 4.20(d) | |
Antitrust Laws | § 7.13(a) | |
Audited Financial Statements | § 4.07(a) | |
Blue Sky Laws | § 4.05(b) | |
Certificate of Merger | § 2.04 |
Defined Term |
Location of Definition | |
Change of Control | Annex I | |
Closing | § 2.05 | |
Closing Date | § 2.05 | |
Closing Press Release | § 7.10 | |
Code | Recitals | |
Company | Preamble | |
Company Board | Recitals | |
Company Common Stock Warrants | § 4.03(a)(iv) | |
Company Disclosure Schedule | Article IV | |
Company Officer’s Certificate | § 8.02(c) | |
Company Permits | § 4.06 | |
Company Preferred Stock | § 4.03(a)(ii) | |
Company Series A Preferred Stock | § 4.03(a)(ii) | |
Company Series A Preferred Stock Warrants | § 4.03(a)(iv) | |
Company Series B Preferred Stock | § 4.03(a)(ii) | |
Company Series B Preferred Stock Warrants | § 4.03(a)(iv) | |
Company Series C Preferred Stock | § 4.03(a)(ii) | |
Company Series C Preferred Stock Warrants | § 4.03(a)(iv) | |
Company Series C-1 Preferred Stock |
§ 4.03(a)(ii) | |
Company Series D Preferred Stock | § 4.03(a)(ii) | |
Company Series D Preferred Stock Warrants | § 4.03(a)(iv) | |
Company Series D-1 Preferred Stock |
§ 4.03(a)(ii) | |
Company Series D-2 Preferred Stock |
§ 4.03(a)(ii) | |
Company Series E Preferred Stock | § 4.03(a)(ii) | |
Company Series Seed Preferred Stock | § 4.03(a)(ii) | |
Company Stockholder Approval | § 4.19 | |
Company Stockholders Meeting | § 7.03 | |
Company Subsidiary | § 4.01(a) | |
Company Warrants | § 4.03(a)(iv) | |
Completion 8-K |
§ 7.10 | |
Continuing Employees | § 7.06(a) | |
Converted Option | § 3.01(a)(v) | |
Converted RSU Award | § 3.01(a)(vi) | |
Converted Warrant | § 3.01(a)(vii) | |
Data Security Requirements | § 4.13(h) | |
Davis Polk | § 10.14 | |
Dissenting Shares | § 3.05(a) | |
Domestication | Recitals | |
Domestication Effective Time | § 2.01 | |
Earnout Period | Annex I | |
Earnout Shares | § 3.06 | |
Effective Time | § 2.05 | |
Environmental Permits | § 4.16 | |
ERISA Affiliate | § 4.10(c) | |
Exchange Agent | § 3.02(a) | |
Exchange Fund | § 3.02(a) | |
FDCA | § 4.14(a) | |
Financial Statements | § 4.07(b) | |
Food and Drug Law | § 4.14(a) | |
GAAP | § 1.03(d) | |
Governmental Authority | § 4.05(b) |
Defined Term |
Location of Definition | |
Group | Annex I | |
Health Plan | § 4.10(k) | |
Indemnitee | § 7.07(a) | |
Intended Tax Treatment | § 7.11(a) | |
Interim Financial Statements | § 4.07(b) | |
Interim Financial Statements Date | § 4.07(b) | |
IPO | § 6.03 | |
IRS | § 4.10(b) | |
Law | § 4.05(a) | |
Lease | § 4.12(b) | |
Lease Documents | § 4.12(b) | |
Material Contracts | § 4.17(a) | |
Maximum Annual Premium | § 7.07(b) | |
Merger | § 2.04 | |
Merger Payment Schedule | § 3.02(h) | |
Merger Sub | Preamble | |
Merger Sub Board | Recitals | |
Merger Sub Common Stock | § 5.03(c) | |
Merger Sub Sole Stockholder Approval | § 7.02(b) | |
Milestone | Annex I | |
New Incentive Plan | § 7.01(a) | |
New Stock Purchase Plan | § 7.01(a) | |
Newco | Recitals | |
Newco Board | § 2.08(b) | |
Newco Bylaws | Recitals | |
Newco Certificate of Incorporation | Recitals | |
Non-Disclosure Agreement |
§ 7.04(b) | |
Nonparty Affiliate | § 10.12 | |
Outside Date | § 9.01(b) | |
Outstanding Company Transaction Expenses | § 3.04(a) | |
Outstanding Parent Transaction Expenses | § 3.04(b) | |
Outstanding Transaction Expenses | § 3.04(b) | |
Parent | Preamble | |
Parent Board | Recitals | |
Parent Disclosure Schedule | Article V | |
Parent Holders’ Meeting | § 7.01(a) | |
Parent Material Contracts | § 5.18 | |
Parent Officer’s Certificate | § 8.03(c) | |
Parent Proposals | § 7.01(a) | |
Parent SEC Reports | § 5.07(a) | |
Permitted Transferee | Annex I | |
PIPE Financing | Recitals | |
PIPE Financing Amount | Recitals | |
PIPE Investors | Recitals | |
Plans | § 4.10(a) | |
PPACA | § 4.10(k) | |
Prospectus | § 6.03 | |
Proxy Statement | § 7.01(a) | |
Public Shareholders | § 6.03 | |
Registration Statement | § 7.01(a) | |
Related Party | § 4.21 |
Defined Term |
Location of Definition | |
Released Claims | § 6.03 | |
Remedies Exceptions | § 4.04 | |
Representatives | § 7.04(a) | |
Sarbanes-Oxley Act | § 5.07(a) | |
Section 16 | § 7.16 | |
Sponsor | Recitals | |
Sponsor Letter Agreement | Recitals | |
Stock Price | Annex I | |
Stockholder Support Agreement | Recitals | |
Subscription Agreements | Recitals | |
Surviving Corporation | § 2.04 | |
Terminating Company Breach | § 9.01(e) | |
Terminating Parent Breach | § 9.01(f) | |
Top 10 Vendors | § 4.22(a) | |
Top Customers | § 4.22(b) | |
Trading Day | Annex I | |
Trust Account | § 5.14 | |
Trust Agreement | § 5.14 | |
Trust Fund | § 5.14 | |
Trustee | § 5.14 | |
Written Consent | § 7.03 |
VIRGIN GROUP ACQUISITION CORP. II | ||
By: | /s/ Evan Lovell | |
Name: Evan Lovell | ||
Title: Chief Financial Officer |
TREEHOUSE MERGER SUB, INC. | ||
By: | /s/ Harold Brunink | |
Name: Harold Brunink | ||
Title: Secretary |
GROVE COLLABORATIVE, INC. | ||
By: | /s/ Stuart Landesberg | |
Name: Stuart Landesberg | ||
Title: Chief Executive Officer |
(1) | any person or any group of persons acting together which would constitute a “group” for purposes of Section 13(d) of the Exchange Act or any successor provisions thereto (a “ Group ”) (excluding a corporation or other entity owned, directly or indirectly, by the stockholders of Newco in substantially the same proportions as their ownership of stock of Newco) (x) is or becomes the beneficial owner, directly or indirectly, of securities of Newco representing more than fifty percent (50%) of the combined voting power of Newco’s then outstanding voting securities or (y) has or acquires control of the Newco Board; |
(2) | a merger, consolidation, reorganization or similar business combination transaction involving Newco, and, immediately after the consummation of such transaction or series of transactions, either (x) the Newco Board immediately prior to the merger or consolidation does not constitute at least a majority of the board of directors of the company surviving the merger or, if the surviving company is a Subsidiary, the ultimate parent thereof, or (y) the voting securities of Newco immediately prior to such merger or consolidation do not continue to represent or are not converted into more than fifty percent (50%) of the combined voting power of the then outstanding voting securities of the person resulting from such transaction or series of transactions or, if the surviving company is a Subsidiary, the ultimate parent thereof; or |
(3) | the sale, lease or other disposition, directly or indirectly, by Newco of all or substantially all of the assets of Newco and its Subsidiaries, taken as a whole, other than such sale or other disposition by Parent of all or substantially all of the assets of Newco and its Subsidiaries, taken as a whole, to an entity at least a majority of the combined voting power of the voting securities of which are owned by stockholders of Newco; |
1 | The name of the Company is Virgin Group Acquisition Corp. II |
2 | The Registered Office of the Company shall be at the offices of Maples Corporate Services Limited, PO Box 309, Ugland House, Grand Cayman, KY1-1104, Cayman Islands, or at such other place within the Cayman Islands as the Directors may decide. |
3 | The objects for which the Company is established are unrestricted and the Company shall have full power and authority to carry out any object not prohibited by the laws of the Cayman Islands. |
4 | The liability of each Member is limited to the amount unpaid on such Member’s shares. |
5 | The share capital of the Company is US$22,100 divided into 200,000,000 Class A ordinary shares of a par value of US$0.0001 each, 20,000,000 Class B ordinary shares of a par value of US$0.0001 each and 1,000,000 preference shares of a par value of US$0.0001 each. |
6 | The Company has power to register by way of continuation as a body corporate limited by shares under the laws of any jurisdiction outside the Cayman Islands and to be deregistered in the Cayman Islands. |
7 | Capitalised terms that are not defined in this Amended and Restated Memorandum of Association bear the respective meanings given to them in the Amended and Restated Articles of Association of the Company. |
1 |
Interpretation |
1.1 | In the Articles Table A in the First Schedule to the Statute does not apply and, unless there is something in the subject or context inconsistent therewith: |
“Affiliate” |
in respect of a person, means any other person that, directly or indirectly, through one or more intermediaries, controls, is controlled by, or is under common control with, such person, and (a) in the case of a natural person, shall include, without limitation, such person’s spouse, parents, children, siblings, mother-in-law father-in-law sisters-in-law, | |
“Applicable Law” |
means, with respect to any person, all provisions of laws, statutes, ordinances, rules, regulations, permits, certificates, judgments, decisions, decrees or orders of any governmental authority applicable to such person. | |
“Articles” |
means these amended and restated articles of association of the Company. | |
“Audit Committee” |
means the audit committee of the board of directors of the Company established pursuant to the Articles, or any successor committee. | |
“Auditor” |
means the person for the time being performing the duties of auditor of the Company (if any). | |
“Business Combination” |
means a merger, share exchange, asset acquisition, share purchase, reorganisation or similar business combination involving the Company, with one or more businesses or entities (the “ target business |
“business day” |
means any day other than a Saturday, a Sunday or a legal holiday or a day on which banking institutions or trust companies are authorised or obligated by law to close in New York City. | |
“Clearing House” |
means a clearing house recognised by the laws of the jurisdiction in which the Shares (or depositary receipts therefor) are listed or quoted on a stock exchange or interdealer quotation system in such jurisdiction. | |
“Class A Share” |
means a Class A ordinary share of a par value of US$0.0001 in the share capital of the Company. | |
“Class B Share” |
means a Class B ordinary share of a par value of US$0.0001 in the share capital of the Company. | |
“Company” |
means the above named company. | |
“Company’s Website” |
means the website of the Company and/or its web-address or domain name (if any). | |
“Compensation Committee” |
means the compensation committee of the board of directors of the Company established pursuant to the Articles, or any successor committee. | |
“Designated Stock Exchange” |
means any United States national securities exchange on which the securities of the Company are listed for trading, including the New York Stock Exchange. | |
“Directors” |
means the directors for the time being of the Company. | |
“Dividend” |
means any dividend (whether interim or final) resolved to be paid on Shares pursuant to the Articles. | |
“Electronic Communication” |
means a communication sent by electronic means, including electronic posting to the Company’s Website, transmission to any number, address or internet website (including the website of the Securities and Exchange Commission) or other electronic delivery methods as otherwise decided and approved by the Directors. | |
“Electronic Record” |
has the same meaning as in the Electronic Transactions Act. | |
“Electronic Transactions Act” |
means the Electronic Transactions Act (As Revised) of the Cayman Islands. | |
“Equity-linked Securities” |
means any debt or equity securities that are convertible, exercisable or exchangeable for Class A Shares issued in a financing transaction in connection with a Business Combination, including but not limited to a private placement of equity or debt. | |
“Exchange Act” |
means the United States Securities Exchange Act of 1934, as amended, or any similar U.S. federal statute and the rules and regulations of the Securities and Exchange Commission thereunder, all as the same shall be in effect at the time. | |
“Founders” |
means all Members immediately prior to the consummation of the IPO. | |
“Independent Director” |
has the same meaning as in the rules and regulations of the Designated Stock Exchange or in Rule 10A-3 under the Exchange Act, as the case may be. | |
“IPO” |
means the Company’s initial public offering of securities. |
“Member” |
has the same meaning as in the Statute. | |
“Memorandum” |
means the amended and restated memorandum of association of the Company. | |
“Nominating and Corporate Governance Committee” |
means the nominating and corporate governance committee of the board of directors of the Company established pursuant to the Articles, or any successor committee. | |
“Officer” |
means a person appointed to hold an office in the Company. | |
“Ordinary Resolution” |
means a resolution passed by a simple majority of the Members as, being entitled to do so, vote in person or, where proxies are allowed, by proxy at a general meeting, and includes a unanimous written resolution. In computing the majority when a poll is demanded regard shall be had to the number of votes to which each Member is entitled by the Articles. | |
“Over-Allotment Option” |
means the option of the Underwriters to purchase up to an additional 15 per cent of the firm units (as described in the Articles) issued in the IPO at a price equal to US$10 per unit, less underwriting discounts and commissions. | |
“Preference Share” |
means a preference share of a par value of US$0.0001 in the share capital of the Company. | |
“Public Share” |
means a Class A Share issued as part of the units (as described in the Articles) issued in the IPO. | |
“Redemption Notice” |
means a notice in a form approved by the Company by which a holder of Public Shares is entitled to require the Company to redeem its Public Shares, subject to any conditions contained therein. | |
“Register of Members” |
means the register of Members maintained in accordance with the Statute and includes (except where otherwise stated) any branch or duplicate register of Members. | |
“Registered Office” |
means the registered office for the time being of the Company. | |
“Representative” |
means a representative of the Underwriters. | |
“Seal” |
means the common seal of the Company and includes every duplicate seal. | |
“Securities and Exchange Commission” |
means the United States Securities and Exchange Commission. | |
“Share” |
means a Class A Share, a Class B Share, or a Preference Share and includes a fraction of a share in the Company. | |
“Special Resolution” |
subject to Article 29.4, has the same meaning as in the Statute, and includes a unanimous written resolution. | |
“Sponsor” |
Means Virgin Group Acquisition Sponsor II LLC, a Cayman Islands limited liability company, and its successors or assigns. | |
“Statute” |
means the Companies Act (As Revised) of the Cayman Islands. | |
“Tax Filing Authorised Person” |
means such person as any Director shall designate from time to time, acting severally. | |
“Treasury Share” |
means a Share held in the name of the Company as a treasury share in accordance with the Statute. |
“Trust Account” |
means the trust account established by the Company upon the consummation of the IPO and into which a certain amount of the net proceeds of the IPO, together with a certain amount of the proceeds of a private placement of warrants simultaneously with the closing date of the IPO, will be deposited. | |
“Underwriter” |
means an underwriter of the IPO from time to time and any successor underwriter. |
1.2 | In the Articles: |
(a) | words importing the singular number include the plural number and vice versa; |
(b) | words importing the masculine gender include the feminine gender; |
(c) | words importing persons include corporations as well as any other legal or natural person; |
(d) | “written” and “in writing” include all modes of representing or reproducing words in visible form, including in the form of an Electronic Record; |
(e) | “shall” shall be construed as imperative and “may” shall be construed as permissive; |
(f) | references to provisions of any law or regulation shall be construed as references to those provisions as amended, modified, re-enacted or replaced; |
(g) | any phrase introduced by the terms “including”, “include”, “in particular” or any similar expression shall be construed as illustrative and shall not limit the sense of the words preceding those terms; |
(h) | the term “and/or” is used herein to mean both “and” as well as “or.” The use of “and/or” in certain contexts in no respects qualifies or modifies the use of the terms “and” or “or” in others. The term “or” shall not be interpreted to be exclusive and the term “and” shall not be interpreted to require the conjunctive (in each case, unless the context otherwise requires); |
(i) | headings are inserted for reference only and shall be ignored in construing the Articles; |
(j) | any requirements as to delivery under the Articles include delivery in the form of an Electronic Record; |
(k) | any requirements as to execution or signature under the Articles including the execution of the Articles themselves can be satisfied in the form of an electronic signature as defined in the Electronic Transactions Act; |
(l) | sections 8 and 19(3) of the Electronic Transactions Act shall not apply; |
(m) | the term “clear days” in relation to the period of a notice means that period excluding the day when the notice is received or deemed to be received and the day for which it is given or on which it is to take effect; and |
(n) | the term “holder” in relation to a Share means a person whose name is entered in the Register of Members as the holder of such Share. |
2 |
Commencement of Business |
2.1 | The business of the Company may be commenced as soon after incorporation of the Company as the Directors shall see fit. |
2.2 | The Directors may pay, out of the capital or any other monies of the Company, all expenses incurred in or about the formation and establishment of the Company, including the expenses of registration. |
3 |
Issue of Shares and other Securities |
3.1 | Subject to the provisions, if any, in the Memorandum (and to any direction that may be given by the Company in general meeting) and, where applicable, the rules and regulations of the Designated Stock |
Exchange, the Securities and Exchange Commission and/or any other competent regulatory authority or otherwise under Applicable Law, and without prejudice to any rights attached to any existing Shares, the Directors may allot, issue, grant options over or otherwise dispose of Shares (including fractions of a Share) with or without preferred, deferred or other rights or restrictions, whether in regard to Dividends or other distributions, voting, return of capital or otherwise and to such persons, at such times and on such other terms as they think proper, and may also (subject to the Statute and the Articles) vary such rights, save that the Directors shall not allot, issue, grant options over or otherwise dispose of Shares (including fractions of a Share) to the extent that it may affect the ability of the Company to carry out a Class B Ordinary Share Conversion set out in the Articles. |
3.2 | The Company may issue rights, options, warrants or convertible securities or securities of similar nature conferring the right upon the holders thereof to subscribe for, purchase or receive any class of Shares or other securities in the Company on such terms as the Directors may from time to time determine. |
3.3 | The Company may issue units of securities in the Company, which may be comprised of whole or fractional Shares, rights, options, warrants or convertible securities or securities of similar nature conferring the right upon the holders thereof to subscribe for, purchase or receive any class of Shares or other securities in the Company, upon such terms as the Directors may from time to time determine. The securities comprising any such units which are issued pursuant to the IPO can only be traded separately from one another on the 52nd day following the date of the prospectus relating to the IPO unless the Representative(s) determines that an earlier date is acceptable, subject to the Company having filed a current report on Form 8-K with the Securities and Exchange Commission and a press release announcing when such separate trading will begin. Prior to such date, the units can be traded, but the securities comprising such units cannot be traded separately from one another. |
3.4 | The Company shall not issue Shares to bearer. |
4 |
Register of Members |
4.1 | The Company shall maintain or cause to be maintained the Register of Members in accordance with the Statute. |
4.2 | The Directors may determine that the Company shall maintain one or more branch registers of Members in accordance with the Statute. The Directors may also determine which register of Members shall constitute the principal register and which shall constitute the branch register or registers, and to vary such determination from time to time. |
5 |
Closing Register of Members or Fixing Record Date |
5.1 | For the purpose of determining Members entitled to notice of, or to vote at any meeting of Members or any adjournment thereof, or Members entitled to receive payment of any Dividend or other distribution, or in order to make a determination of Members for any other purpose, the Directors may, after notice has been given by advertisement in an appointed newspaper or any other newspaper or by any other means in accordance with the rules and regulations of the Designated Stock Exchange, the Securities and Exchange Commission and/or any other competent regulatory authority or otherwise under Applicable Law, provide that the Register of Members shall be closed for transfers for a stated period which shall not in any case exceed forty days. |
5.2 | In lieu of, or apart from, closing the Register of Members, the Directors may fix in advance or arrears a date as the record date for any such determination of Members entitled to notice of, or to vote at any meeting of the Members or any adjournment thereof, or for the purpose of determining the Members entitled to receive payment of any Dividend or other distribution, or in order to make a determination of Members for any other purpose. |
5.3 | If the Register of Members is not so closed and no record date is fixed for the determination of Members entitled to notice of, or to vote at, a meeting of Members or Members entitled to receive payment of a |
Dividend or other distribution, the date on which notice of the meeting is sent or the date on which the resolution of the Directors resolving to pay such Dividend or other distribution is passed, as the case may be, shall be the record date for such determination of Members. When a determination of Members entitled to vote at any meeting of Members has been made as provided in this Article, such determination shall apply to any adjournment thereof. |
6 |
Certificates for Shares |
6.1 | A Member shall only be entitled to a share certificate if the Directors resolve that share certificates shall be issued. Share certificates representing Shares, if any, shall be in such form as the Directors may determine. Share certificates shall be signed by one or more Directors or other person authorised by the Directors. The Directors may authorise certificates to be issued with the authorised signature(s) affixed by mechanical process. All certificates for Shares shall be consecutively numbered or otherwise identified and shall specify the Shares to which they relate. All certificates surrendered to the Company for transfer shall be cancelled and, subject to the Articles, no new certificate shall be issued until the former certificate representing a like number of relevant Shares shall have been surrendered and cancelled. |
6.2 | The Company shall not be bound to issue more than one certificate for Shares held jointly by more than one person and delivery of a certificate to one joint holder shall be a sufficient delivery to all of them. |
6.3 | If a share certificate is defaced, worn out, lost or destroyed, it may be renewed on such terms (if any) as to evidence and indemnity and on the payment of such expenses reasonably incurred by the Company in investigating evidence, as the Directors may prescribe, and (in the case of defacement or wearing out) upon delivery of the old certificate. |
6.4 | Every share certificate sent in accordance with the Articles will be sent at the risk of the Member or other person entitled to the certificate. The Company will not be responsible for any share certificate lost or delayed in the course of delivery. |
6.5 | Share certificates shall be issued within the relevant time limit as prescribed by the Statute, if applicable, or as the rules and regulations of the Designated Stock Exchange, the Securities and Exchange Commission and/or any other competent regulatory authority or otherwise under Applicable Law may from time to time determine, whichever is shorter, after the allotment or, except in the case of a Share transfer which the Company is for the time being entitled to refuse to register and does not register, after lodgement of a Share transfer with the Company. |
7 |
Transfer of Shares |
7.1 | Subject to the terms of the Articles, any Member may transfer all or any of his Shares by an instrument of transfer provided that such transfer complies with the rules and regulations of the Designated Stock Exchange, the Securities and Exchange Commission and/or any other competent regulatory authority or otherwise under Applicable Law. If the Shares in question were issued in conjunction with rights, options, warrants or units issued pursuant to the Articles on terms that one cannot be transferred without the other, the Directors shall refuse to register the transfer of any such Share without evidence satisfactory to them of the like transfer of such right, option, warrant or unit. |
7.2 | The instrument of transfer of any Share shall be in writing in the usual or common form or in a form prescribed by the rules and regulations of the Designated Stock Exchange, the Securities and Exchange Commission and/or any other competent regulatory authority or otherwise under Applicable Law or in any other form approved by the Directors and shall be executed by or on behalf of the transferor (and if the Directors so require, signed by or on behalf of the transferee) and may be under hand or, if the transferor or transferee is a Clearing House or its nominee(s), by hand or by machine imprinted signature or by such other manner of execution as the Directors may approve from time to time. The transferor shall be deemed to remain the holder of a Share until the name of the transferee is entered in the Register of Members. |
8 |
Redemption, Repurchase and Surrender of Shares |
8.1 | Subject to the provisions of the Statute, and, where applicable, the rules and regulations of the Designated Stock Exchange, the Securities and Exchange Commission and/or any other competent regulatory authority or otherwise under Applicable Law, the Company may issue Shares that are to be redeemed or are liable to be redeemed at the option of the Member or the Company. The redemption of such Shares, except Public Shares, shall be effected in such manner and upon such other terms as the Company may, by Special Resolution, determine before the issue of such Shares. With respect to redeeming or repurchasing the Shares: |
(a) | Members who hold Public Shares are entitled to request the redemption of such Shares in the circumstances described in the Business Combination Article hereof; |
(b) | Class B Shares held by the Sponsor shall be surrendered by the Sponsor for no consideration on a pro-rata basis to the extent that the Over-Allotment Option is not exercised in full so that the Founders will own 20 per cent of the Company’s issued Shares after the IPO (exclusive of any securities purchased in a private placement simultaneously with the IPO); and |
(c) | Public Shares shall be repurchased by way of tender offer in the circumstances set out in the Business Combination Article hereof. |
8.2 | Subject to the provisions of the Statute, and, where applicable, the rules and regulations of the Designated Stock Exchange, the Securities and Exchange Commission and/or any other competent regulatory authority or otherwise under Applicable Law, the Company may purchase its own Shares (including any redeemable Shares) in such manner and on such other terms as the Directors may agree with the relevant Member. For the avoidance of doubt, redemptions, repurchases and surrenders of Shares in the circumstances described in the Article above shall not require further approval of the Members. |
8.3 | The Company may make a payment in respect of the redemption or purchase of its own Shares in any manner permitted by the Statute, including out of capital. |
8.4 | The Directors may accept the surrender for no consideration of any fully paid Share. |
9 |
Treasury Shares |
9.1 | The Directors may, prior to the purchase, redemption or surrender of any Share, determine that such Share shall be held as a Treasury Share. |
9.2 | The Directors may determine to cancel a Treasury Share or transfer a Treasury Share on such terms as they think proper (including, without limitation, for nil consideration). |
10 |
Variation of Rights of Shares |
10.1 | Subject to Article 3.1, if at any time the share capital of the Company is divided into different classes of Shares, all or any of the rights attached to any class (unless otherwise provided by the terms of issue of the Shares of that class) may, whether or not the Company is being wound up, be varied without the consent of the holders of the issued Shares of that class where such variation is considered by the Directors not to have a material adverse effect upon such rights; otherwise, any such variation shall be made only with the consent in writing of the holders of not less than two thirds of the issued Shares of that class (other than with respect to a waiver of the provisions of the Class B Ordinary Share Conversion Article hereof, which as stated therein shall only require the consent in writing of the holders of a majority of the issued Shares of that class), or with the approval of a resolution passed by a majority of not less than two thirds of the votes cast at a separate meeting of the holders of the Shares of that class. For the avoidance of doubt, the Directors reserve the right, notwithstanding that any such variation may not have a material adverse effect, to obtain consent from the holders of Shares of the relevant class. To any such meeting all the provisions of the Articles relating to general meetings shall apply mutatis mutandis |
shall be one person holding or representing by proxy at least one third of the issued Shares of the class and that any holder of Shares of the class present in person or by proxy may demand a poll. |
10.2 | For the purposes of a separate class meeting, the Directors may treat two or more or all the classes of Shares as forming one class of Shares if the Directors consider that such class of Shares would be affected in the same way by the proposals under consideration, but in any other case shall treat them as separate classes of Shares. |
10.3 | The rights conferred upon the holders of the Shares of any class issued with preferred or other rights shall not, unless otherwise expressly provided by the terms of issue of the Shares of that class, be deemed to be varied by the creation or issue of further Shares ranking pari passu therewith or Shares issued with preferred or other rights. |
11 |
Commission on Sale of Shares |
12 |
Non Recognition of Trusts |
13 |
Lien on Shares |
13.1 | The Company shall have a first and paramount lien on all Shares (whether fully paid-up or not) registered in the name of a Member (whether solely or jointly with others) for all debts, liabilities or engagements to or with the Company (whether presently payable or not) by such Member or his estate, either alone or jointly with any other person, whether a Member or not, but the Directors may at any time declare any Share to be wholly or in part exempt from the provisions of this Article. The registration of a transfer of any such Share shall operate as a waiver of the Company’s lien thereon. The Company’s lien on a Share shall also extend to any amount payable in respect of that Share. |
13.2 | The Company may sell, in such manner as the Directors think fit, any Shares on which the Company has a lien, if a sum in respect of which the lien exists is presently payable, and is not paid within fourteen clear days after notice has been received or deemed to have been received by the holder of the Shares, or to the person entitled to it in consequence of the death or bankruptcy of the holder, demanding payment and stating that if the notice is not complied with the Shares may be sold. |
13.3 | To give effect to any such sale the Directors may authorise any person to execute an instrument of transfer of the Shares sold to, or in accordance with the directions of, the purchaser. The purchaser or his nominee shall be registered as the holder of the Shares comprised in any such transfer, and he shall not be bound to see to the application of the purchase money, nor shall his title to the Shares be affected by any irregularity or invalidity in the sale or the exercise of the Company’s power of sale under the Articles. |
13.4 | The net proceeds of such sale after payment of costs, shall be applied in payment of such part of the amount in respect of which the lien exists as is presently payable and any balance shall (subject to a like lien for sums not presently payable as existed upon the Shares before the sale) be paid to the person entitled to the Shares at the date of the sale. |
14 |
Call on Shares |
14.1 | Subject to the terms of the allotment and issue of any Shares, the Directors may make calls upon the Members in respect of any monies unpaid on their Shares (whether in respect of par value or premium), and each Member shall (subject to receiving at least fourteen clear days’ notice specifying the time or times of payment) pay to the Company at the time or times so specified the amount called on the Shares. A call may be revoked or postponed, in whole or in part, as the Directors may determine. A call may be required to be paid by instalments. A person upon whom a call is made shall remain liable for calls made upon him notwithstanding the subsequent transfer of the Shares in respect of which the call was made. |
14.2 | A call shall be deemed to have been made at the time when the resolution of the Directors authorising such call was passed. |
14.3 | The joint holders of a Share shall be jointly and severally liable to pay all calls in respect thereof. |
14.4 | If a call remains unpaid after it has become due and payable, the person from whom it is due shall pay interest on the amount unpaid from the day it became due and payable until it is paid at such rate as the Directors may determine (and in addition all expenses that have been incurred by the Company by reason of such non-payment), but the Directors may waive payment of the interest or expenses wholly or in part. |
14.5 | An amount payable in respect of a Share on issue or allotment or at any fixed date, whether on account of the par value of the Share or premium or otherwise, shall be deemed to be a call and if it is not paid all the provisions of the Articles shall apply as if that amount had become due and payable by virtue of a call. |
14.6 | The Directors may issue Shares with different terms as to the amount and times of payment of calls, or the interest to be paid. |
14.7 | The Directors may, if they think fit, receive an amount from any Member willing to advance all or any part of the monies uncalled and unpaid upon any Shares held by him, and may (until the amount would otherwise become payable) pay interest at such rate as may be agreed upon between the Directors and the Member paying such amount in advance. |
14.8 | No such amount paid in advance of calls shall entitle the Member paying such amount to any portion of a Dividend or other distribution payable in respect of any period prior to the date upon which such amount would, but for such payment, become payable. |
15 |
Forfeiture of Shares |
15.1 | If a call or instalment of a call remains unpaid after it has become due and payable the Directors may give to the person from whom it is due not less than fourteen clear days’ notice requiring payment of the amount unpaid together with any interest which may have accrued and any expenses incurred by the Company by reason of such non-payment. The notice shall specify where payment is to be made and shall state that if the notice is not complied with the Shares in respect of which the call was made will be liable to be forfeited. |
15.2 | If the notice is not complied with, any Share in respect of which it was given may, before the payment required by the notice has been made, be forfeited by a resolution of the Directors. Such forfeiture shall include all Dividends, other distributions or other monies payable in respect of the forfeited Share and not paid before the forfeiture. |
15.3 | A forfeited Share may be sold, re-allotted or otherwise disposed of on such terms and in such manner as the Directors think fit and at any time before a sale, re-allotment or disposition the forfeiture may be cancelled on such terms as the Directors think fit. Where for the purposes of its disposal a forfeited Share is to be transferred to any person the Directors may authorise some person to execute an instrument of transfer of the Share in favour of that person. |
15.4 | A person any of whose Shares have been forfeited shall cease to be a Member in respect of them and shall surrender to the Company for cancellation the certificate for the Shares forfeited and shall remain liable to |
pay to the Company all monies which at the date of forfeiture were payable by him to the Company in respect of those Shares together with interest at such rate as the Directors may determine, but his liability shall cease if and when the Company shall have received payment in full of all monies due and payable by him in respect of those Shares. |
15.5 | A certificate in writing under the hand of one Director or Officer that a Share has been forfeited on a specified date shall be conclusive evidence of the facts stated in it as against all persons claiming to be entitled to the Share. The certificate shall (subject to the execution of an instrument of transfer) constitute a good title to the Share and the person to whom the Share is sold or otherwise disposed of shall not be bound to see to the application of the purchase money, if any, nor shall his title to the Share be affected by any irregularity or invalidity in the proceedings in reference to the forfeiture, sale or disposal of the Share. |
15.6 | The provisions of the Articles as to forfeiture shall apply in the case of non payment of any sum which, by the terms of issue of a Share, becomes payable at a fixed time, whether on account of the par value of the Share or by way of premium as if it had been payable by virtue of a call duly made and notified. |
16 |
Transmission of Shares |
16.1 | If a Member dies, the survivor or survivors (where he was a joint holder), or his legal personal representatives (where he was a sole holder), shall be the only persons recognised by the Company as having any title to his Shares. The estate of a deceased Member is not thereby released from any liability in respect of any Share, for which he was a joint or sole holder. |
16.2 | Any person becoming entitled to a Share in consequence of the death or bankruptcy or liquidation or dissolution of a Member (or in any other way than by transfer) may, upon such evidence being produced as may be required by the Directors, elect, by a notice in writing sent by him to the Company, either to become the holder of such Share or to have some person nominated by him registered as the holder of such Share. If he elects to have another person registered as the holder of such Share he shall sign an instrument of transfer of that Share to that person. The Directors shall, in either case, have the same right to decline or suspend registration as they would have had in the case of a transfer of the Share by the relevant Member before his death or bankruptcy or liquidation or dissolution, as the case may be. |
16.3 | A person becoming entitled to a Share by reason of the death or bankruptcy or liquidation or dissolution of a Member (or in any other case than by transfer) shall be entitled to the same Dividends, other distributions and other advantages to which he would be entitled if he were the holder of such Share. However, he shall not, before becoming a Member in respect of a Share, be entitled in respect of it to exercise any right conferred by membership in relation to general meetings of the Company and the Directors may at any time give notice requiring any such person to elect either to be registered himself or to have some person nominated by him be registered as the holder of the Share (but the Directors shall, in either case, have the same right to decline or suspend registration as they would have had in the case of a transfer of the Share by the relevant Member before his death or bankruptcy or liquidation or dissolution or any other case than by transfer, as the case may be). If the notice is not complied with within ninety days of being received or deemed to be received (as determined pursuant to the Articles), the Directors may thereafter withhold payment of all Dividends, other distributions, bonuses or other monies payable in respect of the Share until the requirements of the notice have been complied with. |
17 |
Class B Ordinary Share Conversion |
17.1 | The rights attaching to the Class A Shares and Class B Shares shall rank pari passu |
17.2 | Class B Shares shall automatically convert into Class A Shares on a one-for-one Initial Conversion Ratio |
17.3 | Notwithstanding the Initial Conversion Ratio, in the case that additional Class A Shares or any other Equity-linked Securities, are issued, or deemed issued, by the Company in excess of the amounts offered in the IPO and related to the consummation of a Business Combination, all Class B Shares in issue shall automatically convert into Class A Shares at the time of the consummation of a Business Combination at a ratio for which the Class B Shares shall convert into Class A Shares will be adjusted (unless the holders of a majority of the Class B Shares in issue agree to waive such anti-dilution adjustment with respect to any such issuance or deemed issuance) so that the number of Class A Shares issuable upon conversion of all Class B Shares will equal, on an as-converted basis, in the aggregate, 20 per cent of the sum of all Class A Shares and Class B Shares in issue upon completion of the IPO plus all Class A Shares and Equity-linked Securities issued or deemed issued in connection with a Business Combination, excluding any Shares or Equity-linked Securities issued, or to be issued, to any seller in a Business Combination and any private placement warrants issued to the Sponsor, or its Affiliates, officers or directors upon conversion of working capital loans made to the Company. |
17.4 | Notwithstanding anything to the contrary contained herein, the foregoing adjustment to the Initial Conversion Ratio may be waived as to any particular issuance or deemed issuance of additional Class A Shares or Equity-linked Securities by the written consent or agreement of holders of a majority of the Class B Shares then in issue consenting or agreeing separately as a separate class in the manner provided in the Variation of Rights of Shares Article hereof. |
17.5 | The foregoing conversion ratio shall also be adjusted to account for any subdivision (by share subdivision, exchange, capitalisation, rights issue, reclassification, recapitalisation or otherwise) or combination (by share consolidation, exchange, reclassification, recapitalisation or otherwise) or similar reclassification or recapitalisation of the Class A Shares in issue into a greater or lesser number of shares occurring after the original filing of the Articles without a proportionate and corresponding subdivision, combination or similar reclassification or recapitalisation of the Class B Shares in issue. |
17.6 | Each Class B Share shall convert into its pro rata number of Class A Shares pursuant to this Article. The pro rata share for each holder of Class B Shares will be determined as follows: each Class B Share shall convert into such number of Class A Shares as is equal to the product of 1 multiplied by a fraction, the numerator of which shall be the total number of Class A Shares into which all of the Class B Shares in issue shall be converted pursuant to this Article and the denominator of which shall be the total number of Class B Shares in issue at the time of conversion. |
17.7 | References in this Article to “ converted conversion exchange |
17.8 | Notwithstanding anything to the contrary in this Article, in no event may any Class B Share convert into Class A Shares at a ratio that is less than one-for-one. |
18 |
Amendments of Memorandum and Articles of Association and Alteration of Capital |
18.1 | The Company may by Ordinary Resolution: |
(a) | increase its share capital by such sum as the Ordinary Resolution shall prescribe and with such rights, priorities and privileges annexed thereto, as the Company in general meeting may determine; |
(b) | consolidate and divide all or any of its share capital into Shares of larger amount than its existing Shares; |
(c) | convert all or any of its paid-up Shares into stock, and reconvert that stock into paid-up Shares of any denomination; |
(d) | by subdivision of its existing Shares or any of them divide the whole or any part of its share capital into Shares of smaller amount than is fixed by the Memorandum or into Shares without par value; and |
(e) | cancel any Shares that at the date of the passing of the Ordinary Resolution have not been taken or agreed to be taken by any person and diminish the amount of its share capital by the amount of the Shares so cancelled. |
18.2 | All new Shares created in accordance with the provisions of the preceding Article shall be subject to the same provisions of the Articles with reference to the payment of calls, liens, transfer, transmission, forfeiture and otherwise as the Shares in the original share capital. |
18.3 | Subject to the provisions of the Statute, the provisions of the Articles as regards the matters to be dealt with by Ordinary Resolution and Article 29.4, the Company may by Special Resolution: |
(a) | change its name; |
(b) | alter or add to the Articles; |
(c) | alter or add to the Memorandum with respect to any objects, powers or other matters specified therein; and |
(d) | reduce its share capital or any capital redemption reserve fund. |
19 |
Offices and Places of Business |
20 |
General Meetings |
20.1 | All general meetings other than annual general meetings shall be called extraordinary general meetings. |
20.2 | The Company may, but shall not (unless required by the Statute) be obliged to, in each year hold a general meeting as its annual general meeting, and shall specify the meeting as such in the notices calling it. Any annual general meeting shall be held at such time and place as the Directors shall appoint. At these meetings the report of the Directors (if any) shall be presented. |
20.3 | The Directors, the chief executive officer or the chairman of the board of Directors may call general meetings, and, for the avoidance of doubt, Members shall not have the ability to call general meetings. |
20.4 | A Members’ requisition is a requisition of Members holding at the date of deposit of the requisition not less than ten per cent in par value of the issued Shares which as at that date carry the right to vote at general meetings of the Company. |
20.5 | The Members’ requisition must state the objects of the meeting and must be signed by the requisitionists and deposited at the Registered Office, and may consist of several documents in like form each signed by one or more requisitionists. |
20.6 | If there are no Directors as at the date of the deposit of the Members’ requisition or if the Directors do not within twenty-one days from the date of the deposit of the Members’ requisition duly proceed to convene a general meeting to be held within a further twenty-one days, the requisitionists, or any of them representing more than one-half of the total voting rights of all of the requisitionists, may themselves convene a general meeting, but any meeting so convened shall be held no later than the day which falls three months after the expiration of the said twenty-one day period. |
20.7 | A general meeting convened as aforesaid by requisitionists shall be convened in the same manner as nearly as possible as that in which general meetings are to be convened by Directors. |
20.8 | Members seeking to bring business before the annual general meeting or to nominate candidates for appointment as Directors at the annual general meeting must deliver notice to the principal executive offices of the Company not less than 120 calendar days before the date of the Company’s proxy statement released to Members in connection with the previous year’s annual general meeting or, if the Company did not hold an annual general meeting the previous year, or if the date of the current year’s annual general meeting has been changed by more than 30 days from the date of the previous year’s annual general meeting, then the deadline shall be set by the board of Directors with such deadline being a reasonable time before the Company begins to print and send its related proxy materials. |
21 |
Notice of General Meetings |
21.1 | At least five clear days’ notice shall be given of any general meeting. Every notice shall specify the place, the day and the hour of the meeting and the general nature of the business to be conducted at the general meeting and shall be given in the manner hereinafter mentioned or in such other manner if any as may be prescribed by the Company, provided that a general meeting of the Company shall, whether or not the notice specified in this Article has been given and whether or not the provisions of the Articles regarding general meetings have been complied with, be deemed to have been duly convened if it is so agreed: |
(a) | in the case of an annual general meeting, by all of the Members entitled to attend and vote thereat; and |
(b) | in the case of an extraordinary general meeting, by a majority in number of the Members having a right to attend and vote at the meeting, together holding not less than ninety-five per cent in par value of the Shares giving that right. |
21.2 | The accidental omission to give notice of a general meeting to, or the non receipt of notice of a general meeting by, any person entitled to receive such notice shall not invalidate the proceedings of that general meeting. |
22 |
Proceedings at General Meetings |
22.1 | No business shall be transacted at any general meeting unless a quorum is present. The holders of a majority of the Shares being individuals present in person or by proxy or if a corporation or other non-natural person by its duly authorised representative or proxy shall be a quorum. |
22.2 | A person may participate at a general meeting by conference telephone or other communications equipment by means of which all the persons participating in the meeting can communicate with each other. Participation by a person in a general meeting in this manner is treated as presence in person at that meeting. |
22.3 | A resolution (including a Special Resolution) in writing (in one or more counterparts) signed by or on behalf of all of the Members for the time being entitled to receive notice of and to attend and vote at general meetings (or, being corporations or other non-natural persons, signed by their duly authorised representatives) shall be as valid and effective as if the resolution had been passed at a general meeting of the Company duly convened and held. |
22.4 | If a quorum is not present within half an hour from the time appointed for the meeting to commence, the meeting shall stand adjourned to the same day in the next week at the same time and/or place or to such other day, time and/or place as the Directors may determine, and if at the adjourned meeting a quorum is not present within half an hour from the time appointed for the meeting to commence, the Members present shall be a quorum. |
22.5 | The Directors may, at any time prior to the time appointed for the meeting to commence, appoint any person to act as chairman of a general meeting of the Company or, if the Directors do not make any such appointment, the chairman, if any, of the board of Directors shall preside as chairman at such general |
meeting. If there is no such chairman, or if he shall not be present within fifteen minutes after the time appointed for the meeting to commence, or is unwilling to act, the Directors present shall elect one of their number to be chairman of the meeting. |
22.6 | If no Director is willing to act as chairman or if no Director is present within fifteen minutes after the time appointed for the meeting to commence, the Members present shall choose one of their number to be chairman of the meeting. |
22.7 | The chairman may, with the consent of a meeting at which a quorum is present (and shall if so directed by the meeting) adjourn the meeting from time to time and from place to place, but no business shall be transacted at any adjourned meeting other than the business left unfinished at the meeting from which the adjournment took place. |
22.8 | When a general meeting is adjourned for thirty days or more, notice of the adjourned meeting shall be given as in the case of an original meeting. Otherwise it shall not be necessary to give any such notice of an adjourned meeting. |
22.9 | If, prior to a Business Combination, a notice is issued in respect of a general meeting and the Directors, in their absolute discretion, consider that it is impractical or undesirable for any reason to hold that general meeting at the place, the day and the hour specified in the notice calling such general meeting, the Directors may postpone the general meeting to another place, day and/or hour provided that notice of the place, the day and the hour of the rearranged general meeting is promptly given to all Members. No business shall be transacted at any postponed meeting other than the business specified in the notice of the original meeting. |
22.10 | When a general meeting is postponed for thirty days or more, notice of the postponed meeting shall be given as in the case of an original meeting. Otherwise it shall not be necessary to give any such notice of a postponed meeting. All proxy forms submitted for the original general meeting shall remain valid for the postponed meeting. The Directors may postpone a general meeting which has already been postponed. |
22.11 | A resolution put to the vote of the meeting shall be decided on a poll. |
22.12 | A poll shall be taken as the chairman directs, and the result of the poll shall be deemed to be the resolution of the general meeting at which the poll was demanded. |
22.13 | A poll demanded on the election of a chairman or on a question of adjournment shall be taken forthwith. A poll demanded on any other question shall be taken at such date, time and place as the chairman of the general meeting directs, and any business other than that upon which a poll has been demanded or is contingent thereon may proceed pending the taking of the poll. |
22.14 | In the case of an equality of votes the chairman shall be entitled to a second or casting vote. |
23 |
Votes of Members |
23.1 | Subject to any rights or restrictions attached to any Shares, including as set out at Article 29.4, every Member present in any such manner shall have one vote for every Share of which he is the holder. |
23.2 | In the case of joint holders the vote of the senior holder who tenders a vote, whether in person or by proxy (or, in the case of a corporation or other non-natural person, by its duly authorised representative or proxy), shall be accepted to the exclusion of the votes of the other joint holders, and seniority shall be determined by the order in which the names of the holders stand in the Register of Members. |
23.3 | A Member of unsound mind, or in respect of whom an order has been made by any court, having jurisdiction in lunacy, may vote by his committee, receiver, curator bonis, or other person on such Member’s behalf appointed by that court, and any such committee, receiver, curator bonis or other person may vote by proxy. |
23.4 | No person shall be entitled to vote at any general meeting unless he is registered as a Member on the record date for such meeting nor unless all calls or other monies then payable by him in respect of Shares have been paid. |
23.5 | No objection shall be raised as to the qualification of any voter except at the general meeting or adjourned general meeting at which the vote objected to is given or tendered and every vote not disallowed at the meeting shall be valid. Any objection made in due time in accordance with this Article shall be referred to the chairman whose decision shall be final and conclusive. |
23.6 | Votes may be cast either personally or by proxy (or in the case of a corporation or other non-natural person by its duly authorised representative or proxy). A Member may appoint more than one proxy or the same proxy under one or more instruments to attend and vote at a meeting. Where a Member appoints more than one proxy the instrument of proxy shall specify the number of Shares in respect of which each proxy is entitled to exercise the related votes. |
23.7 | A Member holding more than one Share need not cast the votes in respect of his Shares in the same way on any resolution and therefore may vote a Share or some or all such Shares either for or against a resolution and/or abstain from voting a Share or some or all of the Shares and, subject to the terms of the instrument appointing him, a proxy appointed under one or more instruments may vote a Share or some or all of the Shares in respect of which he is appointed either for or against a resolution and/or abstain from voting a Share or some or all of the Shares in respect of which he is appointed. |
24 |
Proxies |
24.1 | The instrument appointing a proxy shall be in writing and shall be executed under the hand of the appointor or of his attorney duly authorised in writing, or, if the appointor is a corporation or other non natural person, under the hand of its duly authorised representative. A proxy need not be a Member. |
24.2 | The Directors may, in the notice convening any meeting or adjourned meeting, or in an instrument of proxy sent out by the Company, specify the manner by which the instrument appointing a proxy shall be deposited and the place and the time (being not later than the time appointed for the commencement of the meeting or adjourned meeting to which the proxy relates) at which the instrument appointing a proxy shall be deposited. In the absence of any such direction from the Directors in the notice convening any meeting or adjourned meeting or in an instrument of proxy sent out by the Company, the instrument appointing a proxy shall be deposited physically at the Registered Office not less than 48 hours before the time appointed for the meeting or adjourned meeting to commence at which the person named in the instrument proposes to vote. |
24.3 | The chairman may in any event at his discretion declare that an instrument of proxy shall be deemed to have been duly deposited. An instrument of proxy that is not deposited in the manner permitted, or which has not been declared to have been duly deposited by the chairman, shall be invalid. |
24.4 | The instrument appointing a proxy may be in any usual or common form (or such other form as the Directors may approve) and may be expressed to be for a particular meeting or any adjournment thereof or generally until revoked. An instrument appointing a proxy shall be deemed to include the power to demand or join or concur in demanding a poll. |
24.5 | Votes given in accordance with the terms of an instrument of proxy shall be valid notwithstanding the previous death or insanity of the principal or revocation of the proxy or of the authority under which the proxy was executed, or the transfer of the Share in respect of which the proxy is given unless notice in writing of such death, insanity, revocation or transfer was received by the Company at the Registered Office before the commencement of the general meeting, or adjourned meeting at which it is sought to use the proxy. |
25 |
Corporate Members |
25.1 | Any corporation or other non-natural person which is a Member may in accordance with its constitutional documents, or in the absence of such provision by resolution of its directors or other governing body, authorise such person as it thinks fit to act as its representative at any meeting of the Company or of any class of Members, and the person so authorised shall be entitled to exercise the same powers on behalf of the corporation which he represents as the corporation could exercise if it were an individual Member. |
25.2 | If a Clearing House (or its nominee(s)), being a corporation, is a Member, it may authorise such persons as it sees fit to act as its representative at any meeting of the Company or at any meeting of any class of Members provided that the authorisation shall specify the number and class of Shares in respect of which each such representative is so authorised. Each person so authorised under the provisions of this Article shall be deemed to have been duly authorised without further evidence of the facts and be entitled to exercise the same rights and powers on behalf of the Clearing House (or its nominee(s)) as if such person was the registered holder of such Shares held by the Clearing House (or its nominee(s)). |
26 |
Shares that May Not be Voted |
27 |
Directors |
27.1 | There shall be a board of Directors consisting of not less than one person provided however that the Company may by Ordinary Resolution increase or reduce the limits in the number of Directors. |
27.2 | The Directors shall be divided into three classes: Class I, Class II and Class III. The number of Directors in each class shall be as nearly equal as possible. Upon the adoption of the Articles, the existing Directors shall by resolution classify themselves as Class I, Class II or Class III Directors. The Class I Directors shall stand appointed for a term expiring at the Company’s first annual general meeting, the Class II Directors shall stand appointed for a term expiring at the Company’s second annual general meeting and the Class III Directors shall stand appointed for a term expiring at the Company’s third annual general meeting. Commencing at the Company’s first annual general meeting, and at each annual general meeting thereafter, Directors appointed to succeed those Directors whose terms expire shall be appointed for a term of office to expire at the third succeeding annual general meeting after their appointment. Except as the Statute or other Applicable Law may otherwise require, in the interim between annual general meetings or extraordinary general meetings called for the appointment of Directors and/or the removal of one or more Directors and the filling of any vacancy in that connection, additional Directors and any vacancies in the board of Directors, including unfilled vacancies resulting from the removal of Directors for cause, may be filled by the vote of a majority of the remaining Directors then in office, although less than a quorum (as defined in the Articles), or by the sole remaining Director. All Directors shall hold office until the expiration of their respective terms of office and until their successors shall have been appointed and qualified. A Director appointed to fill a vacancy resulting from the death, resignation or removal of a Director shall serve for the remainder of the full term of the Director whose death, resignation or removal shall have created such vacancy and until his successor shall have been appointed and qualified. |
28 |
Powers of Directors |
28.1 | Subject to the provisions of the Statute, the Memorandum and the Articles and to any directions given by Special Resolution, the business of the Company shall be managed by the Directors who may exercise all the powers of the Company. No alteration of the Memorandum or Articles and no such direction shall invalidate any prior act of the Directors which would have been valid if that alteration had not been made or that direction had not been given. A duly convened meeting of Directors at which a quorum is present may exercise all powers exercisable by the Directors. |
28.2 | All cheques, promissory notes, drafts, bills of exchange and other negotiable or transferable instruments and all receipts for monies paid to the Company shall be signed, drawn, accepted, endorsed or otherwise executed as the case may be in such manner as the Directors shall determine by resolution. |
28.3 | The Directors on behalf of the Company may pay a gratuity or pension or allowance on retirement to any Director who has held any other salaried office or place of profit with the Company or to his widow or dependants and may make contributions to any fund and pay premiums for the purchase or provision of any such gratuity, pension or allowance. |
28.4 | The Directors may exercise all the powers of the Company to borrow money and to mortgage or charge its undertaking, property and assets (present and future) and uncalled capital or any part thereof and to issue debentures, debenture stock, mortgages, bonds and other such securities whether outright or as security for any debt, liability or obligation of the Company or of any third party. |
29 |
Appointment and Removal of Directors |
29.1 | Prior to the consummation of a Business Combination, the Company may by Ordinary Resolution of the holders of the Class B Shares appoint any person to be a Director or may by Ordinary Resolution of the holders of the Class B Shares remove any Director. For the avoidance of doubt, prior to the consummation of a Business Combination, holders of Class A Shares shall have no right to vote on the appointment or removal of any Director. |
29.2 | The Directors may appoint any person to be a Director, either to fill a vacancy or as an additional Director provided that the appointment does not cause the number of Directors to exceed any number fixed by or in accordance with the Articles as the maximum number of Directors. |
29.3 | After the consummation of a Business Combination, the Company may by Ordinary Resolution appoint any person to be a Director or may by Ordinary Resolution remove any Director. |
29.4 | Prior to the consummation of a Business Combination, Article 29.1 may only be amended by a Special Resolution passed by at least 90 per cent of such Members as, being entitled to do so, vote in person or, where proxies are allowed, by proxy at a general meeting of which notice specifying the intention to propose the resolution as a special resolution has been given, or by way of unanimous written resolution. |
30 |
Vacation of Office of Director |
(a) | the Director gives notice in writing to the Company that he resigns the office of Director; or |
(b) | the Director absents himself (for the avoidance of doubt, without being represented by proxy) from three consecutive meetings of the board of Directors without special leave of absence from the Directors, and the Directors pass a resolution that he has by reason of such absence vacated office; or |
(c) | the Director dies, becomes bankrupt or makes any arrangement or composition with his creditors generally; or |
(d) | the Director is found to be or becomes of unsound mind; or |
(e) | all of the other Directors (being not less than two in number) determine that he should be removed as a Director, either by a resolution passed by all of the other Directors at a meeting of the Directors duly convened and held in accordance with the Articles or by a resolution in writing signed by all of the other Directors. |
31 |
Proceedings of Directors |
31.1 | The quorum for the transaction of the business of the Directors may be fixed by the Directors, and unless so fixed shall be a majority of the Directors then in office. |
31.2 | Subject to the provisions of the Articles, the Directors may regulate their proceedings as they think fit. Questions arising at any meeting shall be decided by a majority of votes. In the case of an equality of votes, the chairman shall have a second or casting vote. |
31.3 | A person may participate in a meeting of the Directors or any committee of Directors by conference telephone or other communications equipment by means of which all the persons participating in the meeting can communicate with each other at the same time. Participation by a person in a meeting in this manner is treated as presence in person at that meeting. Unless otherwise determined by the Directors, the meeting shall be deemed to be held at the place where the chairman is located at the start of the meeting. |
31.4 | A resolution in writing (in one or more counterparts) signed by all the Directors or all the members of a committee of the Directors or, in the case of a resolution in writing relating to the removal of any Director or the vacation of office by any Director, all of the Directors other than the Director who is the subject of such resolution shall be as valid and effectual as if it had been passed at a meeting of the Directors, or committee of Directors as the case may be, duly convened and held. |
31.5 | A Director may, or other Officer on the direction of a Director shall, call a meeting of the Directors by at least two days’ notice in writing to every Director which notice shall set forth the general nature of the business to be considered unless notice is waived by all the Directors either at, before or after the meeting is held. To any such notice of a meeting of the Directors all the provisions of the Articles relating to the giving of notices by the Company to the Members shall apply mutatis mutandis. |
31.6 | The continuing Directors (or a sole continuing Director, as the case may be) may act notwithstanding any vacancy in their body, but if and so long as their number is reduced below the number fixed by or pursuant to the Articles as the necessary quorum of Directors the continuing Directors or Director may act for the purpose of increasing the number of Directors to be equal to such fixed number, or of summoning a general meeting of the Company, but for no other purpose. |
31.7 | The Directors may elect a chairman of their board and determine the period for which he is to hold office; but if no such chairman is elected, or if at any meeting the chairman is not present within five minutes after the time appointed for the meeting to commence, the Directors present may choose one of their number to be chairman of the meeting. |
31.8 | All acts done by any meeting of the Directors or of a committee of the Directors shall, notwithstanding that it is afterwards discovered that there was some defect in the appointment of any Director, and/or that they or any of them were disqualified, and/or had vacated their office and/or were not entitled to vote, be as valid as if every such person had been duly appointed and/or not disqualified to be a Director and/or had not vacated their office and/or had been entitled to vote, as the case may be. |
31.9 | A Director may be represented at any meetings of the board of Directors by a proxy appointed in writing by him. The proxy shall count towards the quorum and the vote of the proxy shall for all purposes be deemed to be that of the appointing Director. |
32 |
Presumption of Assent |
33 |
Directors’ Interests |
33.1 | A Director may hold any other office or place of profit under the Company (other than the office of Auditor) in conjunction with his office of Director for such period and on such terms as to remuneration and otherwise as the Directors may determine. |
33.2 | A Director may act by himself or by, through or on behalf of his firm in a professional capacity for the Company and he or his firm shall be entitled to remuneration for professional services as if he were not a Director. |
33.3 | A Director may be or become a director or other officer of or otherwise interested in any company promoted by the Company or in which the Company may be interested as a shareholder, a contracting party or otherwise, and no such Director shall be accountable to the Company for any remuneration or other benefits received by him as a director or officer of, or from his interest in, such other company. |
33.4 | No person shall be disqualified from the office of Director or prevented by such office from contracting with the Company, either as vendor, purchaser or otherwise, nor shall any such contract or any contract or transaction entered into by or on behalf of the Company in which any Director shall be in any way interested be or be liable to be avoided, nor shall any Director so contracting or being so interested be liable to account to the Company for any profit realised by or arising in connection with any such contract or transaction by reason of such Director holding office or of the fiduciary relationship thereby established. A Director shall be at liberty to vote in respect of any contract or transaction in which he is interested provided that the nature of the interest of any Director in any such contract or transaction shall be disclosed by him at or prior to its consideration and any vote thereon. |
33.5 | A general notice that a Director is a shareholder, director, officer or employee of any specified firm or company and is to be regarded as interested in any transaction with such firm or company shall be sufficient disclosure for the purposes of voting on a resolution in respect of a contract or transaction in which he has an interest, and after such general notice it shall not be necessary to give special notice relating to any particular transaction. |
34 |
Minutes |
35 |
Delegation of Directors’ Powers |
35.1 | The Directors may delegate any of their powers, authorities and discretions, including the power to sub-delegate, to any committee consisting of one or more Directors (including, without limitation, the Audit Committee, the Compensation Committee and the Nominating and Corporate Governance Committee). Any such delegation may be made subject to any conditions the Directors may impose and either collaterally with or to the exclusion of their own powers and any such delegation may be revoked or altered by the Directors. Subject to any such conditions, the proceedings of a committee of Directors shall be governed by the Articles regulating the proceedings of Directors, so far as they are capable of applying. |
35.2 | The Directors may establish any committees, local boards or agencies or appoint any person to be a manager or agent for managing the affairs of the Company and may appoint any person to be a member of such committees, local boards or agencies. Any such appointment may be made subject to any conditions the Directors may impose, and either collaterally with or to the exclusion of their own powers and any such appointment may be revoked or altered by the Directors. Subject to any such conditions, the proceedings of any such committee, local board or agency shall be governed by the Articles regulating the proceedings of Directors, so far as they are capable of applying. |
35.3 | The Directors may adopt formal written charters for committees and, if so adopted, shall review and assess the adequacy of such formal written charters on an annual basis. Each of these committees shall be empowered to do all things necessary to exercise the rights of such committee set forth in the Articles and shall have such powers as the Directors may delegate pursuant to the Articles and as required by the rules |
and regulations of the Designated Stock Exchange, the Securities and Exchange Commission and/or any other competent regulatory authority or otherwise under Applicable Law. Each of the Audit Committee, the Compensation Committee and the Nominating and Corporate Governance Committee, if established, shall consist of such number of Directors as the Directors shall from time to time determine (or such minimum number as may be required from time to time by the rules and regulations of the Designated Stock Exchange, the Securities and Exchange Commission and/or any other competent regulatory authority or otherwise under Applicable Law). For so long as any class of Shares is listed on the Designated Stock Exchange, the Audit Committee, the Compensation Committee and the Nominating and Corporate Governance Committee shall be made up of such number of Independent Directors as is required from time to time by the rules and regulations of the Designated Stock Exchange, the Securities and Exchange Commission and/or any other competent regulatory authority or otherwise under Applicable Law. |
35.4 | The Directors may by power of attorney or otherwise appoint any person to be the agent of the Company on such conditions as the Directors may determine, provided that the delegation is not to the exclusion of their own powers and may be revoked by the Directors at any time. |
35.5 | The Directors may by power of attorney or otherwise appoint any company, firm, person or body of persons, whether nominated directly or indirectly by the Directors, to be the attorney or authorised signatory of the Company for such purpose and with such powers, authorities and discretions (not exceeding those vested in or exercisable by the Directors under the Articles) and for such period and subject to such conditions as they may think fit, and any such powers of attorney or other appointment may contain such provisions for the protection and convenience of persons dealing with any such attorneys or authorised signatories as the Directors may think fit and may also authorise any such attorney or authorised signatory to delegate all or any of the powers, authorities and discretions vested in him. |
35.6 | The Directors may appoint such Officers as they consider necessary on such terms, at such remuneration and to perform such duties, and subject to such provisions as to disqualification and removal as the Directors may think fit. Unless otherwise specified in the terms of his appointment an Officer may be removed by resolution of the Directors or Members. An Officer may vacate his office at any time if he gives notice in writing to the Company that he resigns his office. |
36 |
No Minimum Shareholding |
37 |
Remuneration of Directors |
37.1 | The remuneration to be paid to the Directors, if any, shall be such remuneration as the Directors shall determine, provided that no cash remuneration shall be paid to any Director by the Company prior to the consummation of a Business Combination. The Directors shall also, whether prior to or after the consummation of a Business Combination, be entitled to be paid all travelling, hotel and other expenses properly incurred by them in connection with their attendance at meetings of Directors or committees of Directors, or general meetings of the Company, or separate meetings of the holders of any class of Shares or debentures of the Company, or otherwise in connection with the business of the Company or the discharge of their duties as a Director, or to receive a fixed allowance in respect thereof as may be determined by the Directors, or a combination partly of one such method and partly the other. |
37.2 | The Directors may by resolution approve additional remuneration to any Director for any services which in the opinion of the Directors go beyond his ordinary routine work as a Director. Any fees paid to a Director who is also counsel, attorney or solicitor to the Company, or otherwise serves it in a professional capacity shall be in addition to his remuneration as a Director. |
38 |
Seal |
38.1 | The Company may, if the Directors so determine, have a Seal. The Seal shall only be used by the authority of the Directors or of a committee of the Directors authorised by the Directors. Every instrument to which the Seal has been affixed shall be signed by at least one person who shall be either a Director or some Officer or other person appointed by the Directors for the purpose. |
38.2 | The Company may have for use in any place or places outside the Cayman Islands a duplicate Seal or Seals each of which shall be a facsimile of the common Seal of the Company and, if the Directors so determine, with the addition on its face of the name of every place where it is to be used. |
38.3 | A Director or Officer, representative or attorney of the Company may without further authority of the Directors affix the Seal over his signature alone to any document of the Company required to be authenticated by him under seal or to be filed with the Registrar of Companies in the Cayman Islands or elsewhere wheresoever. |
39 |
Dividends, Distributions and Reserve |
39.1 | Subject to the Statute and this Article and except as otherwise provided by the rights attached to any Shares, the Directors may resolve to pay Dividends and other distributions on Shares in issue and authorise payment of the Dividends or other distributions out of the funds of the Company lawfully available therefor. A Dividend shall be deemed to be an interim Dividend unless the terms of the resolution pursuant to which the Directors resolve to pay such Dividend specifically state that such Dividend shall be a final Dividend. No Dividend or other distribution shall be paid except out of the realised or unrealised profits of the Company, out of the share premium account or as otherwise permitted by law. |
39.2 | Except as otherwise provided by the rights attached to any Shares, all Dividends and other distributions shall be paid according to the par value of the Shares that a Member holds. If any Share is issued on terms providing that it shall rank for Dividend as from a particular date, that Share shall rank for Dividend accordingly. |
39.3 | The Directors may deduct from any Dividend or other distribution payable to any Member all sums of money (if any) then payable by him to the Company on account of calls or otherwise. |
39.4 | The Directors may resolve that any Dividend or other distribution be paid wholly or partly by the distribution of specific assets and in particular (but without limitation) by the distribution of shares, debentures, or securities of any other company or in any one or more of such ways and where any difficulty arises in regard to such distribution, the Directors may settle the same as they think expedient and in particular may issue fractional Shares and may fix the value for distribution of such specific assets or any part thereof and may determine that cash payments shall be made to any Members upon the basis of the value so fixed in order to adjust the rights of all Members and may vest any such specific assets in trustees in such manner as may seem expedient to the Directors. |
39.5 | Except as otherwise provided by the rights attached to any Shares, Dividends and other distributions may be paid in any currency. The Directors may determine the basis of conversion for any currency conversions that may be required and how any costs involved are to be met. |
39.6 | The Directors may, before resolving to pay any Dividend or other distribution, set aside such sums as they think proper as a reserve or reserves which shall, at the discretion of the Directors, be applicable for any purpose of the Company and pending such application may, at the discretion of the Directors, be employed in the business of the Company. |
39.7 | Any Dividend, other distribution, interest or other monies payable in cash in respect of Shares may be paid by wire transfer to the holder or by cheque or warrant sent through the post directed to the registered address of the holder or, in the case of joint holders, to the registered address of the holder who is first named on the Register of Members or to such person and to such address as such holder or joint holders |
may in writing direct. Every such cheque or warrant shall be made payable to the order of the person to whom it is sent. Any one of two or more joint holders may give effectual receipts for any Dividends, other distributions, bonuses, or other monies payable in respect of the Share held by them as joint holders. |
39.8 | No Dividend or other distribution shall bear interest against the Company. |
39.9 | Any Dividend or other distribution which cannot be paid to a Member and/or which remains unclaimed after six months from the date on which such Dividend or other distribution becomes payable may, in the discretion of the Directors, be paid into a separate account in the Company’s name, provided that the Company shall not be constituted as a trustee in respect of that account and the Dividend or other distribution shall remain as a debt due to the Member. Any Dividend or other distribution which remains unclaimed after a period of six years from the date on which such Dividend or other distribution becomes payable shall be forfeited and shall revert to the Company. |
40 |
Capitalisation |
41 |
Books of Account |
41.1 | The Directors shall cause proper books of account (including, where applicable, material underlying documentation including contracts and invoices) to be kept with respect to all sums of money received and expended by the Company and the matters in respect of which the receipt or expenditure takes place, all sales and purchases of goods by the Company and the assets and liabilities of the Company. Such books of account must be retained for a minimum period of five years from the date on which they are prepared. Proper books shall not be deemed to be kept if there are not kept such books of account as are necessary to give a true and fair view of the state of the Company’s affairs and to explain its transactions. |
41.2 | The Directors shall determine whether and to what extent and at what times and places and under what conditions or regulations the accounts and books of the Company or any of them shall be open to the inspection of Members not being Directors and no Member (not being a Director) shall have any right of inspecting any account or book or document of the Company except as conferred by Statute or authorised by the Directors or by the Company in general meeting. |
41.3 | The Directors may cause to be prepared and to be laid before the Company in general meeting profit and loss accounts, balance sheets, group accounts (if any) and such other reports and accounts as may be required by law. |
42 |
Audit |
42.1 | The Directors may appoint an Auditor of the Company who shall hold office on such terms as the Directors determine. |
42.2 | Without prejudice to the freedom of the Directors to establish any other committee, if the Shares (or depositary receipts therefor) are listed or quoted on the Designated Stock Exchange, and if required by the rules and regulations of the Designated Stock Exchange, the Securities and Exchange Commission and/or any other competent regulatory authority or otherwise under Applicable Law, the Directors shall establish and maintain an Audit Committee as a committee of the Directors and shall adopt a formal written Audit Committee charter and review and assess the adequacy of the formal written charter on an annual basis. The composition and responsibilities of the Audit Committee shall comply with the rules and regulations of the Designated Stock Exchange, the Securities and Exchange Commission and/or any other competent regulatory authority or otherwise under Applicable Law. The Audit Committee shall meet at least once every financial quarter, or more frequently as circumstances dictate. |
42.3 | If the Shares (or depositary receipts therefor) are listed or quoted on the Designated Stock Exchange, the Company shall conduct an appropriate review of all related party transactions on an ongoing basis and shall utilise the Audit Committee for the review and approval of potential conflicts of interest. |
42.4 | The remuneration of the Auditor shall be fixed by the Audit Committee (if one exists). |
42.5 | If the office of Auditor becomes vacant by resignation or death of the Auditor, or by his becoming incapable of acting by reason of illness or other disability at a time when his services are required, the Directors shall fill the vacancy and determine the remuneration of such Auditor. |
42.6 | Every Auditor of the Company shall have a right of access at all times to the books and accounts and vouchers of the Company and shall be entitled to require from the Directors and Officers such information and explanation as may be necessary for the performance of the duties of the Auditor. |
42.7 | Auditors shall, if so required by the Directors, make a report on the accounts of the Company during their tenure of office at the next annual general meeting following their appointment in the case of a company which is registered with the Registrar of Companies as an ordinary company, and at the next extraordinary general meeting following their appointment in the case of a company which is registered with the Registrar of Companies as an exempted company, and at any other time during their term of office, upon request of the Directors or any general meeting of the Members. |
42.8 | At least one member of the Audit Committee shall be an “audit committee financial expert” as determined by the rules and regulations of the Designated Stock Exchange, the Securities and Exchange Commission and/or any other competent regulatory authority or otherwise under Applicable Law. The “audit committee financial expert” shall have such past employment experience in finance or accounting, requisite professional certification in accounting, or any other comparable experience or background which results in the individual’s financial sophistication. |
43 |
Notices |
43.1 | Notices shall be in writing and may be given by the Company to any Member either personally or by sending it by courier, post, cable, telex, fax or e-mail to him or to his address as shown in the Register of Members (or where the notice is given by e-mail by sending it to the e-mail address provided by such Member). Notice may also be served by Electronic Communication in accordance with the rules and regulations of the Designated Stock Exchange, the Securities and Exchange Commission and/or any other competent regulatory authority or by placing it on the Company’s Website. |
43.2 | Where a notice is sent by: |
(a) | courier; service of the notice shall be deemed to be effected by delivery of the notice to a courier company, and shall be deemed to have been received on the third day (not including Saturdays or Sundays or public holidays) following the day on which the notice was delivered to the courier; |
(b) | post; service of the notice shall be deemed to be effected by properly addressing, pre paying and posting a letter containing the notice, and shall be deemed to have been received on the fifth day (not including Saturdays or Sundays or public holidays in the Cayman Islands) following the day on which the notice was posted; |
(c) | cable, telex or fax; service of the notice shall be deemed to be effected by properly addressing and sending such notice and shall be deemed to have been received on the same day that it was transmitted; |
(d) | e-mail or other Electronic Communication; service of the notice shall be deemed to be effected by transmitting the e-mail to the e-mail address provided by the intended recipient and shall be deemed to have been received on the same day that it was sent, and it shall not be necessary for the receipt of the e-mail to be acknowledged by the recipient; and |
(e) | placing it on the Company’s Website; service of the notice shall be deemed to have been effected one hour after the notice or document was placed on the Company’s Website. |
43.3 | A notice may be given by the Company to the person or persons which the Company has been advised are entitled to a Share or Shares in consequence of the death or bankruptcy of a Member in the same manner as other notices which are required to be given under the Articles and shall be addressed to them by name, or by the title of representatives of the deceased, or trustee of the bankrupt, or by any like description at the address supplied for that purpose by the persons claiming to be so entitled, or at the option of the Company by giving the notice in any manner in which the same might have been given if the death or bankruptcy had not occurred. |
43.4 | Notice of every general meeting shall be given in any manner authorised by the Articles to every holder of Shares carrying an entitlement to receive such notice on the record date for such meeting except that in the case of joint holders the notice shall be sufficient if given to the joint holder first named in the Register of Members and every person upon whom the ownership of a Share devolves by reason of his being a legal personal representative or a trustee in bankruptcy of a Member where the Member but for his death or bankruptcy would be entitled to receive notice of the meeting, and no other person shall be entitled to receive notices of general meetings. |
44 |
Winding Up |
44.1 | If the Company shall be wound up, the liquidator shall apply the assets of the Company in satisfaction of creditors’ claims in such manner and order as such liquidator thinks fit. Subject to the rights attaching to any Shares, in a winding up: |
(a) | if the assets available for distribution amongst the Members shall be insufficient to repay the whole of the Company’s issued share capital, such assets shall be distributed so that, as nearly as may be, the losses shall be borne by the Members in proportion to the par value of the Shares held by them; or |
(b) | if the assets available for distribution amongst the Members shall be more than sufficient to repay the whole of the Company’s issued share capital at the commencement of the winding up, the surplus shall be distributed amongst the Members in proportion to the par value of the Shares held by them at the commencement of the winding up subject to a deduction from those Shares in respect of which there are monies due, of all monies payable to the Company for unpaid calls or otherwise. |
44.2 | If the Company shall be wound up the liquidator may, subject to the rights attaching to any Shares and with the approval of a Special Resolution of the Company and any other approval required by the Statute, divide amongst the Members in kind the whole or any part of the assets of the Company (whether such assets shall consist of property of the same kind or not) and may for that purpose value any assets and determine how the division shall be carried out as between the Members or different classes of Members. The liquidator may, with the like approval, vest the whole or any part of such assets in trustees upon such trusts for the benefit of the Members as the liquidator, with the like approval, shall think fit, but so that no Member shall be compelled to accept any asset upon which there is a liability. |
45 |
Indemnity and Insurance |
45.1 | Every Director and Officer (which for the avoidance of doubt, shall not include auditors of the Company), together with every former Director and former Officer (each an “ Indemnified Person |
45.2 | The Company shall advance to each Indemnified Person reasonable attorneys’ fees and other costs and expenses incurred in connection with the defence of any action, suit, proceeding or investigation involving such Indemnified Person for which indemnity will or could be sought. In connection with any advance of any expenses hereunder, the Indemnified Person shall execute an undertaking to repay the advanced amount to the Company if it shall be determined by final judgment or other final adjudication that such Indemnified Person was not entitled to indemnification pursuant to this Article. If it shall be determined by a final judgment or other final adjudication that such Indemnified Person was not entitled to indemnification with respect to such judgment, costs or expenses, then such party shall not be indemnified with respect to such judgment, costs or expenses and any advancement shall be returned to the Company (without interest) by the Indemnified Person. |
45.3 | The Directors, on behalf of the Company, may purchase and maintain insurance for the benefit of any Director or Officer against any liability which, by virtue of any rule of law, would otherwise attach to such person in respect of any negligence, default, breach of duty or breach of trust of which such person may be guilty in relation to the Company. |
46 |
Financial Year |
47 |
Transfer by Way of Continuation |
48 |
Mergers and Consolidations |
49 |
Business Combination |
49.1 | Notwithstanding any other provision of the Articles, this Article shall apply during the period commencing upon the adoption of the Articles and terminating upon the first to occur of the consummation of a Business Combination and the full distribution of the Trust Account pursuant to this Article. In the event of a conflict between this Article and any other Articles, the provisions of this Article shall prevail. |
49.2 | Prior to the consummation of a Business Combination, the Company shall either: |
(a) | submit such Business Combination to its Members for approval; or |
(b) | provide Members with the opportunity to have their Shares repurchased by means of a tender offer for a per-Share repurchase price payable in cash, equal to the aggregate amount then on deposit in the Trust Account, calculated as of two business days prior to the consummation of such Business Combination, including interest earned on the Trust Account (net of taxes paid or payable, if any), divided by the number of then issued Public Shares, provided that the Company shall not repurchase Public Shares in an amount that would cause the Company’s net tangible assets to be less than US$5,000,001 upon consummation of such Business Combination. |
49.3 | If the Company initiates any tender offer in accordance with Rule 13e-4 and Regulation 14E of the Exchange Act in connection with a proposed Business Combination, it shall file tender offer documents with the Securities and Exchange Commission prior to completing such Business Combination which contain substantially the same financial and other information about such Business Combination and the redemption rights as is required under Regulation 14A of the Exchange Act. If, alternatively, the Company holds a general meeting to approve a proposed Business Combination, the Company will conduct any redemptions in conjunction with a proxy solicitation pursuant to Regulation 14A of the Exchange Act, and not pursuant to the tender offer rules, and file proxy materials with the Securities and Exchange Commission. |
49.4 | At a general meeting called for the purposes of approving a Business Combination pursuant to this Article, in the event that such Business Combination is approved by Ordinary Resolution, the Company shall be authorised to consummate such Business Combination, provided that the Company shall not consummate such Business Combination unless the Company has net tangible assets of at least US$5,000,001 immediately prior to, or upon such consummation of, or any greater net tangible asset or cash requirement that may be contained in the agreement relating to, such Business Combination. |
49.5 | Any Member holding Public Shares who is not the Sponsor, a Founder, Officer or Director may, at least two business days’ prior to any vote on a Business Combination, elect to have their Public Shares redeemed for cash, in accordance with any applicable requirements provided for in the related proxy materials (the “ IPO Redemption per-Share redemption price payable in cash, equal to the aggregate amount then on deposit in the Trust Account calculated as of two business days prior to the consummation of the Business Combination, including interest earned on the Trust Account (such interest shall be net of taxes payable) and not previously released to the Company to pay its taxes, divided by the number of then issued Public Shares (such redemption price being referred to herein as the “Redemption Price Redemption Limitation |
49.6 | A Member may not withdraw a Redemption Notice once submitted to the Company unless the Directors determine (in their sole discretion) to permit the withdrawal of such redemption request (which they may do in whole or in part). |
49.7 | In the event that the Company does not consummate a Business Combination within 24 months from the consummation of the IPO, or such later time as the Members may approve in accordance with the Articles, the Company shall: |
(a) | cease all operations except for the purpose of winding up; |
(b) | as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-Share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to the Company (less taxes payable and up to US$100,000 of interest to pay dissolution expenses), divided by the number of then Public Shares in issue, which redemption will completely extinguish public Members’ rights as Members (including the right to receive further liquidation distributions, if any); and |
(c) | as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining Members and the Directors, liquidate and dissolve, |
49.8 | In the event that any amendment is made to the Articles: |
(a) | to modify the substance or timing of the Company’s obligation to allow redemption in connection with a Business Combination or redeem 100 per cent of the Public Shares if the Company does not consummate a Business Combination within 24 months from the consummation of the IPO, or such later time as the Members may approve in accordance with the Articles; or |
(b) | with respect to any other provision relating to Members’ rights or pre-Business Combination activity, |
49.9 | A holder of Public Shares shall be entitled to receive distributions from the Trust Account only in the event of an IPO Redemption, a repurchase of Shares by means of a tender offer pursuant to this Article, or a distribution of the Trust Account pursuant to this Article. In no other circumstance shall a holder of Public Shares have any right or interest of any kind in the Trust Account. |
49.10 | After the issue of Public Shares, and prior to the consummation of a Business Combination, the Company shall not issue additional Shares or any other securities that would entitle the holders thereof to: |
(a) | receive funds from the Trust Account; or |
(b) | vote as a class with Public Shares on a Business Combination. |
49.11 | A Director may vote in respect of a Business Combination in which such Director has a conflict of interest with respect to the evaluation of such Business Combination. Such Director must disclose such interest or conflict to the other Directors. |
49.12 | As long as the securities of the Company are listed on the New York Stock Exchange, the Company must complete one or more Business Combinations having an aggregate fair market value of at least 80 per cent of the assets held in the Trust Account (excluding the deferred underwriting commissions and taxes payable on the income earned on the Trust Account) at the time of the Company’s signing a definitive agreement in connection with a Business Combination. A Business Combination must not be effectuated with another blank cheque company or a similar company with nominal operations. |
49.13 | The Company may enter into a Business Combination with a target business that is Affiliated with the Sponsor, a Founder, a Director or an Officer. In the event the Company seeks to consummate a Business Combination with a target that is Affiliated with the Sponsor, a Founder, a Director or an Officer, the Company, or a committee of Independent Directors, will obtain an opinion from an independent investment banking firm or another valuation or appraisal firm that regularly renders fairness opinions on the type of target business the Company is seeking to acquire that is a member of the United States Financial Industry Regulatory Authority or an independent accounting firm that such a Business Combination is fair to the Company from a financial point of view. |
50 |
Certain Tax Filings |
51 |
Business Opportunities |
51.1 | To the fullest extent permitted by Applicable Law, no individual serving as a Director or an Officer (“ Management |
51.2 | Except as provided elsewhere in this Article, the Company hereby renounces any interest or expectancy of the Company in, or in being offered an opportunity to participate in, any potential transaction or matter which may be a corporate opportunity for both the Company and Management, about which a Director and/or Officer who is also a member of Management acquires knowledge. |
51.3 | To the extent a court might hold that the conduct of any activity related to a corporate opportunity that is renounced in this Article to be a breach of duty to the Company or its Members, the Company hereby waives, to the fullest extent permitted by Applicable Law, any and all claims and causes of action that the Company may have for such activities. To the fullest extent permitted by Applicable Law, the provisions of this Article apply equally to activities conducted in the future and that have been conducted in the past. |
[Newco] | ||
By: | |
Name: | ||
Title: |
VGII: |
VIRGIN GROUP ACQUISITION CORP. II | |||
By: | /s/ Evan Lovell | |||
Name: Evan Lovell | ||||
Title: Chief Financial Officer | ||||
CREDIT SUISSE: |
CREDIT SUISSE SECURITIES (USA) LLC | |||
By: | /s/ Ryan Kelley | |||
Name: Ryan Kelley | ||||
Title: Director | ||||
Acting on behalf of itself and as the representative of the several Underwriters | ||||
SPONSOR: |
VIRGIN GROUP ACQUISITION SPONSOR II LLC | |||
By: | Corvina Holdings Limited, its manager | |||
By: | /s/ Kerry Graziola | |||
Name: Kerry Graziola | ||||
Title: Alternate Director | ||||
INSIDERS: |
/s/ Rayhan Arif | |||
RAYHAN ARIF, individual | ||||
/s/ Chris Burggraeve | ||||
CHRIS BURGGRAEVE, individually | ||||
/s/ Latif Peracha | ||||
LATIF PERACHA, individually | ||||
/s/ Elizabeth Nelson | ||||
ELIZABETH NELSON, individually | ||||
/s/ Evan Lovell | ||||
EVAN LOVELL, individually | ||||
/s/ Josh Bayliss | ||||
JOSH BAYLISS, individually |
GROVE COLLABORATIVE, INC. | ||
By: | /s/ Stuart Landesberg | |
Name: Stuart Landesberg | ||
Title: Chief Executive Officer |
Name |
Number of Class A Shares Currently Held |
Number of Class A Shares Issuable Upon exercise of Warrants Currently Held |
Number of Class B Shares Currently Held |
Number of Earn-Out Shares |
||||||||||||
Sponsor : |
||||||||||||||||
Virgin Group Acquisition Sponsor II LLC |
— | 6,700,000 | 9,972,500 | 3,490,375 | ||||||||||||
Insiders : |
||||||||||||||||
Rayhan Arif |
— | — | — | |||||||||||||
Josh Bayliss |
— | — | — | |||||||||||||
Chris Burggraeve |
— | — | 30,000 | |||||||||||||
Evan Lovell |
— | — | — | |||||||||||||
Elizabeth Nelson |
— | — | 30,000 | |||||||||||||
Latif Peracha |
— | — | 30,000 | |||||||||||||
Holders : |
||||||||||||||||
Virgin Group Acquisition Sponsor II LLC |
See “Sponsor” above |
VIRGIN GROUP ACQUISITION CORP. II |
By: |
Name: |
Title: |
Signature of Subscriber: | Signature of Joint Subscriber, if applicable: | |
By: |
By: | |
Name: | Name: | |
Title: | Title: |
Name of Subscriber: | Name of Joint Subscriber, if applicable: | |
(Please print. Please indicate name and | (Please print. Please indicate name and | |
Capacity of person signing above) | Capacity of person signing above) | |
Name in which securities are to be registered |
||
(if different from the name of Subscriber listed directly above): |
Subscriber’s EIN: |
Joint Subscriber’s EIN: |
Business Address-Street: | Mailing Address-Street (if different): | |
City, State, Zip: | City, State, Zip: | |
Attn: | Attn: | |
Telephone No.: |
Telephone No.: | |
Facsimile No.: |
Facsimile No.: |
A. | QUALIFIED INSTITUTIONAL BUYER STATUS |
1. | ☐ We are a “qualified institutional buyer” (as defined in Rule 144A under the Securities Act of 1933, as amended (the “ Securities Act ”) (a “QIB |
2. | ☐ We are subscribing for the Subscribed Shares as a fiduciary or agent for one or more investor accounts, and each owner of such account is a QIB. |
B. | INSTITUTIONAL ACCREDITED INVESTOR STATUS (Please check the applicable subparagraphs): |
1. | ☐ We are an “accredited investor” (within the meaning of Rule 501(a) under the Securities Act) or an entity in which all of the equity holders are accredited investors within the meaning of Rule 501(a) under the Securities Act, and have marked and initialed the appropriate box on the following page indicating the provision under which we qualify as an “accredited investor.” |
2. | ☐ We are not a natural person. |
C. | AFFILIATE STATUS |
☐ | is: |
☐ | is not: |
☐ | Any bank as defined in section 3(a)(2) of the Securities Act, or any savings and loan association or other institution as defined in section 3(a)(5)(A) of the Securities Act whether acting in its individual or fiduciary capacity; |
☐ | Any broker or dealer registered pursuant to section 15 of the Securities Exchange Act of 1934, as amended; |
☐ | Any insurance company as defined in section 2(a)(13) of the Securities Act; |
☐ | Any investment company registered under the Investment Company Act of 1940, as amended (the “ Investment Company Act ”) or a business development company as defined in section 2(a)(48) of the Investment Company Act; |
☐ | Any Small Business Investment Company licensed by the U.S. Small Business Administration under section 301(c) or (d) of the Small Business Investment Act of 1958, as amended; |
☐ | Any plan established and maintained by a state, its political subdivisions, or any agency or instrumentality of a state or its political subdivisions, for the benefit of its employees, if such plan has total assets in excess of $5,000,000; |
☐ | Any employee benefit plan within the meaning of the Employee Retirement Income Security Act of 1974, as amended (“ ERISA |
☐ | Any private business development company as defined in section 202(a)(22) of the Investment Advisers Act of 1940, as amended; |
☐ | Any (i) corporation, limited liability company or partnership, (ii) Massachusetts or similar business trust, or (iii) organization described in section 501(c)(3) of the Internal Revenue Code of 1986, as amended, not formed for the specific purpose of acquiring the securities offered, and with total assets in excess of $5,000,000; |
☐ | Any director, executive officer, or general partner of the issuer of the securities being offered or sold, or any director, executive officer, or general partner of a general partner of that issuer; |
☐ | Any natural person whose individual net worth, or joint net worth with that person’s spouse, exceeds $1,000,000. For purposes of calculating a natural person’s net worth: (a) the person’s primary residence shall not be included as an asset; (b) indebtedness that is secured by the person’s primary residence, up to the estimated fair market value of the primary residence at the time of the sale of securities, shall not be included as a liability (except that if the amount of such indebtedness outstanding at the time of sale of securities exceeds the amount outstanding sixty (60) days before such time, other than as a result of the acquisition of the primary residence, the amount of such excess shall be included as a liability); and (c) indebtedness that is secured by the person’s primary residence in excess of the estimated fair market value of the primary residence at the time of the sale of securities shall be included as a liability; |
☐ | Any natural person who had an individual income in excess of $200,000 in each of the two most recent years or joint income with that person’s spouse in excess of $300,000 in each of those years and has a reasonable expectation of reaching the same income level in the current year; |
☐ | Any trust, with total assets in excess of $5,000,000, not formed for the specific purpose of acquiring the securities offered, whose purchase is directed by a sophisticated person as described in Section 230.506(b)(2)(ii) of Regulation D; |
☐ | Any entity in which all of the equity owners are “accredited investors”; |
☐ | Any natural person holding in good standing one or more professional certifications or designations or credentials from an accredited educational institution that the SEC has designated as qualifying an individual for accredited investor status, such as a General Securities Representative license (Series 7), a Private Securities Offerings Representative license (Series 82) and an Investment Adviser Representative license (Series 65); |
☐ | Any “family office” as defined in Rule 202(a)(11)(G)-1 under the Investment Advisers Act of 1940 which was not formed for the purpose of investing in the Issuer, has assets under management in excess of $5,000,000 and whose prospective investment is directed by a person who has such knowledge and experience in financial and business matters that such family office is capable of evaluating the merits and risks of the prospective investment; or |
☐ | Any “family client,” as defined in rule 202(a)(11)(G)-1 under the Investment Advisers Act of 1940, of a family office, whose prospective investment in the Issuer is directed by such family office, and such family office is one (i) with assets under management in excess of $5,000,000, (ii) that was not formed for the specific purpose of investing in the Issuer , and (iii) whose prospective investment in the Issuer is directed by a person who has such knowledge and experience in financial and business matters that such family office is capable of evaluating the merits and risks of such prospective investment. |
Page |
||||||
SECTION 1. |
G-1 | |||||
SECTION 2. |
G-5 | |||||
2.1. |
G-5 | |||||
2.2. |
G-8 | |||||
2.3. |
G-9 | |||||
2.4. |
G-11 | |||||
2.5. |
G-16 | |||||
2.6. |
G-16 | |||||
2.7. |
G-17 | |||||
2.8. |
G-17 | |||||
2.9. |
G-17 | |||||
2.10. |
G-20 | |||||
SECTION 3. |
G-20 | |||||
3.1. |
G-20 | |||||
3.2. |
G-21 | |||||
SECTION 4. |
G-21 | |||||
4.1. |
G-21 | |||||
4.2. |
G-21 | |||||
4.3. |
G-21 | |||||
4.4. |
G-22 | |||||
4.5. |
G-22 | |||||
4.6. |
G-22 | |||||
4.7. |
G-22 | |||||
4.8. |
G-23 | |||||
4.9. |
G-23 | |||||
4.10. |
G-23 | |||||
4.11. |
G-23 | |||||
4.12. |
G-23 | |||||
4.13. |
G-24 | |||||
4.14. |
G-24 | |||||
4.15. |
G-24 | |||||
4.16. |
G-24 | |||||
4.17. |
G-25 | |||||
Exhibit A |
Joinder Agreement | G-28 |
THE COMPANY : | ||
Grove Collaborative, Inc., a Delaware public benefit corporation | ||
By: | | |
Name: | ||
Title: |
HOLDERS | ||
Virgin Group Acquisition Sponsor II LLC, | ||
a Cayman Islands limited liability company | ||
By: | | |
Name: | ||
Title: | ||
[OTHER HOLDERS] |
[TRANSFERRING HOLDER] | ||
[ ] | ||
By: | | |
Name: | ||
Title: | ||
NEW HOLDER | ||
[ ] | ||
By: | | |
Name: | ||
Title: | ||
Notice Address: [ ] | ||
[ ] | ||
[ ] | ||
Attn: [ ] | ||
Facsimile: | [ ] |
Accepted and Agreed to as of | ||||
the date first written above: | ||||
COMPANY |
||||
Grove Collaborative, Inc. |
By: | | |||
Name: | ||||
Title: |
PARENT: | ||
VIRGIN GROUP ACQUISITION CORP. II | ||
Name: | | |
By: | | |
Title: | |
COMPANY: | ||
GROVE COLLABORATIVE, INC. | ||
Name: | | |
By: | | |
Title: | |
[INDIVIDUAL/ENTITY] | ||
By: | | |
[Signature] | ||
Name: | | |
[Print Name of Signatory] | ||
Title: | | |
[Print Title of Signatory] |
Name | Address | Voting Interests | ||||||
[ ] |
||||||||
[ ] |
||||||||
[ ] |
||||||||
[ ] |
||||||||
[ ] |
||||||||
[ ] |
||||||||
[ ] |
||||||||
[ ] |
||||||||
[ ] |
(1) | require that (i) some or all outstanding options and SARs shall become exercisable in full or in part, either immediately or upon a subsequent termination of employment, (ii) the Restriction Period applicable to some or all outstanding Stock Awards shall lapse in full or in part, either immediately or upon a subsequent termination of employment, (iii) the Performance Period applicable to some or all outstanding awards shall lapse in full or in part, and (iv) the Performance Measures applicable to some or all outstanding awards shall be deemed to be satisfied at the target, maximum or any other level, in each case, on such terms and conditions and at such time or times as the Committee shall determine; |
(2) | require that any outstanding award shall be assumed or continued or that shares of capital stock of the corporation resulting from or succeeding to the business of the Company pursuant to such Change in Control (or a parent corporation thereof) or other property be substituted for some or all of the Shares subject to an outstanding award, with an appropriate and equitable adjustment to such award as determined by the Board in accordance with Section 5.7 ; and/or |
(3) | require outstanding awards, in whole or in part, to be surrendered to the Company by the holder, and to be immediately cancelled by the Company, and to provide for the holder to receive (i) a cash payment in an amount equal to (A) in the case of an option or a SAR, the aggregate number of |
Shares then subject to the portion of such option or SAR surrendered, whether or not vested or exercisable, multiplied by the excess, if any, of the Fair Market Value of a Share as of the date of the Change in Control, over the purchase price or base price per Share subject to such option or SAR, (B) in the case of a Stock Award or a Performance Award denominated in Shares, the number of Shares then subject to the portion of such award surrendered to the extent the Performance Measures applicable to such award have been satisfied or are deemed satisfied pursuant to Section 5.8(a)(1) , whether or not vested, multiplied by the Fair Market Value of a Share as of the date of the Change in Control, and (C) in the case of a Performance Award denominated in cash, the value of the Performance Award then subject to the portion of such award surrendered to the extent the Performance Measures applicable to such award have been satisfied or are deemed satisfied pursuant to Section 5.8(a)(1) ; (ii) shares of capital stock of the corporation resulting from or succeeding to the business of the Company pursuant to such Change in Control (or a parent corporation thereof) or other property, having a fair market value not less than the amount determined under clause (i) above; or (iii) a combination of the payment of cash pursuant to clause (i) above and the issuance of shares or other property pursuant to clause (ii) above, in each case, on such payment and other terms and conditions (which need not be the same as the terms and conditions applicable to holders of Shares generally) as the Committee determines. For the avoidance of doubt, if the per share purchase price, exercise price, or base price of an award or portion thereof is equal to or greater than the fair market value of one Share, such award or portion may be cancelled with no payment due hereunder or otherwise in respect thereof. |
(1) | any Exchange Act Person becomes the Owner, directly or indirectly, of securities of the Company representing more than 50% of the combined voting power of the Company’s then outstanding securities other than by virtue of a merger, consolidation or similar transaction. Notwithstanding the foregoing, a Change in Control will not be deemed to occur (A) on account of the acquisition of securities of the Company directly from the Company, (B) on account of the acquisition of securities of the Company by an investor, any affiliate thereof or any other Exchange Act Person that acquires the Company’s securities in a transaction or series of related transactions the primary purpose of which is to obtain financing for the Company through the issuance of equity securities or (C) solely because the level of Ownership held by any Exchange Act Person (the “ Subject Person ”) exceeds the designated percentage threshold of the outstanding voting securities as a result of a repurchase or other acquisition of voting securities by the Company reducing the number of shares outstanding, provided that if a Change in Control would occur (but for the operation of this sentence) as a result of the acquisition of voting securities by the Company, and after such share acquisition, the Subject Person becomes the Owner of any additional voting securities that, assuming the repurchase or other acquisition had not occurred, increases the percentage of the then outstanding voting securities Owned by the Subject Person over the designated percentage threshold, then a Change in Control shall be deemed to occur; |
(2) | there is consummated a merger, consolidation or similar transaction involving (directly or indirectly) the Company and, immediately after the consummation of such merger, consolidation or similar transaction, the stockholders of the Company immediately prior thereto do not Own, directly or indirectly, either (A) outstanding voting securities representing more than 50% of the combined outstanding voting power of the surviving entity in such merger, consolidation or similar transaction or (B) more than 50% of the combined outstanding voting power of the parent of the surviving entity in such merger, consolidation or similar transaction, in each case in substantially the same proportions as their Ownership of the outstanding voting securities of the Company immediately prior to such transaction; |
(3) | there is consummated a sale, lease, exclusive license or other disposition of all or substantially all of the consolidated assets of the Company and its Subsidiaries, other than a sale, lease, license or other disposition of all or substantially all of the consolidated assets of the Company and its Subsidiaries to an entity, more than 50% of the combined voting power of the voting securities of which are Owned by stockholders of the Company in substantially the same proportions as their Ownership of the outstanding voting securities of the Company immediately prior to such sale, lease, license or other disposition; or |
(4) | during any twenty-four (24) month period, individuals who, as of the beginning of such period, constitute the Board (the “ Incumbent Directors ”) cease for any reason to constitute at least a majority of the Board, provided that any person becoming a director subsequent to the beginning of such period whose election or nomination for election was approved by a vote of at least a majority of the Incumbent Directors then on the Board (either by a specific vote or by approval of the proxy statement of the Company in which such person is named as a nominee for director, without written objection to such nomination) shall be an Incumbent Director; provided , however , that no individual initially elected or nominated as a director of the Company as a result of an actual or threatened election contest with respect to directors or as a result of any other actual or threatened solicitation of proxies by or on behalf of any person other than the Board shall be deemed to be an Incumbent Director. |
1. | reviewed a draft, dated December 5, 2021, of the Agreement; |
2. | reviewed certain publicly available business and financial information relating to Parent and the Company that we deemed to be relevant; |
3. | reviewed certain information relating to the historical, current and future operations, financial condition and prospects of the Company made available to us by the Company and Parent, including financial projections prepared by the management of the Company relating to the Company (the “Projections”); |
4. | spoken with certain members of the managements of Parent and the Company and certain of their respective representatives and advisors regarding the business, operations, financial condition and prospects of the Company, the Transaction and related matters; |
5. | compared the financial and operating performance of the Company with that of companies with publicly traded equity securities that we deemed to be relevant; and |
6. | conducted such other financial studies, analyses and inquiries and considered such other information and factors as we deemed appropriate. |
* | To be filed by amendment. |
+ | Indicates management contract or compensatory plan or arrangement. |
† | Schedules and exhibits to this Exhibit omitted pursuant to Regulation S-K Item 601(b)(2). The Registrant agrees to furnish supplementally a copy of any omitted schedule of exhibit to the SEC upon request. |
†† | The Registrant has redacted provisions or terms of this Exhibit pursuant to Regulation S-K Item 601(b)(10)(iv). The Registrant agrees to furnish an unredacted copy of the Exhibit to the SEC upon its request. |
11. | The undersigned Registrant hereby undertakes: |
(a) | To file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement: |
(i) | To include any prospectus required by section 10(a)(3) of the Securities Act; |
(ii) | To reflect in the prospectus any facts or events arising after the effective date of this Registration Statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in this Registration Statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than 20% change in the maximum aggregate offering price set forth in the “Calculation of Registration Fee” table in the effective registration statement; and |
(iii) | To include any material information with respect to the plan of distribution not previously disclosed in this Registration Statement or any material change to such information in this Registration Statement. |
(b) | That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment that contains a form of prospectus shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. |
(c) | To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering. |
(d) | That, for the purpose of determining liability under the Securities Act to any purchaser, each prospectus filed pursuant to Rule 424(b) as part of a registration statement relating to an offering, other than registration statements relying on Rule 430B or other than prospectuses filed in reliance on Rule 430A, shall be deemed to be part of and included in the registration statement as of the date it is first used after effectiveness. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such first use, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such date of first use. |
(e) | That, for the purpose of determining liability of the registrant under the Securities Act to any purchaser in the initial distribution of the securities, the undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, |
(i) | Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424; |
(ii) | Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant; |
(iii) | The portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant or its securities provided by or on behalf of the undersigned registrant; and |
(iv) | Any other communication that is an offer in the offering made by the undersigned registrant to the purchaser. |
12. | Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by them is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue. |
13. | The undersigned registrant hereby undertakes as follows: that prior to any public reoffering of the securities registered hereunder through use of a prospectus which is a part of this registration statement, by any person or party who is deemed to be an underwriter within the meaning of Rule 145(c), the issuer undertakes that such reoffering prospectus will contain the information called for by the applicable registration form with respect to reofferings by persons who may be deemed underwriters, in addition to the information called for by the other items of the applicable form. |
14. | The registrant undertakes that every prospectus: (1) that is filed pursuant to the immediately preceding paragraph, or (2) that purports to meet the requirements of Section 10(a)(3) of the Securities Act and is used in connection with an offering of securities subject to Rule 415, will be filed as a part of an amendment to the registration statement and will not be used until such amendment is effective, and that, for purposes of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. |
15. | The undersigned Registrant hereby undertakes to respond to requests for information that is incorporated by reference into the prospectus pursuant to Items 4, 10(b), 11, or 13 of this Form S-4, within one business day of receipt of such request, and to send the incorporated documents by first class mail or other equally prompt means. This includes information contained in documents filed subsequent to the effective date of the Registration Statement through the date of responding to the request. |
16. | The undersigned Registrant hereby undertakes to supply by means of a post-effective amendment all information concerning a transaction, and the company being acquired involved therein, that was not the subject of and included in the Registration Statement when it became effective. |
VIRGIN GROUP ACQUISITION CORP. II | ||||
By: | /s/ Josh Bayliss | |||
Name: | Josh Bayliss | |||
Title: | Chief Executive Officer |
NAME |
POSITION |
DATE | ||
/s/ Josh Bayliss Josh Bayliss |
Chief Executive Officer and Director (Principal Executive Officer) |
January 14, 2022 | ||
/s/ Evan Lovell Evan Lovell |
Chief Financial Officer and Director (Principal Financial and Accounting Officer) |
January 14, 2022 | ||
/s/ Latif Peracha Latif Peracha |
Director | January 14, 2022 | ||
/s/ Elizabeth Nelson Elizabeth Nelson |
Director | January 14, 2022 | ||
/s/ Chris Burggraeve Chris Burggraeve |
Director | January 14, 2022 |